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Abstract 
Background 
In modern neurological physiotherapy practice, a patient’s neuroplasticity is harnessed, 
teaching them to develop motor control at ‘impairment’ level. Consequently, the patient 
relearns ‘normal’ movement, which in turn enables them to gain more efficient function 
and independence that has significant impact on their ‘life’. However, there are no 
outcome measures that capture the patient’s quality of movement, or the specific effects 
of physiotherapy intervention. 
Such an outcome measure, the Leeds Movement Performance Index, was developed to 
fill this gap. It was hypothesised to be a valid, reliable and clinically useful tool. 
Methods 
A multi-centre, three-part, mixed-methods study was undertaken with three groups of 
neurological physiotherapists (n=34) and patients with neurological diagnoses (n=42). A 
range of quantitative and qualitative methods were used: Consensus methods to develop 
the new outcome measure; psychometric tests to examine reliability and validity against 
existing outcome measures in the field; focus groups, face-to-face interviews and 
reflective writing to further explore clinical utility.  
Results  
The Leeds Movement Performance Index was shown to be a tool with strong 
measurement properties i.e.: internal consistency (Chronbach’s, overall scale=0.862), 
inter-rater reliability (ICC=0.959); test-re-test reliability (rho=0.792); and criterion 
validity compared with the Berg Balance Scale (rho=0.468, SD±2).  Thematic analysis 
demonstrated robust content validity and clinical utility.  Furthermore, it un-expectedly 
revealed that the Leeds Movement Performance Index also supported fundamental 
aspects of neurological physiotherapy clinical practice, including assessment, analysis 
and clinical reasoning, and potential usefulness as an education aid. 
Conclusion 
The Leeds Movement Performance Index makes an important and novel contribution to 
the field of neurological physiotherapy, both clinically and within research practice.  It is 
the first outcome measure to conceptually map the nature and definition of quality of 
movement for patients with motor impairment, and it captures the impact of 
neurological physiotherapy intervention more responsively compared with other outcome 
measures routinely used within the field. 
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An overview of the thesis 
The focus of this thesis lies within the field of neurological physiotherapy.  The senior 
clinicians within this specialism work with patients who have complex movement 
difficulties, and deliver equally complex interventions that are necessarily individualised 
according to each person’s impairment and functional need. 
Within the author’s workplace, a gradual iterative process of senior neurological 
physiotherapist’s reasoning resulted in the deduction that there is a clinical need to be 
able to measure a patient at impairment level.  An outcome measure is needed that is 
sensitive and specific enough to reflect small amounts of change in control of movement.   
According to the World Health Organisation’s Classification of Function, Disability and 
Health (WHO 2001) (figure [i] page 34); specific neurological physiotherapy intervention 
‘sits’ within the impairment domain, and has impact on the patient’s function and 
interaction with ‘life’.   Available outcome measures within this field tend to sit within the 
‘function’ domain and measure movement, but not how ‘well’ the patient can move, i.e. 
the quality of their movement. 
The clinicians feel that there are no outcome measures that can meet their clinical 
demand; that reflect their therapeutic approach, and are supportive of the knowledge 
that underpins this approach.  Furthermore, the ability to be able to measure the quality 
of their patient’s movement is considered to be necessary both at base-line and post 
intervention.   
This thesis describes the development of a new outcome measure that is intended to 
meet a clinical demand within neurological physiotherapy.  That is, a tool that can reflect 
specific intervention to improve the quality of a patient’s motor control.  The aim of the 
research is to develop a suitable outcome measure, then to establish its reliability, 
validity and clinical utility within neurological physiotherapy.  The thesis is structured to 
set out the several stages involved in the research, and is summarised below: 
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Chapter 1(Background) 
This chapter sets the context of modern neurological physiotherapy practice within the 
healthcare arena, providing an overview of the relevant empirical knowledge.  The 
history and theories of motor control and neuroplasticity are presented along with how 
this knowledge is related to the concept of ‘normal movement’, the analysis of 
movement and movement quality.   
 
Chapter 2, (Outcome measures, set in the context of neurological 
physiotherapy)  
This chapter places the use of outcome measures into the context of physiotherapy 
practice, presenting: the importance of using outcome measures, the significance of 
their robust measurement properties, how outcome measures are developed, and some 
of the difficulties found by physiotherapists when using them within their practice.  
 
Chapter 3 (Literature review)  
The aim of this chapter is to review the available outcome measures that could meet the 
needs of neurological physiotherapists (as described within Chapters 1 and 2).  Firstly, a 
narrative review of the literature presents the number of available outcome measures 
within the field.  Secondly, these outcome measures are reviewed using criteria drawn 
from Chapters 1 and 2, and, the three most appropriate outcome measures; the Berg 
Balance Scale (Berg et al 1989), the Trunk Impairment Scale (Verheyden et al 2004) 
and Goal Attainment Scaling (Kiresuk & Sherman 1968), are critically analysed to assess 
their suitability. The results of this review helped to inform the development of a new 
outcome measure.   
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Chapter 4 (Research design and methodology)  
This chapter presents the two research questions that direct both the methodology and 
research design used within this thesis. That is: -  
1. Can a tool be developed that is able to measure movement quality according to 
the needs of neurological physiotherapists? 
2. Is the newly developed tool reliable, valid and functional within modern 
neurological physiotherapy clinical practice? 
To answer these questions, a mixed methods approach is used, and three sequential 
studies are conducted.   
Three groups of neurological physiotherapists are introduced: The Physiotherapist 
Research Group, the Senior Physiotherapist Participants Group, and the Expert 
Physiotherapists Group.  The knowledge of these Physiotherapists is utilised to guide and 
examine the conceptualisation and subsequent testing of the measurement properties 
and clinical utility of the LMPI.   
 
Chapters 5, 6, 7, 8, 9 and 10 present the methods and results of the three studies in a 
sequential manner. 
 
Chapter 5 (Study 1) 
In this chapter, the conceptualisation, development and initial testing of a new outcome 
measure (the Leeds Movement Performance Index (LMPI)), are described. 
 
Chapter 6 (the results of Study 1) 
In this chapter, the results of Study 1 are presented, along with a definition of 
movement quality derived from the Physiotherapist Research Group. 
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Chapter 7 (Study 2) 
In this chapter, the quantitative methods used to test the measurement properties of the 
LMPI are described.   
 
Chapter 8 (the results of Study 2) 
The measurement properties of the LMPI are presented, along with demographic data 
from patient participants and the Senior Physiotherapist Participants Group. 
 
Chapter 9 (Study 3)  
In this chapter, the qualitative methods used to examine the clinical utility, face and 
content validity of the LMPI are described; and conducted with the Senior 
Physiotherapist and Expert Physiotherapist Groups.  
 
Chapter 10 (the results of Study3) 
In this chapter, the results of study 3 are presented.   
 
Chapter 11 (Discussion)  
This chapter summarises the research and the results found; critically evaluating the 
strengths, unexpected findings, limitations of the research and recommendations for 
taking this work forwards.   It is concluded that the LMPI has potential to be used as 
both a clinical support and educational tool. 
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Chapter 1 Background 
1.1 Neurological Physiotherapy 
Physiotherapists work in a variety of different streams, i.e. Health, Higher Education, and 
Research; and in a diversity of clinical settings, ranging from the sports field to the 
intensive care unit; this is clearly demonstrated in the Chartered Society of 
Physiotherapy’s database (CSP 2014) which contains over 50 specialist clinical interest 
networks.  In order to meet international expectations and requirements, including those 
of the UK Chartered Society of Physiotherapy (CSP 2014), a physiotherapist is expected 
to cover the five key steps of: 
1) Assessment. 
2) Evaluation. 
3) Diagnosis. 
4) Treatment / Intervention. 
5) Recording of outcome.   
 
Neurological physiotherapy is a specialism within Physiotherapy, and within the larger 
United Kingdom National Health Service there are also specialisations within neurological 
physiotherapy, i.e. acute stroke, stroke rehabilitation, neuro-surgery, neurology, 
multiple sclerosis, Parkinson’s disease and neurological out-patient clinics. The 
theoretical and empirical knowledge that necessarily underpins the treatment approach 
of a neurological physiotherapist is generated and acquired in many different ways and is 
discussed in more depth in Chapter 4 (Research Design and Methodology), but the four 
key topics are those of:  
 Neurological damage / diseases of the Central Nervous System. 
 The theories of motor control. 
 Neuroplasticity. 
 Normal movement, incorporating quality of movement. 
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These will be discussed in greater depth in the following passages. 
 
1.2 Neurological damage and diseases of the Central Nervous 
System 
The number of people suffering from a neurological condition in the United Kingdom is 
large, and the variety of potential conditions along with their associated impairments 
makes the assessment, treatment and measurement of these people complex. The 
Health and Social Care Information Centre (hscic2014) publish data related to the 
number of people admitted into hospital each year with a primary diagnosis or a 
‘mention’ of a neurological condition: of all hospital admissions during 2012/2013, 6.9% 
had a neurological diagnosis, of these, 43% had a primary diagnosis and 19% of these 
had a stroke. Unfortunately, up-to-date information on the prevalence and incidence of 
people with a neurological condition living in the United Kingdom is not readily available.  
However, although it is possibly out of date, the Neurological Alliance (Neurological 
Alliance 2003) has published data which gives an overview of the most commonly seen 
conditions within neurological physiotherapy clinical practice, and is corroborated by 
more recent data regarding stroke and multiple sclerosis prevalence (Stroke Association 
2013; Mackenzie et al 2013). 
 
The most common form of neurological pathology is stroke, followed by; spinal cord 
injury, traumatic brain injury, multiple sclerosis, and Parkinson’s disease.  The most 
common neurological damage to the CNS is upper-motor-neurone damage, with the 
exceptions of spinal cord injury, muscular dystrophy and some types of dystonia.  Motor 
neurone disease and multiple sclerosis can affect either or both upper and lower motor 
neurones.  
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Damage to the central nervous system caused by disease, pathology or direct trauma, 
has a life affecting impact on a person’s body and how they move and interact within 
their environment.  The amount of primary impact is dependent on the location of the 
damage.  The amount of secondary impact is dependent on the person as an individual 
(their health and the ability of their brain to plastically adapt to change), and the 
environment in which they are living.  Primary and secondary symptoms (impacts) of 
central nervous system damage are well known, e.g., symptoms of primary damage:- 
 Paralysis (loss of or decreased movement). 
 Loss of or altered sensation. 
 Loss of or decreased perceptual awareness. 
 Loss of or decreased cognition. 
Symptoms of secondary damage:- 
 Compensatory activity such as: 
o Spasticity. 
o Associated reactions. 
o Contra-lateral (or less affected limb/s) over activity. 
 Joint contractures. 
 Shortened stiff muscles. 
 Weakness. 
 Pain. 
Understanding the damage that can happen to the human body and the implications that 
this impact has is a science underpinned by motor control theory, which continues to 
develop as new technologies are invented that can measure and observe activity in the 
brain and nerves. 
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1.3 The theories of motor control 
The history of the development of the theories of motor control is owed to the pioneering 
work of many scientists (Bracewell 2010).  As scientific techniques have been developed 
and invented, research methods have also progressed from observational techniques to 
include more in-detail research such as the use of electron microscopes, positron 
emission tomography and functional magnetic resonance imaging.  Over the last 
century, as knowledge and understanding has increased, credit has been given to 
individual scientists; however there have been no major conflicts of interpretation, and 
the knowledge gained by many has been developed and built into the complex modern 
theory of motor control.   
 
From the late 19th century to the middle of the 20th century, Sir Charles Sherrington’s 
work (Sherrington 1973) developed the theory that all movement was based on the 
basic reflex of a ‘stimulus producing a response’; he believed that motor control was a 
complex combination of multiple reflexes.   Sherrington based his scientific knowledge 
on simple animal preparations that could reproduce stereotypical reflex behaviour.  
Hughlings Jackson’s pioneering work of the late 19th and early 20th centuries is 
considered to be revolutionary (Foerster 1936).  He studied and observed in minute 
detail the impact of disease (in particular epilepsy), electrical stimulation and excision on 
movement; presenting a map of the human brain based on the results of almost 300 
brain operations done mostly under local anaesthetic.  The brain geography within this 
map is recognisable today within our current knowledge base, as are Jackson’s theories 
regarding 1) the anatomy and functions of different parts of the brain, in particular  the 
very specific localisation of hand and finger movement,  2) the multiple repeated 
representations of body parts within the brain, 3) the brain’s capacity to compensate for 
loss of movement as a result of pathology or trauma by using abnormal muscle 
synergies, 4) the motor response to a sensory stimulation, and 5) the brains capacity to 
learn / re-learn movement.   
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Motor programming theories have developed more recently in the middle and towards 
the end of the 20th century as the result of the cumulative work of many scientists; the 
most notable of them is Bernstein (1967).  Bernstein observed the complexity of central 
nervous system control over movement; hypothesising  that ‘motor programmes’ were 
formed and remembered within the brain and spinal cord for future utilisation on the 
basis of lived experiences.  This contributed to the development of the systems theory 
(Whiting &  Bernshtein 1984), which was intended to be a consideration of all the 
different systems within the whole body (including the musculo-skeletal system and the 
cardio-vascular system), enabling the body to move in a complex and coordinated way.  
Bernstein supported the fact that hierarchical control must still exist to give some control 
of the infinite variety and variability within the choice of movement, but that central 
motor patterns and synergies of movement can more easily explain the super-fast 
responses observed during movement.  By 1975, Schmidt (1975) had put forward  the 
Schema theory, proposing that the capacity of the Central Nervous System was not big 
enough to remember and program every fine nuance and choice of movement at an 
individual movement level, suggesting the presence of pre-programmed ‘movements’ 
that incorporated both sensory information and sensory feedback.  A ‘movement 
Schema’ or synergy could be triggered according to the required movement which could 
then be ‘fine-tuned’ according to the task being performed.   
 
It is clear that as scientific knowledge has progressed throughout the last century, so 
has the understanding of the theory of movement control.  We know that the human 
body is able to move in both volitional and non-volitional ways as a result of a combined 
complex interaction of the many different interdependent internal systems which interact 
within the body’s external environment to achieve a desired task or goal.   The historical 
science that supports this current theory could be considered weak, because it is 
dependent on observation, nonetheless, it has significant clinical resonance and in the 
last 20 years, the science to support the theories has become more sophisticated.  
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‘Observation’ remains crucial, but the technology that is used to observe has progressed 
significantly.  This is evident in the work of Kelso (1997), who found that movement 
deteriorated without sensory feedback;  suggesting  that  the presence of two different 
processes of movement control were necessary, and were dependent on whether the 
task was planned or not.  Research has also been carried out to investigate abnormal, in 
comparison with normal motor control using positron emission tomography and 
electromyography.  Stenekes et al (2010) established that movement is initiated within 
the CNS and is dependent on sensory feedback to maintain its integrity.   
 
During its development, the theory and knowledge that underpins our current 
understanding of motor control has revealed strong evidence that not only is the brain 
able to adapt and compensate for loss of normal motor control; it is also able to 
plastically develop in direct response to both inactivity and rehabilitation intervention, 
the term used to describe this phenomenon is neuroplasticity. 
 
1.4 Neuroplasticity 
The word ‘neuroplasticity’ describes the ability of the central nervous system to learn 
and it has an important presence within neuro-rehabilitation.  It occurs within the central 
nervous system at many levels, ranging from cellular changes due to learning, to large-
scale changes involved in cortical remapping in response to injury (Kandel et al 2000). 
Neuroplasticity commonly occurs during healthy development, learning, memory, and 
recovery from brain damage.  It is well known that brain-derived neurotrophic factor has 
been shown to promote neuroplasticity, and that its production can be stimulated by 
physiotherapy (Frazzitta et al 2014).It is also known that neuroplasticity is not time 
limited, but is dependent on an individual’s ‘normal’ ability to learn (Chelette et al 2013). 
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Thus, the brain is able to learn through experience, this is utilised within the field of 
neurological rehabilitation and very specifically within neurological physiotherapy.  
During the clinical reasoning process of assessment, diagnosis, analysis and treatment 
planning; the neurological physiotherapist requires a sound practical and theoretical 
knowledge of ‘normal movement’ in order to understand the components of their 
patient’s movement that are impaired as a result of neurological pathology. 
 
1.5 Normal movement and movement analysis 
For a neurological physiotherapist, the knowledge of ‘normal movement’ and the ability 
to analyse and identify components of movement that may be missing as a result of the 
primary and secondary effects of neurological damage in their patient is a key 
competence.  This knowledge assists the diagnosis of any specific aspects of movement 
control that are ‘missing’, and have a consequent impact on function. Thus, the skill of 
analysing ‘normal movement’ is fundamental for the recognition and subsequent analysis 
of ‘abnormal movement’ (Bobath and Bobath 1989).  This is a major component of both 
‘in-service’ and ‘on-the-job’, under and post-graduate training; as well as within formally 
run post-graduate training which can be seen within the courses run by the British 
Bobath Tutors Association (BBTA 2014). Equally, within the clinical setting, this ability 
must be utilised without the aid of kinematic and kinetic analyses because of the cost, 
knowledge and training implications.   
 
Within the available literature there are many studies where the research aims to 
analyse the components and biomechanics of normal movement, however, without 
exception, kinematic and kinetic analyses are used, the results of which then need to be 
extrapolated into clinical practice.  A summary of examples of this phenomenon include; 
Protopapadaki et al (2007), Ebaugh et al (2010) and Fotoohabadiet al (2010). 
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Protopapadaki et al (2007) used kinematic and kinetic recordings collected from an 8-
camera 3-dimensional motion analysis system, and a force platform positioned in the 
second stair step, to investigate and compare the biomechanics of stair ascent and 
descent in 11 healthy, neurologically intact individuals.   The results reported a very 
complex detailed analysis of rotations, flexion and extension in all the lower limb joints, 
with, as would be expected, very small deviations between subjects.  Ebaugh et al 
(2010) compared scapulo-thoracic motion and muscle activity between the raising and 
lowering phases of an overhead reaching task with kinematic and electromyographic 
data.  The differences between the 19 neurologically intact participants arm raising, 
reaching and lowering movements were small, and the differences were related to 
different arm length and height rather than motor control.  Fotoohabadi et al (2010) 
recruited 41 healthy elderly people to examine the sagittal thoracolumbar kinematics 
and hip-lumbar interaction during the sit-to-stand task. Retro-reflective markers and a 
2-dimensional video analysis system were used to evaluate the movement from a ‘side 
facing’ view.  Again, the movement patterns were similar in all the subjects. 
 
Having knowledge and understanding of normal movement is important, and the above 
three tasks (stair ascent and descent, overhead reach, sit to stand) are good examples 
of important functional activities that patients wish to achieve during their rehabilitation.  
The advantage of using ‘in-service’, ‘on-the-job’ training and the post-graduate courses 
from educational organisations such as the British Bobath Tutors Association (BBTA 
2014), is that the ‘practical’ component of movement analysis without technology can be 
taught.  Importantly, research such as the examples discussed in this section can be 
directly applied into clinical practice.  
 
In their review, Toro et al (2003) argue that the ‘observation’ of movement without the 
use of kinematics in clinical practice is subjective and therefore must be unreliable.  
However, the work by Pomeroy et al (2003) disagrees; in their study, they ask ten 
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physiotherapists to rate the videoed movement performed by ten stroke patients and ten 
age and gender matched controls using a visual analogue scale.  No specific ‘quality of 
movement’ criteria were used and the physiotherapists were asked to use their clinical 
judgment to rate the movements.  The researchers found that inter-rater reliability was 
low but intra-rater reliability was found to be acceptable; reflecting that inter-rater 
reliability may have been better if the physiotherapists had been asked to rate the same 
characteristics of ‘movement quality’. 
 
When a patient has been judged to have ‘normal’ movement, this is generally perceived 
to be of good quality.  Nevertheless, gaining an understanding of what ‘quality of 
movement’ truly means is important when analysing and assessing the patient’s ‘base 
line’, and then the effects of physiotherapy intervention. 
 
1.6 The concept of movement quality  
Understanding the notion of movement quality is challenging because little evidence can 
be found that specifically explains the concept.  In his blog, Robertson (2015) defines 
movement quality by writing that: 
 
“it’s not just about moving more; it’s about moving better.” (Robertson n.d.) 
 
Within the context of the complexities of the analysis of movement and the application of 
the knowledge of ‘normal movement’ within neurological physiotherapy practice, this is a 
simplistic statement.  It is intended that this concept will be expanded within the course 
of the research within this thesis.   
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Research within the area of movement quality spans the sport, physiotherapy and dance 
literature.  In 2003, Skjaerven et al examined the perceptions of quality of movement 
and the corresponding therapeutic interventions of one highly experienced neuro-
physiotherapist.  The results found three basic elements which were presented as critical 
to the phenomenon of the quality of movement, that is; postural stability, free breathing 
and body / movement awareness.  In 2010 the same authors (Skjaerven et al 2010) 
interviewed 15 physiotherapists to understand how they promoted quality of movement 
within their treatment interventions. Three key themes emerged:  
 Movement awareness, i.e. the therapist needed to be aware of their own 
movement. 
 Platform for promoting movement quality, i.e. this was considered to be the 
potential of the patient to acquire a better quality of movement in combination 
with the therapy environment. 
 Action strategies such as: how to learn movement awareness, the learning cycle, 
guidance versus correction, the use of language, and internal and external 
movement reference points. 
 
In these studies, although a vague understanding of how movement quality is promoted 
or gained, on a pragmatic level it remains difficult to understand what ‘quality of 
movement’ actually means.   
 
Within the field of dance, research to evaluate the quality of a ballet dancer’s movement 
performance led to the development of the Radell Evaluation Scale for Dance Technique 
(Radell, et al 2011).  The items within the scale contain terms such as: 
 Rhythmic accuracy and smooth, uninterrupted ease and flow of movement. 
 Mastery of steps, creating a clear and accurate performance of steps and rhythm. 
 Alignment of the body, specifically, a well aligned spine and appendages. 
31 
 
With the exception of initial inter-rater reliability, the measurement properties of the 
Radell Evaluation Scale for Dance Technique have not been tested.  However, these 
terms appear to have professional resonance within the field of dance, are considered to 
represent good quality dance movements by the authors, and are corroborated within 
the examination system of the Royal Academy of Dance (RAD 2013).  The Royal 
Academy of Dance has a well-developed system of evaluation that includes terminology 
such as; tempo, timing, rhythmical accuracy and harmonious relationship of body parts.  
Again, there is no empirical research evidence to support these evaluations which are 
based on experience, professional knowledge and skills.  These descriptions of good 
quality movement, although related to dance, may have clinical relevance for 
neurological physiotherapists. 
 
Within neurological physiotherapy clinical practice; when intervention is focussed on the 
patient’s movement impairment in order to improve their movement quality, their 
functional ability also improves.  The content of a variety of published literature can be 
extrapolated and used to support this statement, examples of which are found in 
literature from the specialities of musculoskeletal physiotherapy (Alricsson et al 2003), 
sports physiotherapy (McDonnell et al 2005), and neurological physiotherapy (Smedal et 
al 2006). 
 
Alricsson et al (2003) recruited 20 elite cross country skiers (ten in an intervention and 
ten in a control group).  The aim of the investigation was to evaluate the effect of dance 
training on joint mobility and muscle flexibility and also on speed and agility, that is, 
their movement quality.  The results suggested that strength, flexibility, speed and 
agility can be increased within elite cross country skiers using dance training focussed at 
these specific components of movement control.  Interestingly, the outcome measures 
used were either focussed on deconstructed components of movement such as joint 
range, or on function such as speed of skiing.  No consideration was able to be given to 
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the concept of change of movement quality and efficiency during the skiing, and the 
small sample size has an impact on the ability to generalise the findings; especially into 
neurological physiotherapy clinical practice. 
 
Within musculoskeletal physiotherapy, McDonnell et al (2005) describe a single case 
study about a man suffering from severe cervicogenic headaches. His muscle strength, 
alignment and selective movement within his cervical, thoracic and lumbar spines were 
treated very specifically to improve his alignment, motor control and thus his movement 
quality during function.    At discharge the patient’s symptoms were either completely 
improved or manageable with a home exercise programme.  Again, although it could be 
suggested that improving the components of this patient’s normal movement resulted in 
improved movement quality and efficiency; and thus reduced his pain; there was no 
outcome measure used that could quantify the observed improved movement quality. 
 
Smedal et al (2006) used a single subject study design to see whether physiotherapy 
directed towards specific movement impairment could improve the quality of gait pattern 
and balance for two patients with multiple sclerosis.  The interventions were tailored to 
each patient’s needs and although the treatment interventions were different for each 
patient, the outcome measures used at baseline, treatment, early and late follow up 
were similar.  An explicit problem within this study was that although both patients and 
their therapists reported significant and positive effects of intervention, the outcome 
measures used (although considered to have strong measurement properties) were not 
sensitive enough to discriminate clinically important improvement in either patient’s 
quality of motor control. 
 
This last section has focussed on movement quality, and how physiotherapy intervention 
directed towards impairment is claimed to improve the patients function.   In their ‘point 
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of view’ paper, Levin et al (2009) describe the reasonable assumption that neurological 
injury leads to the loss of skilled motor behaviour, and that appropriate neuro-
physiotherapy intervention can lead to full or part recovery of skilled movement or 
adaptation. They also state that no intervention can lead to the patient learning to 
adapt, compensate or substitute movement in an endeavour to achieve the task they are 
attempting.   
 
The neurological physiotherapy approach sits within a larger holistic bio psychosocial 
model of treatment intervention; The World Health Organisation’s International 
Classification of Function Disability and Health (WHO-ICF) (WHO 2001). 
 
1.7 The World Health Organisation’s Bio-Social, International 
Classification of Function, Disability and Health (WHO-ICF)  
Within rehabilitation medicine it is important to be able to consistently harness and 
apply: 1) the knowledge and understanding of motor control, and 2) the brain’s capacity 
to adapt and recover according to the sensory information that it receives (neuroplastic 
ability).  The international rehabilitation community (Doctors, Nurses and Therapists) set 
this knowledge into the framework of the WHO-ICF (WHO 2001) so that appropriate 
patient focussed rehabilitation could be organised, standardised and coordinated.  This 
model (Figure [i]) is applied into the context of each patient’s individual requirements. 
 
The WHO defines ‘impairment’, within the body functions and structures domain as: 
problems with joint mobility, muscle power, muscle tone, involuntary movements and 
pain.  Its definition of the ‘activity and participation’ domains include: lifting and carrying 
objects, fine hand use (e.g. writing and cooking), walking, driving, self-care and 
domestic life.  Those of the ‘environment’ and ‘personal factors’ domains include; 
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products, technology services, personal attitudes and beliefs, support and relationships 
from others (WHO 2001 p3-4).   
 
In an attempt to apply the WHO-ICF model into physiotherapy practice, Mittrach et al 
(2008) demonstrated that their physiotherapy interventions could be categorised 
according to ICF codes within the ‘body functions’ (impairment) domain, and that their 
treatment goals could be focussed within the ‘activity and participation’ domain.   
Although the authors felt that using this technique could quantify and standardise 
physiotherapy intervention by demonstrating the ‘fit’ of potential interventions into the 
ICF domains of body functions and activity, this conceptual approach to physiotherapy 
intervention would necessitate the deployment of instruments that could measure at 
both the patient’s ‘base line’ and post intervention. 
 
 
 
Body functions and 
structures 
(Impairment) Activity 
(Limitation) 
Participation 
(Restriction) 
Environmental factors Personal factors 
Health condition (disorder or disease) 
Figure [i]: Interactions between components of the WHO- ICF (WHO 2001 p9) 
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In order to simply express how the seemingly reductionist interventions employed by a 
neurological physiotherapist ‘fit’ within the WHO-ICF model, Shumway-Cook and 
Woollacott (2012) present a simple model, where ‘movement’ is considered in 
relationship to the ‘task’ that is being performed, the ‘individual’ (in terms of their 
impairments and personal factors) and the ‘environment’ in which the task is being 
executed (see Figure [ii]). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To place this within the specific context of neurological physiotherapy clinical practice 
(Ross et al 2014), a ‘stroke’ patient may have an inability to stabilise their scapula on 
their thorax and therefore suffer from impaired upper limb function and be dependent on 
carer support during dressing.  The impairment (scapula stability) is treated specifically 
before enabling activity (arm movement) within the context of meaningful function 
(dressing).  The patient then becomes more functionally independent and is able to 
Movement 
(Arm and hand movement) 
M 
 
 
 
 
 
 
       I 
 
 
I 
Individual 
(stroke, 
upper 
extremity 
weakness, 
scapula 
instability) 
T 
Task (dressing, 
standing up) 
E 
Environment  
(at home, in  
preparation 
for going to 
work) 
Figure [ii]: Movement emerges from an interaction between  
the individual, the task, and the environment  
(Shumway-Cook and Woollacott 2012, p4) 
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interact within their environment with less support from others or from technology, and 
potentially may feel less disabled. The goal that underpins the focus of the 
physiotherapist’s treatment approach, is to improve the ability, efficiency and therefor 
the quality of their patient’s movement.   
 
1.8 Summary  
The paradigm of neurological physiotherapy intervention has been described; in which 
the complex cycle of patient focussed assessment, diagnosis, clinical reasoning, 
prognosis, and treatment is 1) underpinned by theoretical and practical knowledge, 2) 
focussed at impairment level, and 3) impacts at all other levels within the WHO-ICF 
(WHO 2001). 
 
In order to meet both international expectations and requirements (WCPT 2013), and 
those of the UK Chartered Society of Physiotherapy (CSP 2014), it is suggested that a 
physiotherapist is expected to measure the patient at ‘base-line’ and at intervention 
outcome.  Chapter 2 will present the outcome measurement tools used within 
neurological physiotherapy in more depth, and Chapter 3, will describe and report the 
results of a literature review that is intended to identify and critique the available 
outcome measures that could potentially meet the clinical demands of neurological 
physiotherapy. 
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Chapter 2: Outcome measures set in the context 
of neurological physiotherapy 
 
2.1 Introduction  
Chapter 1 has presented the clinical paradigm within which neurological physiotherapists 
work.  In Chapter 2, the use of outcome measures will be placed in the context of 
neurological physiotherapy including: how they are developed, how it is known if they 
are reliable and valid for use, guidance as to which tool should be used within the clinical 
setting, and the constraints and difficulties of using outcome measures in clinical 
practice.   
 
The United States of America Department of Health and Human Sciences; National 
Quality Measures Clearinghouse (NQMC 2014) define a clinical outcome as: 
 
"..a health state of a patient resulting from health care..…an outcome measure thus 
requires data about health states, i.e., states occurring within the body of a patient” 
(NQMC 2014) 
 
In 2010, the Chartered Society of Physiotherapy published a document (CSP 2010) that 
used a panel of 60 expert members to prioritise research topics within neurological 
physiotherapy.  Out of 16 key themes, 11 identified effectiveness of intervention as a 
topic; the topic subjects covered included stroke, multiple sclerosis, spinal cord injury 
and ataxia.  Out of the 43 specific topics identified, 17 require the use of outcome 
measures that can measure the effects of very specific interventions.  Therefore, in this 
case, the outcome measures required by both researchers and clinicians need to possess 
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the appropriate measurement properties that can discriminate the effects of the very 
specific interventions identified. 
 
2.2 The development of outcome measures 
The European Organisation for Research and Treatment of Cancer has developed 
guidelines for the development of patient completed questionnaires (Johnson et al 
2011). Although these are patient reported outcome measures, the developmental 
process is rigorous and the process can be applied in other settings.  Four key phases 
are described and simplified below (Table [i]).  The two important factors of this process 
are that;1) the users of the outcome measure are involved in the developmental process 
from the beginning to the end, and 2) it is underpinned with academic resources and 
knowledge; enabling the measurement properties of face and content validity to be 
firmly established. 
 
 
Table [i] : The European Organisation for Research and Treatment of Cancer guidelines for the 
development of patient completed questionnaires 
(Johnson et al 2011) 
 
 
Phase 1 
 
Literature searches 
Interviews with patients 
Review of provisional list of issues 
Interviews with health care professionals 
Amendments of the list 
Creation of the list 
 
 
Phase 2 
 
Transforming the list into items  
All items related to functioning should be scored in a positive direction 
 
Phase 3 
 
Pre testing…administration to patients in the target population, 
analysis, retention or deletion of items 
 
Phase 4 
 
Field testing of measurement properties 
Patient sample – should be representative of the target population 
 
 
 
During development, or once an outcome measure has been developed, it is important 
to test its measurement properties to ascertain reliability and validity. 
 
39 
 
2.3 Establishing the validity and reliability of outcomes measures 
The establishment of the measurement properties of an outcome measure requires the 
use of both qualitative and quantitative methodology.  It is important for both clinicians 
and scientists to know that an outcome measure is both reliable and valid for use in the 
setting in which it is to be used.  That is, they need to know that the tool is trustworthy 
in that it:- 
 Can be used by one or several physiotherapists to measure their patient’s 
movement, with the confidence that they will score in very similar ways (internal 
reliability). 
 Can be transferred between therapists as part of the clinical information that 
follows the patient along their rehabilitation pathway, with the confidence that 
they will score in very similar ways (external reliability). 
 Can measure the changes to the patient’s movement control that occurs during a 
treatment session or course of treatment (sensitivity to effects of treatment). 
 Can measure people with large complex movement control difficulties e.g. 
someone with significant paralysis (low floor effects). 
 Can measure people with a small amount of movement control difficulty, e.g. 
someone with a small amount of weakness (high ceiling effects). 
 Is clinically useful and meaningful for both the patient and their physiotherapist. 
 
 
2.4 The measurement properties of outcome measures 
In an attempt to concisely present the different measurement properties, their clinical 
impact, how the properties can be tested and useful parameters that are clinically 
relevant; guidance has been extrapolated from several sources, including within the 
patient reported outcome measurements world, and combined in Table [ii].   
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Table [ii]: Psychometric tests and criteria used in the evaluation of reliability¹ and 
validity² for outcome measurement instruments - 1 
Property  Definition  Clinical 
relevance 
 
How it can be 
tested 
Expected 
outcome 
Clinical utility  An outcome 
measure should be 
appropriate, 
accessible, practicle 
and acceptable for 
use in clinical 
practice. 
If an outcome 
measure does not 
have these 
properties, it is 
unlikely that it will 
be used. 
Qualitative 
methods, e.g.- 
interview,  
focus groups,  
observation 
Description of 
qualities. 
Reliability¹ The degree to which the measurement is free from measurement error.  There are 2 
aspects of reliability: 1) internal consistency and 2) reproducibility (test re-test and intra-
rater reliability) 
Internal 
consistency  
 
“individual items 
should highly 
correlate with each 
other and with the 
summed score of 
the total of items in 
the same scale” 
Fitzpatrick et al 
1998 
The items within the 
scale are all 
necessary  
Cronbach’s alpha 
coefficient, applied 
to the entire scale 
and to each item 
 
excellent = alpha ≥ 
0.8  
good = alpha ≥ 0.7  
inadequate = alpha 
< 0.7  
Reproducibility 
/ External 
reliability 
Can therapists use the scale consistently by themselves or within a group of therapists, 
i.e. 1) the same therapist can use the scale on the same patient repeatedly and expect it 
to measure without error, and 2) different therapists can measure the same patient and 
expect to agree with each other.  Thus if the score changes, an assumption can be made 
that the patient has changed. 
Test re-test 
reliability 
 
When an instrument 
yields the same 
results on repeated 
applications, when 
neither the 
respondents nor the 
domain being 
measured has 
changed. 
Sometimes called 
intra-rater reliability 
(Horner & Larmer 
2006) 
The scale can be 
used on the same 
patient over time, 
with knowledge that 
any changes in 
score are due to the 
patient and not the 
scale’s unreliability. 
That is the tool is 
clinically stable  
Spearman’s rank 
correlation 
coefficient 
A variance 
components 
analysis: between-
patient, between 
therapist, between 
testing variability  
Re-test between 2 
and 14 days  
almost perfect: >  
0.8       
substantial:  0.6 to 
0.8    
moderate:  0.41 to 
0.6  
poor:  < 0.4       
 
clinical 
recommendations to 
measure progress:        
individuals - ICC > 
0.9   large group - 
ICC > 0.7  
Inter-rater 
reliability 
The level of 
agreement when 
two or more raters 
complete the same 
measurement on 
the same patient 
where there is no 
evidence of any 
change in condition 
The scale can be 
used on the same 
patient by different 
physiotherapists, 
with the knowledge 
that any changes in 
score are due to the 
patient and not the 
scale’s unreliability.  
Intra-class 
correlation 
coefficient (ICC) for 
total scores and 
individual items 
Percentage 
agreement between 
raters 
Kappa and weighted 
Kappa 
ICC 
Excellent:  > 0.75 
Adequate:  0.40  to 
< 0.74 
Poor:  < 0.40 
 
Kappa values 
0.00-0.20 = slight 
0.21-0.40 = fair 
0.41-0.60 = 
moderate 
0.61-0.80 = 
substantial 
0.81-1.00 = almost 
perfect 
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Table [ii]: Psychometric tests and criteria used in the evaluation of reliability¹ and 
validity² for outcome measurement instruments - 2 
Property Definition  Clinical 
relevance 
How it can be 
tested 
Expected 
outcome 
Validity² An instrument measures what it purports to measure.  
Construct / 
criterion 
 
The degree to 
which the scores of 
the instrument are 
consistent with 
another instrument. 
i.e. with regard to 
internal 
relationships, 
relationships to 
scores, 
or differences 
between relevant 
groups.  This is 
based on the 
assumption that the  
instrument being 
compared validly 
measures the 
construct 
 
The scale is 
correlated / 
compared with an 
outcome measure (s) 
that are recognised 
as ‘gold standard’. 
 
Spearmans rank 
correlation 
coefficient.   
See above 
Correlation between 
the averages and 
the differences of 
the pre and post 
intervention scores 
( Bland & Altman 
2010) 
Standard Deviation 
± 2 
Pearson’s 
correlation 
coefficient 
0.00-0.19 =“very 
weak” 
0.20-0.39 = “weak” 
0.40-0.59 = 
“moderate” 
0.60-0.79 = 
“strong” 
0.80-1.0 = “very 
strong” 
Floor and 
ceiling effects 
Floor effects occur 
when a measure’s 
lowest score is 
unable to assess a 
patient’s level of 
ability 
When an outcome 
measure is used with 
patients who have 
very good or very 
poor ability, it may 
not be able to 
demonstrate change 
/ effect of 
intervention. 
Excellent: No floor effects,   
Adequate: Floor effects < 20%,  
Poor:  Floor effects for > 20% 
Ceiling effects occur 
when a measure’s 
highest score is 
unable to assess a 
patient’s level of 
ability 
Excellent: No ceiling effects,  
Adequate: Ceiling effects < 20%,  
Poor: Ceiling effects > 20% 
Face validity What an item 
appears to measure 
based on its 
content 
It is essential for 
clinicians to know 
that the outcome 
measurement tool 
measures what it is 
supposed to 
measure.  The items 
need to be relevant 
and comprehensive. 
This is a key property 
to establish, 
particularly due to 
the number of 
outcome measures 
developed for one 
purpose then used 
for another. 
Items should be judged by experts 
Qualitative methods e.g.: - 
The development process 
Interview 
Focus group 
Questionnaire 
Observation  
Content 
validity 
How well a 
measurement tool 
covers the 
important parts of 
the health 
components to be 
measured  
How extensively 
individuals with 
relevant clinical or 
health status 
methodology 
expertise 
participated in 
generating the 
content 
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Table [ii]: Psychometric tests and criteria used in the evaluation of reliability¹ and 
validity² for outcome measurement instruments – 3 
Name of the 
test 
Definition  Clinical relevance How it can be 
tested 
Expected 
outcome 
Predictive 
Validity 
Indicates that the 
outcomes of an 
instrument can 
predict a future 
state or outcome. 
 
Within the healthcare 
setting, predictions 
can be of length of 
stay, discharge 
destination and risk of 
falls. 
Spearmans rank 
correlation 
coefficient. 
See above 
Receiver 
Operating 
Characteristic 
(ROC) analysis - 
area under the 
curve. 
Excellent: > 0.9  
Adequate: 0.7 to 
0.89 
Poor: < 0.7 
Responsiveness 
 
Effect size                The ability of a scale 
to detect clinically 
significant change 
following treatment of 
known efficacy. 
Cohen’s d 
statistic. 
Within patient 
change scores 
before and after 
treatment.  
Calculating an 
effect size statistic 
(mean change 
score divided by 
standard deviation 
of pre-treatment 
scores) 
 
≥0.80 = Large 
0.50   = Moderate  
0.20   = Small  
Measurement 
error 
The Standard 
Error of 
Measurement 
(SEM) is a 
reliability measure 
that assesses 
response stability.   
 
 
The SEM estimates the 
standard error in a set 
of repeated scores 
 
 
Limits of 
agreement (LoA) 
and  Smallest 
detectable change 
(SDC) 
 
 
 
Measured in units of 
the outcome 
measure 
 
Minimal or 
Smallest 
Detectable 
Change 
(MDC/SDC)  
A statistical estimate 
of the smallest 
amount of change that 
can be detected by a 
measure that 
corresponds to a 
noticeable change in 
ability important to 
the patient 
1.96 x √2 x SEM. Measured in units of 
the outcome 
measure 
Andresen (2000);Bland& Altman (2002; 2010);de-Vet et al (2006);Evans et al (1996); Fitzpatrick 
et al (1998); Goreki et al (2013); Horner& Larmer (2006); Johnson et al (2011); Kazis et al 
(1989); Landis& Koch (1977); Messick (1995); Rehabilitation Measures Database (2010); Wade 
(2004). 
 43 
 
It is important that neurological physiotherapists and researchers, providers and 
purchasers of physiotherapy services, and national organisations such as the UK 
Rehabilitation Outcomes Collaborative (UK-ROC 2014) should have clear criteria when 
selecting an outcome measure for use, in order to ascertain that the results of patient 
measurement are scientifically credible and trustworthy.  Nonetheless, for clinicians, the 
issues of which outcome measure to use can be problematic. 
 
2.5 Recommended outcome measures for use within neurological 
physiotherapy practice 
Nearly 20 years ago, in her review paper, Greenhalgh (1998) recognised that whilst 
outcome measures are widely used within research so that the effectiveness of a ‘tested’ 
intervention can be judged; they were not widely used in clinical practice.  Given the 
number of available outcome measures that could potentially be used within clinical 
practice, the issues that she identified are still relevant today, making the decision by a 
physiotherapist of which outcome measure to use a complex one.  There are several 
resources that can be accessed by neurological physiotherapists to support them in this 
choice: The British Society of Rehabilitation Medicine (BSRM 2005), The UK Department 
of Health (DOH 2001; 2005), The Rehabilitation Measures Database (2010), National 
Clinical Guideline for Stroke (RCP 2012), the American Physical Therapy Association 
Neurology Section Task Force (Sullivan et al 2013) and the UK Rehabilitation Outcomes 
Collaborative (UK ROC 2014). 
 
However, despite this advice, in the UK, the ultimate decision of choice of outcome 
measure rests with the physiotherapists, who are required to meet the demands and 
requisites of national organisations, their service managers, their patients and their own 
professional and clinical need.  They also have to ensure that the chosen measurement 
tool is both valid, reliable, designed to measure impact of intervention and concurs with 
their patient’s neurological pathology.  
 44 
 
Thus, although the use of standardised, reliable and validated outcome measures have 
been encouraged; within the clinical setting, the adoption of this practice has been 
challenging (Duncan and Murray 2012); encouraging researchers to investigate the 
reasons why physiotherapists do or do not use outcome measures. 
 
2.6 Using outcome measures within neurological physiotherapy 
practice 
Several authors have published their findings of research into the drivers, facilitators, 
constraints and difficulties found by physiotherapists regarding the use of outcome 
measures in their practice; they have utilised a mixture of methodologies: - 
 Postal or on-line questionnaire (Chesson et al 1996; Abrams et al 2006; Van 
Peppen et al 2008; Yoward et al 2008; Jette et al 2009). 
 Semi-structured interview (Wedge et al 2012). 
 Questionnaire plus semi-structured interview (Swinkels et al 2011). 
 Literature review (Wedge et al 2012). 
This selection of research papers, methodology, authors, geographical location 
researched and physiotherapy speciality (general, musculo-skeletal, neurology) have 
exposed a common set of barriers and facilitators to the use of outcome measures by 
physiotherapists. 
 
2.7 Barriers to the use of outcome measures within physiotherapy 
practice 
A barrier for a physiotherapist in the use of an outcome measure within their clinical 
practice would be any factor that provides a reasonable rationale for not using one.  The 
work of Swinkels et al (2011) gives the richest understanding of barriers, feasibly due to 
the mixture of methodology, these authors found four main ‘barrier’ themes. 
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Physiotherapists 
The physiotherapists had problems with their levels of competence to use outcome 
measures, describing: a lack of knowledge regarding the outcome measures available 
and how to use them appropriately, and also not being experienced at using them in 
their routine work, although they also stated that they were aware that they should use 
them.  One of their problems was that their intervention had a focus on the diagnosis of 
patient impairment, and it was difficult to find an outcome measure that met this focus.  
The physiotherapists attitude towards using outcome measures was also described, in 
that they had a resistance to changing their practice (being ‘fixed’ in their normal 
working methods), they weren’t ‘convinced’ of the value of using outcome measures, 
they felt overloaded with information, they described the outcome of their intervention in 
other ways (e.g. within their written clinical records) and didn’t feel confident in using 
the tools that were available to them. 
Organisation 
The organisational barriers were described as being: time constraints (the mangers did 
not give the physiotherapists’ time to use the outcome measures), there were no 
financial incentives (although this is not relevant in UK practice); there were also 
insufficient supportive technology (such as computers) and no organisational mandatory 
practice or policy.  Within colleagues, there was a lack of discussions and meetings to 
facilitate use, and no compliance with any previous agreements made regarding the use 
of outcome measures. 
Patients 
The physiotherapists described their patient’s expectations as a barrier because they felt 
that patients didn’t want to spend time being tested - preferring just to be treated.  They 
also found that using patient questionnaires were difficult because of potential language 
and cognitive difficulties. 
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Measurement instruments 
The measurement instruments themselves were also seen as a barrier to use because of 
their poor availability, the large amount of choice, poor clinical utility and unclear 
instructions and interpretation.  
 
2.8 Facilitators to the use of outcome measures within 
physiotherapy practice 
A facilitator for a physiotherapist in the use of an outcome measure within their clinical 
practice would be any factor that provides reasonable rationale and thus motivation for 
using one. Facilitators to the use of outcome measures in clinical practice emerged into 
three main themes: communication, mandatory / policy requirements, physiotherapist 
attitude and clinical drivers. 
Communication 
Providing patients with information related to their change in status and patient related 
discussion with colleagues were found to be enhanced with the use of outcome measures 
(Chesson1996; Jette et al 2009). 
Policy 
The changing policy requirements both within the physiotherapy profession and within 
the organisations in which they are employed have created a strong driver for changing 
clinical practice.  
Attitude and clinical drivers 
The physiotherapist’s attitudes towards using outcome measures seem to be very 
positive despite the difficulties previously described.  Some respondents felt that using 
outcome measures could: 1) demonstrate intervention effectiveness (Yoward et al 
2008), 2) help direct a treatment plan and determine progress (Jette et al 2009), and 3) 
improve quality of treatment (Swinkels et al 2012). 
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The barriers facing physiotherapists trying to use outcome measures within their clinical 
practice appear to be similar in the UK, Australia, Holland and the USA, and they do not 
appear to have changed over the years.  Similar problems were being faced in 1996 
(Chesson et al 1996) as in 2012 (Wedge et al 2012), however, despite this, it appears 
that the use of outcome measures has increased (Yoward et al 2008; Swinkels 2012,) 
even though the difficulties remain.  It is possible that this is due to the Physiotherapists 
professional values and motivation, plus increased professional and managerial 
mandatory requirements.  
To summarise; in his editorial, Duncan (2011) wrote: 
 
“Outcome measures are more likely to be used in practice if they are developed to be 
brief, straightforward and meaningful. Therapists are more likely to use measures in 
practice when they are easily available; they have choice over their selection and feel 
skilled in their use.  And a supportive culture is required at an organisational level to 
successfully embed routine outcome measurement into practice” (Duncan 2011, p221) 
 
Although this statement is directed towards the Occupational Therapy profession, it is 
clearly relevant for neurological physiotherapists.   
 
2.9 Summary of Chapter 2 
There are significant potential problems within neurological physiotherapy research and 
clinical practice, in that: 
 There is no clinical or scientifically accepted ‘gold standard’ outcome measure 
that can be used within neurological physiotherapy, although a confusing array of 
many different outcome measures are recommended for use (DOH 2001; DOH 
2005; BSRM 2005; The Rehabilitation Measures Database 2010; RCP 2012; 
Sullivan et al 2013; UK ROC 2014). 
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 An intervention being tested could be effective but the outcome measure being 
used doesn’t reflect a clinically meaningful ‘base line’ of impairment or a change 
in the patients quality of movement, possibly because: 
o The measurement tools are not sensitive enough to assess the ‘base line’ 
or measure the intervention that is focussed on the patient’s impairment 
(Janssen et al 2012; Wang et al 2005). 
o The items in the scale are not clinically relevant or functionally meaningful 
to the patient or therapist (Barak & Duncan 2006). 
 An intervention being tested could be ineffective (i.e. could be teaching the 
patient to abnormally compensate for their movement deficit) and therefore the 
patient may appear to have improved in terms of for example gait speed, or 
balance, but has actually learnt to efficiently and abnormally compensate for their 
lack of motor control.  Of course, this judgement is very dependent on the focus 
of the patient’s treatment goals, which may be to learn how to compensate for 
loss of movement.  It should be argued however, that the goal of learning to 
compensate as ‘efficiently’ as possible still requires an outcome measure that is 
clinically sensitive and meaningful. 
 
To gain an understanding of the outcome measures that are currently available for 
neurological physiotherapists to use with their patients, that 1) meet the requirements of 
International and National professional bodies (WCPT 2013, CSP 2005) and2) meet the 
clinical demand; a review of the available literature was conducted. 
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Chapter 3:  Literature review  
 
The goals of this literature review were to: 
 Identify which outcome measures are being used or developed within neurological 
physiotherapy or neurological rehabilitation research and clinical practice. 
 Ascertain which outcome measures fit specific inclusion and exclusion criteria 
extrapolated from within the contexts of both neurological physiotherapy clinical 
practice (Chapter 1) and the relevant measurement properties of outcome 
measurement tools (Chapter 2). 
 Subject the selected outcome measures to in-depth review. 
 
3.1 The literature review methods  
This narrative review of the literature falls into three clear phases (two literature 
searches and an in-depth appraisal); in Phase 1, the literature will be searched for 
research papers describing the conception and development of specific outcome 
measurement tools, the search will be refined by the use of explicit inclusion and 
exclusion criteria in order to find a range of outcome measures that are fit for modern 
neurological physiotherapy use.  In Phase 2, a literature search related to each of the 
emergent outcome measures will result in a selection of research papers pertaining to 
each tool.  In Phase 3, an in depth appraisal of each outcome measure will be made, 
using the collection of research papers found for each tool that were identified in Phase 
2.   
 
To maximise simplicity within such a complex strategy, the results of each phase are 
presented following a description of the methods, and figure [iii] gives an over-view of 
all three phases and their steps, along with how they are connected. 
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3.2 Phase 1 
Methods 
Box [i] (Search 1) gives an overview of the methods that will be followed during the first 
search of this literature review.  The questions that underpin the search goals are 
intended to focus the findings.  Firstly (Step 1), a search for research papers was carried 
out within:-  
 The electronic databases appropriate to health care and rehabilitation. 
 The Cochrane database of systematic reviews and clinical trials. 
 A hand search of reference lists and personal literature collection. 
 Specialist websites. 
 
The search terms were kept broad (‘Physiotherapy’ AND ‘Outcome Measure’) to ensure a 
maximum number of results; as were the search limits (Step 1b) of: ‘adult’, ‘human’, 
‘English language’ and ‘no age limit’.  Specific inclusion and exclusion conditions (Step 
2b) drawn from Chapters 1 and 2 established selection criteria which were also then 
used:- 
Phase 1: Literature 
review 
•Search for papers 
on outcome 
measures 
•Synthesis and 
selection of three  
key outcome 
measures 
Phase 2: Literature 
review of three 
outcome measures 
•Search for papers 
describing each of 
the three outcome 
measures 
•Selection of 
pertinent articles 
for in-depth 
analysis 
Phase 3: In-depth 
analysis 
•In-depth analysis 
of the Berg 
Balance Scale 
•In-depth analysis 
of the Trunk 
Impairment Scale 
•In-depth analysis 
of Goal Attainment 
Scaling 
Figure [iii]: An over-view of all three phases of the literature review 
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 Within Step 2 - the initial title and abstract screen of research papers related to 
outcome measurement tools; so that papers could be rejected or collated. 
 Within Step 3 - the subsequent full text screen of the surviving source research 
papers; again, the criteria enabled rejection or collation.  
 
It was expected that this inclusion and exclusion process would identify a selection of 
source research papers describing outcome measurement tools that may meet the needs 
of neurological physiotherapists within their clinical practice. 
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Questions to guide the search goals 
 
1. What outcome measures are being used in Neurological Physiotherapy research? 
 
2. Have any outcome measures been developed that are not being used in research? 
 
3. What other available measures are there? 
Step 1a) Literature search 
Search terms:      Physiotherapy  
AND  
Outcome Measure 
 
a) Electronic databases: AMED, EMBASE, 
MEDLINE, PsycINFO, CINAHL, Web of Science, 
Global Health, Pub Med, Science direct, PEdro, 
Evidence search, Scopus, TRIP, EThOS 
 
b) Cochrane database of Randomised controlled 
Trials; Cochrane database of systematic reviews 
 
c) Hand search of reference lists 
d) Specialist web sites:  Rehabilitation Measures database  Clinical Measurement Instruments 
database  Stroke Engine Assess  The Neurology Section  American Physical Therapy Association  Chartered Society of Physiotherapy (UK)  Australian Physiotherapy Association  Canadian Stroke Network  UK National Clinical Guidelines 
Step 2) Title and 
abstract screen 
Inclusion and exclusion 
criteria applied 
 
Step 2b) Selection criteria 
Inclusion   Could be used within clinical 
practice.  Therapist completed.  Adults.  Validated for use with more than 
one neurological pathology.  Measures  more than one 
element of movement.  Measurement properties tested. 
 
Exclusion   Non-neurological.  Measures function.  Not free.  All standing / ambulation tests.  Obvious floor/ceiling effects.  Patient completed questionnaires.  Kinematics.  Activities of daily living (ADL) 
scales. 
Box [i]: Search 1: The search and review method to identify source research papers          
of outcome measurement tools 
4334 
Papers 
related to 
outcome 
measures 
rejected 
Step 1b) Limits   Adult.  Human.  No age limit of publication.  English language 
Step 3) Full text screen Inclusion and 
exclusion criteria applied to source 
papers of outcome measurement tools 
Step 4) Outcome  
3 outcome measures 
selected 
Progress to Phase 2 of 
literature review 
 
30 source papers of outcome 
measurement tools selected for full 
text screen. 
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Results 
For simplicity, Search 1 was sub-divided into four more detailed steps. 
Step 1a: Electronic databases were accessed via the libraries of the Universities of 
Huddersfield and Leeds, and personal reference databases were searched using the 
search terms of ‘Physiotherapy’ AND ‘Outcome Measure’.  The Cochrane databases were 
browsed by:  
I. Topic; ‘Neurology’. 
II. Within each specific neurological pathology category (e.g. head injury, multiple 
sclerosis). 
III. Within ‘rehabilitation’ section or further pathology / disease sub-category.   
 
Specialist websites were accessed via personal internet access and searched for specific 
outcome measures that met the inclusion and exclusion selection criteria within Step 2b, 
from Box [i].  This process resulted in over 4300 research papers; Table [iii] presents 
the extent of the search results. 
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Table[iii] : The results of Literature Search 1 
Electronic 
database 
Search terms Refined by or with 
additional limits 
Number of 
records 
TRIP Physiotherapy AND Outcome measure clinical area -(neurology) 
& ’guidelines’ 
23 
CINAHL – from 
1960 
Physiotherapy AND Outcome measure (In 
abstract) 
 129 
SPORTdiscus Physiotherapy AND Outcome measure  373 
PEDro – from 
1929 
Systematic 
reviews  
Clinical trials 
Physiotherapy AND Outcome measure (in 
abstract & title) 
 926 
Scopus – from 
1960 
Physiotherapy AND Outcome measure (in 
title, abstract & keyword) 
Subject area –(neurology) 
Limit – human & 
physiotherapy 
184 
EMBASE – from 
1947 
Physiotherapy AND Outcome measure (In 
keyword) 
 645 
PsycINFO from 
1806 
Physiotherapy AND Outcome measure (In 
keyword) 
 37 
Ovid Medline from 
1946 
Physiotherapy AND Outcome measure (In 
keyword) 
 199 
AMED from 1995 Physiotherapy AND Outcome measure (In 
keyword) 
 113 
PubMed Physiotherapy AND Outcome measure (In 
title & abstract) 
 202 
Science Direct – 
from 1823 
Physiotherapy AND Outcome measure (In 
title, abstract & keyword) 
 511 
Web of Science 
from 1900 
Physiotherapy AND Outcome measure Neuroscience & neurology, 
English 
802 
Global Health Physiotherapy AND Outcome measure  3 
Cochrane library 
from 2005. 
Database of 
systematic 
reviews 
Browsed by topic - neurology Head injury                            
Motor neurone disorders         
MS                                        
Stroke  
30                        
17                        
48                      
176 
Cochrane library 
from 2005, 
Register of 
controlled trials 
Physiotherapy AND Outcome measure Stroke group                     
Movement disorders               
MS and rare diseases of 
the CNS 
86                        
0                          
 
12 
Total    4366 
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Step 2 
After duplicate papers were removed, the title and abstracts of these research papers 
were screened using specific inclusion and exclusion selection criteria shown in Step 2a 
of Search 1 shown in Box[i].  Research papers were rejected if they did not pass this 
initial screening process.  A total of 4366 citations were reviewed, of which 4334 were 
excluded and 30 source research papers were assessed as potentially relevant.  Full text 
of these papers was obtained for further scrutiny. 
Step 3 
The full text of these 30 selected source research papers of outcome measurement tools 
(Table [iv], were evaluated using the inclusion and exclusion criteria shown in Step 2a of 
search 1 shown in Box [i].  Twenty-seven source research papers of outcome measures 
were rejected because they did not meet the criteria.  Three source research papers of 
outcome measures were retained. 
 
 
 
 
 
 
 
 
 
 
 
 56 
 
Table [iv]: Thirty outcome measures selected for review - 1 
 The outcome 
measure 
Reference Inclusion 
criteria not 
met 
1 Activities-
specific Balance 
Confidence 
Scale 
Powell, LE. &Myers, AM. (1995). The Activities-specific 
Balance Confidence (ABC) Scale. Journals of Gerontology. 
Series A, Biological Sciences and Medical Sciences, 
50A(1), M28-34. 
Patient 
completed 
level of 
confidence  
2 Activity 
Measure Post-
acute Care 
Haley, SM., Coster, WJ., Andres, PL., Ludlow, LH., Ni, P., 
Bond, TL., Sinclair, SJ. &Jette, AM. (2004). Activity 
outcome measurement for post-acute care. Medical Care, 
42(1 Suppl), I – 49. 
Not free 
Measures ADL 
3 Ashworth Scale 
/ Modified 
Ashworth Scale 
 
Bohannon, RW. & Smith, MB. (1987). Interrater reliability 
of a modified Ashworth scale of muscle spasticity. Physical 
therapy, 67(2), 206-7. 
Measures 
spasticity not 
movement 
4 Barthel Index 
 
Wade, DT. (1992). Measurement in Neurological 
Rehabilitation. New York: Oxford University Press. 
Measures ADL 
5 Balance and 
Mini Balance 
Evaluation 
Systems Test / 
Brief Balance 
Evaluation 
Systems Test 
Horak, FB., Wrisley, DM. & Frank, J. (2009). The Balance 
Evaluation Systems Test (BESTest) to differentiate 
balance deficits. Physical Therapy, 89(5), 484-498. 
Not free 
Obvious floor 
effects 
6 Berg Balance 
Scale 
 
Berg, K., Wood-Dauphinee, S., Williams, JJ. & Gayton, D. 
(1989). Measuring balance in the elderly: preliminary 
development of an instrument. Physiotherapy Canada, 
41(6), 304-11. 
To review in 
more detail 
7 Canadian 
Neurological 
Scale 
 
Cote, R., Hachinski, VC.,Shurvell, BL., Norris, JW. 
&Wolfson, C. (1986). The Canadian Neurological Scale: a 
preliminary study in acute stroke. Stroke, 17(4), 731-7. 
Tool for 
medical 
assessment 
Acute stroke 
only 
8 Chedoke-
McMaster 
Stroke 
Assessment 
Measure  
Gowland, C., Stratford, P., Ward, M., Moreland, J., 
Torresin, W., Van Hullenaar, S., Sanford, J., Barreca, S., 
Vanspall, B. &Plews, N. (1993). Measuring physical 
impairment and disability with the Chedoke-McMaster 
Stroke Assessment. Stroke, 24(1), 58-63. 
Stroke only 
9 Community 
Balance and 
Mobility Scale 
 
Howe, J., Inness, E., Venturini, A., Williams, JI. &Verrier, 
MC. (2006). The Community Balance and Mobility Scale: 
A balance measure for individuals with traumatic brain 
injury. Clinical Rehabilitation, 20, 885-95. 
Measures 
ambulation 
Obvious floor 
effects 
10 Dynamic Gait 
Index / 
Functional Gait 
Assessment 
Marchetti, GF. & Whitney, SL. (2006). Construction and 
validation of the 4-item dynamic gait index. Physical 
Therapy, 86(12),1651-60. 
Measures 
ambulation 
Obvious floor 
effects 
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Table [iv]: Thirty outcome measures selected for review - 2 
 
The outcome 
measure 
Reference Inclusion 
criteria not 
met 
11 Dynamometer 
scores  
 
Wiles, CM. & Karni, Y. (1983). The measurement of 
muscle strength in patients with peripheral neuromuscular 
disorders. Journal of neurology, Neurosurgery, and 
Psychiatry, 46(11), 1006-13. 
Not free 
12 Emory 
Ambulation 
Profile; /  
Modified 
Functional 
Ambulation 
Profile 
Wolf, SL., Catlin, PA., Gage, K., Gurucharri, K., 
Robertson, R. & Stephen, K. (1999). Establishing the 
reliability and validity of measurements of walking time 
using the Emory Functional Ambulation Profile. Physical 
Therapy, 79(12), 1122-1133. 
Stroke only 
Measures 
ambulation,  
Obvious floor 
effects 
13 Fugl-Meyer 
Assessment of 
Motor Recovery 
after Stroke 
Gladstone, DJ.,Danells, CJ. & Black, SE. (2002). The Fugl-
Meyer Assessment of Motor Recovery after Stroke: A 
critical review of its measurement properties. 
Neurorehabilitation and Neural Repair, 16(3), 232-240. 
Stroke only  
14 Function in 
Sitting Test 
Gorman, SL., Radtka, S., Melnick, ME., Abrams, GM. & 
Byl, NN. (2010). Development and validation of the 
function in sitting test in adults with acute stroke. Journal 
of Neurologic Physical Therapy 34(3), 150-160 
Validated for 
acute stroke 
only 
15 Functional 
Assessment 
Measure (FAM) 
 
Donaghy, S. & Wass, PJ. (1988). Interrater reliability of 
the Functional Assessment Measure in a brain injury 
rehabilitation program. Archives Physical and Medical 
Rehabilitation,79(10),1231-6. 
Not free 
16 Functional 
Independence 
Measure (FIM) 
 
Keith, RA., Granger, CV., Hamilton, BB. & Sherwin, FS. 
(1987). The functional independence measure: a new tool 
for rehabilitation. Advances in Clinical Rehabilitation,1, 6-
18. 
Not free, 
measures ADL 
17 Functional Axial 
Rotation 
Schenkman, M., Hughes, MA., Bowden, MG. & Studenski, 
SA. (1995). A clinical tool for measuring functional axial 
rotation. Physical Therapy, 75(2),151-6. 
Limited to 
rotation in 
sitting, PD 
only, not free,  
18 Functional 
Reach test & 
Modified 
Anterior 
Functional 
reach 
Duncan, PW., Weiner, DK., Chandler, J. & Studenski, S. 
(1990). Functional reach: a new clinical measure of 
balance. The Journals of Gerontology, 45(6), M192-7. 
Obvious floor 
effects 
19 GAS Goal 
Attainment 
Scaling  
 
Kiresuk, TJ. &Sherman, RE. (1968). Goal attainment 
scaling: A general method for evaluating comprehensive 
community mental health programs. Community Mental 
Health Journal, 4(6), 443-53. 
To review in 
more detail 
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Table [iv]: Thirty outcome measures selected for review - 3 
 The outcome 
measure 
Reference Inclusion 
criteria not 
met 
20 Motor 
Assessment 
Scale (MAS) 
Carr, JH., Shepherd, RB., Nordholm, L. & Lynne, D. 
(1985).  Investigation of a new motor assessment scale 
for stroke patients. Physical Therapy, 65(2),175-80. 
Stroke only 
21 Motor Function 
Measure 
Berard, C., Payan, C., Hodgkinson I. & Fermanian, J. 
(2005). A motor function measure scale for 
neuromuscular diseases.  Construction and validation 
study. Neuromuscular Disorders,15(7), 463-470. 
Neuromuscular 
diseases only 
22 Motricity  Index 
 
Collin, C. & Wade, D. (1990). Assessing motor impairment 
after stroke: a pilot reliability study. Journal of Neurology 
Neurosurgery and Psychiatry, 53, 576-579. 
Stroke only 
23 Rivermead 
Mobility Index 
(RMI) 
Collen, FM., Wade, DT., Robb, GF. & Bradshaw, CM. 
(1991). The Rivermead Mobility Index: a further 
development of the Rivermead Motor Assessment. 
International Disability Studies, 13, 50-54. 
Patient 
completed 
questionnaire  
24 Stroke Impact 
Scale  
Duncan, PW., Wallace, D., Lai, SM., Johnson, D., 
Embretson, S. & Laster, LJ. (1999). The stroke impact 
scale version 2.0. Evaluation of reliability, validity, and 
sensitivity to change. Stroke, 30(10), 2131-40. 
Patient 
completed 
Stroke only 
25 Stroke 
Rehabilitation 
Assessment of 
Movement 
Measure 
(STREAM) 
Daley, K., Mayo, N. & Wood-Dauphinée, S. (1999). 
Reliability of scores on the Stroke Rehabilitation 
Assessment of Movement (STREAM) measure. Physical 
Therapy, 79(1), 8-19. 
Stroke only 
26 Tardieu 
Scale/Modified 
Tardieu Scale  
Haugh, AB., Pandyan, AD. & Johnson, GR. (2006). A 
systematic review of the Tardieu Scale for the 
measurement of spasticity. Disability and Rehabilitation, 
28(15):899-907. 
Measures 
spasticity and 
muscle tone 
using stretch 
27 Tinetti 
Performance 
Oriented 
Mobility 
Assessment  
Tinetti, ME., Williams, TF. & Mayewski, R. (1986).  Fall 
Risk Index for elderly patients based on number of 
chronic disabilities. American Journal of Medicine, 80(3), 
429-34. 
Obvious floor 
effects 
28 Trunk Control 
Test  
Collin, C. & Wade, D. (1990). Assessing motor impairment 
after stroke: a pilot reliability study. Journal of Neurology, 
Neurosurgery and Psychiatry, 53(7), 576-579. 
Stroke only 
29 Trunk 
Impairment 
Scale  
Verheyden, G., Nieuwboer, A., Mertin, J., Preger, R., 
Kiekens, C. & De Weerdt, W. (2004). The Trunk 
Impairment Scale: a new tool to measure motor 
impairment of the trunk after stroke. Clinical 
Rehabilitation, 18(3), 326-334. 
To review in 
more detail 
30 Wolf Motor 
Function Test 
Wolf, SL., Catlin, PA., Ellis, M., Archer, AL., Morgan, B. & 
Piacentino, A. (2001).  Assessing Wolf motor function test 
as outcome measure for research in patients after stroke. 
Stroke, 32(7), 1635-9. 
Upper limb 
only 
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Step 4 
Three outcome measures emerged that met the requirements of the selection criteria:- 
1) The Berg Balance Scale (Berg et al 1989) (BBS). 
2) The Trunk Impairment Scale (Verheyden & Nieuwboer 2004) (TIS). 
3) Goal Attainment Scaling (Kiresuk & Sherman 1968) (GAS). 
 
 
3.3 Phase 2 
Methods 
The selection of source outcome measurement instrument papers that were identified 
within Search 1 of this literature review were the foundations of Search 2, and Box [ii] 
gives an overview of the methods followed.   
 
Each outcome measure was reviewed separately, so a literature search related to each 
outcome measure was carried out, using a similar stepwise process to Search1. 
Again, a question was used to underpin the search aims and help focus the findings.  
Firstly (Step 1a), a search for research papers was carried out within:-  
 The electronic databases appropriate to health care and rehabilitation. 
 A hand search of reference lists and personal literature collection. 
 The accessing and searching of specialist websites.   
 
Again, the search terms were kept broad (the ‘name’ of the outcome measure being 
reviewed) to ensure a maximum number of results, as were the search limits (Step 1b) 
of: ‘adult’, ‘human’, ‘English language’ and ‘no age limit’.   Note that for this search, 
databases containing systematic reviews and randomised controlled trials were not 
included because research papers that examined the properties of outcome measures 
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are not relevant for this methodology.  Specific inclusion conditions were again drawn 
from within the context of neurological physiotherapy clinical practice and also included 
research papers related to the testing of measurement properties (Step2b).  These 
selection criteria were used:- 
 Within Step 2 - the initial title and abstract screen, so that papers could be 
rejected or collated. 
 Within Step 3 - the full text screen so that further papers could be rejected or 
collated. 
 
The resulting selection of research papers pertaining to each of the surviving outcome 
measures were then reviewed in depth in Phase 3. 
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Box [ii]: Search 2: The search and review method to identify research papers related to each 
outcome measurement tool; the Berg Balance Scale, the Trunk Impairment Scale and Goal 
Attainment Scaling  
Step 2) Title and 
abstract screen 
Selection criteria used 
 
Step 2b): Selection Criteria  Validated for use with more than one neurological 
pathology. 
  Measures more than one element of movement  or 
body part. 
  Research set within neurological physiotherapy. 
  Research paper related to one or more measurement 
properties OR clinical utility. 
 
Research papers selected for 
full text screen 
Step 3) Full text screen 
Selection criteria used 
Research 
papers 
rejected 
Step 1b): Limits   Adult.  Human.  No age limit of publication.  English language. 
 
4) Outcome  
A selection of research papers specifically related to each outcome measure: 
Progress to in-depth full text review using a critical appraisal checklist (Box [iii]) within Phase3. 
Questions to guide the search 
 
1. What measurement properties of this outcome measurement tool (the Berg Balance Scale, Goal 
Attainment Scaling and the Trunk Impairment Scale) have been established? 
Step 1a): Literature search 
Search terms:       
“name of selected outcome measure” 
 
1) Electronic databases: AMED, EMBASE, 
MEDLINE, PsycINFO, CINAHL, Web of 
Science, Global Health, Pub Med, Science 
direct,  Scopus, TRIP, EThOS. 
 
2) Hand search of reference lists. 
 
3) Specialist web sites:  Rehabilitation Measures database.  Clinical Measurement Instruments 
database.  Stroke Engine Assess.  The Neurology Section.  American Physical Therapy 
Association. 
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Results 
Box [ii] gives an overview of the process followed for each of the three outcome 
measures, and again, for simplicity the process is sub-divided into four steps.   
Step 1 
Electronic databases were accessed via the libraries of the Universities of Huddersfield 
and Leeds, and personal reference databases were searched using the search terms of 
the name of the outcome measure (Table [v]). 
Table [v]: The results of Literature Search 2 using electronic databases 
 Search terms  &number of records 
 
Electronic 
database 
“Berg Balance Scale” “Trunk Impairment 
Scale” 
“Goal Attainment 
Scaling” 
TRIP 320 8 114 
CINAHL – from 
1960 (in abstract) 
522 20 132 
SPORTDiscus 329 17 47 
Scopus – from 
1960 
816 27 235 
EMBASE – from 
1947 (title) 
80 10 136 
PsycINFO from 
1806 
12 2 126 
Ovid Medline from 
1946 
53 8 104 
AMED 35 6 39 
PubMed 851 33 231 
Science Direct – 
from 1823 
272 5 54 
Web of Science 
from 1898 – in 
title 
103 15 151 
Global Health 
from 1910 
4 0 4 
Total  3097 302 1270 
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Step 2 
After duplicates were removed, the title and abstracts of these research papers were 
screened using the selection criteria shown in Box [ii], Search 2, Step 2b.  Research 
papers were rejected if they did not pass this initial screening process.   
Step 3 
The full text of selected research papers were screened using the same inclusion and 
exclusion criteria as Step 2 above, and then rejected or retained for progression into 
Step 4.    
 For the BBS, a total of 3097 citations were reviewed, of which 3053 were 
excluded and 43 research papers were assessed as potentially relevant.  Full text 
of these papers was obtained for further scrutiny. 
 For the TIS, a total of 302 citations were reviewed, of which 289 were excluded 
and 13 research papers were assessed as potentially relevant.  Full text of these 
papers was obtained for further scrutiny. 
 For GAS, a total of 1270 citations were reviewed, of which 1258 were excluded 
and 11 research papers were assessed as potentially relevant. Full text of these 
papers was obtained for further scrutiny. 
Step 4 
A selection of research papers specifically related to each outcome measure, were 
carried forward into Phase 3 of the literature review. 
 
3.4 Phase 3 
Methods 
A critical appraisal checklist was used to review each of the papers emerging from 
Search 2, so that a full in depth evaluation of both the measurement properties and 
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clinical utility of each outcome measure could be achieved.  This checklist (Box [iii]) has 
been created with initial guidance from Greenhalgh (1998) and Wade (2004), and then 
updated and developed to meet the needs of this review, by incorporating derivations 
from several sources previously discussed within this thesis: 
1) The presence of modern measurement properties necessary to ensure 
appropriate reliability and validity of an outcome measure (table [ii]).   
2) The developmental process of the outcome measure, enabling strong face and 
content validity (Table [i], (Johnson et al 2011). 
3) The barriers and facilitators that have been found for physiotherapists using 
outcome measures within their clinical practice (Chapter 1). 
4) The phenomenon of neurological physiotherapy clinical practice (Chapter 1). 
 
The rationale of using this checklist to support the evaluation of each outcome measure 
is to find a tool that is fit for purpose within modern neurological physiotherapy clinical 
practice. 
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Box [iii]: The critical appraisal checklist used for 
each outcome measurement tool 
•The aims and design of the instrument, the rationale behind its design, domains 
and items within the scale, training required, normative data, face and content 
validity. 
Background 
•The items within the scale are all necessary and correlate both with each other 
and with the whole scale. 
Internal consistency 
•Clinically useful, meaningful for both therapist and patient, focus on impairment, 
quick to use,  help to direct a treatment plan, improve quality of treatment. 
Clinical utility  
•The scale can be used on the same patient over time, with knowledge that any 
changes in score are due to the patient and not the scale’s unreliability. 
Test re-test reliability  
•The scale can be used on the same patient by different physiotherapists, with the 
knowledge that any changes in score are due to the patient and not the scale’s 
unreliability. 
Inter-rater reliability  
•In the classical model of validity, construct validity is one of three main types of 
validity evidence, alongside content validity and criterion validity.  For the 
purposes of this review, the terms are grouped together because they are 
interrelated both operationally and logically. 
Construct validity  
•Useable with patients who have either very good or very poor ability. 
Floor and ceiling effects  
•Can demonstrate treatment effectiveness. 
Responsiveness 
Other relevant research specific to the scale  
•The settings and applications / neurological diagnoses that it has been tested to 
be used in 
•Overall impressions of the scale, it’s strengths and weaknesses. 
Summary  
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Results 
The set of research papers related to each outcome measure were reviewed in depth 
using the critical appraisal checklist (Box [iii]) and the results are presented separately 
below. 
 
3.5 A review of the Berg Balance Scale (BBS) 
The BBS was developed in 1989 by Berg et al, as an evaluative outcome instrument to 
measure preparatory and reactive response to balance perturbations in elderly patients; 
the focus being on assessment of performance as opposed to that of impairment.  The 
rationale behind its design was to meet a clinical need because at the time, there were 
no other outcome measures that could easily be used within the healthcare setting that 
were: easy to use, required little equipment and were able to provide a quantitative 
score for recording purposes.  In their paper (Berg et al 1989), the authors describe the 
process of the scale’s development; 38 patients and 32 heath care professionals were 
recruited to develop the content and structure, and then to test internal and external 
reliability.   
 
Utilising the opinions of patients and health care professionals during the development of 
the BBS ensured that it had both good face and content validity.  Although the authors 
stated that no training was needed to complete the scale; an assumption should be 
made that a professional health worker with knowledge related to neurological 
rehabilitation would be able to use the BBS, as the raters within this and all the studies 
discussed in this section have these pre-requisite skills. 
 
Box [iv] (The items within the Berg Balance Scale) presents the items of the scale for 
clarity, and Appendix 1 (The Berg Balance Scale) the full version - including instructions. 
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Box [iv]: The items within the Berg Balance Scale (Berg et al 1989) 
Name: … … … … … …  Date: … … … … … … 
Location: … … … … … … Rater: … … … … … … 
Item description score (0-4) 
1)   Sitting to standing  … … … 
2)   Standing unsupported  … … … 
3)   Sitting unsupported  … … … 
4)   Standing to sitting … … … 
5)   Transfers … … … 
6)   Standing with eyes closed  … … … 
7)   Standing with feet together  … … … 
8)   Reaching forward with outstretched arm  … … … 
9)   Retrieving object from floor  … … … 
10) Turning to look behind  … … … 
11) Turning 360 degrees  … … … 
12) Placing alternate foot on stool  … … … 
13) Standing with one foot in front … … … 
14) Standing on one foot  … … … 
 
Total 
 
… … … 
 
 
This 14 item scale assesses a patient’s balance through direct observation of their 
performance, it requires 10 to 20 minutes to complete and measures the patient’s ability 
to maintain their balance either statically or whilst performing specific movements. The 
items are scored from 0 to 4; a score of 0 represents an inability to complete the 
movement or task and a score of 4 represents independent item completion. An overall 
score is calculated out of 56 possible points and using it requires minimal equipment 
(chair, stopwatch, ruler and step), space and no specialised training. 
 
Appendix 1 presents a summary of the available literature that has been full text 
reviewed, using the critical appraisal checklist framework previously described (Box [iii]).  
It is clear from these results that the BBS is widely used within research and within 
clinical practice, the measurement properties will now be critiqued in more detail. 
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3.5.1 Internal consistency 
The BBS has been consistently found to have strong internal consistency (Berg et al 
1995;Frangionini et al 2005; Steffen & Senney 2008); with Chronbach’s alpha for total 
scores ranging from 0.83 (Berg et al 1995) to 0.95 (Franchignoni et al 2005), and 
individual items ranging from 0.41 to 0.64 (Berg et al 1998).  This measurement 
property has been tested in different neurological patient populations: Stroke (Berg et al 
1995; Liston & Brouwer 1996; Mao & Hsueh 2002; Conradsson et al 2007; Hiengkaew et 
al 2012), acquired brain injury (Farlow et al 1997), traumatic brain injury (Newstead et 
al 2005), adults with learning disability plus neurological impairment (Sackley et al 
2005) and Parkinson’s disease (Steffen & Seney 2008; Leddy et al 2011).  Although 
these results suggest that the BBS has internal consistency when used within these 
patient populations; the potential for variability between the different raters in terms of 
their skills, knowledge and experience has not been examined, and may be a source of 
bias causing misleading results. Rasch analysis (La Porta et al 2012), found that if the 
static sitting and standing balance items (Items 3 and 2) were removed a good uni-
dimensional ‘fit’ was found; thus firmly establishing strong internal consistency. 
 
3.5.2 Clinical utility 
With the exception of the original study (Berg et al 1989), clinical utility has not been 
widely examined, although evidence suggests that within clinical practice the BBS is 
widely used (Yoward et al 2008) so an assumption could be made that it has good utility.  
However, Datta et al (2009; 2012) concluded that although the BBS appeared to be 
clinically useful at the lower or upper end of the scale, in general, it had limited use for 
the incomplete spinal cord injury patient population who appeared to require an outcome 
measure that was more dynamic and sensitive. These findings are in some conflict with 
the work by Lemay and Nadeau (2010), who found strong correlations between outcome 
measures already validated for the incomplete spinal cord injury patient population; 
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suggesting that if the BBS were to be used for either physiotherapy clinical or research 
purposes, consideration should be made in order to meet the needs of the patient 
population, the therapists intervention and the researcher’s methods. 
 
3.5.3 Test re-test reliability 
During and since its conception in 1989 (Berg et al 1989), the BBS has been tested 
repeatedly for test re-test reliability within varied populations of adults with a 
neurological diagnosis, that is: Stroke, acquired brain injury, traumatic brain injury, 
adults with learning disability plus neurological impairment and Parkinson’s disease.  The 
consistently strong results (Spearman’s rho above 0.91) suggest that the BBS has 
excellent stability, despite the risk of biased results from small sample size (Newstead et 
al 2005) and ceiling effects (Mao & Hsueh 2002; Newstead et al 2005).  
 
3.5.4 Inter-rater reliability 
As with test re-test reliability, inter-rater reliability of the BBS has been extensively 
tested (Berg et al1995;Farlow et al 1997;Sackley et al 2005; de Figueiredo et al 
2009;Leddy et al 2011) within elderly, stroke, Parkinson’s disease, adults with learning 
disability, and acquired brain injury patient populations; and has been consistently found 
to be strong. Video was also used to reduce the risk of difference in scores being due to 
patient change as opposed to consistency in the rater (Farlow et al 1997). 
 
Within these studies, the raters have all been described as senior and experienced, 
suggesting that there may be an element of knowledge required, however, de Figueiredo 
et al (2009) examined the inter-rater reliability of the BBS between novice and 
experienced physiotherapists, and no statistical differences were found.  Nonetheless, in 
terms of ‘novice’ or ‘experienced’ skills of physiotherapists, whose baseline post graduate 
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ability to complete the BBS would be expected to be sound, the strong ICC found in this 
study should not be surprising.  
 
3.5.5 Construct / criterion validity  
In the absence of any ‘gold standard’ outcome measure within neurological 
rehabilitation, the BBS has been compared with many different outcome measures 
focussing on balance (Liston & Brouwer 1996), movement (Mao & Hsueh 2002), 
functional activities of daily living (Berg et al 1992;Feld et al 2001) and gait (Data et al 
2009;  Lemay & Nadeau 2010; Whitney et al 2003); in conjunction with different patient 
cohorts such as incomplete spinal cord injury (Lemay & Nadeau 2010), Huntington’s 
disease (Rumpf et al 2010), multiple sclerosis (Fjeldstad et al 2009), Parkinson’s disease 
(Qutubuddin et  al 2005) and stroke (Mao & Hsueh 2002).  The BBS was been found to 
correlate moderately to strongly within these studies, suggesting that balance is a 
significant component of gait, movement and function, and that the BBS is a valid 
instrument to use within the neurological patient populations.   
 
3.5.6 Floor and ceiling effects 
Ceiling effects have been found in studies that include patient populations who are 
mainly ambulant (Newstead et al 2005; Nilsagård et al 2009; Lemay & Nadeau 2010; 
Leddy et al 2011).  However, both significant ceiling (32%) and floor (35%) effects were 
found by Mao & Hsueh (2012) suggesting that the patient’s motor control status should 
be carefully considered before the BBS is used.  
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3.5.7 Responsiveness / Effect size / Standard Error of 
Measurement / Minimal Detectable Change  
Because responsiveness of the BBS has been assessed and measured in several different 
ways, it is difficult to compare both the results of the different studies, and the 
responsiveness of the BBS in comparison with other outcome measures.   
 
The results found by Wood-Dauphinee et al (1997) and Mao and Hsueh (2002)presented 
effect size and were in agreement (effect size ranged up to 1.11), although the results 
from the Mao et al group were stronger, reflecting the greater range of patient abilities. 
However, the results from the study by Amusat (2009) disagree, finding very low effect 
size for the BBS (0.22) which should nonetheless be interpreted with caution because 
the scale was ‘capped’ at item 3 (sitting) and therefore was used in a constrained non-
valid manner.  In an intervention study, Hackney and Earhart (2009) found a strong 
effect size of 0.83, which was in agreement with the Unified Parkinson’s Disease Rating 
Scale (Goetz et al 2003) and stronger than the timed up and go (Podsiadlo & Richardson 
1991) and 6 minute walk test(Wade 1992).  These results suggest that effect size 
calculations of BBS used to measure treatment effects within the Parkinson’s disease 
population may be reliable and are comparable to effect sizes found in larger populations 
such as stroke (Mao & Hsueh 2002). 
 
The Standard Error of Measurement and Minimal Detectable Change values for the BBS 
have been calculated in a number of studies.  Donaghue et al (2009) found a Standard 
Error of Measurement between ‘1’ and ‘2’ and a Minimal Detectable Change between ‘3’ 
and ‘6’, both values being dependent on the low, middle or high score range with high 
scores having less potential variability.  This study used a non-neurological population so 
could be considered representative of normative values but is not in agreement with the 
non-symptomatic / pre-manifest Huntington’s disease patient group in the study by 
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Quinn et al (2013). Studies using neurological patient groups (Stevensen 2001; 
Hiengkaew et al 2012; Godi et al 2013; Quinn et al 2013) are in general agreement that 
for the BBS, a Standard Error of Measurement value falls between ‘2’ and ‘3’, whereas a 
Minimal Detectable Change value falls between ‘5’ and ‘6’.   
Thus, the implications are that:- 
 When measuring the effect of treatment interventions and programmes; 
researchers and clinicians should account not only for the potential variability in 
their patients, but also in the Minimal Detectable Change value range. 
 Effect size, Standard Error of Measurement and Minimal Detectable Change 
values vary according to the patient population being tested and the intervention 
administered. 
 
3.5.8 Predictive Validity  
Tests of prediction have been examined using the BBS within two main areas: 1) that of 
destination on discharge from hospital, length of stay and functional ability on discharge, 
and 2) of risk of falling. 
Predictive validity related to discharge from hospital 
Wee et al (1999; 2003), Feld et al (2001) and Wirz et al (2010)found that a BBS score 
on admission was only moderately related to discharge destination and length of hospital 
stay, due to the bias of:  
 Family support. 
 Whether the person was living alone pre-morbidly. 
 The necessity of waiting for placement in nursing and residential homes. 
Nonetheless, admission scores of more than ‘28’ were found to predict discharge home, 
around ‘22’ predicted discharge to a residential home and around ‘8’ predicted discharge 
to nursing home; so whilst only moderately strong, these values may have clinical 
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resonance when planning the level of care and rehabilitation facilities appropriate for this 
patient population. 
Predictive validity of falls 
Whilst it is accepted that the risk of falling is multi-factorial, i.e., it is related to reduced 
balance ability, weakness, vision impairment, low blood pressure, pain, environment, 
use of a walking aid etc.  Significant work has been done in attempts to find cut-off 
scores of the BBS that can predict risk of falling.  Bogle and Newton (1996) found 
participants with a BBS score of more than ‘45’ were less likely to fall than those with a 
score of less than ‘45’, but also conversely, that decreased scores did not predict an 
increased frequency of fall.  The participants who fell most frequently were those with 
BBS scores between ‘31’ and ‘45’, maybe because: - 
 A score of less than ‘31’ would indicate either an inability to be ambulant, or a 
need for assistance from another person to walk; and therefore have less risk of 
falling.  
 A score of ‘45’ and above would indicate a higher level of balance ability and 
therefore less risk of falling. 
 
Using a stroke population recruited from an acute hospital setting, Maeda et al (2009) 
found that the ‘fallers’ had lower BBS scores on admission (mean16.9; SD17.9) than 
‘non-fallers’ (mean 40.4; SD16.2). However, the degree of variation is large, and may 
account for other factors (such as infection, altered blood pressure) often found within a 
patient acutely admitted to hospital.  The difference in the BBS scores that are 
suggestive of prediction of falls within these two studies are different, which could be 
expected, because of the difference in the patient populations tested.  That is; Bogle and 
Newton (1996) recruited a stable population, with only 17% of patients having a 
neurological diagnosis and who were generally more mobile, whereas Maeda et al (2009) 
recruited a cohort of patients who were neurologically unstable, with new, unknown 
difficulties with their balance, and who were in general less stable. 
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When recruiting people with multiple sclerosis for studies to ascertain cut off scores in 
the BBS to identify risk of falls for the greater multiple sclerosis population, 
methodological care has to be taken in order to recruit patients that are representative 
of the many variations of motor control, sensory and cognitive difficulties.  Two groups 
of researchers (Cattaneo et al 2006; Nilsagård et al 2009), found that the BBS could not 
predict falls or reliably discriminate between fallers and non-fallers.  This is likely due to 
the complexity and unpredictability of motor control and motor and sensory processing 
impairment that this patient group has, which consequently increases the number of 
variables causing risk of falling.  
 
On the other hand, within a stable population such as incomplete spinal cord injury, 
where prediction of falling could be expected to be more reliable, Wirz et al (2010) found 
no correlation between falls and BBS scores.  A possible reason may be that although 
the patients were at risk of falling,  if an assumption is made that the participants were 
cognitively intact, it may be that they were able to ‘manage’ the risk of falling more 
successfully than a population who have pathological or traumatic brain damage. 
 
3.5.9 Summary of the BBS 
Despite the risk of insufficient methodological strength in some of the research discussed 
in this section; the levels of agreement between them and the number and variety of 
studies (Appendix 1), participants and raters all serve to strengthen and establish the 
internal and external reliability and validity of the BBS for use both within clinical 
practice and in research related to neurological patient populations (specifically: stroke, 
multiple sclerosis, Parkinson’s disease, incomplete spinal cord injury, Huntington’s 
disease and adults with a learning disability plus neurological impairment).   
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This review has discovered that within the population of people suffering from 
neurological damage, the BBS was found to have strong internal and external reliability; 
its content validity is also strong, as is its construct and criterion validity.  However, the 
BBS may be better suited for use with patients who have acute neurological conditions to 
reduce the risk of ceiling effects and paradoxically in this population, care also needs to 
be taken to avoid floor effects, e.g. Mao & Hsueh (2002) initially tested their patients two 
weeks post stroke.  The BBS may also be limited in use in patients with Parkinson’s 
disease to those in the middle stages because of the ceiling effects found in less disabled 
patients and floor effects found in more disabled patients (Leddy et al 2011). 
 
It has been suggested that the BBS has only a low to moderate ability to predict falls in 
medically stable populations and a poor ability in unstable populations; probably due to 
the multi factorial component of falls risk.  
 
The effect size, Standard Error of Measurement and Minimal Detectable Change of the 
BBS has also been shown to be comparable or better than other similar outcome 
measures.  Interestingly, the agreement between patient and clinician judgement of 
ability to balance with the BBS is only moderate (Berg et al 1992) suggesting that the 
BBS may have elements of low clinical utility. 
 
Nonetheless, despite the overall established strengths of the BBS, it has not been 
designed to measure the quality of patient’s movement, and it is not clinically useful for 
patients who require physiotherapy intervention and are either very disabled (low floor), 
or have small levels of impairment (high ceiling).  
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3.6 A review of the Trunk Impairment Scale (TIS) 
There are two outcome measures called the ‘Trunk Impairment Scale’, both developed in 
2004: 1) by Verheyden et al (2004) and 2) by Fujiwara et al (2004).  The latter was 
rejected during the inclusion and exclusion criteria review of full text within this current 
review of the literature, because it has been validated for stroke only.  The former has 
been included for further in-depth discussion because it has been validated within the 
stroke, traumatic brain injury, multiple sclerosis and Parkinson’s disease patient 
populations.   
 
The TIS was developed and published by Verheyden et al (2004), in response to a 
clinical need; at that time there were no outcome measures that could capture the 
‘observation’ of impaired  trunk activity.  The authors intended that the TIS would be 
able to monitor clinical progress, predict treatment outcome and measure the effect of 
intervention. There are three subscales within the TIS: 1) static sitting balance, 2) 
dynamic sitting balance and 3) co-ordination.  Each subscale contains between three and 
ten items, and the TIS total score ranges from a minimum of 0 to a maximum of 23.  
Within each subscale, items are designed to test the ability of the trunk to maintain 
stability and to describe the presence of specific compensatory strategies.  The full data 
sheet including test instructions and score criteria are available in Appendix 2 
 
Appendix 2 presents a summary of the available literature that has been full text 
reviewed using the critical appraisal checklist framework previously described (Box 
[iii]).No information is available regarding the process of development of the TIS, i.e. 
how it was developed and by  whom, although there are strong similarities and author 
link to the work by Nieuwboer et al (1996) where  the initial development of a scale that 
was intended to measure the quality of trunk movement was presented.  Qualitative 
methods of interview and patient observation were used to develop a 12 item scale that, 
on face value, was intended to test: postural adjustments during volitional movement, 
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the quality of posture, and the ability to perform selective movements of the trunk. This 
scale was found to have moderate inter-rater reliability for all items pertaining to the 
ability to balance or not, but poor reliability for items that attempted to measure quality 
of movement.   The authors (Nieuwboer et al 1996) suggested that one of the reasons 
for poor reliability may have been due to the difference in experience of the raters.  An 
assumption could be made that this scale was developed into the TIS but this is neither 
clearly stated nor claimed. 
 
Training needs of personnel aiming to complete the TIS are not presented, but in the 
source paper (Verheyden et al 2004) raters were physiotherapists and the language 
within the scale is technical suggesting that physiotherapists may be qualified to 
complete it.  
 
Since 2004, further work has been published concerning: internal consistency, test re-
test reliability, inter-rater reliability, construct validity, predictive validity, floor and 
ceiling effects and the standard error of measurement.  A small amount of research that 
establishes the correlation between recovery of the components of movement post 
stroke (Verheyden et al 2008), lung function post stroke (Jandt et al 2011), and testing 
the effects of a specific physiotherapy intervention (Verheyden et al 2009) have also 
been published.     
 
3.6.1 Internal consistency     
Using Cronbach alpha coefficients, Verheyden et al (2004) found internal consistency to 
range from inadequate to excellent(0.65 to 0.89).  Rasch analysis (Bond & Fox 2001) 
has also been used to test the internal validity of the TIS (Verheydenk & Kersten 2010), 
finding that the ‘static sitting balance’ sub-section of the TIS should be removed because 
it demonstrated large ceiling effects, and that both the dynamic sitting balance and 
 78 
 
coordination sub-scales adequately fitted the Rasch model.  The authors suggest that 
ceiling effects may have been reached because the majority of patients were three 
weeks or more post stroke, and once the ‘static sitting balance’ sub-scale was removed, 
the authors presented version 2.0 of the TIS.  No other research has been published 
related to the TIS 2.0; therefore this critique will focus on the original version. 
 
3.6.2 Test re-test reliability  
Within their original paper, Verheyden et al (2004) found test re-test reliability to be 
strong (ICC=0.96).  These results are supported in further research by the same authors 
within different patient diagnostic populations (Verheyden et al 2006b; Verheyden et al 
2006c), including a Bland-Altman plot for test re-test agreement, which demonstrates 
TIS values falling between 2 Standard Deviations of the mean across the range of the 
scale.  These results firmly demonstrate that the TIS has strong test re-test reliability 
when used with stroke, multiple sclerosis and Parkinson’s disease patient populations. 
 
3.6.3 Inter-rater reliability  
Strong inter-rater reliability has been established, with ICC’s of above 0.93 (Verheyden 
et al 2004; Verheyden et al 2006b; Verheyden et al 2006c); the patient populations also 
varied, to include stroke, multiple sclerosis and traumatic brain injury. 
 
3.6.4 Construct / criterion validity 
In the absence of any ‘gold standard’ outcome measure within neurological 
rehabilitation, the TIS has been compared with several different outcome measures 
focussing on balance (Verheyden et al 2006a), movement (Verheyden et al 2006b), 
functional activities of daily living (Verheyden et al 2004; Verheyden et al 2006c ) and 
gait (Verheyden et al 2006a); in conjunction with different patient cohorts such as: 
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multiple sclerosis (Verheyden et al 2006b), Parkinson’s disease (Verheyden et al 2007b), 
traumatic brain injury (Verheyden et al 2006c) and stroke (Verheyden et al 2004; 
Verheyden et al 2007a; di Monaco et al 2010).  The TIS was been found to correlate 
moderately to strongly with other outcome measures used within these studies, 
suggesting that trunk control is a significant component of gait, movement and function, 
and that the TIS is a robust tool with which to measure it. 
 
3.6.5 Predictive Validity  
Three research studies have been published (Verheyden et al 2007a; Verheyden et al 
2008; Di Monaco et al 2010), which strongly suggest that trunk activity measured by the 
TIS shortly after an acute stroke attack, is a prediction of functional outcome on 
discharge home and after six months as assessed by the Functional Independence 
Measure (Keith et al 1987). 
 
3.6.6 Floor and ceiling effects 
Although floor and ceiling effects within the TIS have not been formally examined, in one 
of their studies Verheyden et al (2006a) stated that the TIS had no ceiling effect, 
however the study by Verheyden et al (2005) showed that 45% of neurologically 
unimpaired adults could not achieve full scores so this is not surprising.  Interestingly, in 
their Rasch study Verheyden and Kersten (2010) discarded the ‘static sitting balance’ 
sub-scale of the TIS because ceiling effects within this item made analysis impossible; 
although this could have been a reflection of the ability of the patients that were 
recruited. 
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3.6.7 Responsiveness 
The sensitivity of the TIS in relation to effect size and Minimal Detectable Change values 
have not been published, however, the results found by Verheyden et al (2006b) 
indicate that the Standard Error of Measurement for total TIS scores of people with 
multiple sclerosis (1.23 for inter-rater reliability and 1.58 for test-retest reliability) are 
comparable to other outcome measures such as the BBS (Stevenson 2001).  It is difficult 
to establish a reliable understanding of responsiveness for the TIS because there have 
been relatively few studies published; and as previously discussed, effect size, Standard 
Error of Measurement and Minimal Detectable Change values vary according to the 
patient population being tested and the intervention administered.  
 
3.6.8 A summary of the TIS 
Although on face value the TIS appears to have been vigorously tested; face and content 
validity, and clinical utility have not been established, and the small variability in 
publishing authors (three groups) would suggest that the TIS is not widely used either in 
research or clinical practice.  Despite these issues, Van Veppen et al (2007), based on 
the consensual opinion of clinicians, advise that the TIS should be used as a ‘specific 
optional' outcome measure within stroke rehabilitation.  
 
3.7 A review of Goal Attainment Scaling (GAS) 
Goal Attainment Scaling (GAS) was originally developed in response to clinical demand 
within the psychology field (Kiresuk& Sherman 1968), because at the time, there was a 
tendency to use a fixed battery of outcome measures regardless of each individual’s 
characteristics or problems. Clinicians (psychologists) argued that the use of these 
batteries did not represent their therapy aims or interventions, thus, GAS was conceived.  
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However, at the time, despite this face validity; content validity was not established as 
there is no information related to how GAS was developed or by whom.  
 
GAS was originally designed to be sensitive to change found in patients as a response to 
psychological intervention, to enable comparison of treatment interventions within a 
group, and to be able to evaluate psychological rehabilitation programs.  The process of 
setting appropriate goals and scaling them occurred in a two part process: 
Firstly: 
 A realistic set of mental health goals were set by a committee. 
 A scale for each goal was composed of a graded series of likely treatment 
outcomes. 
 These likely treatment outcomes were given points and assigned numerical 
values:- -2, -1, 0, +1, +2 (a minimum of 2 are needed), where: 
o -2 is considered to be baseline. 
o 0 is considered to be the most likely outcome. 
o +1 and +2 are considered to reflect ‘better than expected’ outcomes. 
 ‘Weights’ could be set for goals of higher importance. 
Secondly: 
 The patient was assigned to a treatment therapist (psychologist). 
 The patient was re-assessed by the committee after a pre-determined 
intervention interval. 
 The standardised composite goal attainment score was calculated (see Figure 
[iv]). 
 
T = 50 + (10Σ(wᵢxᵢ)   
 √[1-r∑Wi² + r(∑Wi)²]  
Figure [iv]: GAS calculation (Doig et al 2010) 
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It should be noted that this complex GAS calculation is facilitated and freely accessible 
alongside practical guidance via the Kings College London website (GAS n.d.). 
 
At the time of the conception of GAS (Kiresuk & Sherman 1968), there were potential 
issues regarding: 1) possible bias of the person or committee who selected the patient’s 
goals, 2) the goals were not chosen by the patient, 3) a suggestion by the authors that 
GAS goals shouldn’t even be known to the therapist, and 4) in its original format GAS 
was considered to be individualised but not patient focussed.  Since its creation, GAS has 
subsequently been used in partnership between patients and their therapists in a 
number of areas relating to rehabilitation.  These include: cognitive (Jones et al 2006; 
Bouwens et al 2009), elderly care (Stolee et al 1999; Gordon et al 1999), neurological 
(Joyce et al 1994; Reid & Chesson 1998; Ponsford et al 1999; Turner-Stokes 2009) and 
amputee rehabilitation (Rushton & Miller 2002).  Within the field of paediatric 
rehabilitation, several papers have been published which evaluate measurement 
properties of GAS (e.g. Steenbeek et al 2005; 2007; 2010).  However, this review will 
focus on the change of use of GAS within modern adult neurological physiotherapy 
rehabilitation.   
 
Appendix 3 presents a summary of the available literature that has been full text 
reviewed using the critical appraisal checklist framework previously described (Box [iii]).  
During the analysis of the available literature pertaining to GAS, there was found to have 
been no studies that discuss training requirements prior to use, however, Khan et al 
(2008) comment on the training needed to use GAS; not in actually applying the scale to 
the patient, but having the clinical skill and experience to be able to prognose or predict 
outcome following intervention. 
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Although no formal examination of content validity have been undertaken, the study by 
Joyce et al (1994) initiates its establishment, by comparing the goals set by and with the 
patients, with the then current literature.   
 
3.7.1 Internal consistency  
No studies have formally investigated internal consistency, although Tennant (2007) 
published the results of a comprehensive Rasch analysis, and suggested that GAS did 
not meet the basic mathematical requirements across the range of scores, and the risk 
of either under or over misinterpretation was present across the spectrum.  He advised 
that although the development of an ‘item bank’ of potential GAS items would be 
challenging to create, the result could satisfy sound mathematical principals, enabling 
cross patient and group comparisons; and therefore allowing sound scientific 
measurement within research trials of intervention. 
 
3.7.2 Clinical utility  
Several studies and literature reviews have discussed and reflected on the strong clinical 
utility of GAS (Joyce et al 1994; Reid & Chesson 1998; Khan et al 2008; Turner Stokes 
et al 2010; Stevens et al 2013).  Within the neurological rehabilitation literature, the 
consistent and overwhelmingly strong opinion is that although GAS has been found to be 
complex to calculate, difficult and time consuming to use (especially for patients with 
cognitive difficulties), it also:   
 Can facilitate patient focussed goal-setting. 
 Is a feasible and practical method to evaluate outcomes following rehabilitation 
intervention. 
 Encourages communication and collaboration between multidisciplinary team 
members and patients. 
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Turner-Stokes and Williams (2010) attempted to address the complexity of the rating 
method, by examining alternate methods, such as introducing half scores to reflect 
partial achievement of a goal.  They found significant impact on the calculation method, 
with score outcomes being underestimated, but no evidence was provided to 
demonstrate improved reliability or validity. 
 
3.7.3 Test re-test reliability   
No studies were found within the available literature related to the testing of test re-test 
reliability within the population of adults with neurological motor control disability. 
 
3.7.4 Inter-rater reliability   
Two papers have been published reporting inter-rater reliability of the GAS (Joyce et al 
1994; Bovend'Eerdt et al 2011).  Joyce et al, using different members of the 
rehabilitation team to rate the patients, found strong inter-rater reliability (ICC = 0.92 
on admission and 0.94 on discharge).  However, Bovend'Eerdt et al, using a second rater 
blinded to the patient, found only adequate results (ICC 0.48) suggesting that scoring a 
patient using GAS should be done by a rater who is familiar with the patients movement 
control difficulties.  These results are in agreement with the study by Steenbeek et al 
(2010), and although the study investigates the inter rater reliability of the GAS within 
the cerebral palsy paediatric population, reliability was shown to be strong (r=0.82) 
when used by therapists familiar with the child’s treatment and progress, but less so 
when measured by independent raters unfamiliar with the child (r=0.64). 
 
The results of these three studies suggest that for maximum inter-rater reliability, GAS 
requires the collaborative involvement of both the patient and their treating team, and 
that exclusion of one of these elements does not deliver the same strength. 
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3.7.5 Construct / criterion validity 
In the absence of any ‘gold standard’ outcome measure within neurological 
rehabilitation, GAS has been compared with many different outcome measures focussing 
on movement (Khan et al 2008; Turner-Stokes et al 2009), functional activities of daily 
living (Joyce et al 1994;Ashford & Turner-Stokes 2006; Turner-Stokes et al 2009), 
spasticity (Turner-Stokes et al 2010) and clinical judgement (Joyce et al 1994;Khan et al 
2008); in conjunction with different patient cohorts such as traumatic brain injury (Joyce 
et al 1994), acquired brain injury (Ashford & Turner-Stokes 2006), multiple sclerosis 
(Khan et al 2008) and complex neurological disability (Turner-Stokes & Williams 2010).  
GAS was been found to correlate moderately to strongly with outcome measures that 
reflected patient or clinician judgement; e.g. the Clinical Global Impression scale (Busner 
& Targum 2007), but weakly against outcome measures that measure function (Turner-
Stokes et al 2009).   Testing the validity of GAS is likely to be difficult because of its 
individual application to patients, therefore it should be expected that GAS scores will 
correlate weakly or moderately with the more ‘standard’ outcome measures such as the 
Barthel Index (Wade 1992) or the Functional Independence Measure (Keith et al 1987); 
interestingly GAS correlates strongly with clinician global impressions. 
 
3.7.6 Predictive Validity  
Predictive validity of response to intervention has been demonstrated by Ashford and 
Turner-Stokes (2006).  However, as Khan (2008) suggests, although specific training is 
not required prior to using GAS,  clinical skill and experience to be able to prognose or 
predict outcome following intervention is necessary.  Therefore it should be expected 
that a study that investigates the ability of GAS to predict outcome has strong results. 
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3.7.7 Floor and ceiling effects      
No studies have been found within the available literature that have tested or 
commented on floor and ceiling effects within GAS, this is probably due to the fact that 
individualised goals are agreed with the patient therefore restricting this phenomenon. 
 
3.7.8 Responsiveness  
Effect size, using Cohen’s d statistic, has been used in two studies (Khan et al 2008; 
Turner-Stokes et al 2009), both of which found GAS more responsive than the Barthel 
Index (Wade 1992) or the Functional Independence Measure (Keith et al 1987).  Turner-
Stokes et al (2010) found strong agreement between GAS with measures of clinician and 
patient perceived benefit of intervention (r= 0.46 and 0.41 respectively) and although 
when they were correlated against the Modified Ashworth Scale (Bohannon & Smith 
1987) they were good (r=0.35), but as time progressed, GAS scores continued to 
improve whereas the Modified Ashworth Scale scores remained constant, suggesting that 
GAS was more sensitive to change. It is difficult to establish a reliable understanding of 
responsiveness for GAS because there have been relatively few studies published; and 
as previously discussed, effect size values vary according to the patient population being 
tested and the intervention administered. 
 
3.7.9 A summary of GAS 
Turner-Stokes (2009) captured the essence of the difference of using GAS in comparison 
to other standardised outcome measures, when she wrote: 
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“This approach is conceptually different from standardized measures. If interval 
measures may be described as measuring with ‘a straight ruler’, and ordinal measures 
as ‘a piece of string’, then this method is the equivalent of measuring with a set of 
elastic bands!” (Turner-Stokes 2009, p368) 
 
However, in agreement with Tennant (2007) she concludes with the suggestion that 
mapping of goals onto the WHO-ICF framework could give added value, validity and 
reliability.  No research has yet been published that examines this technique. 
 
There appear to be clear strengths, limitations and cautions to using GAS.  The literature 
agrees that GAS takes goal setting and achievement a step further, because it allows a 
‘calibration’ of ‘degree of success’, recognising partial achievement, it also allows a 
baseline measurement which is then able to be compared to the patients post 
intervention measurement.  However, using GAS successfully depends on two key facts: 
the patient has to have the potential and ability to change and the clinician has to have 
the experience and skill to be able to accurately predict the change; hence limiting its 
use.  It is also open to bias, because clinicians both set the goals and ‘rate’ the 
outcomes; therefore caution should be applied when using it. 
 
GAS has been found to have strong clinical utility, face and content validity, and to be 
very useful within the patient focussed intra-disciplinary rehabilitation team approach 
(Ertzgaard et al 2011).  Nonetheless, there are clear difficulties when using GAS within 
intervention studies, because any scales that are used within research of clinical practice 
should be supported by psychometric evidence to demonstrate appropriate 
measurement properties such as reliability and validity.  Although, as Turner-Stokes et 
al (2010) suggest, it can be used as a secondary outcome measure to describe the more 
qualitative aspects of treatment effects.  GAS falls into the category of individualised, as 
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opposed to standardised scales in that the patient and/or therapist devise the item 
content. Using scales that are scientifically standardised and tested is important because 
of the risk of misinterpretation of change scores i.e. patients may be judged as having 
failed to reach a clinically significant change, when in reality they have, and vice versa 
(Tennant 2007). 
 
Patient focussed outcomes such as GAS are important, and are attractive to both 
patients, because they can determine their own outcomes, and professionals, because 
the GAS can be a useful clinical management tool.  Goals can be made to be very 
specific for particular interventions, for example, a patient with multiple sclerosis may 
have a goal to become functionally independent when using the lavatory.  In this 
instance, the very specific physiotherapy goals could be to improve: 1) pelvic stability 
during sit to stand, and / or 2) foot interaction with the floor for balance, and / or 3) 
selective scapular stability on the thorax for hand function.  However, GAS cannot 
measure or record these very specific physiotherapy interventions; i.e. it does not have 
the capacity to measure the quality of pelvic stability, foot interaction or scapula stability 
on the thorax. 
 
Nonetheless, GAS has strong clinical resonance, and it appears to be widely used 
(Yoward et al 2008) but there are very few research papers that can be directly related 
to neurological physiotherapy intervention.  Even so, within their clinical practice, 
therapists providing the intervention, who are familiar with the patient’s actual abilities 
can score reliably; but, independent assessors cannot have that advantage, indicative of 
weak inter-rater reliability. 
 
In conclusion, GAS in its original format (Kiresuk & Sherman 1968) was intended for 
both patient and programme evaluation, however the strength of its use within the 
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neurological rehabilitation clinical setting has been clearly demonstrated in the literature 
and despite questions regarding its reliability and validity, the sustained use of GAS is a 
testimony to its clinical resonance (Yoward et al 2008).  However, although GAS can be 
used and focussed at the individual patient’s goals during therapy, and reflects to some 
extent the way neurological physiotherapists work; especially within an inter-disciplinary 
team in terms of goal setting and prognosis of potential for change as a result of 
intervention.  GAS does not reflect quality of movement, neither does it focus within the 
impairment domain of the WHO-ICF, understandably so because it was adapted to 
elucidate individual patient functional rehabilitation goals. 
 
3.8 A summary of the review of the BBS, the TIS and GAS 
The BBS is an extensively researched outcome measure and has well established 
measurement properties; its clinical utility is also sound and is used widely within both 
clinical practice and research.  However it does not consider movement quality and 
cannot be used to assess impairments of movement that occur after damage to motor 
control caused by neurological pathology. 
 
In comparison to the BBS, although its measurement properties have been studied, the 
TIS appears to be a less well used outcome measure both in clinical practice and 
research.  However during development whilst there was an attempt to identify and 
measure components of trunk impairment and movement quality, the depth with which 
this was achieved does not meet the clinical demand of neurological physiotherapists. 
 
GAS has been clearly shown to be a clinically useful measurement tool that encourages 
patient and intra-disciplinary team collaboration towards the achievement of 
individualised goals.  However GAS can really only be used as a secondary instrument 
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because of its weak measurement properties, and no specific recognition is made in 
relation to quality of movement. 
 
In conclusion, functional outcome measures enable the physiotherapist to assess 
performance of activities of daily living at the activity level, and quantify whether a task 
is performed within the constraints specified by the test (e.g., BBS, TIS), within these 
outcome measures though, no attention is paid to how well the movement is performed.  
Thus, the problem encountered by neurological physiotherapists when attempting to 
assess both their patient’s ‘base line’, and the efficacy of their treatment intervention is 
the lack of tools sensitive to the movement parameters they specifically want to change. 
Therefore, there is often little choice but to use qualitative assessment (i.e. written 
description within clinical records) to describe movement impairment and improvement, 
making it difficult to transfer information reliably between therapists. 
 
3.9 Conclusion  
With the exceptions of Levin et al (2004) and Horak et al (2009), there are no 
impairment scales that are based on movement analysis and that can also reflect the 
complex components of movement that are required to achieve a task.  This means that 
within the available literature, it has been difficult to relate quality of movement to 
function. On the other hand, the lack of a clear relationship between quality and function 
is partly due to the lack of appropriate outcome measures.  For several reasons, it would 
be useful for neurological physiotherapists to have a scale that measures the quality of 
movement performance specific to a task and which can also reflect the patients 
impairments, or elements of the task that are missing:  
 To measure the patient at ‘baseline’ assessment. 
 To enable the identification of missing elements of a task or 
movement. 
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 To track recovery. 
 To provide evidence that normal movement can recover. 
Several authors have published evidence to suggest that scientific and empirical 
knowledge are progressing towards achieving this goal (Tyson and Desouza 2003; Levin 
et al 2004; Tyson & Connell 2009). 
 
Using focus group methodology to investigate how 27 experienced neurological 
physiotherapists assessed posture and balance in people who had suffered a stroke, 
Tyson and DeSouza (2003) found that the therapists asked themselves three key 
questions 1) what can the patient do?, 2) how do they do it?, and 3) why do they do it in 
that particular way?  The authors developed a clinical model that used observation 
(alignment and movement of body segments) and palpation (of muscle activity), with 
the intention of informing a new outcome measure; this has not been published. 
 
Levin et al (2004) describe the development of a scale (The Reaching Performance 
Scale) that attempts to meet this need.  Underpinned by previous research completed by 
the group (Cirstea & Levin 2000; Michaelsen et al 2001; Levin et al 2002), consensus 
group methods using experienced neurological physiotherapists and occupational 
therapists; defined scale items to assess forward reach in a hemiparetic upper limb.  
Components of the outcome measure included: smooth or fluid movement, appropriate 
direction, appropriate alignment of trunk and shoulder, and it was focused on the degree 
of compensation at trunk, shoulder and elbow.  The therapist was asked to visually 
decompose ‘reaching’ into the elements of movement, that is, trunk displacement, 
movement smoothness, shoulder displacement, elbow displacement, and quality of 
prehension.  Initial tests of measurement properties found that good intra rater and inter 
rater reliability were likely to be dependent on the skill of the rater’s visual analysis of 
movement, and more work was planned to refine the scale.  This has not been 
published. 
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In 2009, Tyson and Connell (2009) published a systematic review aiming to identify 
outcome measures that were 1) psychometrically robust and 2) clinically feasible to 
measure balance within the neurological patient population.  Whilst 19 outcome 
measures met their criteria, including the TIS and the BBS, the authors concluded that 
future outcome measure development should consider scale sensitivity and the 
underpinning theoretical construct of neurological physiotherapy. 
 
Clearly, the contents of existing scales that purport to measure a patient’s movement 
that is impaired as a result of neurological pathology; do not sufficiently reflect clinical 
practice, or provide enough detail to meet the requirements relevant to neurological 
physiotherapists. 
 
Therefore, this study will attempt to meet these demands of measurement within 
modern neurological clinical practice.  An instrument will be developed to measure 
movement quality according to the clinical needs of neurological physiotherapists and 
their patients: the Leeds Movement Performance Index (LMPI).  The reliability, validity 
and clinical utility of the LMPI will then be established in a multi-centre, mixed methods 
study. 
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Chapter four: Research design and methods 
 
4.1 Introduction  
This chapter presents the research design, methods and methodology adopted in order 
to address the following research questions: 
1. Can a tool be developed that is able to measure movement quality according to 
the needs of neurological physiotherapists? 
2. Is the newly developed tool reliable, valid and functional within modern 
neurological physiotherapy clinical practice? 
 
Epistemological and ontological issues that are focussed within the context of 
neurological physiotherapy as a profession will be discussed, in conjunction with the 
knowledge generated and utilised within this research.  A multi-centre mixed methods 
research design will be described, along with the different styles of analysis that will be 
used to interpret the results.   
 
4.2 The Epistemological and Ontological framework supporting 
this thesis 
Crotty (1998) describes ‘ontology’ as the study of being, and ‘epistemology’ as the study 
of knowledge.  These philosophical concepts are embedded within this research, 
directing both the conception and then the investigation of the measurement properties 
and clinical utility of the newly developed measurement tool; the Leeds Movement 
Performance Index (LMPI) (Ross et al 2014).In order to answer the research questions 
and meet the aims of this research study, a mixed methods approach was used (Johnson 
& Onwuegbuzie 2004; Creswell & Piano-Clark 2011; Shaw et al 2010) as a pragmatic 
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style, that is able to utilise the phenomenon, culture and epistemology of the 
Physiotherapy profession.  Three studies will be utilised in a sequential manner exploiting 
the strengths of both qualitative and quantitative methods.  The use of different 
methodology is expected to achieve triangulation (O’Cathain 2010), gaining reliable, 
valid, rich and informative answers. 
 
Higgs and Titchen (1995) present a model (Figure [v]) that consolidates and applies 
epistemological and ontological perception, neatly into both neurological physiotherapy 
clinical practice and this research design. 
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Figure [v]: Types of knowledge and internal influences on knowledge 
generation (Higgs & Titchen 1995 p526) 
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Personal knowledge 
This is very individual and pertains to the clinician’s professional and life experience; it 
includes values, spirituality, perception and self-understanding. Reflexivity and ‘knowing’ 
oneself is critical in this area of knowledge.  This type of knowledge is developed during 
the physiotherapist’s career pathway, and is influenced by: - 
 Interaction with colleagues within the profession and with other members of the 
inter-disciplinary team, with patients and with their families. 
 Personal development during life experiences with family, friends and other life 
contacts. 
 Developing spirituality and values within the context of lives both at home and at 
work. 
 
Professional craft knowledge 
This type of knowledge describes the practical neurological physiotherapy expertise and 
skills which are built up over time, that guide day to day clinical practice. The 
‘knowledge’ is reported and reflected upon within patient’s physiotherapy clinical 
records; Higgs and Titchen (1995) describe it as ‘tacit’ and ‘intuitive’, used in partnership 
with analytical clinical reasoning; they state that: 
“The depth of clinical judgement demonstrated by an expert clinician is, we argue, born 
of a wealth of personal experience of clinical practice in combination with a processing of 
prior learning”. (P 527) 
 
Propositional knowledge 
This type of knowledge is developed and publicised academically; having a solid base of 
science and theory, in contrast with both professional craft knowledge and personal 
knowledge, which are developed with experience, primarily in clinical practice. 
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All three types of knowledge are amalgamated within a neurological physiotherapist, 
being implicitly part of each individual therapist’s ‘lived’ professional and personal life 
experiences. 
 
The history of the development of the culture within the Physiotherapy profession 
combined with expectations from both patients and inter-disciplinary colleagues have 
ensured that professional craft knowledge and personal knowledge have a well-
established and strong foundation in comparison with propositional knowledge.  As a 
group of people who are educated to degree level (with strong depths of personal 
knowledge), once qualified, very few neurological physiotherapists specialise within the 
research arena to gain propositional knowledge; and it could be reasonably argued that 
once they do, they lose professional craft knowledge (Murray et al 2014).  Conversely, 
Higgs and Titchen (1995) support the notion that society is ‘unreasonably dominated’ by 
academic knowledge and that other forms of knowledge are considered less important, 
they propose that in reality there should be a balance between the clinical and academic 
settings, with each extreme feeding and supporting the other.  
 
Within this research, the knowledge of three groups of physiotherapists was utilised, 
namely; a Physiotherapy Research Group, a Senior Physiotherapist Participant Group and 
an Expert Physiotherapist Group.  The geographical locations of these groups are 
presented in Figure [vi]. 
 
4.3 The Physiotherapy Research Group 
This is a group of senior neurological physiotherapists, employed by a large teaching 
hospital in Yorkshire (Leeds Teaching Hospital NHS Trust: Centre 1).  Within the group: 
 Members have knowledge and skills representative of the major clinical specialist 
areas within neurological physiotherapy (neuro-surgery, acute neurology, stroke 
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rehabilitation, acute stroke unit, neurological out-patients, neurological 
rehabilitation, multiple sclerosis and neuro-oncology).   
 As well as being ‘senior’ within the clinical field, the group also manage clinical 
physiotherapy teams, deliver treatment interventions to patients and provide in-
service and ‘on the job’ education for more junior physiotherapists and 
physiotherapy students.   
 Number of years post graduate experience ranges from 16 year to 49 years with 
an average of 25 years and a total of 222 years. 
 All members have completed a three week Bobath course, 6 members (60%) 
have completed one or more advanced courses, one member recently retired as a 
Bobath tutor 
 Throughout this research project, the group also provided on-going clinically 
related guidance, expertise and support to the researcher. 
 
4.4 The Senior Physiotherapist Participants Group 
This group of senior neurological physiotherapists were recruited from three other 
participating organisations (Centres 2, 3 and 4) within Yorkshire (Leeds Community 
Health Care Trust, Airedale NHS Foundation Trust and Mid Yorkshire NHS Foundation 
Trust).   Group members worked in a variety of clinical areas: acute stroke, stroke 
rehabilitation, neurological rehabilitation, community stroke team, community 
neurological rehabilitation team, community brain injury team and neurological out-
patients.  This group of physiotherapists used the LMPI in Study 2: Phases 2 and 3 and 
then reflected on these experiences in Study 3: Phase 2.  
 
4.5 The Expert Physiotherapists Group 
This group of physiotherapists are widely considered to be national and international 
experts within neurological physiotherapy.  They are all members of a non-NHS 
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organisation; The British Bobath Tutors Association (BBTA) (BBTA 2014), and although 
work clinically within the NHS, higher education and the private sector; are also in 
demand to organise and teach on internationally respected and demanded clinically 
focused courses specifically for specialist neurological physiotherapists and occupational 
therapists.  This group’s headquarters are in Yorkshire (Centre 5) and they agreed to 
participate within Study 3: Phase 1; using the LMPI within their clinical practice then 
discussing the experience within two Focus Groups.  
 
An epistemological and ontological balance is thus created in this research design, by 
encompassing the strengths of all three knowledge bases, i.e.: - 
 The use of an academic framework supported by relevant published research. 
 The use of senior neurological physiotherapist’s individual perceptions, clinical 
experience and knowledge. 
 The judgements and opinions of acknowledged clinical experts. 
 The support and challenge achieved by rigorous academic supervision. 
 
4.6 The research design used within this thesis 
In order to answer the research questions stated above, this study adopted a multi-
centre, three-part, mixed-methods design.    Using both qualitative and quantitative 
methods allowed the specifics of both measurement properties and clinical utility to be 
investigated.  Multiple research centres were also used in-order to maximise the 
generalisability of the results (Figure [vi]).  Because of the nature of mixed methods 
research, this study’s design is complex and inter-related over time.  Figures [vii] and 
[viii] present a clear overview of the research process.  
 
The methods used for creating a new outcome measure (Study 1) were guided by 
Johnson et al (2011) (Table [i]), using the qualitative techniques of consensus group and 
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Delphi rounds with members of the Physiotherapy Research Group.   In Study 2, 
quantitative psychometric tests were used to examine the measurement properties of 
the new outcome measure using the Senior Physiotherapist Participants group and 
patient participants who have neurological diagnoses.  The psychometric tests used, 
were guided by a significant amount of research (Andresen 2000; Bland & Altman 2010, 
2002; de-Vet et al 2006; Evans et al 1996; Fitzpatrick et al 1998; Goreki et al 2013; 
Horner & Larmer 2006; Johnson et al 2011; Kazis et al 1989; Landis & Koch 1977; 
Messick 1995; Rehabilitation Measures Database 2010; Wade 2004.) previously 
described in table [ii].   Further examination of face and content validity with clinical 
utility will be investigated in Study 3 using qualitative methods and participation from 
both the Senior Physiotherapist Participants Group and the Expert Physiotherapists 
Group.   
   
 
 
Centre 3: 
Mid Yorkshire Hospitals NHS Foundation Trust 
Centre 1: 
Leeds Teaching Hospitals NHS Trust 
Centre 2:  
Leeds Community Health Care 
Trust 
Centre 4: 
Airedale NHS Foundation Trust 
Centre 5:  
British Bobath Tutors Association 
Headquarters, York 
Figure [vi] Map of research centres 
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Figure [vii]: A pictorial presentation of the research process 
Study 1, conceptualisation and development of a new outcome 
measure 
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4.7 The ethical considerations for this research and its 
participants 
Ethical issues were addressed in line with the International Conference on Harmonisation 
Good Clinical Practice guidelines (ICH-GCP 2000) (Appendix 4).  Although these 
guidelines have been developed for clinical trials, the principles should be applied to all 
research studies. 
 
4.7.1 NHS patient participants 
The patient participant group consisted of people who had a neurological diagnosis (e.g. 
stroke, traumatic brain injury, multiple sclerosis). These people were potentially 
vulnerable (because they had difficulty in moving, and because they were receiving 
physiotherapy treatment from the person recruiting them into the study) and could have 
had cognitive, communication and/or emotional problems as a result of their neurological 
damage.  To address this issue both patients and their spouses or carers were given 
verbal and written study information to enable informed consent.  There are special 
considerations regarding the recruitment and gaining of informed consent from adults 
who do not have capacity. That is, in the clinical population, patients may have 
decreased conscious levels or have cognitive impairment as a result of their neurological 
condition.  It is possible to assess the measurement properties and clinical utility of the 
LMPI using patients who did not have capacity to consent, since the instrument testing 
requires clinical observation which could be undertaken irrespective of cognitive 
function.  However, using guidance from the International Conference on Harmonisation 
Good Clinical Practice guidelines (ICH-GCP 2000), this study did not recruit patients who 
did not have, or who were perceived not to have capacity to consent to participate in this 
research (as decided by their physiotherapist).   
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The patient’s physiotherapy treatment was not be affected by this study; however 
information regarding their movement, diagnosis, age and gender were recorded.  
Anonymity was ensured by the removal of personal information from data collected, and 
this was made clear in both verbal and written information. 
 
Video of patient’s movement was used in part of this study. It was not possible to 
disguise the identity of the patient by digitally obscuring part of their faces, because the 
alignment and relationship of their facial features to their head, and their head to their 
neck and trunk can be an important part of their physiotherapy assessment.  This issue 
was made explicit in specific written and verbal information so that informed consent 
was clear.  All patient video was kept on an encrypted lap-top computer; the videos 
were only watched by the Physiotherapy Research Group (during the preparation of the 
training package), the physiotherapy participants as part of the training and reliability 
testing and the academic supervision team.  
 
In order to ensure that the patient’s medical care was not affected during their 
involvement with the study, the relevant multi-disciplinary team members working with 
the patient were informed (with the patient’s permission) via a letter to the lead clinician 
(their Consultant if they were resident in hospital, or their GP if they were an outpatient 
or treated in the community setting). 
 
4.7.2 NHS physiotherapist participants 
Only senior physiotherapists were eligible for recruitment into the study if they 
predominantly treated patients with neurological diagnoses.  These therapists carried 
full-time clinical caseloads and taking part in this study may have added burden on their 
clinical commitments.  However, involvement within this research is expected to support 
and enhance a physiotherapist’s assessment and clinical reasoning skills so there may be 
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an overall benefit of impact on service delivery.  This issue was both discussed verbally 
and included in participant information sheets. 
 
4.7.3 All Physiotherapists within this thesis 
Therapist participants may have felt that they were under professional and clinical 
scrutiny (by their peers, managers or the researcher) because the study introduced an 
outcome measure that was alleged to support their assessment and clinical reasoning 
skills.  Confidentiality was assured by the removal of all information that could identify 
the participant and this issue was also discussed during training.  This risk was also 
reduced by 1) blinding during Study 2, Phase 2 testing protocol, and 2) Focus Group 
‘rules’ (see Appendix 5) during Study 3, Phase 1. 
 
In accordance with national research guidance, all data gathered and stored during the 
course of this research will be destroyed after five years of study completion. 
 
4.8 Ethical approval and research governance 
Ethical approval for the study was granted by: Leeds Central Research Ethics committee 
on 09/04/2008 (REC Reference: 08/H1313/23), The University of Huddersfield School of 
Human and Health Sciences School Research Ethics Panel on 28/09/2010, and Bradford 
NHS Research Ethics Committee on 24/11/2010 (REC reference number 10/H1302/82).  
 
Local Research and Development approval was also obtained from Leeds Teaching 
Hospitals NHS Trust, Leeds Community Health Care Trust, Mid Yorkshire Hospitals 
Foundation Trust and Airedale NHS Foundation Trust.  Approval dates and references are 
as follows:- 
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 Leeds Teaching Hospitals NHS Trust reference NE10/9497, approval received 
14/01/2011. 
 Leeds Community Health Care Trust received 06/01/2011. 
 Mid Yorkshire Hospitals Foundation Trust reference JS/vd/N:R&D(10/700), 
approval received15/12/2010 . 
 Airedale NHS Foundation Trust reference EPS: 0506 CSP, approval received 
29/11/2010. 
Appendix 4 contains all letters confirming ethical approval. 
 
 4.9 Summary  
This chapter has described and presented the research design and methodology that was 
used to answer the research questions and meet the research objectives.  Chapters 5 to 
10 will firstly present the methods, then the results of each of the three studies in a 
sequential manner, i.e. the methods and results of the first study, followed by the 
methods and results of the second study, and finally the methods and results of the third 
study.  The nature of mixed methodology research is complex and inter-related, which 
although gives richness and depth to the research, can also cause difficulty in following 
the flow of information.  To address this issue, Figure [ix] is presented for clarity. 
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Chapter 5:  Methods, Study 1: The 
conceptualisation, development and initial field 
testing of a new outcome measure (the LMPI) 
 
5.1 Introduction  
The aim of this study was to create a new outcome measure that encompasses 
movement quality.  In order to achieve this, several objectives were set: - 
1. To explore the meaning of and develop a definition for ‘quality of movement ‘. 
2. To define parameters / factors within the ‘quality of movement’. 
3. To establish a means of scoring or recording movement quality. 
4. To run a small pilot study to investigate the clinical utility of the new outcome 
measure. 
 
Within the course of this study, it was expected that: 1) an understanding of face and 
content validity and clinical utility would be gained, and 2) the foundation of a set of a-
priori themes would be established in preparation for use in Study 3. 
 
5.2 The design of Study 1 
This study ran sequentially through two phases.  Phase 1 focussed on the 
conceptualisation and creation of the LMPI; and Phase 2 used a qualitative pilot study in 
order understand whether the LMPI had face and content validity, and could be a 
clinically useful and meaningful way to record the movement difficulties of people who 
were receiving treatment from neurological physiotherapists. 
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5.3 Study 1, Phase 1: The conceptualisation and creation of the 
LMPI 
The aim of this study was to define ‘movement quality’ and define the parameters within 
this term. 
This study used consensus group methods described by Jones and Hunter (1995). 
1. Firstly, nominal group technique to gather and organise information and 
knowledge. 
2. Secondly, a Delphi process to anonymously refine terminology and reach 
agreement. 
 
5.3.1 Nominal group meetings 
Three structured meetings were used: 
Meeting 1: Initial meeting to define ‘quality of movement’ and identify key 
parameters within the resulting definition. 
Meeting 2:  To agree score criteria. 
Meeting 3:  To prepare research material for Phase 2 of Study 1. 
 
5.3.2 The Delphi process 
Three rounds of Delphi were utilised using e-mail within a secure internal server, and a 
space of one month was applied between rounds. Delphi methods were used, not as a 
method for creating new knowledge, but for accessing the knowledge of the 
Physiotherapist Research Group members in a quick un-biased manner and to help 
structure and organise group communication without the risk of influence (Mokkink et al 
2006). 
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5.3.3 Nominal and Delphi Group members 
This is a group of ten senior neurological physiotherapists previously described, known 
as the Physiotherapy Research Group.  
 
5.3.4 Data collection 
The results of the consensus group methods were collected over the course of ten 
months, and the data that emerged were used to inform the progression of the research 
process within this phase.  Whilst an overview of this process is presented within the 
context of the full research study (Figure [vii]), the micro-detail of this process is 
described in Figure [x], i.e. the data gathered from nominal group meeting 1 informed 
the first Delphi round; the consensus from the Delphi study was used to form the draft 
LMPI; nominal group meeting 2 further developed the LMPI; nominal group meeting 3 
analysed the results from Study 1 Phase 2.    
 
  
  
  
  
  
  
 
  
  
  
  
  
  
 
 
Nominal group 
meeting 1 
1stDelphi round 
Draft LMPI 
Nominal group 
meeting 2 
2ndDelphi round 3rdDelphi round 
Further 
development of 
the LMPI 
Study 1 Phase 2 
Nominal group 
meeting 3 
Analysis of study 
1 Phase 2 results 
Figure [x]: The micro-detail of the research process within Study 1 Phase 1 
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5.3.5 Nominal group meetings 
Meeting 1 
The meeting was facilitated by the lead researcher.  The ten group members spent 
several minutes writing down their views about their own interpretations of what ‘the 
‘quality of movement’ meant to them.  Each member in turn contributed one idea to the 
facilitator, who recorded it on a flip chart, the ‘turns’ continued until no further ideas 
were left.  The group then discussed the phenomenon of ‘movement quality’ and agreed 
a definition.  The flip chart was re-visited and the ‘ideas’ were grouped together, where 
appropriate to form agreed components of movement quality. 
Meeting 2 
The draft LMPI was presented to the group members, who then spent several minutes 
writing down their views about how the LMPI should be scored.  This was then discussed, 
and agreement was achieved. 
Meeting 3 
Group members discussed and agreed a training programme that would be used in 
Phase 2 of Study 1.  A Microsoft PowerPoint presentation would be prepared containing 
information related to 1) how the LMPI was developed and 2) how to apply the use of 
the LMPI into routine clinical practice.  Simple guidelines were written to support the 
training session(Appendix 6: LMPI guidelines).  During the planning of the pilot study, 
the group members also agreed to provide supervision and support to participants, and 
to work as a group to analyse the data that were generated. 
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5.3.6 Delphi rounds 
Round 1 
Using secured e-mail, the lead researcher sent each nominal group member 1) the 
definition of movement quality that had been agreed and 2) the agreed set of 
components.  Each member was asked to write a definition that encompassed their 
understanding of each component of movement quality using a proforma designed for 
the process (Figure [xi]). 
 
Parameter 
 
Description 
 
Alignment  
 
Your definition… 
 
Interaction Your definition… 
 
Timing Your definition… 
 
Speed Your definition… 
 
Selective 
movement 
Your definition… 
 
Figure [xi]: The proforma sent to consensus group members, for individual 
completion 
 
Round 2 
The ten definitions for each component were collated and group members were asked to 
rank their agreement of each definition.   
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Round 3 
The ranked definitions of each component were reviewed and where full agreement had 
been reached, were removed from the Delphi.  The remaining components were collated, 
and members were asked to re-rank them.  
 
5.4 Study 1, Phase 2: Pilot study; initial investigation of clinical 
utility 
The aim of this study was to investigate the clinical utility, face and content validity of 
the LMPI. 
A pilot study was run using a small group of senior physiotherapists, who were firstly 
trained to use the LMPI, and then secondly used it within their clinical practice for two 
months.  During this time, the participants could access any support they felt they 
required from a member of the Physiotherapy Research Group.  After two months, semi-
structured interviews were used to gather thoughts, impressions and opinions regarding 
the clinical utility, face and content validity of the LMPI 
 
5.4.1 Participant eligibility 
Senior Physiotherapists who worked for the NHS and who met the inclusion criteria 
below were recruited into the study. 
 
5.4.2 Inclusion criteria  
 Majority of caseload spent treating patients who had a neurological diagnosis; in 
order to ensure familiarity and confidence working with patients who had 
neurologically related movement difficulties. 
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 Working as a senior physiotherapist.  This staff group were chosen because their 
work pattern allowed continuity for the research project, i.e. junior grades of staff 
rotate through different clinical specialities four monthly; senior grade staff are 
either non-rotational or rotate six monthly or yearly. 
 Permission from their manager to participate. 
 Currently working in a clinical area that ensured support from a member of the 
Physiotherapy Research Group. 
 
5.4.3 The recruitment of participants and the consent process 
Physiotherapy mangers were approached and permission was gained for the researcher 
to approach physiotherapists working within the organisation who met the inclusion 
criteria.  Both verbal and written information (Appendix 4) about the study were given to 
prospective physiotherapist participants by the researcher prior to the gaining of 
informed consent.  Written information was sent to prospective participants four weeks 
previously with the invitation to attend a meeting.  At the meeting, verbal information 
was given prior to an invitation to attend a follow on training event. 
 
5.4.4 Data collection 
Training protocol 
A half day training event took place in the participant’s workplace within their normal 
working hours.  The history of the development of the LMPI was explained to the 
participants, they were then taught how to apply it within the clinical setting.  During 
their use of the LMPI, the participants received on-going supervision, support and advice 
from members of the Physiotherapy Research Group.   
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Use within clinical practice 
Participants used the LMPI within their routine practice of clinical record keeping for two 
months, any thoughts, reflections and opinions related to the use of the LMPI were 
recorded on the data-sheets which were anonymised for patients and participant details 
and collected by members of the Physiotherapy Research Group.   
Semi-structured interviews 
Participants were interviewed face to face using the following semi-structured questions: 
 How did you use the LMPI? 
 Was the LMPI easy to use? 
 Did the LMPI affect your clinical reasoning? 
 Did the LMPI affect your handover of clinical information? 
 Was the LMPI useful? 
 Were there any times when it wasn’t appropriate to use the LMPI? And why 
couldn’t you use it? 
 Is there anything that you would like to change about the LMPI?  
 Is there anything that you would like to add to this interview?  
Rich note taking was used to record the interviews and all data were transcribed into 
Microsoft word documents. 
 
5.4.5 Data analysis 
Data from the anonymised LMPI data sheets and the transcribed semi-structured 
interviews were analysed using thematic content analysis guided by Boyatzis (1998) and 
Howitt & Cramer (2008) (Figure [xii]). 
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The Physiotherapy Research Group met to analyse the data; initially familiarising 
themselves with it, then as a group, identifying codes and themes using ‘post it’ notes 
onto a blank wall.  As the meeting progressed, themes were refined until full agreement 
related to the emerging themes was reached. 
 
All data were stored securely. 
 
 
 
 
 
 
Figure [xii]: The process of thematic content analysis used during Study 1, 
Phase 2       (Howitt & Cramer 2008 p344) 
Code A 
 
Original transcribed text 
 
Code D 
 
Code E 
 
Code C 
 
Code B 
 
Theme 1 
 
Theme 2 
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Chapter 6:  Results, Study 1: The 
conceptualisation and development of a new 
outcome measure (the LMPI) 
 
6.1 Introduction  
This chapter presents the results of Study 1, the conception and pilot testing of clinical 
utility of a new outcome measure. The study was organised into two phases, each phase 
will be presented separately: -  
 
Phase 1: The conceptualisation and development of the new outcome measure.  This 
will include the results of consensus group and Delphi methods, producing:   
 A definition of the term ‘movement quality’. 
 Definitions of the parameters which were then used to form the items within the 
new outcome measure. 
 The agreed scoring criteria. 
 The naming of the new outcome measure. 
 
Phase 2: The results of the pilot study used to explore potential clinical utility and 
content validity.  
 
Results presented in this study have been previously published in SYNAPSE (Ross 2008), 
a national quarterly journal published by the Association of Chartered Physiotherapists 
Interested in Neurology (ACPIN) (Appendix 7). 
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6.2 Study 1, Phase 1: The conceptualisation and creation of the 
new measurement tool 
 
6.2.1 Nominal and Delphi group members 
The Physiotherapist Research Group previously described, worked in a consensual 
manner using nominal group and Delphi methods.   
 
The outcomes of nominal group meetings and Delphi rounds will be presented in the 
chronological order in which they occurred (see Figure [x]) because the information 
generated flows and develops between the two techniques, i.e.: nominal group meeting 
one first Delphi roundsecond Delphi round third Delphi round nominal group 
meeting two, and then nominal group meeting three. 
 
6.2.2 Nominal group meeting 1 
Two main themes emerged during the course of this three hour meeting, helping to 
focus 1) the definition of the phrase: ‘quality of movement’ and 2) the understanding of 
where and how ‘quality of movement’ fits within the context of neurological 
physiotherapy intervention:  
 
Theme 1: The quality of a patient’s movement at an impairment level is a key part of 
their Physiotherapy assessment, analysis and treatment planning.  
 
Theme 2: The quality of a patient’s movement within their normal functional daily 
activity is personalised in terms of the patient as an individual, their 
environment in which they exist, the task they are performing, their 
pathology, their age, their motor control deficit and prognosis. 
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The meeting was split into three steps: step 1) brainstormed the concept of movement 
quality, step 2) produced two definitions of ‘movement quality’, and step 3) used 
discussion to agree on specific components of observable quality of movement and 
posture. 
Step 1 
The key parameters that emerged from the brainstorm session within this section are 
presented in Figure [xiii].  The session worked well as an exercise to promote thinking 
and discussion in preparation for the creation of a definition of movement quality within 
Step 2. 
 
 
 
 
Step 2 
Within this section, because of the size of the group (ten participants) it was agreed that 
there were too many people to be able to have an inclusive conversation.  Therefore, for 
Looks 
‘nice’ Good 
Consistent 
Balanced – not falling 
over, the force 
between muscle 
groups, mechanics, 
synergy 
Precise 
Selective 
Timing 
Speed Efficient 
Coordinated 
Minimum amount of 
energy needed to 
complete the task 
Smooth 
Controlled 
Repeatable 
Effective 
Figure [xiii]: The results of the ‘brainstorm’ exercise to define the parameters within quality of 
movement 
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one hour, the members split into two sub-groups of five.  Each sub-group used the 
parameters to produce a definition of their understanding of the meaning of ‘movement 
quality’; these two definitions are presented in Figure [xiv]. 
 
 
 
 
Step 3 
During this section of the meeting, the group used their newly formalised understanding 
of movement quality, and re-visited the work within Step 1.  The group felt that there 
were too much overlap and meaning of the terms (see Figure [xiii]) and the consensus 
of opinion was that the parameters should be re-looked at and be made more explicit 
and focussed.  The results are presented in Figure [xv]; technical ‘jargon’ has been used 
by the group to create condensed and specific terms. 
 
"As Physiotherapists we define a high 
quality movement as an efficient way 
to achieve a desired outcome or goal.  
This would be with the least effort, 
timely, smooth and precise; within 
the context of the individual, task and 
environment" 
"Good quality movement is efficient, 
effective and seemingly effortless.  It 
is performed in a controlled and 
timely manner to achieve a precise 
outcome.  Quality of movement must 
be evaluated within the context of the 
individual; i.e., their age, the 
environment, and is dependant on the 
task" 
Figure [xiv]: The two different definitions of ‘movement 
quality’ defined by the Physiotherapy Research Group 
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The next stage of the process was to agree definitions of these parameters of movement 
quality, and for this, Delphi methods were used. 
 
6.2.3 Delphi rounds: 1, 2 and 3 
Round 1 
Each group member was electronically sent the designed proforma (Figure [xi]) using 
secured e-mail, which was completed and then returned to the researcher. 
With the inclusion of the researcher, all group members participated, resulting in ten 
definitions of each parameter (see Appendix 8). 
Round 2 
After one month, the full list of ten definitions for each parameter was sent to group 
members, who were asked to select their ‘top three’ favoured definitions.  After this 
Delphi round, there were clear favourites identified for: ‘Alignment’, ‘Interaction’ and 
‘Speed’.  These parameters were removed from the subsequent Delphi round.   
 
Alignment 
(muscle, joints, 
soft tissues) 
Interaction 
(between / within 
body segments with 
respect to BOS³) 
Selective 
movement Timing  
of recruitment and 
activity Speed  
Figure [xv]: The five parameters of movement quality within posture and movement. 
BOS³ = Base of Support 
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Round 3: 
After another month, group members were re-sent all ten definitions for ‘Timing’ and 
‘Selective Movement’.  On their return, the clear favourites had been chosen (Figure 
[xvi]). 
 
Parameter   
 
Description 
Alignment  
 
The position/posture of muscles, joints and body parts from which 
movement/activity is most anatomically correct and therefore efficient 
and effective 
Interaction The on-going adjustment between body parts within a posture or during 
movement with respect to its BOS³; that allows the maintenance of the 
posture on a background of balance correction, strength and endurance. 
Timing The appropriate sequence of activation and de-activation of automatic 
and selective movement in order to complete a task. 
Speed How fast or slowly a movement can occur. An optimum speed would be 
one which allows coordination, control, use of minimal energy and allow 
an effective goal to be achieved 
Selective 
movement 
Ability to achieve an isolated, specific and desired movement on a 
background of stability 
BOS³= Base of Support 
 
Figure [xvi]: The definitions of the parameters of quality within posture and 
movement:  post Delphi technique 
 
6.2.4 Nominal group meeting 2 
The definitions of the parameters were reviewed and formally agreed upon.  A discussion 
took place about how these defined components of movement could potentially be used 
as an outcome measure by neurological physiotherapists to score or measure a patient’s 
quality of movement.   A simple scoring system was devised, which ranged from zero to 
three; where 0 = severe, 1 = moderate, 2 = mild and 3 = normal.  The group defined 
what they meant by normal, mild, moderate and severe (see Box [v]). 
 
 122 
 
Box [v]: The scoring criteria of the new measurement tool 
3 =  Normal “Based on what the person’s theoretical optimum normal should be” 
2 = Mild “The ability to meet more than half OR the majority of the components of the 
item, based on what the person’s theoretical optimum normal should be” 
1 = Moderate “The inability to meet more than half OR the majority of the components of 
the item, based on what the person’s theoretical optimum normal should be” 
0 = Severe “An inability to meet any of the components of the item, based on what the 
person’s theoretical optimum normal should be” 
 
The group then agreed that when to measure should be at the discretion of the clinician.  
For example, a patient could be measured:  
 Pre and post treatment session or course of treatment to measure the effect of 
intervention. 
 Post and pre-intervention to measure the carryover effect between treatments or 
courses of treatment. 
 Once per week, or month etc. to measure progress. 
 
The group also agreed that what to measure should also be at the discretion of the 
clinician and be appropriate to the patient, the treatment, and the objectives of the 
treatment e.g., sitting posture, sit to stand, leg on pelvis alignment, resting hand 
alignment.  The nominal group members then used the new measure within their clinical 
practice for two months in order to assess its clinical usefulness. 
 
6.2.5 Nominal group meeting 3 – the naming of the LMPI 
During this group meeting the physiotherapists discussed their experiences of using the 
LMPI within their clinical practice, they felt that it: -  
 Was more sensitive in comparison with other outcome measures 
 Was easier and quicker to use in comparison with other outcome measures 
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 Had low floor and high ceiling effects 
 Could be applied individually according to the patient’s rehabilitation goals  
The group members then agreed on a name for the outcome measure; The Leeds 
Movement Performance Index (LMPI), and prepared a training programme in readiness 
for phase 2.  The data sheet for the LMPI can be seen in Appendix 6. 
 
6.3 Study 1, Phase 2: The pilot study, an initial investigation of 
clinical utility 
 
6.3.1 A description of the participants  
A total of 21 senior neurological physiotherapists were recruited from NHS Centre 1 (see 
Figure [vi]), three participants withdrew from the study (one stopped working for the 
organisation, and two withdrew because their managerial duties prevented their 
continuation).  Of the 18 remaining participants, 13 rotated within different specialities 
related to neurological rehabilitation, i.e. stroke, community, medical wards, 
neurosurgery, and neurological rehabilitation.  The remainder had ‘static’ senior 
specialist posts within different specialities, i.e. neurological rehabilitation unit, acute 
neurology and out-patient clinics.  The participants were considered to be representative 
of both a variety of clinical areas and of grade and experience within neurological 
physiotherapy. 
 
All participants had clinical and research support from a member of the Physiotherapy 
Research Group.  After the participants had used the LMPI within their clinical practice 
for at least three months they participated in a semi-structured interview with the 
researcher.   
 
 124 
 
Eighteen interviews were held, rich note taking was used to record the conversation and 
each participant was asked to read the notes that had been taken to ensure: validity of 
the notes that were taken; that their intended meaning was captured and opportunity to 
add any information.  All data were transcribed into Microsoft word documents and 
stored securely. 
 
6.3.2 Content analysis of the data gathered 
The ‘Physiotherapy Research Group’ met to analyse the data; initially familiarising 
themselves with the content of the transcribed interviews by reading, then re-reading 
them.  Within the group, initial coding was facilitated by using ‘post it’ notes stuck on a 
wall (see Photograph [i]).  Themes were then developed, based on the initial coding, 
then reviewed and organised into three main themes.  Figure [xvii] demonstrates the 
flow and development of the three main themes from the initial coding stage. 
 
 
 
 
 
Photograph [i] The initial identification of codes; thematic 
content analysis: Study 1, Phase 2 
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Initial coding 
 
Themes based on initial coding Review of themes 
A) Patient group   
B) Joint treatment sessions with senior 1) What , where, when and whom to measure  
C) Guided as to how to use by senior   
D) Outcome measures  ‘clinical application’ 
E) Posture or activity measured   
F) Time constraints  2) Time constraints  
G) When measured   
H) To do with parameters    
I) Choosing what to measure   ‘using it’ 
J) Use as a predictive tool  3) Education  
K) Requires practice    
L) Supports clinical reasoning   
M) The written guide    
N) Requires knowledge 4 ) The tool  
O) Format   ‘theoretical underpinning of practice’ 
P) Functionally linked    
Q) Teaching tool 5) Communication  
R) Communication aid   
S) Training need   
  a-priori themes 
Figure [xvii]: The thematic content analysis of clinical utility. Study 1, Phase 2 
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6.3.3 The initial codes 
As the transcribed texts were read by the Physiotherapy Research Group members, 
common themes emerged, and these were designated to a ‘code’.  As new themes 
emerged, new codes were identified, until no more data were left to be analysed.  
Nineteen initial codes were identified, and they are now described in more detail.  
 
Code A) Patient group 
All participants found that within the clinical setting in which they were based; as long as 
the patient required a rehabilitation approach, the LMPI could be used.  For example:  
 When a patient was critically ill, the physiotherapy intervention was directed 
towards life support as opposed to the re-learning of normal motor control. 
 For adults with a learning difficulty, their behaviour was a limiting factor.  The 
participants also commented that using the LMPI with patients who had very 
complex neurological movement problems helped organise a treatment plan. 
Code B) Joint treatment sessions with senior clinician 
The participants found that when they used the LMPI in conjunction with joint treatment 
sessions with a member of the Physiotherapy Research Group; it helped them to think 
and vocalise more deeply about their assessment, diagnosis and clinical reasoning. 
Code C) Use guided by senior clinician 
It was generally felt that having the guidance and support of a member of the 
Physiotherapy Research Group made applying the LMPI into their clinical practice easier.  
More senior participants also reported that they had to be able to understand how to 
analyse normal movement before using the LMPI; reflecting that teaching non-specialist 
physiotherapists to use the LMPI may be difficult. 
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Code D) Outcome measures 
Many of the participants reported that the LMPI could be incorporated into the treatment 
session as opposed to being used separately, such as with the BBS.  Also, that they 
found no ‘floor’ or ‘ceiling’ effects when using the LMPI.  One participant commented that 
she had not come across anything that measured quality of movement before. 
Code E) Posture or activity measured 
There was no consistency related to postures or movements that were measured, but 
participants mostly measured at impairment level e.g. hand orientation to a flat surface 
during contralateral limb activity.   One participant said that measuring impaired 
movement quality helped him to appreciate how much it had changed and impacted on 
the patient’s function. 
Code F) Time constraints  
Time was a significant factor, with participants finding that although the LMPI took some 
time to ‘set up’ it was then quick to use, although one participant commented that using 
the LMPI was time consuming because she had to think more.  Other participants 
reported that using any outcome measures were difficult because of general time 
constraints within clinical practice. 
Code G) When measured 
Several of the participants gave indications as to when in the treatment session the LMPI 
was used, and one of them requested that a ‘key’ should be included on the data sheet 
to indicate when it was used, giving the example of: pre and post treatment, best 
performance during the treatment or post and pre-treatment to measure carryover 
effects. 
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Code H) To do with parameters  
The participants felt that although ‘tricky’ to understand due to their knowledge base, 
the parameters helped them to focus on their patient’s motor control difficulties. 
Code I) Choosing what to measure  
Generally, the participants found choosing what to measure challenging, because it 
made them think about their assessment and treatment plan. One participant described 
the process of thinking about the ‘global’ movement, then measuring a specific impaired 
part of the movement that was being performed.  Although the score criteria and 
technical language generated discussion, no changes were indicated or suggested. 
Code J) Use as a predictive tool  
Participants felt that the LMPI helped them to think about which impaired movements 
were feasible to change; being useful when setting reasonable targets or making 
decisions about their patient’s rehabilitation potential or progress.  
Code K) Requires practice  
Initially the more junior grade participants (i.e. the rotational senior staff) found the 
LMPI difficult to use, but by the end of the project, because of practice and support, they 
were able to use it independently.  The more senior participants were quickly able to use 
the LMPI successfully, with one commenting that she would be happy to use it for every 
patient within her specialty (neurological out-patient clinic). 
Code L) Informs / challenges clinical reasoning 
Throughout the semi-structured interviews, the participants frequently commented on 
the impact that the LMPI had on their clinical reasoning, this was especially so with the 
more junior grade staff; they found that using the LMPI made them really think about 
how they analysed their patient’s movement during assessment. 
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Code M) The written guide  
In general, not many participants referred to the ‘LMPI guidelines’ (Appendix 6), mainly 
because they had good support from the Physiotherapy Research Group members.  
However, one participant felt that the guidelines should be developed to include 
language with less jargon, to ease use for less experienced physiotherapists. 
Code N) Requires knowledge 
Although this was not mentioned specifically, it was clear that in order to use the LMPI 
appropriately and with confidence, users required a good standard of clinical skill; i.e. 
they needed to be able to assess and analyse normal movement in relation to their 
patient’s impaired movement and motor control.   
Code O) Format  
Issues related to the format of the data sheet were few, but suggestions were made: to 
give space to record when the LMPI was used, and to use ‘half’ scores.  Interestingly, 
participants also found that the use of the LMPI made their written clinical records 
quicker and easier to complete. 
Code P) Functionally linked  
The more senior participants (non-rotational senior specialist neurological 
physiotherapists) consistently made links between their patient’s impairment and 
functional abilities; noting that the measurement of movement quality can help the 
therapist appreciate how much it can change and impact on the patient’s function. 
Code Q) Teaching tool 
This code was formulated because of the number of comments, particularly from the 
more junior participants, related to how much they learnt about their patient’s 
movement from their supervising Physiotherapy Research Group member when using 
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the LMPI.  The more senior participant’s comments tended to relate to the usefulness of 
the LMPI within clinical peer review. 
Code R) Communication aid  
Communication (writing clinical records, discussing patients with physiotherapy team 
colleagues and giving confidence to clinical discussions within multi-disciplinary team 
meetings) was all described as being enhanced and simplified with the support of the 
LMPI. 
Code S) Training need 
Possibly due to the novel way of measuring and recording movement, the majority of 
participants commented on the training required to be able to use the LMPI with 
confidence.  They felt that whilst both the training package and guidelines were helpful, 
the support of the Physiotherapy Research Group were also valuable, and suggested that 
video recordings of  patient’s movement during the training session may have been 
beneficial. 
 
6.3.4 The overarching themes 
All participants felt that the LMPI items, wording and scoring criteria should not be 
altered; they also felt that the LMPI met a clinical need. 
 
Participants discussed: the movements they measured in their patients, when they 
measured them and the types of patients they measured.  Participants who were 
experienced needed little support in this area, those who were less experienced needed 
support before they become independent and confident in using the LMPI. 
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All participants felt that training was needed before using the LMPI, and that the tool 
itself provided education in terms of promoting and supporting their clinical reasoning.  
They also thought that the LMPI could potentially be used to help educate junior staff 
and students within the areas of assessment, analysis, diagnosis, goal setting and 
treatment planning. 
 
Time constraints regarding the actual time taken to use the LMPI were identified, 
however, this theme was consistently accompanied by general time constraints within 
clinical practice, and that all outcome measures took time to complete. 
Participants felt that the tool helped communication between therapists in terms of 
treatment planning and continuity, handover of clinical care, and discussion with other 
members of the multi-disciplinary team. 
 
Only two of the participants had used the guidelines, the rest had sought support via the 
Physiotherapy Research Group.  It was noted that simpler language and less jargon 
ought to be used. 
 
To summarise; three important and popular ideas that could be used as a-priori themes 
within future qualitative research methodology emerged from this work: - 
 ‘Clinical application’ – the application of the LMPI into clinical practice. 
 ‘Using it’ – related to the mechanics of using an outcome measure. 
 ‘Theoretical underpinning of practice’ – related to the culture and concept of the 
modern neurological physiotherapy treatment approach. 
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6.3.5 Key actions identified from the themes  
Within an organised Physiotherapy Research Group meeting, following discussions 
related to the results of this pilot study, the following actions were decided: - 
 Some alterations should be made to the demographic patient information area 
and the format of the front page of the LMPI data sheet. 
 The development of a standardised training package designed by the 
Physiotherapy Research Group members, including patient video, should precede 
any future study. 
 The guidelines accompanying the LMPI should be reviewed and modified, using 
feedback and advice from the participants from within this study.  
 
No action would be taken to solve the problems of time constraints, because this was: 1) 
considered to be a service issue and not specifically related to the LMPI, and 2) the use 
of outcome measures was an important standard of clinical practice, and it was 
acknowledged within the qualitative data that all outcome measures were time 
consuming to use. 
 
6.4 Summary of Chapters 5 and 6 
Using consensus methods, a new outcome measure, the LMPI, was developed during the 
course of this study.  The methods used suggest good face and content validity and also 
potentially good clinical utility.  However, there are clear issues of possible bias because: 
1) the Physiotherapy Research Group and study participants work together within the 
neurological physiotherapy team for the same NHS organisation, and 2) the 
Physiotherapy Research Group members could have strongly influenced the participants 
within Study 1 Phase 2.  Nonetheless, scientifically sound ground work has been 
instigated and achieved in preparation for more objective testing within Studies 2 and 3 
of this thesis. 
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Chapter 7: Methods, Study 2: Testing the 
measurement properties of the LMPI 
 
7.1 Introduction  
The aims of this study were to explore the measurement properties of the LMPI, 
specifically:- 
 Internal consistency. 
 External reliability. 
 Criterion validity. 
 Scale responsiveness. 
 
During the course of the study, it was also intended to gain an understanding of face and 
content validity, and to further build on the three a-priori themes in preparation for the 
qualitative methods within Study 3. 
 
This study ran sequentially through three Phases.  Phase 1 focussed on the preparation 
of research tools, Phase 2 examined internal and external reliability and Phase 3 
examined the criterion validity and responsiveness of the LMPI. 
 
Rich note taking and reflexivity throughout this study further established a-priori themes 
which were used for preparation of the Focus Groups in Study 3. 
 
7.2 Study 2, Phase 1: Preparation of the research tools 
The aim of this Phase was to develop a training package for use in the training of 
Physiotherapists and the testing process of Phase 2 of this study. 
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7.2.1 The design of Study 2, Phase 1 
Short (from 7 to 48 seconds) video recordings of patients were made, with each patient 
performing a simple task.  The video recordings were: 1) incorporated into a training 
package to train physiotherapists to use the LMPI or 2) incorporated into a testing 
process to test the LMPI during Phase 2 of this study. The available literature related to 
the use of video for testing the measurement properties of outcome measures varies 
widely in both the number of raters and number of videos.  For example:  Mosely et al 
(2003) used 20 videos and three raters; Carr et al (1985) used five videos and 20 
raters; Whitall et al (2006) used 10 videos and three raters.  Therefore, a pragmatic 
decision (based on resources available, experience of teaching and statistical guidance) 
was made by the author and the Physiotherapy Research Group to use three patient 
videos to help teach the physiotherapists how to use the LMPI, and five videos within the 
test protocol. The use of video is also considered a useful method to reduce the risk of 
change in the patient’s motor control between testing sessions (Pomeroy et al 2003). 
 
7.2.2 Participant eligibility 
Patients who were resident on the acute and rehabilitation wards or attending out-
patient appointments at research Centre 1, the Leeds Teaching Hospitals NHS Trust 
(Figure [vi]) were eligible to be recruited if they met the following criteria. 
 
7.2.3 Inclusion criteria 
 Over 18 years of age. 
 Neurological diagnosis having an impact on motor control. 
 Receiving treatment from a neurological physiotherapist. 
 Deemed (by their Physiotherapist) to be cognitively able to consent to being 
videotaped whilst performing a simple functional task. 
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7.2.4 The recruitment of participants and the consent process  
Patients identified by their Physiotherapist as meeting the inclusion criteria were 
approached by the researcher, who verbally explained the research process and provided 
supporting written information sheets (Appendix4).  Patients were included if they 
provided written informed consent to be videotaped whilst performing a short functional 
task during their physiotherapy treatment session. 
 
7.2.5 Data collection  
Fifteen patients were recruited, and the researcher recorded a short episode of 
movement from each patient using a single hand held digital camera, so that only one 
viewpoint was seen.  The recording was stored securely in a jpeg file format. 
 
Nine men and six women were recruited (see Table [vi]).  Their ages ranged from 28 to 
91 years with a mean age of 55 years (SD 16).  Nine patients had suffered a stroke, two 
had multiple sclerosis and the others presented with peripheral neuropathy or retro-
spinal craniectomy or subarachnoid haemorrhage or traumatic brain injury.  This range 
of pathologies is typically seen within neurological physiotherapy, as is the range of post 
neurological insult recovery stages. The tasks videoed varied, and included: walking, sit 
to stand, forward reach to grasp cup, in supine - elbow flexion with active grasp, supine 
to sit on edge of bed and two handed reach and place hands.  The majority of the tasks 
were functional and all were chosen by the patient and their physiotherapist, reflecting 
their treatment plan and functional goals.  
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Table [vi]: Study 2, Phase 1 participants – video recording of movement 
Gender  9 males, 
6 females 
 
 
Age range from 28 to 91 years 
mean age = 53 years 
SD 16 years 
 
 
Diagnosis  Stroke (3 haemorrhagic / 1 brain stem 
/ 5 infarcts)   Multiple Sclerosis   Peripheral neuropathy   Retro-spinal Craniectomy  Subarachnoid Haemorrhage   Traumatic brain injury 
 
9 
 
2 
1 
1 
1 
1 
 
Recruited from  Neuro-physiotherapy out-patients   Neuro-rehabilitation (ward)  Acute stroke (ward)  Neurosurgery (ward)  Stroke rehabilitation (ward)   
 
8 
4 
1 
1 
1 
 
Functional task recorded  Walking   Sit to stand   Forward reach to glass   In supine, elbow flexion with active 
grasp   Supine to sit on edge of bed   2 handed reach and place  
7 
3 
2 
 
1 
1 
1 
 
Once all the videos had been recorded and stored, they were reviewed by the 
Physiotherapist Research Group who allocated videos for either training physiotherapist 
participants in the use of the LMPI, or testing the LMPI measurement properties, based 
on the following criteria. 
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7.2.6 The videos allocated for training 
Based on their experience of providing clinically based education to less experienced 
physiotherapists, the Physiotherapy Research Group considered that between three and 
four videos would give a sufficient variety of motor control difficulties on which the LMPI 
could be applied.  The criteria used for allocating the videos for the training package 
were that: - 
 A variety of problems should be presented so that physiotherapists could learn to 
apply the concepts of the LMPI to different movement problems. But at the same 
time, the number of videos used should be as small as possible so that the 
process could be kept as simple as possible. 
 The patient’s movement / motor control difficulties should be sufficiently complex 
to initiate discussion about their motor impairments; so that the principles of the 
use of the LMPI could be applied. 
 The motor control difficulties that the patient presented should be fairly typical of 
movement difficulties commonly observed in clinical practice. 
 The videos chosen to support the training should look at different aspects of 
movement. 
 
The videos allocated were: 
Training video 1: A 68-year-old man who had had a stroke that affected the 
movement on the left side of his body three months 
previously.  The video was of him seated, reaching forwards across 
a table to grasp a glass of water with his left hand (9 seconds). 
Training Video 2: A 50-year-old woman who had had a stroke that affected the 
movement on the right side of her body two years previously.  The 
video was of her standing up from a treatment plinth and stepping 
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round to sit in her wheelchair using a quad stick to help her balance 
(20 seconds). 
Training video 3: A 48-year-old man who had had a stroke in his brain stem that 
affected the movement throughout his body 14 years 
previously.  The video was focussed on his lower legs and feet 
during stand up from sitting (17 seconds). 
Training video 4: A 51-year-old woman who had multiple sclerosis that affected her 
core strength and balance, diagnosed two years previously.  The 
video was of her walking down the corridor in the physiotherapy 
department without any walking aid or assistance (28 seconds). 
 
It was intended that discussion related to all or any parts of the patients motor control 
difficulties and the appropriate application of the LMPI would occur during the training 
process.  
 
7.2.7 The videos allocated for testing 
Because the available literature related to the use of video for testing the measurement 
properties of outcome measures varies widely, a pragmatic decision was made to use 
five videos within the test protocol. 
 
The criteria used for selecting the videos to be used during the testing protocol were 
similar to those for the training package, but directed towards an individual viewer as 
opposed to group viewing with discussion: - 
 The motor control difficulties that the patient presented were fairly typical of what 
would commonly be observed in clinical practice. 
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 The videos chosen should focus on different aspects of motor control problems to 
each other. 
 That patient’s movement should be clearly visible; normally, physiotherapists 
observe their patient’s movement difficulties in three dimensions, but for the 
purposes of the testing of the LMPI they were asked to make judgements in only 
two dimensions. 
 
The patient videos allocated were:- 
Test Video 1: A 68-year-old man who had had a stroke that affected the 
movement on the left side of his body three months 
previously.  The video was of a side view of him rising into a 
standing position from seated in his wheelchair (7 seconds). 
Test Video 2: A 55-year-old woman who had had a bi-lateral radiculopathy 
affecting her lower limbs following radiotherapy for cervical cancer 
one year previously. The video was of a side view of her rising into 
a standing position from seated in her wheelchair (8 seconds). 
Test Video 3: A 62-year-old man who had had a stroke in his brain stem that 
affected the movement on the right side of his body two months 
previously.  The video was of him walking up and down the 
corridor, from one stationary view point, so that both front and rear 
views could be observed  (48 seconds). 
Test Video 4: A 65-year-old man who had had a stroke that affected the 
movement on the left side of his body over two years 
previously.  The video was of a front view of him seated, reaching 
forwards across a table to grasp a glass of water with his left hand, 
and then lifting it towards his mouth (8 seconds). 
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Test Video 5; A 65-year-old woman who had a complex history of sub-arachnoid 
haemorrhage and aneurysms with a prolonged hospital admission 
including several weeks on the intensive care unit with artificial life 
support. She had general body weakness and deconditioning, 
combined with a significant right arm weakness.  The video was of 
her laying supine in bed, then rolling onto her right side to sit on 
the edge of her bed.  The video was shot from the bottom of her 
bed at the side that she was moving towards (30 seconds). 
 
7.2.8 The training and testing package 
A Microsoft PowerPoint presentation (see Appendix 9) was prepared by the researcher 
incorporating the background and history of the development of the LMPI and the video 
material previously described.  It was intended that the presentation be used: 1) to train 
then test the Senior Physiotherapists Participant Group; and 2) to train the Expert 
Physiotherapists Group. 
 
7.3 Study 2, Phase 2: Internal consistency and external reliability 
 
7.3.1 Introduction  
The aim of Study 2 Phase 2 was to examine the internal consistency and external 
reliability of the LMPI in order to establish confidence that: 
 The five different items were all necessary parts of the measurement tool. 
 The LMPI could be used by the same physiotherapist to reliably score change over 
time. 
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 The LMPI could be used by a team of therapists treating the same patient, or 
during transfer between therapists as part of the clinical information that follows 
the patient along their rehabilitation pathway. 
 
7.3.2 The design of Study 2, Phase 2 
Senior Physiotherapists (Senior Physiotherapists Participant Group) were trained to use 
the LMPI, and then followed a testing protocol designed to examine its internal and 
external reliability.  Five video recordings were watched and rated using the LMPI.  Two 
weeks later, the video recordings were re-watched and re-rated.  The viewing order 
remained the same. 
 
7.3.3 Participant eligibility 
Senior Physiotherapists (Senior Physiotherapists Participant Group) who worked for the 
NHS and who met the inclusion criteria below were recruited into the study. 
 
7.3.4 Inclusion criteria 
 Majority of caseload spent treating patients who had a neurological diagnosis; in 
order to ensure familiarity and confidence working with patients who had 
neurologically related movement difficulties (see Study 1). 
 Working as a senior therapist; Study 1 results had found that newly qualified or 
junior grade physiotherapists needed to be taught how to analyse movement 
before they could use the LMPI 
 Permission from their manager to participate. 
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7.3.5 The recruitment of participants and the consent process  
Neurological physiotherapy service managers from three participating NHS organisations 
were approached and permission was gained for the researcher to approach 
physiotherapists working within their organisations who met the inclusion criteria 
(Appendix4).  The managers identified eligible physiotherapists who agreed to meet with 
the researcher.  Both verbal and written information about the study were given to 
prospective physiotherapist participants by the researcher prior to the gaining of 
informed consent (Appendix 4).  This written information was sent four weeks previously 
to prospective participants, with the invitation to attend a meeting.  At the meeting, 
verbal information was given about the research study, prior to an invitation to attend a 
follow-on training event; during which, the participants learnt how to use the LMPI. 
 
7.3.6 Data collection 
Training protocol 
In groups of three or four, the Senior Physiotherapist Participants were trained to use 
the LMPI, using the research material developed during Phase 1.  The half day training 
event took place in participant’s workplaces within their normal working hours.  Problem 
solving discussions about each patient’s videoed movement enabled the physiotherapist 
participants to apply the LMPI to clinical problems and use the clinical reasoning process 
to underpin observational assessment and analysis of the patient’s movement. Once the 
physiotherapist participants expressed verbally that they understood how to use the 
LMPI, they progressed to the testing protocol. 
Testing protocol 
After a short break, participants were shown five further video recordings of 
patients.  Each video was played repeatedly, while the physiotherapist participants used 
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a paper datasheet of the LMPI to ‘rate’ each patient’s movement.  The physiotherapists 
were told specifically what to measure i.e.:- 
Test video 1 The actions of the patient’s left leg (pelvis, hip, thigh, lower leg, 
ankle and foot). 
Test video 2  The actions of the patient’s right hip, knee and foot. 
Test video 3    The patient’s ‘whole body’ walking quality. 
Test video 4 The patient’s left shoulder, arm and hand from the start of the 
movement up to the grasp of the glass. 
Test video 5  The patient’s ‘whole of body’ movement. 
 
Two weeks later, the use of the LMPI was reviewed with the participants, who then re-
watched the same videos and re-rated each patient’s movement.  A time gap of two 
weeks is consistent with similar research (Carr et al 1985; Mosely et al 2003; Whitall et 
al 2006) and was considered a long enough period for participants to have poor recall of 
their previous assessment results.  On both occasions the participants were blinded to 
their own and the scores made by other participants; this was done to minimise both 
professional scrutiny and potential bias. All data were gathered together and stored 
confidentially and securely by the researcher prior to the analysis of reliability. 
 
7.3.7 Sample size estimations 
No examples of sample size estimation methods for the evaluation of the measurement 
properties of outcome measures were identified in the literature.  Therefore, literature 
related to the development of quality of life in cancer rating scales was used (Johnson et 
al 2011); here, a ‘rule of thumb’ of five to ten participants for every item in a 
questionnaire is recommended.  A sample size of five patients and 20 Senior 
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Physiotherapist Participants was expected to provide a sufficient number of completed 
assessments to assess the internal consistency and external reliability of the LMPI. 
 
7.3.8 Data analysis 
Data were analysed using SPSS (version 20.0). 
 
7.3.9 Internal consistency 
This was assessed using Cronbach’s alpha coefficient, applied to the overall scale and to 
each individual item.  
 
7.3.10 External (inter-rater) reliability 
This was assessed by calculation of the Intraclass Correlation Coefficient (ICC) for the 
scores awarded by multiple raters, appropriate for the analysis of numerical data 
(Armitage et al 2008). 
 
7.3.11 External (test-retest) reliability 
This was assessed by calculation of Spearman’s rank correlation coefficient for total scale 
scores obtained on two testing occasions. 
 
7.3.12 Measurement error 
Measurement error was assessed by evaluation of the Smallest Detectable Change 
(SDC). This statistic is a function of the ICC and Standard Deviation (SD). 
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7.3.13 Variance components analysis 
This procedure estimates the contribution of each random effect to the variance of the 
dependent variable. Hence in the current context, variance in LMPI score is partitioned 
into components arising from between-patient variability, between-therapist variability 
and between-testing variability; as well as from residual variability; to assess the 
proportion of variability in LMPI score that might arise from instability of the instrument 
when applied by multiple physiotherapists or across multiple measurement 
occasions.  Thus the procedure determines where attention should be focussed in order 
to reduce the variability. In this process it is assumed that both the practitioners and the 
patients featured in the sample represent random selections from larger populations. 
 
7.4 Study 2, Phase 3: Criterion validity and responsiveness 
 
7.4.1 Introduction 
The Senior Physiotherapist Participants group from Study 2 Phase 2 were trained to 
recruit NHS patients for purposes of this research using the International Conference on 
Harmonisation − Good Clinical Practice Guidelines (ICH-GCP 2000).  These guidelines 
were developed with international agreement, and although were intended for use with 
multi-centre pharmaceutical trials, the principles of good research practice are 
transferable. 
The aims of this study were to investigate the criterion validity and the responsiveness of 
the LMPI. 
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7.4.2 The design of Study 2, Phase 3 
The physiotherapists were asked to recruit appropriate patients from their clinical 
caseloads and then measure their movement performance using the LMPI and the BBS 
(Berg et al 1989) prior to; and at the end of a course of treatment, or after six weeks 
(whichever was the soonest).  Site visits were carried out by the researcher in line with 
ICH-GCP guidelines and also: 
 To support the Senior Physiotherapist Participants group in their recruitment of 
participants and use of the LMPI. 
 To gather ‘rich’ notes, perceptions, reflections about how members of the Senior 
Physiotherapist Participants group found using the LMPI in clinical practice. 
All data were gathered together and stored confidentially and securely by the researcher 
prior to analysis. 
 
7.4.3 Participant eligibility 
Patients who were resident on the acute and rehabilitation wards, or attending out-
patient appointments at participating NHS organisations, or who were receiving 
intervention in their own homes by members of the Senior Physiotherapist Participants 
Group; were eligible to be recruited if they met the following criteria. 
 
7.4.4 Inclusion criteria 
 Over 18 years old. 
 Neurological diagnosis having an impact on motor control. 
 Receiving treatment from a member of the Senior Physiotherapist Participants 
Group. 
 Considered (by their Physiotherapist) to be cognitively able to consent to be 
included in the research. 
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7.4.5 The recruitment of participants and the consent process  
The Senior Physiotherapist Participants who had been trained to use the LMPI and to 
recruit patients to research studies identified their patients who met the inclusion 
criteria.  They then approached their patients, verbally explained the study process and 
supported their explanation with written participant information sheets 
(Appendix4).  Patients were included if they met the eligibility criteria and provided 
written consent. 
 
7.4.6 Data assessments 
Physiotherapists measured their patient’s movement using the LMPI and the BBS and 
recorded it on the appropriate data sheets (Appendices6 and 1 respectively).  The data 
sheets were then stored in the patients clinical records.  After a course of treatment (or 
after six weeks, whichever was the sooner) the physiotherapists re-recorded their 
patient’s movement.  They were not blinded to their baseline assessment.  The data 
sheets were then photocopied by the physiotherapist and collected by the researcher 
during a site visit.  The data collected were stored securely in a locked office on NHS 
premises ready for analysis.  The original documents remained in the patient’s 
physiotherapy clinical records. 
 
7.4.7 The Berg Balance Scale 
This scale was chosen to be used in Study 2 Phase 3, because it is a well-known, widely 
used outcome measure (see Chapter 3.5), validated for use within several diagnostic 
patient phenotypes (Blum& Korner-Bitenski 2008; Kornetti et al 2004; La Porta et al 
2012; Qutubuddin et al 2005). The BBS is a measure of balance, it was expected that 
the construct of the LMPI would correlate moderately well with the BBS because 
  
148 
 
successful balance requires a significant element of efficient good quality movement and 
motor control (see Box [iv] andAppendix1). 
 
7.4.8 Sample size estimations 
Again, no examples of sample size estimation methods for the evaluation of the 
measurement properties of outcome measures were identified in the 
literature.  Therefore, the ‘rule of thumb’ guidance by Johnson et al (2011) was again 
applied.  A sample size of between 25 and 50 patients was expected to provide a 
sufficient number of completed assessments to assess the criterion validity and 
responsiveness of the LMPI.  Similar published work that tests the criterion validity of the 
BBS have used comparable numbers of participants: Berg et al (1989) used 38 patients, 
Berg et al (1992) used 31 patients, Liston and  Brouwer (1996) used 22 patients, Bennie 
et al (2003) used 20 patients, Qutubuddin et al (2005) used 38 patients, Lemay & 
Nadeau (2010) used 32 patients.  The recruitment of more patients than the estimated 
requirements were deemed to be unnecessary because of ethical reasons and study 
constraints. 
 
7.4.9 Data analysis 
 
7.4.9.1 Criterion validity 
Criterion validity was assessed by evaluation of the correlation between the BBS and 
LMPI pre and post intervention scores; and by construction and evaluation of the 
corresponding Bland-Altman plots (Bland& Altman 1986); which facilitate a visual 
representation of the relationship between averaged and difference scores evaluated 
from pre and post intervention data. 
  
149 
 
7.4.9.2 Clinical responsiveness 
This was assessed by calculating mean within patient change scores in the BBS and the 
LMPI pre and post intervention, so that the responsiveness of the LMPI can be compared 
with the BBS when the variables of both the physiotherapists and the patients are 
unchanged. 
The magnitude of the effect of the intervention measured by both the LMPI and the BBS 
was also calculated, using a Cohen’s d statistic. 
 
7.5 Field notes 
The technique of rich note taking and reflexivity by the researcher throughout this study 
further established the a-priori themes that emerged during Study 1 Phase 2 which were 
used within the Focus Groups in Study 3. Template analysis (King 2014; King & Brooks 
2014) was used within Study 3, providing a framework to interpret the data. 
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Chapter 8: Results, Study 2: The measurement 
properties of the LMPI 
 
8.1 Introduction  
This chapter presents the results of the testing of measurement properties of the LMPI. 
Phase 1 of this study focusses on the preparation of research tools which have been 
previously discussed in Chapter 7.3. The results from Phase 2 will include a description 
of the participants recruited (the Senior Physiotherapist Participants Group) and a 
presentation of the results of the data analysed to test internal consistency,  external 
(inter-rater and test-retest) reliability, and a variance components analysis.  Results 
presented in this study have been previously published in Physiotherapy Theory and 
Practice (Ross et al 2014), an internationally peer reviewed journal (Appendix10). 
 
Phase 3, will present the results of the testing of criterion validity and the 
responsiveness of the LMPI, including a description of the patient participants recruited 
and a presentation of the data analysed to test criterion validity and clinical sensitivity in 
comparison with the BBS. 
 
8.2 Study 2, Phase 2: Internal consistency and external reliability 
Study 2 Phase 2 investigated the internal consistency and external (inter-rater and test 
re-test) reliability (see Chapter 7.3). 
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8.2.1 A description of the participants  
A total of 12 participants were recruited to the Senior Physiotherapist Participant Group 
from three NHS centres (see Figure [vi]).  Appendix 11 presents the demographics of 
the members of the Senior Physiotherapist Participants Group. Five members were 
recruited from Centre 2, The Leeds Community Health Care Trust (two separate groups 
were recruited to reduce participant burden), three members were recruited from Centre 
3; The Mid Yorkshire Hospitals NHS Foundation Trust, and four members were recruited 
from Centre 4; The Airedale NHS Foundation Trust. The physiotherapists worked in a 
variety of clinical areas, representative of those found within neurological physiotherapy. 
The physiotherapists were all senior grade, and all had been qualified for more than five 
years.  The group’s postgraduate education was also varied: some had completed 
Masters’ degree modules (n=4) or a full Masters’ degree (n=1), all were active within in-
service training programmes and one was enrolled on a Professional Doctorate program.  
Most of the participants had trained within the Bobath concept (BBTA 2014) (n=11), and 
two had motor re-learning backgrounds (Carr & Shepherd 2003). 
 
8.2.2 Sample size 
After being trained to use the LMPI using the material developed during Study 2 Phase 1 
(Chapter 7.2), the 12 Senior Physiotherapist Participants used the LMPI to assess the 
movement of the five patients previously recorded with video.  The physiotherapists re-
assessed the same patient videos two weeks later.  Appendix 12 contains the full data 
gathered during this phase of the study. 
No data is missing. 
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8.2.3 Data analysed 
8.2.3.1 Internal consistency 
Table [vii] summarises the values of Cronbach’s Alpha Coefficient calculated for both the 
overall scale and to each individual item. The alpha value for all items (0.862) indicates 
high overall reliability; the alpha values of the scale with individual items removed is also 
strong (range from 0.795 to 0.892), implying that the reliability of the scale decreases 
with the removal of all scale items except Alignment. However, the removal of the 
Alignment item results in only a very small increase in scale reliability, which would not 
justify the loss of information resulting from the removal of this item. 
Table [vii]: Internal consistency of the LMPI 
Cronbach's Alpha, overall scale 0.862 
 Cronbach's Alpha if Item 
removed 
Item to total correlation 
Alignment 
Interaction 
Timing 
Speed 
Selective Movement 
0.892 
0.833 
0.811 
0.816 
0.795 
0.401 
0.681 
0.773 
0.745 
0.821 
 
 
8.2.3.2 External (inter-rater) reliability 
Table [viii] summarises the assessment of the consistency of the scores made on 
different measurement occasions, and by different physiotherapists using the ICC.  
Overall, external reliability was high (0.959), with individual item reliabilities ranging 
from 0.874 to 0.968.  The p values demonstrate statistical significance of all items, 
implying that the LMPI has strong inter-rater reliability. 
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Table [viii]: External (inter-rater) reliability of the LMPI 
 Intraclass Correlation 
Coefficient 
p-value 
Average measures all items 0.959 <0.001 
Alignment 
Interaction 
Timing 
Speed 
Selective Movement 
0.874 
0.931 
0.957 
0.935 
0.968 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
 
Table [ix] presents the percentage agreement between raters for each item; five items 
plus twelve raters gives a total number of possible agreements for each item to be sixty.  
The percentage agreements between total scores for each patient by each rater are also 
given. 
 
Table [ix]: The percentage agreement between raters when rating individual item and 
total scale values 
Item  Number of agreements 
between raters for 
each item (n=60) 
Percentage agreement 
between raters for 
each item 
Percentage agreement 
between raters for all 
items (n=300) 
Alignment 37 62%  
 
 
71% 
Interaction 50 83& 
Timing 42 70% 
Speed 39 65% 
Selective Movement 44 73% 
Total scores 21 35%  
 
The apparently large levels of disagreement represent only small departures from perfect 
agreement and are not necessarily large discrepancies (Appendix 12).    
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8.2.3.3 External (test-retest) reliability 
Table [x] summarises the results of an item-total rank correlation analysis to assess 
test-re-test reliability; the value of the correlation coefficient for the full scale is high 
(0.792) with values of individual items ranging from 0.397 to 0.674; indicating effects of 
medium size or greater. Furthermore, the corresponding correlation coefficients for 
individual items of the scale were all statistically significant (p<0.002 in all cases). 
 
Table [x]: External (test re-test) reliability of the LMPI 
 Spearman's rho rank 
Correlation Coefficient 
p-value 
All items  0.792 <0.001 
Alignment 
Interaction 
Timing 
Speed 
Selective Movement 
0.397 
0.674 
0.516 
0.655 
0.655 
<0.002 
<0.001 
<0.001 
<0.001 
<0.001 
 
8.2.3.4 Measurement error 
From the values of the ICC and SD previously obtained, the SDC was calculated to be 
1.16, using the method described by Ries et al (2009). 
 
8.2.3.5 Variance components analysis 
Table [xi] summarises a variance components analysis that was used to examine the 
variability of the results, to partition variance into components arising from between-
patient variability, between-therapist variability and between-testing variability; as well 
as from residual variability. The low proportions of variability between therapists and 
between measurement occasions calculated from this procedure (7.8% and 2.8% of total 
variability respectively) provide further evidence of the stability of the scale; with, as 
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might be expected, the largest component of variance arising from natural between-
patient variability. This component represents 55.2% of the total variance and 83.2% of 
all accountable variance.    The high variance between patients reflects the variety of 
different patient presentations. 
 
Table [xi]: Variance components analysis of the LMPI 
Component Variance 
Estimate 
% of total 
Variance between Physiotherapists 
Variance between Patients 
Variance between replicate measurement 
occasions  
Residual variance 
0.467 
3.317 
0.170   
2.056 
7.8% 
55.2% 
2.8% 
34.2% 
 
8.3 Study 2, Phase 3: Criterion validity and clinical sensitivity 
 
8.3.1 Introduction 
As previously described (Chapter 7.4), in order to compare scores between the LMPI and 
the BBS, the Senior Physiotherapist Participants Group was trained, using guidance from 
ICH-GCP guidelines (ICH-GCP 2000) to recruit NHS patients into Phase 3 of this study. 
 
8.3.2 A description of the participants  
Twenty seven patients were recruited; their movement performance was measured by 
the Senior Physiotherapist Participants using the BBS and the LMPI pre and post course 
of physiotherapy treatment intervention.  Appendix 13 displays patient demographic 
data.  Age in years of participants recruited ranged from 19 to 76, with a mean age of 49 
years and a median age of 62 years. Sixty-six percent of participants were women.  Fifty 
percent were recruited from home, 33% from neurological-physiotherapy outpatient 
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clinics and 14% from a hospital ward.  Fifty-nine percent of participants had suffered 
from a stroke; the other participants’ diagnoses were of neurological pathology.   
 
8.3.3 Test results pre and post intervention 
Appendix 13 displays the results of the Senior Physiotherapist Participants assessment of 
their patient’s data gathered pre and post physiotherapy intervention.  The majority of 
patient scores improved.  In two cases (patients 4 and 7) the BBS score did not change 
post treatment when the LMPI score did, and in three cases (patients 22, 25 and 27), 
the LMPI score did not change post treatment when the BBS score did. In one case 
(patient 10) neither the BBS nor the LMPI scores changed post treatment. No patient 
participants withdrew from the study, and all were able to complete their course of 
treatment.  Patient participant 12 had the only incomplete set of data. Appendix 13 
contains the complete results from this phase of the study, including patient 
demographic information and test results.  
 
8.3.4 Data Analysis 
 
8.3.4.1 Criterion validity 
Bivariate Spearmans correlation calculation  
Tables [xii], [xiii] and [xiv] present the results of the Spearmans correlation calculations 
between the LMPI and the BBS:- 
 Between the total scores of the BBS and the LMPI pre physiotherapy intervention 
- Table [xii]. 
 Between the total scores of the BBS and the LMPI post physiotherapy intervention 
- Table [xiii]. 
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 Between the change in scores of the BBS and the LMPI pre and post 
physiotherapy intervention - Table [xiv]. 
 
Table [xii]: A Bivariate  Spearmans correlation calculations between BBS and 
LMPI measured pre physiotherapy intervention 
 LMPI pre 
 BBS pre 0.468 
 p value 0.014 
 
 
 
Table [xiii]: A Bivariate  Spearmans correlation calculation between BBS and 
LMPI measured post physiotherapy intervention 
 LMPI post 
 BBS post 0.461 
p value 0.015 
 
 
Table [xiv]: A Bivariate  Spearmans correlation calculation between BBS change 
in scores pre and post physiotherapy intervention and LMPI change in scores pre 
and post physiotherapy intervention 
 LMPI change 
 BBS change 0.473 
p value 0.013 
 
In each case, a moderate correlation is evident between the BBS and the LMPI.  All 
correlations are statistically significant (p < 0.05 in all cases).  When these results were 
plotted onto scatter plots (Graph[i]), the variability in correlation is clear.  
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Bland Altman scatter plot  
When correlating two tools that measure similar items, in this case the patient’s changing 
movement and balance ability; it is highly probable that the two measures will agree 
with each other.  A Bland-Altman scatter plot (Bland & Altman 1986) was therefore 
carried out after the results had been standardised (see Graph [ii]).   
 
Graph [i] A scatter plot illustrating the linear relationship between BBS change in scores pre and 
post physiotherapy intervention and LMPI change in scores pre and post physiotherapy 
intervention 
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LMPI change in scores: pre and post intervention 
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There are only two points which lie beyond the upper and lower limits of agreement 
(defined as 2 Standard Deviations either side of the mean). This is within expectations 
for a data set of this size and indicates that there is good consistency between the 
measures. 
 
There is no obvious pattern in the data as you look from left to right, the points seem to 
be randomly scattered about the zero line. This indicates that agreement is constant 
over large and small values; i.e. that the level of agreement seen between the BBS and 
the LMPI does not depend on whether the scores are high or low. 
 
Average of standardised BBS and LMPI measures (post intervention) 
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Graph [ii] A Bland-Altman scatter plot between the difference and average of LMPI 
and the BBS post intervention 
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160 
 
This demonstrates: 1) moderate correlation (Graph [i]), 2) consistency whether the 
patient has a low or high score (Graph [ii]), and 3) a repeatable coefficient of only 2 
Standard Deviations (Graph [ii]) (Petrie& Sabin 2009; Bland &Altman 1986) for 93% of 
the plots.  This suggests that a physiotherapist could confidently use this scale with a 
patient who has major (low score) or mild (high score) movement difficulties. 
It is interesting that the scores of patients 4 and 13 do not fit with the trend, and their 
removal improves both reliability and consistency. 
 
8.3.4.2 Clinical sensitivity 
The clinical sensitivity of the BBS and LMPI measures was tested using the 27 patients 
measured pre and post treatment (see Table [xv]). The mean total BBS score pre-
treatment was 31.1; the mean post treatment score was 38.7, demonstrating an 
improvement in balance. Hence a mean difference of 7.6 was recorded on the BBS 
measure. This was significant at the 5% level (p<0.001; 95% confidence interval). The 
mean total LMPI score pre-treatment was 5.78; the mean post-treatment score was 
8.56, demonstrating an improvement in movement performance. Hence a mean 
difference of 2.78 was recorded on the LMPI measure. This was also significant at the 
5% level (p<0.001; 95% confidence interval). 
 
Table [xv]: Clinical sensitivity of the LMPI and the BBS 
 BBS LMPI 
Mean total pre treatment 31.1 5.78 
Mean total post treatment 38.7 8.56 
Mean difference 7.6 2.78 
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Effect size 
The effect size using a Cohen’s d statistic (table [xvi]) was calculated as the difference in 
means divided by the standard deviation of pre and post treatment data measured on 27 
patients.  This was found to be 0.99 for BBS and 1.52 for LMPI.  
 
Table [xvi]: Effect size, comparison between the BBS and the LMPI 
 BBS LMPI 
Cohen’s d statistic 0.99 1.52 
 
 
Whilst both these effects might be considered to be large in magnitude, the higher value 
obtained by the LMPI suggests that this measure may have greater sensitivity in the 
assessment of improvements following treatment than the BBS. 
 
8.4 Summary  
Twelve raters were used to test the measurement properties of internal and external 
reliability, the results are consistently strong, suggesting that the measurement 
properties are good, and furthermore; because of the number of raters tested, it is 
suggested that the confidence of the results having a low risk of error is good. 
The correlation between the LMPI and the BBS is good, but does not definitively prove 
consistency; however, the Bland-Altman plot provides evidence that there is good 
consistency across a range of scores. 
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Chapter 9: Methods, Study 3: Testing the clinical 
utility, face and content validity of the LMPI 
 
9.1 Introduction  
Study 3 investigated the clinical utility (see Table [ii]) and meaning of the LMPI when 
used within clinical practice by: 1) The Expert Physiotherapist Group of senior 
neurological physiotherapists; and 2) the Senior Physiotherapists Participants Group 
recruited into study 2.  The qualitative data that were generated in this study was 
analysed using Template Analysis as described by King (2014) and King and Brooks 
(2012).   
 
9.2 Study 3, Phase 1: Clinical utility, face and content validity: 
Focus Groups with Expert Physiotherapist Group 
 
9.2.1 Design: Focus Groups with national experts 
 
National Expert Physiotherapists (British Bobath Tutors) were recruited to the study, and 
trained to use the LMPI, using the same training package as the participants in Study 2 
Phase 2 (Appendix 9).  The participants were asked to use the LMPI during their clinical 
and teaching practice for six months. At the end of six months, they were asked to 
attend one of two Focus Group meetings. 
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9.2.2 Focus Groups 
Focus group methodology was specifically chosen so that the group’s interactions, 
discussions and challenges could be used as data (Kitzinger 1994; Smithson 2000).  This 
group of therapists knew each other very well within both work and social contexts, and 
they naturally discussed and challenged each other’s thoughts and perceptions regarding 
subjects such as the utility of the LMPI.   
 
The Focus Groups were organised using guidance from Kitzinger (1994; 1995) and White 
and Thomson (1995), it was intended that the Focus Groups would: - 
 Have between four and eight participants. 
  Have agreed rules e.g. confidentiality (see Appendix 5). 
 Be conducted in an informal style. 
 Be run for one hour. 
 Be audio recorded. 
 Use note taking (onto a flip chart) of key themes for immediate validation of the 
Focus Groups member’s important issues. 
 Have minimal input from the researcher, other than to introduce specific 
questions, to request clarification, or urge debate.  This was so that participants 
could be facilitated to move the discussion outside the researcher’s knowledge 
limits, and to ensure all participants had a voice. 
 
9.2.3 Participant eligibility 
The British Bobath Tutors Association (BBTA 2014) is a nationally and internationally 
renowned group of expert neurological physiotherapists who work both: 1) clinically 
within the NHS, higher education and the private sector, and 2) organise and teach on 
internationally respected and demanded clinically focused courses, specifically for 
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specialist neurological physiotherapists and occupational therapists.  The headquarters of 
the British Bobath Tutors Association is based in York. 
 
The British Bobath Tutors Association has 17 members in the UK and Ireland, and all 
available group members who met the following inclusion criteria below were invited to 
participate in the research study.   
 
9.2.4 Inclusion criteria 
 A member of the British Bobath Tutors Association. 
 A Physiotherapist. 
 Spends the majority of work time spent treating patients who have a neurological 
diagnosis, or teaching Physiotherapists to treat patients with movement 
difficulties caused by neurological impairment. 
 Able to complete the study. 
 Able to agree to use the LMPI within their clinical and / or teaching practice. 
 
9.2.5 The recruitment of participants and the consent process  
The BBTA hold business meetings at the British Bobath Tutors Association headquarters 
in York twice per year.  After approaching the chairperson of the British Bobath Tutors 
Association, the researcher was invited to attend a business meeting to present the 
research protocol and to invite British Bobath Tutors Association members who met the 
inclusion criteria to participate.  Both verbal and written information in the form of 
participant information sheets were given prior to the recruitment of participants 
(Appendix 4). 
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9.2.6 The training protocol  
The Expert Group Physiotherapists were trained to use the LMPI using the research 
material developed during Study 2 Phase 1 (Chapter 7) using the same training protocol 
as the Senior Physiotherapists Participants Group received in Study 2 Phase 2 (Chapter 
8).  The training was delivered by the researcher and took place within an allocated 
session during the ‘May’ business meeting of the British Bobath Tutors 
Association.  Problem solving discussions about the patient’s videoed movement enabled 
the expert physiotherapist participants to apply the LMPI to clinical problems and use the 
clinical reasoning process to underpin observational assessment and analysis of patient’s 
movement. Once the Expert Physiotherapist Group participants expressed verbally that 
they understood how to use the LMPI, they were asked to use the LMPI within their 
clinical and teaching practice. 
 
9.2.7 Use within clinical and teaching practice 
The Expert Physiotherapist Group members work in a variety of clinical, academic and 
private settings throughout the UK (England, Scotland, Ireland and Wales); teaching on 
National and International courses.  They were not asked to recruit their patients to the 
study, but to use the LMPI for six months within their routine professional practice, in a 
similar way to how they would use other available outcome measures. 
 
9.2.8 Data collection 
Those who provided consent, attended one of two Focus Groups of six participants each, 
held within allocated sessions during the ‘November’ business meeting of the British 
Bobath Tutors Association.  The Focus Group structure included the a-priori themes 
gathered during Studies 1 and 2, that is; ‘clinical application, ‘ease of use’, and 
‘theoretical underpinning to clinical practice’.  
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The groups were facilitated by the researcher and at the same time, key observational 
notes were taken by an assistant (a physiotherapist from the Physiotherapist Research 
Group) and written onto a flip chart that was visible to the participants.  In this way, the 
participants could give immediate validation of key or important issues.  The Focus 
Group meeting was audio-recorded from start to finish.  Each meeting lasted for 
approximately one hour. The audio-tapes were stored securely. 
 
9.2.9 Sample size estimations 
Kitzinger (1994; 1995) and White and Thomson (1995), state that focus groups should 
have between four and eight participants.   Based on 17 potential participants recruited 
from the British Bobath Tutors Association, it was envisaged that two focus groups would 
be run, with a third group planned if all British Bobath Tutors Association members 
consented to participate in the study.  
 
9.2.10 Analysis 
The audio tapes were transcribed verbatim into line numbered Microsoft word 
documents.  Cross case Template Analysis was carried out, as described by King 
(2014).  This is described in greater depth later in this section. 
 
9.3 Study 3, Phase 2: Clinical utilisation and reflective writing, 
Senior Physiotherapist Participants Group 
 
9.3.1 Introduction  
The aim of this study was to 1) investigate the clinical utility of the LMPI in greater 
depth, and 2) to expose the researcher and the LMPI to peer-review, securing the 
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judgements of the Senior Physiotherapist Participants Group who had been recruited into 
Study 2 Phase 2. 
 
9.3.2 Design: reflective writing by Senior Physiotherapist 
Participants Group. 
The physiotherapists had been using the LMPI and the BBS within their clinical practice 
during Study 2 Phase 3 (this phase ran for approximately six months).  When this phase 
came to an end, they were asked to write a piece of reflective work related to their 
clinical and professional impressions of the LMPI.  Guidance in the form of prompts was 
used in order to focus the participant’s responses (see Appendix 14).  These prompts 
were formed by both the a-priori themes and the emergent themes from the Focus 
Groups and included: ‘clinical application’, ‘ease of use’, ‘theoretical underpinning to 
clinical practice’. 
 
Written reflection as opposed to focus groups methods or interviews was decided for this 
group of participants so that the burden of participation was minimised, this group of 
therapists worked in different NHS organisations, did not know each other and may not 
have felt comfortable in disagreeing with or challenging each other or the LMPI. 
 
9.3.3 Eligibility, inclusion criteria, recruitment of participants and 
consent process 
These physiotherapists had previously been identified for eligibility and inclusion criteria, 
and had consented to participate during Study 2 Phase 2 (Chapter 7) of this research.  
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9.3.4 Data collection 
Once the physiotherapists had written their piece of reflective work, they sent it either 
by royal mail or e-mail to the researcher.  All identifiable information was removed by 
the researcher, then transcribed or copied and saved into a line numbered Microsoft 
word document.  All data were stored securely. 
 
9.4 Cross case Template Analysis 
King (in Cassell & Symon 2004) describes template analysis as a ‘varied but related 
group of techniques’ (p256), as opposed to a distinct methodology that can be used for 
the thematic analysis of textual data.  Using template analysis within this study allowed 
a pragmatic and flexible means of developing and organising the themes emerging from 
several textual sources of data, i.e. from the: 
 A-priori themes, rich notes taken by the researcher in Studies 1 and 2. 
 The two Focus Groups with the Expert Physiotherapists Group. 
 The 12 sets of reflective writing from the Senior Physiotherapist Participants 
Group. 
 
The advantages of using Template Analysis in this study is that it is highly flexible but 
keeps a structured approach,  can be easily understood and followed by an independent 
observer, different sets of data can be compared and the process can result in a clear 
description of its results.  King (in Cassell & Symon 2004) states that one of the 
disadvantages of using Template Analysis is that there is only a small amount of 
literature supporting the method; this could cause potential insecurity for the novice 
researcher in this study.  King (in Cassell & Symon 2004) also warns of the problems of 
over ‘simplification’ or ‘complication’ of themes and codes arising as a result of 
inexperience.  To reduce the risk of this, The Physiotherapist Research Group was 
involved in the analysis of the data, which was then reviewed and audited by the 
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Doctoral supervision team. With this support, the researcher attempted to create a 
balance between the need to be open to the data with the need to be structured and 
organised, because as King advises, novice researchers “more often suffer from too 
much openness than too little” (Cassell & Symon 2004, p269).   Although the template 
analysis will start formally and be a structured and organised process, it is envisaged 
that this analytical and reflexive process will continue through to the writing up, 
reporting and discussion of the results.  There is little guidance as to the appropriate 
sample size for achieving saturation point during the analysis of qualitative data; 
however Guest et al (2006) demonstrated that meaningful themes can typically be 
identified after the analysis of approximately six sets of data.  In this study there are 
nine sets of semi-structured questionnaires plus two Focus Group transcripts and rich 
notes taken by the researcher during Studies 1 and 2, it was therefore expected that a 
good level of saturation would be achieved. 
 
9.4.1 Creating the initial template 
An initial template was set up using three a-priori themes: -  
 Clinical application theme. 
 Quick and easy theme / using the LMPI. 
 Theoretical underpinning to practice theme. 
 
These themes were derived during the original conceptualisation and development of the 
LMPI (Study 1) and the reflexive writing kept during Study 2.  Questions that could fit 
around and develop these themes were agreed during a Physiotherapist Research Group 
meeting (box [vi]), and used to structure the two Expert Physiotherapist’s focus groups 
in Study 3 Phase 1. 
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Box [vi]: The emergent a-priori themes from Studies 1 and 2,  used to create a 
framework for questions 
Clinical application  theme Quick and easy theme Theoretical underpinning to 
practice theme 
Does the scale recognise the 
individual nature of your patient’s 
movement? (content validity) 
Does it take long to 
use? (clinical utility) 
Do you think the items in the 
scale are hierarchical in 
nature? (content validity) 
Can you use it for all of your 
patients? (clinical utility) 
    
What patient phenotypes did you 
use it with? (clinical utility) 
  How does it compare to other 
outcome measures that you 
use or have used? (clinical 
utility) 
What clinical settings have you used 
the LMPI in? (clinical utility) 
Within the patient 
treatment process, 
when do you complete 
it? (clinical utility) 
  
Is the scale sensitive enough to 
measure change? (content validity) 
  Does it underpin your 
approach to clinical practice? 
(content validity) 
Can the LMPI be related to function? 
(content validity) 
    
Are there any missing items in the scale (related to movement only)? (content validity) 
What are its strengths? (content validity & clinical utility) 
 
Initial emergent themes arising from the Focus Groups were added to this template, 
which was then used as a basis for the Senior Physiotherapist Groups reflective 
questionnaire used in Study 3 Phase 2 (Appendix14).  Questions were further generated 
within the Physiotherapist Research Group around these themes:- 
 Clinical application. 
 Ease of use. 
 Theoretical underpinning of clinical practice. 
 Would you change the LMPI? 
 Any problems using it? 
 Your involvement in the research process. 
 The training package. 
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 The testing process. 
In this way, the a-priori themes were added to so that the initial template was developed 
before the formal analysis of the textual data.   
 
9.4.2 Organisation into higher order and lower order codes 
Once completed, all auditory data were transcribed verbatim into line numbered word 
documents and stored electronically.  All handwritten documents were transcribed into 
line numbered word documents and stored electronically.  The researcher then 
‘immersed’ herself in the data by: 
 Reading the text several times. 
 Reading the text whilst listening to the audio-recorded Focus Group meetings. 
 Noting the a-priori themes and codes by underlining and highlighting text. 
 Noting further issues of relevance in the test, and inserting them into the 
template.  New codes were devised for these emerging themes. 
 Using the original template to organise and record the themes and codes as they 
emerged. 
 Grouping themes (lower order codes) into higher order codes (which describe 
broader themes). 
 Changing the scope of the codes if it became apparent that they had greater 
significance or breadth than was originally intended. 
 Changing the classification of the lower or higher order codes or moving them to 
different groups as appropriate. 
 Recording the process clearly and stepwise, using photographs of the data as it 
was coded, and saving progressive versions of the Template as it developed. 
 
Alongside this analytical process, validation of the researcher’s analysis was sought and 
established in four different ways:  
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1) During a Physiotherapist Research Group meeting, where the transcribed anonymised 
reflective questionnaires were thematically analysed within the group. 
2) A senior neurological physiotherapist not previously involved with the research study 
but who followed the analytical process described above using one of the Focus Group 
transcripts. 
3) An academic supervisor with appropriate published experience of using Template 
Analysis (McCluskey et al 2011) independently analysed one of the Focus Groups and 
three anonymised reflective questionnaires. 
4) Discussion of the process, a-priori themes, emerging themes and codes with the 
supervision team.  
 
Using Physiotherapists in this way, gave insight and understanding into the potential 
‘meanings’ and language of statements and reflections.  Using the supervision team in 
this way, gave scientific knowledgeable guidance and direction throughout the process. 
 
9.5 Summary  
In this study, it was intended that clinical utility would be examined.  A multi-centre 
mixed methods research design has been used in order to gather the a-priori themes to 
initiate Template Analysis. Figure [ix] 107) summarises and demonstrates the interaction 
between all aspects of the study. 
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Chapter 10: Results, Study 3: The clinical utility, 
face and content validity of the LMPI 
 
10.1 Introduction  
This section of the results will present the analysis of the qualitative data gathered 
throughout this study (Figure [xviii]), i.e.: - 
 A-priori themes that emerged during the analysis of the qualitative data gathered 
during the pilot work during Study 1. 
 Field notes taken by the researcher during Study 2. 
 Two Focus Group transcripts. 
 Eleven semi-structured questionnaires. 
 
A cross case template analysis (King 2014) method was chosen to allow the a-priori 
themes to be used to develop an initial coding template; applying an inductive organised 
process of analysis that focussed on the real life experiences of using the LMPI within 
clinical practice.  The field notes, Focus Group transcripts and semi-structured 
questionnaires data were then mapped onto the initial code template, modifying it until 
all relevant data were coded satisfactorily.  Although the data were combined for the 
purposes of analysis, the themes emerging from both groups and each senior 
physiotherapist participant were coded so that comparisons, agreements and 
oppositional relationships could be seen and discussed.   
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10.2 A-priori themes 
The a-priori themes were identified during the analysis of the results that emerged 
during the conception of the LMPI, and were discussed within a Physiotherapist Research 
Group meeting, the key a-priori themes were agreed as: - 
 ‘Clinical application’ The application of the LMPI into clinical practice 
 ‘Using it’  Related to the mechanics of using an outcome 
measure 
 ‘Theoretical underpinning of 
practice’ 
Related to the culture and concept of 
neurological physiotherapy treatment approach 
 
10.3 Field notes  
The field notes taken throughout all three phases of Study 2 were analysed by reading 
and re-reading them, highlighting, and then extracting key themes; these themes 
enriched the a-priori themes and were used to develop a framework of questions for the 
A-priori themes 
developed 
during the 
conceptual 
phase of 
development 
(Study 1) 
Field notes taken 
by researcher 
during the 
examination of 
measurement 
properties   
(Study 2) 
Two Focus 
Group 
transcripts from 
the Expert 
Physiotherapist 
Group (Study 3) 
Nine reflective 
questionnaire 
transcripts from 
the Senior 
Physiotherapist 
Participants 
Group (Study3) 
Figure [xviii]: Organisation of the qualitative data throughout all three Studies 
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Focus Groups.  Questions and prompts were identified to be used within the two Focus 
Group meetings and a table format (Box [vi]) was designed in order to facilitate the 
balance required between the need to create a relaxed informal atmosphere whilst 
ensuring that similar questions were asked to both groups. 
 
10.4 Study 3, Phase 1: Clinical utilisation and Focus Groups with 
Expert Physiotherapists Group 
 
10.4.1 A description of the participants  
Twelve of 17 British Bobath Tutors Association members were recruited to the study 
then trained to use the LMPI using the same training package that was used in Study 2.  
The participants were then asked to use the LMPI during their routine clinical practice for 
six months. At the end of this time, they were asked to attend one of two Focus Group 
meetings and all participants agreed.  One participant was unable to attend the Focus 
Group meeting, therefore Focus Group One contained six participants, the other 
contained five, the memberships were chosen randomly just prior to the meetings, which 
were run consecutively.  The clinical and professional experience of these participants 
was extracted from the British Bobath Tutors Association website (BBTA 2014) to 
establish their expert standing.  Within this group, the participants had been working as 
physiotherapists between 15 and 41 years; had been qualified as Bobath tutors between 
8 and 27 years; 42% of them were ‘advance’ tutors’ and 58% of them had a 
professionally related MSc.Most of the participants worked within a combination of roles, 
e.g. private practice, physiotherapy team leader, strategic roles within neurological 
physiotherapy and higher education.  The participants were geographically located 
throughout all of the UK, and were considered to be strongly representative of expert 
opinion, having significantly greater experience than the members of both the Senior 
Physiotherapist Participants and the Physiotherapy Research Groups. 
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10.4.2 A description of the Focus Groups 
Both Focus Groups ran for approximately one hour, the conversations were audio-
recorded and notes were taken onto a flip chart by a research assistant (a member of 
the Physiotherapy Research Group) for immediate validation by the group members.  As 
soon as the Focus Group meeting had finished, the flip chart notes were reviewed and 
agreed by members.  Both sets of audio recordings and flip chart notes were transcribed 
into line numbered Microsoft word documents.  
 
10.4.3 The preparation of the semi-structured questionnaires 
An initial review of the transcribed data revealed six emerging themes which were used 
to structure the reflective questionnaires planned for use in Study 3 Phase 2.  The initial 
emergent themes were that the LMPI appeared to: - 
 Be sensitive to clinical demands. 
 Be able to be focused on the individual patient. 
 Be able to be used for any patient with a motor control difficulty. 
 Underpin the physiotherapist’s theoretical concept towards their treatment 
approach. 
 Reflect and / or support clinical reasoning. 
 Be of potential educational value. 
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10.5 Study 3, Phase 2: Clinical utilisation and reflective writing, 
Senior Physiotherapist Participants Group 
 
10.5.1 A description of the participants  
As previously discussed in Chapter 8, 12 senior physiotherapists were recruited to this 
study.  Their experience of using the LMPI was:-  
1) During the reliability and validity testing within Study 1 Phase 2. 
2) During Study 1 Phase 3 where they recruited a small sample of their patient 
caseload, then measured their patients using the LMPI and the BBS pre and post 
intervention. 
 
Once Phase 3 of Study 2 was completed, the physiotherapists were asked to complete a 
reflexive, semi-structured questionnaire based on the initial emergent themes from 
Study 3 Phase 1 (above), once they were completed, the participants sent them to the 
researcher via royal mail or e mail.   
 
10.5.2 Sample size 
Table [xvii] presents the proportion of data received from each participant.  Eight 
participants recruited a small proportion of their patient caseload into the study; ranging 
from one to six patients.  Nine participants returned the questionnaires (two non-
respondents gave no reason, the third reported that their workload was too high to 
justify on-going participation), the completed and returned data were transcribed into 
line numbered word documents, then analysed using cross case template analysis. 
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Table [xvii] : Number of patients recruited during Study 2 Phase 3, and number of 
returned reflective questionnaires by the Senior Physiotherapist Participants Group 
Senior Physiotherapist  
Participant number 
Recruited 
patient number 
Returned reflective questionnaire  
1 1 
2 
3 
13 
21 
No 
2 none Yes 
3 none Yes 
4 14 
15 
18 Yes 
 
5 16 
17 
20 
27 
Yes 
6 19 Yes 
7 12 
22 
No 
8 none Yes 
9 10 
11 
Yes 
10 none Yes 
11 4 
6 
23 
24 
25 
26 
Yes 
12 5 
7 
8 
9 
Yes 
 
It was questioned whether there was a relationship between the number of patients 
recruited and the number of year’s post-graduate experience of the physiotherapy 
participants; this was investigated using a correlation coefficient. No relationship was 
found (r =0.069) and the correlation was non-significant (p=0.830) (Graph [iii]).  There 
were no other quantifiable variables recorded regarding the physiotherapists except 
gender, and this cannot be used because the members of Senior Physiotherapist 
Participant Group were female except one. 
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10.5.2 Sample size 
 
Appendix 11 presents the demographics of the members of the Senior Physiotherapist 
Participants Group, and as previously discussed, the population of this group is 
representative of the clinical population of senior neurological physiotherapists employed 
by the participating organisations within Yorkshire.   
 
10.6 Template analysis 
Field notes, Focus Group transcripts and semi-structured questionnaires data were 
mapped onto an initial code template (made up of the a-priori themes), modifying it until 
Graph [iii]: A Correlation Coefficient to examine a possible relationship between number 
of years post-graduate experience (of the Senior Physiotherapist Participant Group) and 
number of patients recruited 
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all relevant data were coded satisfactorily.  In order to maximise quality and validity, the 
process was recorded so that an audit trail was clear (Figure [xiv]). 
 
10.6.1 Template Analysis validity 
Independent scrutiny was accessed, providing validity of the interpretation of the data: 
1. By the Physiotherapist Research Group who reviewed and discussed the 
completed reflective questionnaires (from the Senior Physiotherapist Participants 
Group). 
2. By an independent senior neurological physiotherapist (not previously involved 
with the research), who reviewed and discussed one of the Focus Group 
transcripts with the researcher. 
3. Samples of the qualitative results were independently reviewed by an 
experienced member of the supervisory team, and then a joint review with the 
researcher provided an element of clinical interpretation.  
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Figure [xix]: Thematic analysis process using 
cross case template analysis 
9)  Resulted in coding template – 
Figure [xv]: final code template 
1)  ‘Noted’ a-priori themes 
4)  Used ‘post it’ notes to organise a-
priori themes and emerging themes 
into codes 
3)  Read Focus Group transcripts & 
questionnaire transcripts several 
times, highlighted themes 
2)  ‘Noted’ additional themes that 
emerged as a result of reflexivity and 
rich note taking during study 1 
 
8)  Based the organisation of the data 
on a template used by Atwal et al 
(2011) 
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10.6.2 The overarching themes emerging from the data 
Once the template analysis process was complete, the a-priori themes and emergent 
themes were examined in more detail.  As described by King (2014) the reflexive nature 
of template analysis continues throughout all the stages of reading the data, recognising 
the emergent themes, organising the themes into codes and then writing the report.  
King suggests the benefit of pragmatic reasoning to support the timing of the decision 
about when to halt the analysis, so that the conflicting priorities of maximising the 
validity and depth of analysis, with the time constraints of Doctoral research can be met. 
 
Two overarching main themes have emerged from the data: 
1. Related to a theoretical context. 
2. Related to the clinical utility of the LMPI. 
 
One lesser main theme emerged from the data: 
3. Related to the research process. 
 
A report of the findings is now presented using the ‘Final Code Template’ (Figure [xv]) as 
a framework structured around the main themes and sub themes, supported by 
illustrative quotes taken from the data.
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Overarching themes Main sub-themes Sub-themes  
 
 
 
 
Theoretical context 
 
 
 
Clinical application 
 
Teaching tool 
 
Junior staff 
Course participants 
Teaching the patient 
Clinical reasoning 
 
 
Theoretical underpinning 
      of practice 
 
Quality of movement 
Individual nature of movement 
Related to function / goals / patient specific 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clinical utility 
 
Outcome measures 
Comparison with other outcome measures 
 
Outcome measures in general 
GAS 
BBS 
 
 
 
About the LMPI as an outcome measure 
Items in the scale,  
Score criteria 
Novel use of the LMPI 
 
 
Ease of use 
Difficult to use 
Easy to use 
General issues of use 
 
 
 
 
 
 
 
 
 
Strengths / weaknesses  
 
Time it takes to use 
When did you use it? 
What pathologies it was used with 
Sensitivity 
Subjectivity 
 
 
 
 
 
About the research  
process 
 During Study 2, Phase 2, testing of 
measurement properties 
Involvement in the research process 
Ethics 
The training / video 
 
Figure [xx]:   
Final Code Template 
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10.6.3 The ‘key’ for data source 
Table [xviii] presents a reference key to the sources of the data presented to support 
each of the themes described below. 
Table [xviii]: The source of data extracted from the results of the Template Analysis 
Study 1 field notes = S1line…  
Focus Group One= FG1, line…  
Expert Physiotherapist Participant 1 = EP1 Senior Physiotherapist Participant 2 = P2line…  
Expert Physiotherapist Participant 2= EP2 Senior Physiotherapist Participant 3 = P3line…  
Expert Physiotherapist Participant 3= EP3 Senior Physiotherapist Participant 4 = P4line… 
Expert Physiotherapist Participant 4= EP4 Senior Physiotherapist Participant 5 = P5line…  
Expert Physiotherapist Participant 5= EP5 Senior Physiotherapist Participant 6 = P6line…  
Expert Physiotherapist Participant 6= EP6 Senior Physiotherapist Participant 8 = P8line…  
Focus Group Two = FG2, line…. Senior Physiotherapist Participant 9 = P9line… 
Expert Physiotherapist Participant 7= EP7 Senior Physiotherapist Participant 10 = P10line… 
Expert Physiotherapist Participant 8= EP8 Senior Physiotherapist Participant 11 = P11line… 
Expert Physiotherapist Participant 9= EP9 Senior Physiotherapist Participant 12 = P12line… 
Expert Physiotherapist Participant 10= EP10  
Expert Physiotherapist Participant 11= EP11  
 
Ten themes are presented, three of which stem from the a-priori themes: ‘clinical 
application’, ‘using it’ and ‘theoretical underpinning to clinical practice’, the remainder 
have emerged through the process of data analysis. Appendix 15 contains the complete 
results. 
 
10.6.4 A report of the overarching themes 
There are three overarching themes 
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 ‘Theoretical context’ which is further divided into three main sub-themes of 
‘Clinical application’, ‘theoretical underpinning of practice’ and ‘outcome 
measures’. 
 ‘Clinical utility’. 
 ‘About the research process’. 
 
10.6.4.1 Theoretical context 
 
Clinical application 
This is a main sub-theme, containing the two further sub-themes of: ‘teaching tool’, and 
‘clinical reasoning’. Within the sub-theme of ‘teaching tool’,  there are three further 
themes of ‘junior staff’, ‘course participants’ and ‘teaching the patient’.   
Teaching tool 
Teaching tool for Junior staff: 
A key theme emerging from the data of the Focus Groups was the interest in using the 
LMPI as a tool to develop less experienced staff, namely: 1) the junior physiotherapists 
who work with the Expert Physiotherapists within their clinical practice and 2) the 
physiotherapists who attend Bobath courses run by the Expert Physiotherapists: 
 
EP5: “if you were working with junior staff it could be really useful because you 
could actually be very specific you would say “when we are looking at 
alignment of the leg these are the things we are look for” (FG1,line 48) 
 
EP3: “In the end the categories are really good so the delineation in the 
different areas is great because they are things that you actually want to 
get across about how people move so that is why I definitely think that as 
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a teaching tool a training tool for junior / staff grades it is very useful 
because it really homes in on the key things you want people to look at in 
movement rather than - can they can’t they? - sit to stand? – tick” (FG1, 
line 60) 
 
EP8: “It has a feel that it could be a good nurturing  tool in a teaching situation 
for supervision, and  looking at the components  - and you have picked 
your 16 components; your junior has three .......what components were 
they missing?  - and I think it could be a good teaching tool for 
supervision in that respect.” (FG2, line 223) 
 
In contrast, only one Senior Physiotherapist Participant commented on the use of the 
LMPI as a teaching tool for junior staff:  
 
P5: “Some of our team are now using the LMPI and finding it quick and easy to 
use and a good way of teaching junior staff and students.  Also it is useful 
for the senior staff to bring us back to the ‘bread and butter’ analysis of 
human movement” (P5, line 75).   
 
This may be because the Senior Physiotherapist Participants had limited experience of 
developing more junior staff, whereas the expert group all had considerable and on-
going experience of teaching within their clinical work setting and on organised post 
graduate courses, or, that during the research window they did not have junior staff 
working with them so did not have the opportunity to consider using the LMPI in a 
teaching context. 
 
  
187 
 
Teaching tool for Course participants: 
The Expert Physiotherapists all felt that there was potential for the LMPI to be used as a 
teaching tool both within clinical and teaching practice: 
 
EP7: “We need as many tools on the course as we can to get the course 
participants to be able to see what we see and understand what we 
understand” (FG2, line 267) 
 
EP7: “it makes the less skilled practitioner to look more closely at what they are 
doing, then they could use it at the beginning of the course – a three week 
basic course or an advanced course – maybe it is a better tool for the 
advance course for themselves or with their partner - scored the patient 
on day one and then rescored the patient on day five” (FG2, line 282) 
 
Teaching tool for the patient: 
The same Senior Physiotherapist Participant described above (P5) also thought that the 
LMPI was useful to help educate their patients: 
 
P5:  “Using the LMPI meant that an explanation was given to the patient about 
quality of movement, ……...  therefore it was useful as a teaching aid” (P5, 
line 37) 
 
Clinical Reasoning 
This was a very popular theme; it emerged from the data numerous times, Although the 
phrase ‘clinical reasoning’ was not always specifically mentioned, discussions about 
movement analysis, the underlying reasons for the patient’s movement difficulties, and 
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linking treatment plans to assessment are all recognisable topics beneath the umbrella of 
‘clinical reasoning’.  During a site visit in Study 2, the researcher noted that the LMPI: 
 
S1 “…promoted discussion around movement analysis” (S1, line 31).   
 
The Expert group found that:  
 
EP6 “….I wonder in relation to those points the challenging aspect of it is 
because actually when you are clinically reasoning in practice. And I agree 
I think that categories are really nice categories and really pertinent 
categories to consider but when you are working with a patient you are 
kind of considering them in relation / together / as a whole. to each other 
so if we are going to improve the interaction  between  body parts or body 
segments  you are considering in relation to alignment  in relation to 
background activity. (FG1 line71) 
 
EP3 “… it actually DOES reflect the complexity of movement in that it throws 
up a lot of questions for me ...that is what I felt about it”. (FG1,line 57). 
 
Examples of how the Senior Physiotherapist Participants felt included: 
 
P12 “The biggest impact I felt personally, was on my clinical reasoning and 
treatment planning/implementation, using the tool I felt clarified/justified 
my reasoning and made my treatments much more goal specific. 
(P12line30) 
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P11 “Helped tailor analysis and treatment plan and remind me it’s OK to focus 
on one part during a treatment session e.g. arm and that can influence the 
whole patient and their movement patterns more effectively sometimes 
than spending a little time on the whole of them” (P11line23) 
 
P10 “I felt the LMPI does recognise the individual nature of patient’s 
movement. It makes you look more specifically” (P10, line 1) 
 
Theoretical underpinning of practice 
This theme links very closely with the ‘clinical reasoning’ theme because it is related so 
closely to clinical practice; however, they are separated because of these specific 
differences: 
 ‘Clinical reasoning’ occurs during and within clinical practice. 
 ‘Underpinning an approach to clinical practice’ relates to the phenomenon and the 
paradigm of practice. 
In general, all physiotherapists felt that the LMPI underpinned their approach to clinical 
practice and the sub-themes of this section fall into three separate categories: ‘Quality of 
movement’, ‘Individual nature of movement’ and ‘Related to function’.  The focus of the 
Senior Physiotherapist Participants tended to lean towards the analysis of movement and 
clinical reasoning aspects of the theory underpinning their intervention. Whereas the 
focus of the Expert Group Physiotherapists trended towards the analysis of movement 
and the teaching of the analysis of movement: 
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Quality of movement 
During site visits, the researcher noted that: 
 
S1 “the LMPI was good because it’s not just that they (the patients) can 
perform the function, but how well they can perform it”. (S1, line 89). 
 
Physiotherapist P5 noted that: 
 
P5:  “It is easy in community (meaning; working with patients in their own 
homes) to become quite functionally focused and using the LMPI has been 
a good reminder to look at quality of movement first” (P5, line 41) 
 
The Expert Physiotherapists also discussed the quality of movement with reference to 
the LMPI: 
 
EP1  “What has come up with in my mind for what it is worth is it is a bit like 
ice dancing and standing up with high performance - 6 technical merit - 
and 5.8 for artistic impression rather than it being in the Olympics - it 
would be the timed race - the outcome measure would be the timed race 
it is who is first at the post it is a quantitative measure - where this is 
much more the ice dancing of the measure.” 
EP6 “But that is a very good analogy” (FG1, line 226) 
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Individual nature of movement 
The ability to recognise and reflect the movement performed by individual patients 
appeared to be very important within both groups of participants.  The bio-mechanics of 
movement are very personal and can be influenced by age, gender, body mass, previous 
injury and illness, occupation, and the environment and culture in which the individual 
lives. 
EP9: “The fact that it is very individual and it is subject to someone, sometimes 
it’s very helpful, for some of our patients, to support, to show the changes 
that they have.” (FG2, line 218) 
P10: “I felt the LMPI does recognise the individual nature of patient’s 
movement. It makes you look more specifically” (P10, line 1) 
 
An Expert Physiotherapist in Focus Group One thought that: 
 
EP6: “in essence it DOES recognise an individual nature” (FG1, line 15),  
 
An Expert Physiotherapist in Focus Group Two thought that not only was the LMPI able 
to recognise the individual nature of movement, it was also able to manage the 
complexity of movement by simplifying it. 
 
EP7: “a strength of it is it breaks movement down into components” (FG2, line 
447).    
 
EP10: “It prompts you to break things down into components.  The measure 
itself does not break them down.  It prompts the clinician to” (FG2, line 
466). 
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A Senior Physiotherapist thought that the LMPI was the: 
 
P11: “only outcome measure I have come across that looks at each component 
of normal movement, measuring quality rather than just ability” (P11, line 
5).   
 
Related to function and the patient’s treatment goals 
In general, there was agreement that the LMPI could be related to function, a Senior 
Physiotherapist Participant thought that the LMPI:  
 
P6 “Could be related to patients function and goals, for example, for patient 
to be able to stand up from wheelchair……..look at: 
- weight bearing through affected LL (lower limb) 
- adaptability of foot during movement 
- trunk and UL (upper limb) alignment during movement” (P6, line 16) 
 
An Expert Physiotherapist thought that: 
 
EP6:  “it was those patients where you inherently know they are not going to 
look hugely different but they can FEEL different but that can be very 
relevant to them in their overall function” (FG1, line 375).   
 
In contrast to this statement, there was also a feeling in the Focus Groups that the LMPI 
was not related to function: 
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EP1:  “I was looking at a particular alignment issue with regard to a very small 
body part I was not relating it to function but I thought it might work out 
that way but it did not" (FG1, line 104). 
 
Outcome measures 
Comparison with other outcome measures 
Both groups of Physiotherapists compared the LMPI to either other non-specific outcome 
measures, or to other specific popular ones. One Senior Physiotherapist Participant wrote 
that she:  
 
P6 “could use LMPI for all patients, but more likely to use it for patients where 
other OM’s (outcome measures) do not fit. For example, low level patients 
who may score ‘0’ on Trunk Control Test on admission and discharge, but 
may actually demonstrate improvement in posture, head control, etc. This 
would be detected on LMPI but not necessarily on TCT (Trunk Control 
Test). Could also be used for patients with bilateral deficit, for example 
GBS (Guillain-Bare Syndrome) or TBI (Traumatic Brain Injury) where OM’s 
such as MAS (Motor Assessment Scale) do not fit. Also useful for UL 
(upper limb) changes, which may not be functional but may demonstrate 
an improvement in posture, alignment or hand contactual 
responses.”(P6,line1). 
 
This Physiotherapist indicated that the LMPI could: 1) be patient focused, and 2) be 
generalisable across different pathologies; whereas other available outcome measures 
are constrained by floor and ceiling effects, insufficient depth of analysis and are often 
validated for patients who have specific pathologies. 
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In comparison with GAS 
The Expert Physiotherapists compared the LMPI with GAS 
 
EP7: “For me it (the LMPI) is almost quite subjective like the GAS goal where 
you can choose and you can fit it to your patient population because you 
can choose any aspect of movement to look at different components and 
then allocate it so it should fit to any patient” (FG2, line 24).  
 
The Expert group also stated that: 
 
EP8:  “This is looking at the qualitative normal movement aspect but on the 
GAS score you can only have one or two variables – one variable really – 
so you can have lots more variable with this measure” (FG2, line 161).   
Although the LMPI is compared favourably with GAS, within their clinical practice, the 
Expert group appeared to prefer to use GAS because it was an established outcome 
measure. The Senior Physiotherapist Participants group did not compare the LMPI with 
GAS. 
In comparison with the BBS  
The Senior Physiotherapist Participants compared the BBS to the LMPI, probably because 
they were using it in conjunction with the LMPI during the research of Study 2 Phase 3: 
 
P9: “The patient was often unaware that I was using the measure.  In 
contrast, the BBS or timed walk etc. needs the patient to cooperate which 
can have an effect on the outcome” (P9, line 45).   
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Physiotherapist 12 noted that: 
 
P12: “The Berg Balance is a very objective outcome measure which lots of 
patients like as they can see clear measures taking place (involving 
stopwatches and tape measures etc.) however I feel it is a superficial 
measure looking only at tasks and not the quality of movement involved in 
achieving them” (P12, line 22) 
 
Outcome measures in general 
Focus Group Two participants had a short discussion about the use of outcome measures 
in general: 
EP7: “We at Xxxxxxx (a three week Bobath course that was being run at an 
NHS hospital in the UK) last week we were trying to get relatively skilled 
practitioner’s to use GAS but it was difficult very difficult. 
EP9: I think it is the time 
EP8: They had the time on the course – they had the time. 
EP7: Lack of experience was a big excuse.  There is a huge lack of experience 
no matter how much we talk about this health service and the fact that 
every practitioner should be measuring change on their patient.  We found 
amongst 18 course members last week we found quite considerable lack of 
ability to do that” (FG2, line 294) 
 
About the LMPI as an outcome measure 
As an outcome measure, the LMPI was liked because of its association with movement 
quality; and a good example of this is Focus Group One’s discussion of this topic: 
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EP1: “What has come up with in my mind, for what it is worth, is it is a bit like 
ice dancing and standing up with high performance - 6 technical merit - 
and 5.8 for artistic impression rather than it being in the Olympics - it 
would be the timed race - the outcome measure would be the timed race 
it is who is first at the post it is a quantitative measure - where this is 
much more the ice dancing of the measure. 
EP4: But that is a very good analogy” (FG1, line 226) 
 
The Senior Physiotherapist Participants also found that: 
 
P2: “LMPI was clinically useful and more individual to patient”. (P2, line 26) 
 
 And that: 
 
P2:  “the LMPI acknowledges grades of deficits rather than an individual 
movement patterns” (P2, line 2). 
 
Sub-themes within this main theme were related to ‘items in the scale’ and the ‘score 
criteria’. 
Items within the scale 
There was discussion within the Expert Physiotherapist Focus Groups and reports from 
the Senior Physiotherapist Participants about the words and terms used within the LMPI.  
During Study 1 the researcher noted that one of the Senior Physiotherapists Group 
thought that: 
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S1:  “Different terms / jargon would be easier” (S1, line 6). 
 
However, the consensus appeared to be that all participants liked the items within the 
LMPI  
 
EP8: “the interaction with the base of support” is also a huge strength of it 
because it gets missed in a lot of measures it is important to the concept 
that I practice” (FG2, line 215). 
EP7:  “I liked the fact that it has alignment in it because that is where we often 
start and I think that is useful with all of the patients we looked at because 
you are looking at an optimal alignment to underpin the other things so an 
optimal alignment will underpin the on-going interaction of the patient 
with gravity and their supporting surface and the on-going - the alignment 
will underpin the timing, the sequence of movement, the speed and the 
selectivity.  That I think is a strength - it really, that it facilitates the 
person who is doing the measure to look critically at the alignment and not 
just function – the task” (FG2, line 207).   
 
The ‘speed’ item was considered by one Focus Group member to be: 
 
EP1:  “very difficult to deal with because you say the ability to choose how fast 
or slowly - well it depends and that made it very hard to categorise - put a 
number to that” (FG1, line 107).   
None of the Senior Physiotherapist Participants commented on the ‘speed’ item 
When asked if they thought that anything was ‘missing’ from the scale, the Focus Groups 
thought not: 
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EP8: “From a movement component perspective – I don’t think so, it covers all 
bases” (FG2, line 305), 
 
EP7: “it is comprehensive and appropriate” (FG2, line 334).  
In contrast, two of the Senior Physiotherapist Participants thought that changing the 
score system may be useful:  
 
P5:  “Sometimes it is hard to pick a score from 0-3 and wonder whether 
allowing ½ scores would be useful” (P5, line 53);  
 
P4: “could be more sensitive with 5 scores allowed, to help distinguish 
between scores of 2 and 3” (P4, line 9). 
 
Score criteria 
Within both Focus Groups, there were considerable lengthy discussions around what was 
meant by the phrase ‘theoretical optimum’ within the score criteria.   
 
EP10: “I found that extremely difficult because I did not know whether if I was 
looking that the theoretical optimal performance of that person before 
their injury or after” (FG2, line 91).   
Both Focus Groups discussed the issue and came to similar conclusions.  Focus Group 
One concluded that the theoretical optimum could be related to the prognosis as a result 
of assessment and analysis: 
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EP4: “There could never be a ‘3’ because they were never going to have enough 
recovery to be back to their previous level it was the theoretical optimal 
performance and I was not clear on that whether I should be judging  
them against : prior to their assault or the best  I thought they could be 
post lesion”.   
EP3: “Your best prognosis.” 
EP6: “Which is what I was doing” (FG1line122) 
 
Focus Group Two also related prognosis to the theoretical optimum, along with a 
reflection related to the patient’s pre-morbid ability: 
 
EP7: “So how did you score optimal how did you score his theoretical optimal 
performance?” 
EP11: “Against what I thought he might be able to achieve” 
EP7: “With his diagnostic” 
EP11: “Yeh along with the patient’s diagnosis. But obviously I had no idea of 
where he might be able to go to - and this is a guy who declined in terms 
of his functional ability over a period of time so I was trying to move him 
back. 
EP7: “To where it was. To where his optimal was” (FG2, line 344). 
 
Interestingly, in contrast, only one of the Senior Physiotherapist Participants commented 
on the ‘theoretical optimum’: 
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P6: “Scale somewhat subjective. Quite difficult at times to consider patients 
“theoretical” normal (P6, line 11). 
P6: “What if patient surpasses their theoretical normal? Is there a ceiling 
effect? Or does it mean we have scored wrong previously?” (P6, line 14) 
 
Focus Group One questioned what should be done with the score: 
 
EP6: “for example measuring sit to stand  - well yes I could get a different set 
of scores as part of the overall  sit to stand  - but it  is a bit like what 
Xxxxx (another Focus Group member) says -  I am not quite sure what we 
do with them  at this stage do you add them up, do you highlight,  that is 
where the score changed, that is where the score did  not change, and the 
aspect of sit to stand that you are actually recording change of  very much 
impairment level aspects -  you see what I mean?” (FG1, line 206). 
 
In contrast, none of the Senior Physiotherapist Participants noted that this was a 
problem or a weakness of the LMPI. 
Neither the Expert nor the Senior Physiotherapists thought that the LMPI was 
hierarchical, commenting that:   
 
EP2: “I was working with a patient who needed to improve his selective planter-
flexion in terms of terminal stance and sit to stand so I was working very 
specifically on his selective movement of his planter-flexors so that was 
the most important aspect, because that was effecting everything else and 
strength was an issue, so in that respect the most important thing for him 
was... the hierarchy did not even come into it”. (FG1, line 315). 
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 The Senior Physiotherapist Participants were in agreement:  
 
P12: “The importance” of the items in the scale varied with each individual 
patient, for example; in some patient’s selective movement was the key 
limiting factor, in others it was alignment and in some patients all items 
were equally affected.” (P12, line 34) 
 
Novel use of the LMPI 
Both Focus Groups and the Senior Physiotherapist Participants all discussed using the 
LMPI not only as a measure of outcome, but also: - 
1) To support their clinical reasoning. 
2) To teach more junior staff within the clinical setting, i.e. ‘on the job’ training. 
3) To teach Bobath course participants (senior neurological physiotherapists attending an 
organised course) how to analyse and assess movement control. 
4) To help patients to understand their movement control difficulties. 
 
10.6.4.2 Clinical utility  
Ease of use 
This sub-theme includes discussions within the Focus Groups and thoughts from the 
Senior Physiotherapists related to: ‘difficult to use’, easy to use’ and ‘general issues of 
use’. 
Difficult to use 
In general, the Expert Physiotherapists Group found the LMPI quite challenging to use, 
one member in particular found it difficult, stating: 
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EP3: “and I thought it would be straight forward and I actually found it much 
more difficult than I expected to” (FG1, line 7).   
 
EP5: “I would have to say when I started using it  - and I did a couple  - I 
thought I had missed the point  I thought I was getting something 
fundamentally wrong because I was feeling so challenged by it.   I found 
that quite difficult” (FG1, line 28). 
 
EP7: “but I felt that I did not understand what I was doing fully and I still think 
I do not understand what I am doing fully.”  (FG2, line 77)  
 
Easy to use 
In contrast, when three of the Focus Group Two members were using the LMPI together 
in a patient treatment session, they reported that: 
 
EP8: “It was very fast it gave us a good score and showed big change” (FG2, 
line 34). 
EP7: “there were flashes of greater understanding through discussion with my 
colleagues that I had not had when I had done it on my own” (FG2, line 
85). 
 
In contrast, the Senior Physiotherapist Participants consistently found it easy to use and 
due to the nature of this research, had only used the LMPI as sole practitioners:   
P5 “quick and easy tool to try and bring quality of movement back into a busy 
workload” (P5, line 5)  
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Problem solving discussions with Senior Physiotherapist Participants during the site visits 
of Study 1 Phase 3 were noted by the researcher to be helpful in supporting the use of 
the LMPI.  
 
S1: “I found myself teaching and advising successfully; I make this judgement 
from their interaction with me, and their reception of what I said” (S1, line 
80). 
 
General Issues of use 
One Senior Physiotherapist Participant felt that: 
 
P9: “I wasn’t always sure what to measure and often tended to use functional 
activities rather than specific muscle activity” (P9, line 23) 
 
 
Strengths and weaknesses 
The Focus Groups were not specifically asked about the strengths or weaknesses of the 
LMPI, whereas the Senior Physiotherapist Participants were; there was strong agreement 
with the comments about the strengths of the LMPI:  
P9: “Easy to complete, Quick to complete, Focuses on normal movement, 
Appropriate for patients with neurological problems” (P9, line 70) 
 
P5: “aids analysis and observation of movement.  It is quick and easy to use 
and adaptable and sensitive” (P5, line 55) 
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P12: “easy to use, facilitates treatment planning and goal setting, I found it a 
sensitive measure” (P12, line 44) 
 
P6: “same thought process we use every day, looks at quality” (P6, line 46) 
 
There were differing opinions about the weaknesses of the LMPI:  
 
P9: “Not always sensitive enough, would reflect negatively on patients with 
progressive disorders, Limited to therapists with neurological interest” (P9, 
line 75) 
 
However, it could be argued that this would be the case with any outcome measure used 
for a person with a degenerative neurological condition: 
 
P5: “the items feel a little repetitive as there is a blurring of meaning between 
some of them.  For instance, alignment is similar to interaction and timing 
is similar to selective movement.  Sometimes it is hard to draw a 
distinction between items that are only subtly different” (P5, line 58).   
 
P12: “Not always as easy for the patient to understand what we were 
measuring (compared to say the Berg)” (P12,line 46).   
P6: “not well enough known yet, unable to compare patients (if we wanted 
to!), Use of jargon (wordy, for junior staff)” (P6, line 49). 
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Time it takes to use 
The Senior Physiotherapist Participants also found it quick to use: 
 
P5:  ”The LMPI tool itself does not take long to use and because of this it will 
be very useful clinically and more likely that clinicians will use it” (P5, line 
24). 
 
But deciding what to measure could take some time, reporting that the LMPI was: 
 
P6: “Quick to use, although deciding on what to measure, why and how takes 
a little longer.” (P6, line 24) 
 
In contrast, the Expert Physiotherapists found that the tool took too long to use: 
 
EP3: “I think that in real world people increasing under pressure with time it 
that would be pursued as a negative I think even if it was useful it would 
be take too long I think” (FG1, line 424),  
 
Even though they also reported that when using it with two fellow participants within a 
patient treatment: 
 
EP8: “It was very fast it gave us a good score and showed big change” (FG2, 
line 34). 
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When did you use it? 
This question was used in an attempt to understand ‘when’; within the treatment session 
or during clinical record keeping the LMPI was used.  For example pre-treatment and 
post treatment to measure effects of intervention, post treatment to record ‘best 
performance’ during the treatment session, or post treatment and pre-treatment to 
measure carry-over of treatment effects from one treatment session to the next.  The 
Expert group reported:  
 
EP5: “I thought I quite liked the idea of best performance” (FG1, line 195),  
 
Whilst a Senior Physiotherapist Participant stated: 
 
P5:  “When using the LMPI, I generally scored from memory during the record 
keeping and the patient usually had no awareness of the process other 
than the initial consent” (P5, line 34).  
This again indicates flexibility of the LMPI towards the requirements of the patient and 
the therapist. 
 
What pathologies it was used with 
This question was asked, because one of the aims during the development of the LMPI 
was to be able to use it to measure across the spectrum of neurological conditions and it 
was clear that the LMPI was used successfully with several pathologies, Focus Group One 
discussed: 
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EP2: I think it could be used for any condition.  I think you could use it with any 
condition  
ALL: agreeing 
EP5: not just neurological conditions -ANYTHING about movement and the 
indicators and categories apply to any bodies’ movement    - for anyone, 
any area. 
EP2: Yes.  I think so.” (FG1line 353) 
 
Senior Physiotherapist Participant 3 reflected that: 
 
P3: “all types of neuro pathologies and all levels of impairments.  The types of 
pathologies I used were: stroke, MS (multiple sclerosis),brain tumour but I 
could see its use in other neuro pathologies. (P5, line 10). 
 
However, in contrast, Physiotherapist 10 found: 
P10: “I could not use it for all my patients as many of our patients are very 
early strokes….It was more suitable for patients who were a few weeks 
into their rehab and outpatients” (P10, line 3).   
So although the LMPI was adaptable to be used for different pathologies, there appeared 
to be some constraining factors to its use which were dependent on the physiotherapy 
intervention that the patient was receiving. 
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Sensitivity 
There were mixed reports within the area of sensitivity, from: 
 
P5: “very specific to each patient and this means that it can be sensitive” (P5, 
line 4);  
To: 
P2: “possibly not good to use for severely neurologically impaired patients as 
may not be sensitive enough to small changes. This may also apply to 
high level patients who may also have subtle changes” (P2, line 36),  
And: 
EP7: “… I found the high level patient I could not get a reasonable picture of the 
high level patients using the scale so it was more useful with the complex 
patient who had more serious alignment, impairment, movement 
dysfunction issues than the high level patient who made, for me in respect 
of their goals for the weeks treatment, made significant changes but were 
difficult to record.  I needed something that was more sensitive” (FG2, line 
6). 
 
In contrast, Physiotherapist 12 thought that the: 
 
P12:  “… LPMI reflected not only the treatment goal but considered how the 
goal was achieved, by measuring the various components involved such 
as; timing / interaction etc. which are often over looked in other tools, this 
I thought made it quite a sensitive measure” (P12, line 4) 
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Subjectivity 
Both groups thought that the LMPI was subjective: 
 
EP8: “when I did it in combination with two of my tutors it felt like you could 
pick something and you could quickly go through it but it was slightly 
subjective” (FG2, line 31).   
 
One Senior Physiotherapist Participant quantified her statement: 
 
P12: “intrinsically it is a subjective measure (which could be a weakness), but 
because of the items in the framework which are very clear and specific 
this makes it as objective as possible”  
 
 
10.6.4.3 About the research process 
The Senior Physiotherapist Participants group was asked how they felt about being part 
of a Physiotherapy research project, they commented on several factors: 
 
During Study 2, Phase 2, testing of measurement properties 
During Phase 2 the researcher noted that: 
 
S1: “they cannot remember their scores from the first set of tests and they 
thought they would” (S1, line 19).  
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And also that at the re-test session: 
 
S1: “Participants felt they were being quicker with their scoring, they felt more 
confidant, they were just ‘going for it’. Felt they were being harsher with 
scores.  Reported that using the LMPI felt easier” (S1, line 60).  
 
These observations are interesting, considering the suggested strength of the LMPI’s 
internal consistency and external reliability. 
Involvement in the research process 
The Senior Physiotherapist Participants group were asked how they felt being part of 
physiotherapy focussed research project: 
 
P9: “Initially I felt some reluctance to take part due to limited time and extra 
demands to fill in forms and attend meetings.  However I found the 
research of particular interest as it was specifically designed for neuro-
patients.  The support and encouragement given to me by the lead, and 
other colleagues provided motivation” (P9, line 80) 
 
P12: “I found the whole process very interesting especially as the research had 
a very clear remit, physiotherapy focus, and clinically of great professional 
interest” (P12, line 51) 
 
During their participation in Study 2, testing the measurement properties of the LMPI, 
there was some trepidation of how they would perform: 
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P5: “This was a bit challenging in that there was some anxiety as to whether 
the results might vary widely, but it was a good task to do from a personal 
development aspect” (P5, line 73) 
 
P12: “The re-testing was absolutely fine, less threatening than anticipated” 
(P12line65) 
 
P2: “The test re-test was good, I had no recollection of what I’d recorded in 
the 1st session so it was planned in a timely manner” (P2, line 55) 
 
Ethics 
Although the Physiotherapists within Senior Physiotherapist group had been trained how 
to recruit patient participants using the International Conference on Harmonisation − 
Good Clinical Practice Guidelines (ICH-GCP 2000), they found it time consuming, and 
therefore restricted the number of patients that they potentially could have recruited: 
 
P9: “The project would have been easier if patients had not needed to agree to 
taking part” (P9, line 85) 
 
This is probably due to the fact that these physiotherapists were not active researchers, 
and were recruiting patients without additional resource to their caseload. 
 
The training / video 
In general, the Senior Physiotherapist group enjoyed this process, although some of 
them also found it challenging: 
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P2: “The training was really good, the video clips were useful and doing the 
training in groups where discussion was possible helped to gain 
understanding of the assessment” (P2, line 50) 
 
10.7 An overview of the results from Studies 2 and 3 
A strength of using mixed methods research is that both qualitative and quantitative 
results can be presented together to provide a richer insight of the research outcomes.  
This section will present the data gathered from Senior Physiotherapist Participants 5, 11 
and 12, namely that of; intra-rater reliability (Study 2 Phase 2), the patient participants 
they recruited (Study 2 Phase 3) and their written semi-structured reflections from 
Study 3.  These physiotherapist’s data were chosen because they:  
 Attended the training provided. 
 Completed study 2 Phase 3. 
 Recruited the most number of patients. 
 Returned their written reflections.  
 
This section of analysis was framed around the main sub-themes within the final code 
template (Figure [xv]) with reference to the quantitative results so that a more in-depth 
analytical interpretive style could be used. 
 
10.7.1 Senior physiotherapist participant 5 
This Physiotherapist works in a neurological specialist community rehabilitation team and 
at the time of the research had been qualified for 27 years, alongside on-going informal 
and formal in-service training she had completed a post-graduate certificate in adult 
neurology, a basic (three week long) Bobath course and a Professional Diploma in MS. 
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When testing the LMPI, this Physiotherapist’s intra-rater reliability, as measured using 
Spearman’s rank correlation coefficient, was 0.918. This is greater intra-rater reliability 
than the corresponding value for the entire group (r=0.792).  That is, Physiotherapist 5 
is probably better than the overall group, but this cannot be certain, because although 
the value is higher, it is only based on five pairs of readings, and hence is less 
trustworthy than the lower value of 0.792 which applies to the whole group. 
 
This Physiotherapist recruited three men and one woman (patient numbers: 16, 17, 20 
and 27), aged 19, 56, 72 and 76 (respectively), and provided their physiotherapy 
intervention within their own homes.  Their diagnoses causing neurological impairments 
were traumatic brain injury, cerebral meningioma and stroke.  The Physiotherapist used 
the LMPI to measure movement during standing in all four of the participants and 
recorded change in both the LMPI and the BBS (Appendix 13).  When the correlation was 
observed between the LMPI and the BBS scores for these patients (Graph [i]) it would 
appear that these patient’s scores had a weaker correlation, however when the same 
patients are observed in graph [ii], it is clear that the results are consistent with the rest 
of the group.  There are no indications within either the qualitative or quantitative data 
that would suggest why this participant was able to recruit more patients. 
 
10.7.2 Senior Physiotherapist Participant 11 
This participant works in a combined role: 1) within a neurological physiotherapy out-
patients clinic, and 2) on an acute and rehabilitation stroke and neurology unit.  At the 
time of the research, had been qualified for 11 years and alongside on-going informal 
and formal in-service training had completed a basic (three week long) Bobath course.  
 
This Physiotherapist’s intra-rater reliability, as measured using Spearman’s rank 
correlation coefficient (r = 0.782), was comparable to the rest of the group. 
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This Physiotherapist recruited three men and two women into Study 1 Phase 3 (patient 
numbers: 4, 6, 24, 25 and 26), aged 58, 74, 59, 49 and 64 (respectively), and they 
received physiotherapy on the hospital ward (one patient) or in the neurological 
physiotherapy out-patient clinic (four patients) settings.  Their diagnoses causing 
neurological impairments were sub-arachnoid haemorrhage (four patients: - three 
resulted in moderate impairment and one with severe impairment) and stroke (one 
patient).  The Physiotherapist used the LMPI to measure movement during sit to stand 
(two patients), sitting (one patient with leg activity, one patient with arm activity), and 
walking (one patient).  All but one patient demonstrated change in the LMPI, all but one 
patient demonstrated change in the BBS (Appendix 13).  The patient who had 
unchanging LMPI scores (patient 25) only changed by one point with the BBS, despite 
having 17 weeks of treatment intervention between tests.  Interestingly, the patient who 
had unchanging BBS scores (patient 4) showed a significant effect of treatment when the 
LMPI was used, patient four’s results also demonstrated a significant variance within the 
scatter plot illustrating the linear relationships between the LMPI and the BBS (Graph [i])  
and the Bland Altman scatter plot (Graph [ii]).   
 
There are no indications within either the qualitative or quantitative data that would 
suggest why this participant was able to recruit more patients.   
 
10.7.3 Senior Physiotherapist Participant 12 
This participant works in a combined role: 1) as a specialist neurological clinical team 
manager, and 2) within a neurological physiotherapy out-patients clinic.  At the time of 
the research, the participant had been qualified for 31 years and alongside on-going 
informal and formal in-service training had completed a basic Bobath course and a 
Masters module for the administration of botulinum toxin for spasticity.  This 
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Physiotherapist’s intra-rater reliability, as measured using Spearman’s rank correlation 
coefficient (r = 0.761), was comparable to the rest of the group. 
 
This Physiotherapist recruited one man and three woman (patient numbers: 5, 7, 8 and 
9), aged 62, 41, 52 and 62 (respectively), they were recruited and received 
physiotherapy on the hospital ward (three patients) or in the neurological physiotherapy 
out-patient clinic (one patient), their diagnoses causing neurological impairments were 
multiple sclerosis (one patient) and stroke (three patients).  The Physiotherapist used 
the LMPI to measure movement during sit to stand (two patients), walking (one patient) 
and during a transfer from treatment plinth to chair (one patient).  All participants 
demonstrated change in the LMPI, all but one participant demonstrated change in the 
BBS (Appendix 13).  The patient who had unchanging BBS scores (patient 7) showed a 
moderate effect of treatment when the LMPI was used, but did not show significant 
variance within the scatter plot illustrating the linear relationships between the LMPI and 
the BBS (Graph [i]), and the scores were consistent within the group (Graph [ii]) 
 
There are no indications within either the qualitative or quantitative data that would 
suggest why this participant was able to recruit more patients; however, she worked in 
the same department as Senior Physiotherapist Participant 11 which may have given a 
motivational element to them both. 
 
An assumption could be made that all Senior Physiotherapist Participants had similar 
work pressures related to working for the NHS, with the focus on maximising efficiency 
within their caseloads.  The differences in recruitment levels may be due to motivation to 
be research active, availability of patients who were able to consent to participation, or 
high level skills of workload prioritisation. 
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10.8 Summary  
The analysis of the quantitative data gathered Study 2 suggests that the LMPI; when 
used by senior neurological physiotherapists is a reliable and internally consistent 
measurement tool which is more clinically responsive and has greater effect size than 
the BBS when used within this study. 
 
The data that emerged during the thematic analysis of the transcribed data from Study 
3, gathered from a representative group of senior NHS physiotherapists and 
internationally acknowledged expert physiotherapists suggests that the LMPI has been 
found to be clinically useful in that: 
1. It underpins neurological physiotherapy approach to observational assessment. 
2. It supports the clinical reasoning process. 
3. It could potentially be useful as a teaching or educational tool. 
4. Although is quick to use would need support and training to be used most 
effectively.   
However, some issues were identified in relation to the language of the score criteria, 
especially in respect to the phrase “theoretical optimum”. 
 
A combined overview and analysis of both the qualitative and quantitative data enabled 
a more in-depth and richer examination of the results from three members of the Senior 
Physiotherapist Participants Group.  Within this research, the homogenous 
representation of: 1) patients, in terms of their pathology and treatment location, and 2) 
physiotherapists, in terms of their clinical speciality (within neurological physiotherapy), 
experience and skills would suggest that these results could be generalised within the 
profession.  As a consequence of the methodology used within the development and 
testing of the LMPI, strong face and content validity has also been achieved. 
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Chapter 11: Discussion 
 
11.1 Summary 
 
The results of this research indicate that the LMPI can be reliably and validly used to 
measure the movement quality status of people with neurological conditions causing 
motor control impairment, irrespective of their age, gender, pathology or movement 
difficulties.  It  can be applied to any component of movement that is affected, at any 
point during the rehabilitation pathway, irrespective of the severity with which the motor 
control is impaired, and can also be directly associated to the patient’s functional 
rehabilitation goals. Most importantly, the LMPI has also been found to fill a ‘gap’ in 
knowledge: all three groups of Physiotherapists involved in testing the measurement 
properties found that the LMPI could capture the quality of their patient’s movement.  
Furthermore, during the course of this research, it also emerged that the LMPI is a tool 
that: supports clinical reasoning and intervention, can potentially be used as a 
framework for the education and development of less experienced physiotherapists, and 
reflects the theoretical knowledge that underpins both senior and expert 
physiotherapist’s approach to assessment, analysis and prediction of treatment outcome. 
The use of the LMPI can be directed towards the measurement of a ‘status’ or ‘snap shot’ 
of the condition of a patient’s  movement quality, both during baseline assessment and 
analysis at outcome, thus making it a novel tool within this field. 
 
Within modern neurological physiotherapy practice, there are no outcome measures that 
capture the patient’s quality of movement, or the specific effects of physiotherapy 
treatment.  Through intervention, neurological physiotherapists intend to harness their 
patient’s ability to neuro-plastically change, teaching them to develop motor control at 
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‘impairment’ level.  Consequently the patient relearns ‘normal’ movement, which in turn, 
according to the WHO model (WHO 2001), enables them to gain more efficient function 
and independence, having significant impact on their ‘life’. Thus, there is a gap within 
clinical practice: neurological physiotherapists and their patients can both see and feel a 
difference in quality of movement pre and post intervention, but with the exception of 
kinematic techniques, there are no outcome measures that can capture this change in 
quality of movement (Paci 2003). It was hypothesised that the Leeds Movement 
Performance Index (LMPI) would be a more valid, reliable and clinically useful tool for 
use in modern neurological physiotherapy practice than other available existing outcome 
measures.  At the outset, it was understood that a measurement instrument could not 
just be ‘made up’; and as a consequence of this, the conception, development and 
testing of the LMPI were subject to rigorous, evidence based procedures (Table [ii]).  
 
Figures [vii], [viii] and [ix] (pages 99, 100 and 105 respectively) give pictorial 
presentations of the research process, but to briefly re-cap: a multi-centre, three-part 
mixed methods study was undertaken. Study 1 (Chapters 5 and 6) describes the 
creation and pilot testing of a new outcome measure using the qualitative methods of 
nominal group, Delphi and semi-structured face-to-face interviews.  Study 2 (Chapters 7 
and 8) uses psychometric techniques to illustrate the measurement properties of the 
LMPI, namely; internal consistency, external reliability, criterion validity and 
responsiveness.  Study 3 (Chapters 9 and 10), using the qualitative method of Template 
Analysis, further explores the content validity and clinical utility of the LMPI. 
 
11.2 Strengths 
A Strength of this research, is that the development and testing of the measurement 
properties of the LMPI were theoretically driven using a gold standard, conceptual, 
development and testing framework, adapted and designed around key literature from 
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within the field of patient reported outcome measurement (Table [ii]; Johnson et al 
2011).  Furthermore this is the first within the field to do this.  A global approach was 
employed, requiring a combination of quantitative and qualitative methodological 
paradigms as described by Johnson and Onwuegbuzie (2004). 
 
Since the design and completion of this research, new evidence has been published that 
enables the rating of the methodological quality of the development and testing of 
patient reported outcome measures. The COnsensus based Standards for the selection of 
health Measurement Instruments (COSMIN) (Mokkink et al 1010; Terwee et al 2012) 
were developed within the international arena using the knowledge of international 
experts.  Although the LMPI is a clinical outcome measure, and not patient reported; it 
was felt that the rigour of the concepts of COSMIN were a thorough method of 
evaluation of the methodological quality of both development and testing, and could be 
appropriately applied to the LMPI. The COSMIN framework was used to assess the 
properties of the LMPI alongside the BBS, the TIS and GAS; this evaluation is available 
within Appendix 16.   
 
11.2.1 The use of mixed methodology 
Employing a mixed methods design has created strength within this study.  Using a 
scientific, experimental and reductionist approach to Study 2 (Chapters 7 and 8), and 
using a holistic, descriptive, phenomenological and illuminative approach to Studies1 and 
3 (Chapters 5, 6, 9 and 10 respectively); has resulted in the investigation and analysis of 
the properties of the LMPI, and gained ‘real life’ insights into the professional practical 
use of a unique way of measuring movement performance by different groups of 
physiotherapists. This knowledge can be generalised within the profession because of 
both the range of clinical settings that participants (both physiotherapists and patients) 
  
220 
 
were recruited from, and their respective range of levels of clinical skills, experience, 
expertise, pathology and impairment.   
 
Furthermore, as figure [ix] demonstrates (reproduced on page 224 from page 107); the 
qualitative and quantitative methods were not compartmentalised, but used iteratively to 
inform the research progression, enhancing the validity of the results.   
 Content validity was examined using focus groups and reflective questionnaires.  
It was also established within the testing of the measurement properties.  Firstly, 
the movement of patients suffering from neurological damage receiving 
neurological physiotherapy intervention was videoed.  Secondly, the patient’s 
movement was rated by neurological physiotherapists.   
 Rich reflective field notes were recorded by the researcher during the quantitative 
phases of Study 2, and then used to inform and build on the a-priori themes that 
had emerged in Study 1.  The a-priori themes provided the initial source of 
questions for the focus groups and reflective questionnaires, and established the 
initial template for the analysis of the qualitative data.   
 During the analysis of the qualitative data, quantitative information (such as 
individual physiotherapist’s intra-rater reliability) was used to enrich possible 
explanations to the impressions and reflections given by the Senior 
Physiotherapist Participants group.   
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Figure [ix] – re-produced from page 106: A summary of the mixed methods design used 
throughout Studies 1, 2 and 3 
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Therefore, using a mixed methods design worked well, giving the research an interlacing 
of both quantitative and qualitative processes and analysis, this design gave the results 
depth and validity which could not have been achieved with the individual use of either 
methodology (Rauscher & Greenfield 2009). 
 
The concept of using mixed methods research within the Physiotherapy profession is 
interesting.  Culturally, physiotherapists are scientific and are generally pragmatic by 
nature, however, within clinical practice, there is a strong drive to treat patients as 
individuals.  Hence, treatment plans are individualised to help patients to manage their 
movement difficulties within their physical and social environment, thus reflecting the 
bio-social model of the World Health Organisation’s International Classification of 
Function Disability and Health (WHO-ICF) (WHO 2001) (Figure [i]).  Consequently, the 
LMPI will not be accepted if it is not found to be clinically useful.   Being accepting of 
both methodological paradigms and so finding a third paradigm that suited the 
requirements of this research project enabled the convergence and corroboration of 
evidence (Rauscher & Greenfield 2009) to provide both a scientific validation and a 
practical endorsement of a novel way of assessing, analysing, measuring and possibly 
teaching these skills to less experienced physiotherapists.  
 
11.2.2 Content validity 
Once the LMPI had been designed (Study 1, Chapters 5 and 6), the need to scientifically 
establish its reliability and validity became clear.  To further support both initial face and 
content validity, patients with neurological pathology and senior neurological 
physiotherapists (the Senior Physiotherapist Participant Group) with no connection to its 
origin, were recruited to investigate internal and external reliability and validity (Study 2, 
Chapters 7 and 8).  To understand the clinical utility of the LMPI, both the Senior 
Physiotherapist Participant Group and internationally acknowledge experts (the Expert 
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Physiotherapist Group) were invited to critique its use after they had experience of 
applying it within their practice (Study 3, Chapters 9 and 10). 
 
The face to face interviews used within the pilot work of Study 1 (Chapters 5 and 6) may 
have been influenced by ‘personal interest’ researcher bias; but this risk was foreseen 
and contained because similar information was gathered  from both the Senior 
Physiotherapist Participants and the Expert Physiotherapists Groups.  Johnson et al 
(2011) advocate the use of clinicians in these ways, so that good face and content 
validity is assured; and similar methods were also utilised by Berg et al (1989) and 
Horak et al (2009) during the development of the BBS and the Balance Evaluation 
Systems Test.  The use of these methods and the resulting findings suggest robustness 
of the LMPI and comparability with other work within the field. 
 
The use of focus group methods within Study 3 (Chapters 9 and 10) using the Expert 
Physiotherapists Group, was intended as the ultimate test of clinical utility and content 
validity of the LMPI; thus meeting the methodological requirements within figure [ii] and 
the COSMIN framework (Terwee et al 2012).  The clinical skills and experience of the 
participants were similar to each other (Krueger et al 2000), and greater than those of 
the researcher; thus increasing the quality of the information gathered potentially 
outside her knowledge base. It was expected that the participants would openly discuss, 
disagree if necessary, and explore their knowledge in depth and how the LIMP may 
relate to their practice.  It was not feasible to bring together a group of experts within 
this clinical field who did not know each other, and so, potential bias was managed in 
other aspects of this method (FocusGroupTips.com (n.d.) by:- 
 Minimising moderator bias:   
The moderator did not offer opinions. 
 Avoidance of biased questions:   
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The questions and topics were pre-prepared; general prior to specific questions, 
and positive prior to negative questions were asked. 
 Avoidance of biased answers:  
The moderator created a calm atmosphere, recording independent notes in 
conjunction with audio-recording; challenging discussions were responded to in a 
tactful and honest way. 
 Minimised biased reporting:   
More than one individual / group of analyst(s) were used; independent notes on a 
flip chart were kept during the Focus Groups, and then shared with participants 
for immediate validation. 
 
Again, focus group methods fulfil the suggestions of Johnson et al (2011) and this 
approach is seen within the literature (Table [iv]), for example, other researchers have 
used focus group methods, but much earlier in the process (Howe et al 2006); or other 
types of consensus group methods (Horak et al 2009; Daley et al 1999) or interview 
(Berg et al 1989; Gorman et al 2010) in order to gain feedback during the development 
of instruments.  No other researcher groups within the field of outcome measures aimed 
at patients with movement impairment have used focus groups similar to those used 
within this thesis, suggesting that the clinical utility of the LMPI has been tested more 
robustly, and to greater depth than others within the field. 
 
11.2.3 Measurement properties 
Using the COSMIN framework; the LMPI was critiqued alongside the BBS, the TIS and 
GAS (Appendix 16); the findings suggest that the properties of the LMPI are 
comprehensive, meeting the requirements of Table [ii], and stronger than those of the 
BBS, the TIS and GAS because mixed methodology was used.  
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Internal consistency of the LMPI was rated as “excellent” according to table [ii], 
comparable to the BBS (Berg et al 1989; Mao & Hsueh 2002), and stronger than the TIS 
(Verheyden et al 2004). 
 
Test re-test reliability of the LMPI was rated as “substantial” according to table [ii], but 
not as strong as those found for the BBS (Berg et al 1989; Berg et al 1995; Liston & 
Brouwer 1996; Farlow et al1997; Mao & Hsueh 2002; Hiengkaew et al 2012) or the TIS 
(Verheyden et al 2004; Verheyden et al 2006b; Verheyden et al 2006c).  However, 
assuming the perceived greater clinical judgement required to use the LMPI, together 
with its perceived greater sensitivity (given the floor and ceiling effects of both the BBS 
and TIS, and emergent themes from the Template Analysis in Study 3, Chapter 10); it 
should be expected that the test re-test reliability of the LMPI should not be 
exceptionally strong, and that it should perform differently to other less sensitive scales.  
Nonetheless, it is still within acceptable levels. 
 
Inter-rater reliability was found to be “excellent” according to Table [ii] and compares 
well to the BBS (Berg et al 1989; Berg et al 1995; Farlow et al1997; Bennie et al 2003; 
de Figueiredo et al 2009; Leddy et al 2011), the TIS (Verheyden et al 2004; Verheyden 
et al 2006c) and GAS (Joyce et al 1994), the latter of which was interestingly only found 
to be strong if the raters were familiar with the patient being tested.  The testing of the 
LMPI using patient videos enabled blinding of the raters, thus overcoming this potential 
issue.  
 
The measurement error using the Smallest Detectable Change (SDC) of the LMPI is small 
in comparison to the SDC of the BBS which has been found to have a range of values 
from 4 to 6.2 according to the study being reported (Stevenson 2001; Steffen & Seney 
2008; Donoghue & Stokes 2009; Hiengkaew et al 2012; Quinn et al 2013; Godi et al 
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2013).  This would suggest that the LMPI has greater sensitivity than others within the 
field, and could thus have significant impact both within the clinical and research arenas. 
 
Criterion validity of the LMPI was tested by comparing and correlating LMPI and BBS 
scores for a group of patients’ pre and post intervention.  The results demonstrate only 
moderate agreement, which should be expected because although similar constructs 
were being measured, i.e. movement; the items within the scales measure different 
components of motor control.  There is argument within the COSMIN group (Mokkink et 
al 2010), that criterion validity should not be tested against a scale that is not of ‘gold 
standard’.  However, there are no gold standard outcome measures available within this 
field.  In this study, the use of the BBS for comparison with the LMPI is justified on the 
grounds that it:- 
• Has strong clinical resonance. 
• Has strong concurrent validity with other measurement instruments and  
rigorously tested measurement properties (Appendix 1)  
• Meets the requirements of Table [ii] better than any other within the field.  
In practice, the LMPI is unlikely to have strong criterion validity with any of the outcome 
measures currently in use, because it assesses and measures a different construct of 
movement i.e. quality of movement.   
 
Interestingly, studies examining the agreement between patient and clinician 
perceptions of change with an ‘outcome measure’ have been carried out for both the 
BBS during its development (Berg et al 1989); and more recently within the field of 
neurological rehabilitation with GAS (Joyce et al 1994; Khan et al 2008).  Testing the 
agreement between the LMPI and patient and / or clinician perceptions of change seems 
an area worthy of future exploration with the LMPI. 
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11.2.4 Clinical utility 
The COSMIN group (Terwee et al 2102), do not rate or include clinical utility within their 
framework; but it was included in this study because it was present in Table [ii] and also 
perceived to be an important barrier or facilitator for the use of outcome measures 
within neurological physiotherapy clinical practice (Chapter 2).  Within the literature 
associated with the BBS, the TIS and GAS, some work has been published that relates to 
this concept.  For example, two groups of researchers within the incomplete spinal cord 
population (Datta et al 2009; Lemay & Nadeau 2010; Datta et al 2012) have considered 
clinical utility for the BBS, but they did not use qualitative methods and their results did 
not agree: one group felt that the BBS was clinically useful (Lemay & Nadeau 2010) 
whilst the other did not (Datta et al 2009; Datta et al 2012). Several studies have 
reported the clinical utility of GAS: Joyce et al (1994) used clinical observations of the 
authors; Reid & Chesson (1998) used two case studies; Khan et al (2008) used 
quantitative methods, comparing GAS with other outcome measures; and Turner Stokes 
et al (2010) used quantitative methods to compare the sensitivity of GAS with other 
outcome measures.  No previous studies have used a mixed methodology to explore 
clinical utility. This research has used a combination of quantitative and qualitative 
methods indicating that the LMPI is robust, and further strengthened by ‘real life’ 
insights from a range of clinical settings, conditions and levels of clinical skills, 
experience, expertise, pathology and impairment.   
 
Responsiveness  
Within this thesis, responsiveness has been reported in terms of measurement error and 
effect size, it also emerged from the Template Analysis, that the physiotherapists 
suggested that the LMPI was able to assess very specific improvement after 
physiotherapy intervention.  When assessing clinical responsiveness and effect size of an 
outcome measure, the results to some extent must be dependent on the variability of 
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the patients (their diagnosis, prognosis and neuroplasticity) and the expertise of the 
physiotherapist.  In Study 2 (Chapter 6), when the LMPI and BBS were administered pre 
and post intervention by the same physiotherapist (i.e. neither the patients nor the 
physiotherapists varied); the LMPI was compared favourably with the BBS demonstrating 
greater responsiveness and larger effect size; and whilst the BBS and LMPI results were 
both above 0.80 (the suggested criteria for ‘large’ within Table [ii]), the LMPI’s were 
greater.  Furthermore, the effect size of the BBS found within this study is comparable to 
those found by Wood-Dauphinee et al (1997), Amasut (2009), Hackney and Earhart 
(2009), and Mao & Hsueh (2000), thus re-enforcing the reliability of results.  No 
comparisons can be made with the TIS because no data is available; however, the effect 
size of GAS is comparable to that of the LMPI (Ashford & Turner- Stokes 2006; Kahn et 
al 2008; Turner- Stokes et al 2009; Turner-Stokes & Williams 2010). 
 
Respondent burden and ease of use 
This quality, although considered by the COSMIN group (Mokkink et al 2010), was not 
included within the contributors to Table [ii], is nonetheless important because of the 
factors that can inhibit or facilitate the use of outcome measures within neurological 
physiotherapy clinical practice (Chapter 2).   
 
Swinkels et al (2011) found that one of the main contributions to the low use of outcome 
measures within physiotherapy clinical practice, was that those available did not address 
the area to which intervention was directed, that is, the patient’s impairment; another 
was that the patients preferred to be ‘treated’ as opposed to ‘tested’.  Yoward (2008), 
Jette et al (2009) and Swinkels et al (2012) found that outcome measures might be 
utilised more if they could demonstrate treatment effectiveness, direct a treatment plan 
and improve quality of treatment.  The emergent themes from within Study 3(Chapter 
10) of this thesis suggest that the LMPI can meet these demands because: 
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 It has been found to be quick and easy to use once the decision about what 
aspect of the patient’s movement to be measured has been decided. 
 It has to be directed towards both the patient’s impairments and their 
rehabilitation goals. 
 It is best completed during routine clinical record keeping. 
 
Therefore in summary; in comparison with other outcome measures in the same field, a 
significant methodological strength of the measurement properties of the LMPI is that 
not only have they been developed and tested using a robust framework (Table [ii]); but 
are also favourably judged according to COSMIN. 
 
11.3 Unexpected benefits 
A major strength of this study is the use of both quantitative and qualitative data; firstly, 
to conceptualise and develop an outcome measurement instrument, then secondly, to 
establish its robust measurement properties.  It was not anticipated that the LMPI would 
be perceived as a clinical support tool or would have the potential to be used as a tool 
for educational purposes.   
 
11.3.1 Clinical support tool 
The aims of Study 1 Phase 2 (Pilot study; initial investigation of clinical utility) were to 
initially test the LMPI for clinical utility within neurological physiotherapy clinical practice.  
Although the results indicate good clinical utility, a strong emerging theme indicated that 
the clinicians felt that the LMPI underpinned their therapeutic approach, and supported 
their clinical knowledge.   This theme also clearly emerged during the cross case analysis 
of the focus groups and reflective written data, strongly suggesting that the clinicians 
perceived that the LMPI aided their clinical reasoning.  This was especially so for the less 
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experienced Senior Physiotherapist Participants Group.  Therefore the clinicians 
perceived that the LMPI could help the clinicians to assess, clinically reason and treat 
their patients.   
 
There is an interesting difference between the ability of the LMPI to assess outcomes and 
it’s potential ability to also assess clinically and thus guide intervention.  This may imply 
that using the LMPI within clinical practice could help to: firstly, standardise an individual 
patient’s intervention and secondly, standardise practice across a team of neurological 
physiotherapists. 
  
11.3.2 Education support tool 
The data analysed specifically from the Expert Physiotherapists Group suggested that the 
participants perceived that the LMPI could be used as a framework for the education and 
development of the observational and analytical skills of both experienced and less 
experienced physiotherapists.  That is, the LMPI could be used as a tool to teach 
physiotherapists to treat their patients.  This perception should be judged to be valid 
because of the educational element of the Expert Group’s teaching roles within their 
organisation (the British Bobath Tutors Association). 
 
Furthermore, it is suggested that the use of the LMPI can be directed towards the 
measurement of a ‘status’ or ‘snap shot’ of the condition of a patient’s  movement 
quality, both during assessment and analysis at outcome, therefore making it a unique 
tool within this field. 
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11.4 Limitations 
Using the COSMIN group criteria for the assessment of the quality of measurement 
properties of patient reported outcome measures (Terwee et al 2102) (Appendix 16): 
helped demonstrate the robustness of the development of the LMPI in comparison to 
other outcome measures in the same field (the BBS, the TIS and GAS); and also 
provided useful indicators for future work.   However, the three criteria assessed by 
Terwee et al (2012) which were not met within this thesis were the use of Rasch analysis 
to determine ordinal scale structure (Bond & Fox 2001), the use of specific sample size 
of participants to ensure low risk of interpretation error, and the testing of floor and 
ceiling effects. 
 
Rasch analysis was not appropriate in this study because the sample size required for 
this method was unachievable within the constraints and resources of a Doctoral study.  
It is also suggested that Rasch methods were not appropriate, because the items of the 
LMPI were not hierarchical in nature, and the ranking of importance of the items within 
the LMPI were dependent on each individual patient’s motor control impairments. 
 
Although the sample size used to test internal consistency was appropriate, the rule of 
thumb estimate being for approximately five patients per item (Nunnally and Bernstein 
1994).  Terwee et al (2012) advise that when testing scale external reliability and 
validity: an adequate sample size should consist of more than 100 patients; a good 
sample size should consist of between 50 and 99 patients; a moderate sample size 
should consist of between 30 and 49 patients; and a sample size is considered small 
when less than 30 patients are recruited. Between 25 and 50 patients were expected to 
be recruited into Study 2 Phase 3 (Chapters 7 and 8) and although 27 were recruited, 
four of the Senior Physiotherapist Participants did not take part in patient recruitment, 
creating a significant impact on patient access.  It was not appropriate to extend the 
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window of time for recruitment because of the ethical issues of physiotherapist 
participant burden and PhD study time constraints.  However,  the results from Study 2 
also indicate that findings are free from type I (error in detecting reliability) or type II 
errors (failure to detect reliability); suggesting that although the sample sizes used were 
considered ‘small’, they were able to meet the requirements of this research.  The 
sample sizes used within the many different studies relating to the testing of the 
measurement properties of the BBS, the TIS and GAS are largely comparable to those 
used within this thesis; that is, they are considered small by the standards advocated by 
Terwee et al (2012).   
 
Similar to GAS (Turner-Stokes et al 2009); floor and ceiling effects are not relevant for 
the LMPI, because the movement being measured is focussed on the individual patient’s 
impairment and is directly related to the criteria within the items i.e.:  
• Alignment of the relevant body parts, soft tissues and muscles. 
• Interaction between the relevant body parts and the patient’s base of support. 
• Timing of motor control. 
• Appropriate Speed of movement.  
• The ability to achieve the task being performed using Selective Movement. 
 
Nonetheless, despite the decision of not to quantitatively investigate the floor and ceiling 
effects for the LMPI, there is qualitative evidence of the lack of effects in different parts 
of the results.  During Study 1 Phase 1 (Chapter 6), the Physiotherapy Research Group 
felt that the LMPI did not have floor or ceiling effects.  Within Study 1 Phase 2 (Chapter 
6), the physiotherapists participating in the pilot study (an initial investigation of clinical 
utility) reported that they found no floor or ceiling effects.  Physiotherapist 6 (Study 3, 
Chapter 10), when comparing the LMPI to another outcome measure, indicated that 
some patients may score ‘0’ on both admission and discharge when rated with the Trunk 
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Control Test (Collin and Wade 1990) yet would demonstrate change if the LMPI were to 
be used. The findings throughout the results may have emerged because floor and 
ceiling effects found in other outcome measures (e.g. the BBS) constrain their use within 
clinical practice.  Since the LMPI can be used with people who have large or small levels 
of impairment, floor and ceiling effects are not an issue of concern.  In contrast; the BBS 
was found to have both floor and ceiling effects (Mao et al 2002), and whilst its authors 
claim no such effects within the TIS (Verheyden et al 2006a), a study by Verheyden et al 
(2005) showed that 45% of neurologically unimpaired adults could not achieve full 
scores. 
 
It is important to acknowledge other inherent limitations in the methodological 
approaches used in this study.  
 
Whilst the consensus methods employed in Study 1 (Chapters 5 and 6) were designed to 
be as rigorous as possible, and a ‘strength’ of nominal group methods is considered to be 
a useful way of harnessing collective knowledge from group members, there is also a 
risk of ‘collective ignorance’ (Murphy et al 1998).  However, the results from the face to 
face interviews used during the pilot work within Study 1 (Chapter 6) and the themes 
arising from the semi-structured questionnaires and Focus Groups in Study 3 (Chapter 
10) established the reliability of the results, and thus re-enforce the content validity of 
the LMPI.  The Delphi methods used in Study 1 (Chapters 5 and 6) also helped to 
support the strength of the findings by enabling independence of opinions without the 
bias of potentially stronger members of the group inhibiting the opinions of others.  
 
The thematic analysis techniques used within Study 1 (Chapters 5 and 6) may have been 
influenced by both researcher and consensus group ‘personal interest’; however this risk 
was removed, because similar findings from the results of the Template Analysis used in 
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Study 3 (Chapter 10). Furthermore, these results were also independently scrutinised in 
order to manage potential ‘personal interest’ bias of the researcher and Physiotherapy 
Research Group.  Template Analysis was used so that the a-priori themes emerging 
during Studies 1 and 2 (Chapters 5, 6, 7 and 8) could be utilised to initially organise and 
ultimately strengthen the final code template created within Chapter 10 (Figure [xiv]).  
Thus, it is suggested that using the method of Template Analysis and accessing 
independent scrutiny was an effective way of organising qualitative data to gain an 
understanding of the LMPI, enabling the employment of the a-priori themes developing 
during both the quantitative and qualitative approaches. 
 
There was a concern that the videos prepared for both the training and testing sessions 
within Study 2 (Chapters 7 and 8) were not representative of a typical neurological 
physiotherapy patient caseload; because a large number of the ‘normal’ patient 
population have impairments related to comprehension, expression or cognition.  This 
was considered unavoidable because the ethical approach required consent to participate 
and these patients were excluded.  However, in practice, it was found within the 
qualitative data, that the LMPI was a tool that enabled neurological physiotherapists to 
assess, analyse and plan intervention by supporting the clinical reasoning and theory 
that underpins practice.  In other words, using the LMPI was not considered to be 
dependent on the patient’s ability to communicate, but on the physiotherapists ability to 
analyse movement and motor impairment.  Furthermore, within clinical practice the 
observational assessment skills of neurological physiotherapists are transferable between 
clinical areas and the patient’s neurological pathology and complexity.  The recruitment 
of patients within Study 2 Phase 3 was also limited to those who were able to give 
informed consent; again, for the reasons explained above this was deemed not to be a 
significant constraint of the research findings.  
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Within Study 2 (Chapters 7 and 8), the risk of contamination between raters was 
managed by organising the training and testing sessions within small groups of Senior 
Physiotherapist Participants, and requesting that participants did not confer either during 
or after testing the LMPI.  This practice also helped to reduce physiotherapist participant 
burden because the sessions were organised during both their normal working hours and 
at their places of work. 
 
Because all the physiotherapists and physiotherapist participants contributing to this 
research are either experienced or expert clinicians, the validity of the results are 
maximised.  On the other hand, the findings cannot be generalisable throughout the 
profession as a whole.  It is therefore not known whether the LMPI could be used by less 
experienced physiotherapists, student physiotherapists, or physiotherapists from within 
different specialisms, e.g. musculoskeletal, haemophilia, respiratory medicine or 
paediatrics.  Nonetheless, a clear argument can be made for the implementation of this 
tool for use by senior neurological physiotherapists.  Patients who have motor control 
difficulties because of neurological damage are complex, they therefore require 
treatment from senior clinicians; the LMPI can thus be used by these clinicians both to 
support and reflect their intervention, and possibly also to support the education of less 
experienced physiotherapists. No actions were taken to reduce or manage this potential 
limitation, although future work would be indicated to explore these prospective 
expansions of use. 
 
It could be argued that the language used within the LMPI is technical and therefore not 
easily understood by a patient or other members of the rehabilitation team.  Other 
outcome measures have used similar technical language to that of the LMPI: that is, the 
Radell Evaluation Scale for Dance Technique (Radell, et al 2011), the Reaching 
Performance Scale (Levin et al 2004) and the Balance Evaluation Systems Test (Horak et 
al 2009) but none of these are satisfactory for use within the neurological patient 
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population: the former being developed by and for the dance industry; the Reaching 
Performance Scale is not fully developed and limited to upper limb use; and the latter is 
not free, and limited to the measurement of movement in standing.  It was found in 
Study 3 (Chapter 10) that the technical language used within the LMPI is meaningful 
within the context in which it is used, and was designed to be as succinct and as clear as 
possible.   
 
11.5 Conclusion 
The LMPI is a novel and potentially important contribution to the field of neurological 
physiotherapy, both clinically and within research practice.  It is the first outcome 
measure to conceptually map the nature and definition of quality of movement for 
patients with motor impairment and captures the impact of neurological physiotherapy 
intervention more responsively compared with other outcome measures routinely used 
within the field. Horner and Larmer (2006) state that health outcome measures should 
sit: 
 
‘within conceptual frameworks and be practical’  (Horner & Larmer 2006, p23). 
 
The developmental process of the LMPI and its resulting face and content validity 
enables the LMPI to sit within the conceptual framework of modern UK clinical practice.  
Horner and Larmer also state that measures should be 
 
“reliable, valid and responsive for a particular purpose in a particular population”          
(Horner & Larmer 2006, p23). 
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The results of the three studies within this thesis suggest that the LMPI has strong 
internal and external reliability, clinical utility and validity.  Furthermore, unexpected 
benefits within this research demonstrated that the LMPI was much more than ‘just’ a 
measurement instrument and has potential value as a clinical support tool and an 
educational tool within clinical practice. 
 
The findings from this Doctoral programme of research make an important contribution 
to the field of neurological physiotherapy, drawing on a wide range of methodologies.  
The resulting tool, the LMPI, has many potential uses within clinical practice, including:   
 The assessment and recording of the patient’s quality of movement at base line, 
monitoring of changes and recording outcome of neurological physiotherapy 
intervention.   
 The support of clinical reasoning, i.e. the identification and prioritisation of motor 
control difficulties at impairment level according to the WHO-ICF model (figure 
[i]), presenting a more consistent holistic approach to neurological physiotherapy 
assessment and intervention. 
 The facilitation of: between physiotherapist communication and shared treatment 
planning. 
 Subject to further research findings, the potential of using the LMPI as a 
framework for training less experienced staff or physiotherapy students to 
develop the skills of assessment of impairment, analysis of assessment and 
treatment, and measurement at both baseline and post intervention. 
 Within intervention and evaluation research; i.e., the selection of appropriate 
outcome measures to underpin the meaningful interpretation of study results 
(data can only be meaningful if the instruments used to collect the data are valid 
and reliable and appropriate to address the research question).   
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11.6 Recommendations for taking this work forward 
During the analysis, interpretation and discussion of the results of this research, a 
number of recommendations for further work have been identified. 
 
11.6.1 Further testing of measurement properties 
Because of the constraints of this study, sample size was restricted as were further 
investigations of measurement properties.  Further research would be appropriate to 
examine:- 
 Convergent validity with patient perceptions of improvement such as has been 
published for the BBS (Berg et al 1989) or clinician perceptions of change as has 
been published for GAS (Joyce et al 1994; Khan et al 2008). 
 The effect of larger sample sizes of patient participants to reduce the risk of type 
I and type II errors, as suggested by Terwee et al (2012). 
 The potential of the application of Rasch analysis (Bond & Fox 2001) so that the 
LMPI could more reliably be used in multi-site interventional studies. 
 
Different grades 
This research has focussed on the reliability of the LMPI using senior neurological 
physiotherapists and could be repeated and results compared with different/more junior 
grades of physiotherapists working within neurological physiotherapy. 
 
Different specialities 
Again, this research has focussed on the reliability of the LMPI using senior neurological 
physiotherapists.  The exploration of the clinical utility, internal and external reliability 
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and validity of the LMPI within different specialisms of physiotherapy, using similar 
methods to Studies 2 and 3 may gain generalisability across the profession. 
 
11.6.2 Educational tool 
The use of the LMPI as an educational tool was suggested by the Expert Physiotherapist 
Group, and this could be further explored: within the higher education, organised post 
graduate course and clinical settings, recruiting student physiotherapists, inexperienced 
and experienced physiotherapists. It is suggested that the LMPI would be used as an 
intervention (to teach the analysis of movement), and the effects of the intervention 
measured using the perceptions of participants and the clinical judgement of their 
educators. 
 
11.6.3 Clinical support tool 
The use of the LMPI as clinical support tool was suggested by both the Expert 
Physiotherapist and Senior Physiotherapist Participant Groups, and this could be further 
explored within the clinical and post-graduate course settings.  Could clinicians use the 
LMPI to guide their intervention as well as record the effects of their intervention?  
Again, it is suggested that the LMPI could be the intervention, acting as a framework for 
analysis and clinical reasoning alongside outcome measurement.  Then used by a group 
of physiotherapists during their day to day clinical work or during a post-graduate 
course.  The effects of the intervention could then be analysed using the perceptions of 
both the participating physiotherapists and their patients. 
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Appendices 
 
Appendix 1 
 The Berg Balance Scale data sheet 
 A summary of the available literature that has been reviewed in relation to the 
measurement properties and clinical utility of the Berg Balance Scale 
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Berg Balance Scale data sheet (Berg  et al 1989) 
Patient number: 
Item  Description  Date 1 
score 
Date 2 
score 
1 Sitting to 
standing 
Instructions: Please stand up.  Try not to use your hands for 
support 
4-able to stand without using hands and stabilise independently 
3-able to stand independently using hands 
2-able to stand using hands after several tries 
1-needs minimal aid to stand or stabilise 
0-needs moderate or maximal assistance to stand 
  
2 Standing 
unsupported 
Instructions: Please stand for 2 minutes without holding 
4-able to stand for 2 minutes 
3-able to stand for 2 minutes with supervision 
2-able to stand for 30 seconds unsupported 
1-needs several tries to stand for 30 seconds unsupported 
0-unable to stand for 30 seconds  unsupported 
If a subject is able to stand for 2 minutes unsupported, score 
full points for next item and proceed to item 4. 
  
3 Sitting 
supported 
Instructions: Please sit with arms folded for 2 minutes (back 
supported) 
4-able to sit safely and securely for 2 minutes 
3-able to sit for 2 minutes under supervision 
2-able to sit for 30 seconds 
1-able to sit for 10 seconds 
0- unable to sit without support for 10 seconds 
  
4 Standing to 
sitting 
Instructions: Please sit down 
4-sits safely with minimum use of hands 
3-controls descent by using hands 
2-uses back of legs against chair to control descent 
1-sits independently but has uncontrolled descent 
0-needs assistance to sit 
  
5 Transfers 
(arrange as for 
pivot transfer, 
using either 2 
chairs (1 with and 
1 without 
armrests) or a 
bed and a chair 
Instructions: Ask subject to transfer one way toward a seat with 
armrests and one way toward a seat without armrests 
4-able to transfer safely with minor use of hands 
3-able to transfer safely with definite need of hands 
2-able to transfer with verbal cueing and / or supervision 
1-needs 1 person to assist 
0-needs 2 people to assist or supervise to be safe 
  
6 Standing 
unsupported with 
eyes closed 
Instructions: Please close your eyes and stand still for 10 seconds 
4-able to stand for 10 seconds safely 
3-able to stand for 10 seconds with supervision 
2-able to stand for 3 seconds 
1-unable to keep eyes closed but stands safely 
0-needs help to keep from falling 
  
7 Standing 
unsupported with 
feet together 
Instructions: Place your feet together and stand without holding 
4-able to place feet together independently and stand for 1minute 
safely 
3- able to place feet together independently and stand for 1 min with 
supervision 
2- able to place feet together independently, but unable to hold for 
30 seconds 
1-needs help to attain the position but able to stand for 15 seconds. 
Feet together 
0- needs help to attain the position but unable to hold for 15 seconds 
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Item  Description  Date 1 
score 
Date 2 
score 
8 Reaching 
forward with 
outstretched arm 
(ruler placed at 
fingertips when 
arm at 90º. 
Fingers not 
touching ruler 
while reaching) 
Instructions: lift arm to 90º. Stretch your fingers and reach forward 
as far as you can. The recorded measure is the distance forward 
that the fingers reach while the subject is in the most forward lean 
position. When possible, ask the subject to use both arms when 
reaching to avoid rotation of the trunk. 
4-can reach forward confidently 25cm (10 inches) 
3-can reach forward 12cm (5 inches) safely 
2-can reach forward 5cm (2 inches) safely 
1-reaches forward but needs supervision 
0-loses balance while trying / requires external support 
  
9Pick up object 
from the floor from 
a standing 
position 
Instructions: pick up the shoe / slipper placed in front of your feet 
4- able to pick up slipper safely and easily 
3- able to pick up slipper but needs supervision 
2- unable to pick up but reaches 2-5 cm from slipper and keeps 
balance independently 
1- unable to pick up and needs supervision while trying 
0.- unable to try / needs assist to keep from losing balance or falling 
  
10 turning to look 
behind over left 
and right 
shoulders while 
standing 
Instructions: turn to look directly behind you over your left 
shoulder. Repeat to the right. The examiner may pick an object to 
look at directly behind the subject to encourage a better twist turn. 
4-looks behind from both sides and shifts weight well 
3-looks behind one side only. Other side shows less weight shift 
2- turns sideways only but maintains balance 
1- needs supervision when turning 
0-needs assistance when turning 
  
11 Turn 360º Instructions: turn completely round in a full circle. Pause. Then 
turn a full circle in the other direction 
4-able to turn 360º safely in 4 seconds or less 
3- able to turn 360º safely in 1 direction only in 4 seconds or less 
2- able to turn 360º safely but slowly 
1-needs supervision when turning 
0- needs assistance when turning 
  
12 placing 
alternate foot on 
step or foot stool 
whilst standing 
unsupported 
Instructions: place each foot alternatively on the step. Continue 
until each foot has touched the step 4 times. 
 
  
13 standing 
unsupported 1 
foot in front 
Instructions: (DEMONSTRATE TO SUBJECT) Place 1 foot 
directly in front of the other. If you fell that you cannot place your 
foot directly in front, try to step far enough ahead that the heel of 
your forward foot is ahead of the toes of the other foot. (to score 3 
points, the length of the step should exceed the length of the other 
foot and the width of the stance should approximate the subjects 
normal stride width) 
4- able to place foot tandem independently and hold for 3 seconds 
3- able to place foot ahead of other independently and hold for 3 
seconds 
2- able to take small step independently and hold for3 seconds 
1- needs help to step but can hold for 15 seconds 
0- loses balance while stepping or standing 
  
14 standing on 1 
leg 
Instructions: stand on 1 leg as long as you can without holding 
4-able to lift leg independently and hold for more than 10 seconds 
3- able to lift leg independently and hold for 5 - 10 seconds 
2- able to lift leg and hold for 3 or more seconds 
1- tries to lift leg unable to hold for 3 seconds but remains standing 
independently. 
0- unable to try or needs assist to prevent a fall 
  
TOTAL SCORE 56 Maximum   
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A summary of the available literature that has been reviewed in relation to the measurement properties and clinical utility of the BBS – 1. 
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1) Berg et al 1989 +++ PD 
Stroke 
Elderly 
38 pts  
32 HCP 
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14pts   
5PTs 
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14pts   
5PTs 
Carer 
opinion 
+++ - - - - - - 
2) Berg et al 1992 - Elderly 
Neuro 
31 pts - - - Tinetti 
Barthel  
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+++ - - - - - - 
3) Berg et al 1995 - Elderly 
Stroke 
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30pts 
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30pts 
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4) Liston & Brouwer 
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master 
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0.97 
- 
7) Farlow et al1997 - ABI 18 pts   
4 raters 
- +++ +++ - - - - - - - - 
8) Wee et al 1999 - Stroke 128 pts - - - - - - - - - - LOS ++ 
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A summary of the available literature that has been reviewed in relation to the measurement properties and clinical utility of the BBS - 2.   
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9) Salbach et al 2001 - Stroke 50 pts - - - - - - - - 26% - - 
10) Stevenson 2001 - Stroke 48 pts - - - - - - - - - MDC 
SEM 
- 
11) Feld et al 2001 - ABI 40 pts - - - FIM - - - - - - D/C ++ 
12) Mao et al 2002 - Stroke 112 pts 
2 OTs 
+++ +++ - FM   
PASS 
+++ - - 28% 35% ES up to 
1.11 
- 
13) Bennie et al 2003 - Neuro 
rehab 
20 pts - +++ +++ TUG     
FR 
++ - - - - - - 
14) Wee et al 2003 - Stroke 313 pts  - - - - - - - - - D/C++ 
15) Whitney et al 2003 - PD 70 pts - - - DGI +++ - - - - - - 
16) Kornetti et al 2004 - Neuro 
Elderly 
100 pts - - - - - + - - - - - 
17) Wang et al 2004 - Stroke 70 pts - - - PASS ++ - - - - - - 
18) Franchignoni et al  
2005 
- PD 70 pts ++ - - FFM 
PCS 
 
++ - - - - - - 
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A summary of the available literature that has been reviewed in relation to the measurement properties and clinical utility of the BBS - 3.   
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19) Newstead et al 2005 - TBI 5 pts     
2 raters 
- +++ - - - - - 40% - - - 
20) Qutubuddin et  al  
2005 
- PD 38 pts - - - UPDRS 
H&Y    
SE-ADL 
+++ - - - - - - 
21) Sackley et al 2005 - ADL 47 pts   
2 raters 
- +++ +++ -- - - - - - - - 
22) Cattaneo et al 2006 - MS 51 pts - - - - - - - - - - Falls + 
23) Conradsson et al  
2007 
- Stroke 
Elderly 
45pts 
1rater 
- +++ - - -  - - - - - 
24) Steffen & Seney 
     2008 
- PD 37 pts - +++ - - - - - - - SEM 
MDC 
- 
25) Hackney & Earhart       
     2009 
- PD 14 pts - 
- 
- 
UPDRS 
TUG 
6MWT  
- - - - - ES 0.83 - 
26) Amasut 2009 - Stroke  51 pts - - - - - - - - - ES 0.22 - 
27) Datta et al 2009 - ISCI 97 pts - - - 6MWT 
10mWT 
SCFAI 
- - + - - - - 
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A summary of the available literature that has been reviewed in relation to the measurement properties and clinical utility of the BBS - 4.   
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28) Donoghue & Stokes 
     2009 
- Elderly 118 pts - - - - - - - - - SEM 
MDC 
- 
29) Fjeldstad et al 2009 - MS 14 pts - - - Lab tests - - - - - - - 
30) de Figueiredo et al  
    2009 
- Elderly 12pts  
18PTs 
- - +++ - - - - - - - - 
31) Maeda et al 2009 - Stroke 72 pts - - - - - - - - - - Falls 
++ 
32) Nilsagård et al  
    2009 
- MS 76 pts - - - - - - - 17% - - + 
33) Lemay& Nadeau  
    2010 
- ISCI 32 pts - - - 2MWT 
10mWT 
WISCII 
SCI-FAI 
+++ - ++ 37% - - - 
35) Wirz et al 2010 - Stroke 128 pts - - - - - - - - - - D/C ++ 
36) Leddy  et al 2011 - PD 80pts    
3 raters 
- +++ +++ - - - - 10% - - Falls++ 
37) Datta et al 2012 - ISCI 124 pts - - - - -  ++ - - - - 
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A summary of the available literature that has been reviewed in relation to the measurement properties and clinical utility of the BBS - 5. 
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39) Flansbjer et al 2012 - Stroke 50pts - - - - - - - - - SEM  - 
40) Hiengkaew et al  
2012 
- Stroke 61 pts   
2 PTs 
- +++ - - - - - - - MDC  - 
41) La Porta et al 2012 - Neuro 
rehab 
217 pts - - - - - + - - - - - 
44) Godi et al 2013 - Neuro 
rehab  
93 pts - - - - - - - - - SEM 
MDC 
- 
43) Quinn et al 2013 - HD 75 pts - - - - - - - - - MDC - 
KEY: Strong = +++;  Moderate = ++; Weak = +; Not tested = - . 
Abbreviations & references: 2MWT= 2 minute walk test; 6MWT=6 minute walk test; 10mWT = 10 metre walk  test  (Wade 1992);  BI= Barthel Index (Wade 1992);D/C = discharged; DGI- Dynamic 
Gait Index (Rehabilitation Measures database 2010); EDSS = Expanded Disability Status Scale,(Kurtzke 1983); FIM= functional Independence Measure (Wright 2000);FM = Fugl-Meyer 
(Gladstone et al 2002); FR = functional reach (Duncan et al 1990);H&Y= Hoehn and Yahr Staging Scale (Hoehn&Yahr 1967); HD= Huntington’s Disease; ISCI = Incomplete Spinal Cord Injury; 
LD= Adults with Learning Disability; MDC = Minimal Detectable Change; MS = Multiple Sclerosis; Neuro rehab = Neurological Rehabilitation; OTs=occupational therapists; PD = Parkinsons 
Disease; pts= patient; PTs= physiotherapists; PASS= Postural Assessment Scale for Stroke (Benaim et al 1999); SCI-FAI= Spinal Cord Injury Functional Ambulation Inventory (Field-Fote et al 
2001);SE-ADL= Modified Schwab and England Capacity for Daily Living Scale (EPDA n.d.); SEM= Standard Error of Measurement ; Tinetti(Abbruzzese 1998); TUG=timed up and go (Podsiadlo 
& Richardson 1991); UHDRS-TM=  Unified Huntington’s Disease Rating Scale Total Motor Score  (UHDRS n.d.); UPDRS= Unified Parkinson’s Disease Rating Scale (Goetz et al 2003); WISCII = 
Walking index for spinal cord injury (Dittuno et al 2001) 
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Appendix 2 
 The Trunk Impairment Scale data sheet 
 A summary of the available literature that has been reviewed in relation to the 
measurement properties and clinical utility of the Trunk Impairment Scale 
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Trunk Impairment Scale data sheet (Verheyden et al 2004) 
The starting position for each item is the same. The patient is sitting on the edge of a bed or treatment table without back and arm support. The thighs make full contact with 
the bed or table, the feet are hip width apart and placed flat on the floor. The knee angle is 908. The arms rest on the legs. If hypertonia is present the position of the 
hemiplegic arm is taken as the starting position. The head and trunk are in a midline position. If the patient scores 0 on the first item, the total score for the TIS is 0.  Each item 
of the test can be performed three times. The highest score counts. No practice session is allowed.  The patient can be corrected between the attempts.  The tests are verbally 
explained to the patient and can be demonstrated if needed. 
Item  
Static sitting balance Score  
1 Starting position Patient falls or cannot maintain starting position for 10 seconds without arm support 
Patient can maintain starting position for 10  
If score = 0, then TIS total score = 0 
0 
2 
2 Therapist crosses the unaffected leg over the hemiplegic leg Patient falls or cannot maintain sitting position for 10 seconds without arm support 
Patient can maintain sitting position for 10 seconds 
0 
2 
3 Patient crosses the unaffected leg over the hemiplegic leg Patient falls  
Patient cannot cross the legs without arm support on bed or table  
Patient crosses the legs but displaces the trunk more than 10cm backwards or assists 
crossing with the hand 
Patient crosses the legs without trunk displacement or assistance 
0 
1 
 
2 
3 
Total static sitting balance   /7 
Dynamic sitting balance 
1 Starting position 
Patient is instructed to touch the bed or table with the hemiplegic 
elbow (by shortening the hemiplegic side and lengthening the 
unaffected side) and return to the starting position 
Patient falls, needs support from an upper extremity or the elbow 
does not touch the bed or table 
Patient moves actively without help, elbow touches bed or table e 1 
If score = 0, then items 2 and 3 score 0 
 
0 
1 
2 Repeat item 1 Patient demonstrates no or opposite shortening/lengthening 
Patient demonstrates appropriate shortening/lengthening   
If score = 0, then item 3 scores 0 
0 
1 
3 Repeat item 1 Patient compensates. Possible compensations are: (1) use of upper 
extremity, (2) contralateral hip abduction, (3) hip flexion 
(if elbow touches bed or table further then proximal half of femur), 
(4) knee flexion, (5) sliding of the feet 
Patient moves without compensation 
 
 
 
0 
1 
4 Starting position 
Patient is instructed to touch the bed or table with the unaffected 
elbow (by shortening the unaffected side and lengthening the 
hemiplegic side) and return to the starting position 
Patient falls, needs support from an upper extremity or the elbow 
does not touch the bed or table 
Patient moves actively without help, elbow touches bed or table 
If score = 0, then items 5 and 6 score 0 
 
0 
1 
5 Repeat item 4 Patient demonstrates no or opposite shortening/lengthening 
Patient demonstrates appropriate shortening/lengthening  
If score = 0, then item 6 scores 0 
0 
1 
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Dynamic sitting balance - continued 
6 Repeat item 4 Patient compensates. Possible compensations are: (1) use of upper 
extremity, (2) contralateral hip abduction, (3) hip flexion (if elbow touches bed or table 
further then proximal half of femur), (4) knee flexion, (5) sliding of the feet 
Patient moves without compensation 
 
 
0 
1 
7 Starting position 
Patient is instructed to lift pelvis from bed or table at the unaffected 
side (by shortening the unaffected side and lengthening the 
hemiplegic side) and return to the starting position 
Patient demonstrates no or opposite shortening/lengthening 
Patient demonstrates appropriate shortening/lengthening 
If score = 0, then item 8 scores 0 
0 
1 
8 Repeat item 7 Patient compensates. Possible compensations are: (1) use of upper 
extremity, (2) pushing off with the ipsilateral foot (heel loses contact 
with the floor) 
Patient moves without compensation 
 
 
0 
1 
9 Starting position 
Patient is instructed to lift pelvis from bed or table at the unaffected 
side (by shortening the unaffected side and lengthening the 
hemiplegic side) and return to the starting position 
Patient demonstrates no or opposite shortening/lengthening  
Patient demonstrates appropriate shortening/lengthening  
If score = 0, then item 10 scores 0 
0 
1 
10 Repeat item 9 Patient compensates. Possible compensations are: (1) use of upper 
extremities, (2) pushing off with the ipsilateral foot (heel loses 
contact with the floor) 
Patient moves without compensation 
 
 
0 
1 
Total dynamic sitting balance   /10 
Co-ordination 
1 Starting position 
Patient is instructed to rotate upper trunk 6 times (every shoulder 
should be moved forward 3 times), first side that moves must be 
hemiplegic side, head should be fixated in starting position 
Hemiplegic side is not moved three times  
Rotation is asymmetrical  
Rotation is symmetrical  
If score = 0, then item 2 scores 0 
0 
1 
2 
2 Repeat item 1 within 6 seconds Rotation is asymmetrical  
Rotation is symmetrical 
0 
1 
3 Starting position 
Patient is instructed to rotate lower trunk 6 times (every knee should 
be moved forward 3 times), first side that moves must be hemiplegic 
side, upper trunk should be fixated in starting position 
Hemiplegic side is not moved three times  
Rotation is asymmetrical  
Rotation is symmetrical  
If score = 0, then item 4 scores 0 
0 
1 
2 
4 Repeat item 3 within 6 seconds Rotation is asymmetrical  
Rotation is symmetrical 
0 
1 
Total co-ordination   /6 
Total Trunk Impairment Scale   /23 
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A summary of the available literature that has been reviewed in relation to the measurement properties and clinical utility of the TIS 
– 1. 
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1) Nieuwboer et al  
    1996 
++    
3 pts, 
5 PTs 
- 
- 
- - ++27
pts, 
2PTs 
- 
- - - - - - - - 
2) Verheyden et al  
     2004 
- 
Stroke 28 pts   
2 PTs 
+++ +++ +++ BI          
TCT 
++ - - - - - - - 
3) Verheyden et al  
    2005 
- 
Stroke  
‘normal’  
40 pts   
40 ctrls 
- - - 
- 
- - - ++ - - - Norm. 
4) Verheyden et al  
     2006a 
- 
Stroke 51 pts  
1 rater 
- - - 
TCT 
Tinetti 
FAC  
10mWT 
TUG 
FIMm     
+++ - - none - - - - 
5) Verheyden et al  
     2006b 
- 
MS 30 pts  
2 PTs 
- +++ +++ FIM   
EDSS  
BI 
++ - - - - SEM - - 
6) Verheyden et al  
     2006c 
- 
TBI 30 pts   
2 PTs 
- +++ +++ BI ++ - - - - - - - 
7) Verheyden et al  
    2007a 
- 
Stroke  102 
- - - 
BI    
FIM 
- - - - - - 
D/C 
function 
++ 
- 
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A summary of the available literature that has been reviewed in relation to the measurement properties and clinical utility of the TIS 
– 2. 
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8) Verheyden et al  
    2007b 
- 
PD 26 pts 
26 ctrls 
- - - 
UPDRS ++ - - - - - - - 
9) Verheyden et al  
    2008 
- 
Stroke  32 pts 
- - - 
FM arm  
BI 
- - - - - - 
recovery - 
10) Verheyden et al  
     2009 
- 
Stroke  33 
- - - 
Tinetti  
FAC 
- - ++ - - - - Rx 
effect 
11) Di Monaco et al  
     2010 
- 
Stroke  60 pts 
- - - 
BI      
PASS   
FIM 
- - - - - - 
D/C 
function 
++ 
- 
12) Verheydenk &     
Kersten 2010 
- 
- 162 pts 
- - - 
- 
- ++ - yes - - - - 
13) Jandt et al 2011 - Stroke  21 pts - - - Resp 
function +++ 
- + - - - - - 
KEY: Strong = +++;  Moderate = ++; Weak = +; Not tested = -. 
Abbreviations & references: 10mWT = 10 metre walk  test  (Wade 1992); ctrls= controls; BI= Barthel Index (Wade 1992); D/C = discharged; EDSS = Expanded Disability Status 
Scale(Kurtzke 1983); FMa = Fugl-Meyer-arm (Gladstone et al 2002); FAC = Functional Ambulation Category (Holden et al 1984); FIM =   functional Independence Measure (Wright 
2000);FIMm= functional Independence Measure-motor (Wright 2000);Norm = normal; pts= patients; PD = Parkinson’s Disease; PTs= physiotherapists; PASS= Postural 
Assessment Scale for Stroke (Benaim et al 1999); Resp = respiratory; Rx = treatment; SEM= Standard Error of Measurement; TUG = timed up and go (Podsiadlo & Richardson 
1991); Tinetti = (Abbruzzese 1998);TBI = Traumatic Brain Injury; TCT = Trunk Control Test (Collin & Wade 1990);  UPDRS= Unified Parkinson’s Disease Rating Scale (Goetz et al 
2003). 
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Appendix 3 
 A summary of the available literature that has been reviewed in relation to the 
measurement properties and clinical utility of Goal Attainment Scaling 
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A summary of the available literature that has been reviewed in relation to the measurement properties and clinical utility of GAS – 
1. 
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1) Kiresuk& Sherman  
   1968 
+ None  - - - - - - - - - - - - - 
2) Joyce et al 1994 +++ TBI  16 pts  
Team 
raters 
- - +++ CGI 
RDR 
MEDLS 
 KELS  
IADL 
+++    
+++    
++     
+      
+ 
- +++ - - - - - 
3) Reid &Chesson 
   1998 
- Stroke  - - - - - - - +++   - - - 
4) Ashford & Turner- 
   Stokes 2006 
- ABI 18 pts - - - BI - - - - - ++ - - 
5) Tennant 2007 - - - - - - - - + - - - - - - 
6) Khan et al 2008 - MS 24 pts - - - BI    
FIM 
CGI 
+      
+    
+++ 
- +++ - - ES - Training 
need 
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A summary of the available literature that has been reviewed in relation to the measurement properties and clinical utility of GAS – 
2. 
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7) Turner-Stokes et al  
2009 
- Neuro 164 
pts 
- - - FIM    
FAM 
BI 
+      
+ 
+ 
- - - - ES - - 
8) Turner-Stokes et al  
2010 
- Neuro 90 pts - - - MAS - - - - - ++ - - 
9) Turner-Stokes & 
Williams 2010 
- ABI 
ISCI 
Neuro 
243 
pts 
- - - GAS 
version
2 
- - ++ - - - - - 
10) Bovend'Eerdt et al  
2011 
- Neuro  29 pts 
1PT 
1IR 
- - + - - - - - - - - - 
11) Stevens et al 2013 - - - - - - - - - ++ - - - - - 
KEY: Strong = +++;  Moderate = ++; Weak = +; Not tested = - 
Abbreviations &references:ABI = Acquired Brain Injury; BI= Barthel Index (Wade 1992); CGI= Clinical Global Impression (Busner&Targum 2007); FAM=  Functional Assessment 
Measure (Donaghy et al 1988); FIM= functional Independence Measure (Keith et al 1987); GASv2 = GAS version used by Steenbeek et al 2005;ES = Effect Size; IADL = 
Instrumented Activities of Daily Living; IR= independent rater; KELS= Kohlman Evaluation of Living Skills (Burnett et al 2009); MAS= Modified Ashworth Scale (Bohannon & Smith 
1987); MEDLS= Milwaukee Evaluation of Daily Living Skills (Leonardelli 1988);MS = Multiple Sclerosis;Neuro = patients with neurological diagnoses; OAIADL= Older Americans 
Resources Survey Instrumental Activities of Daily Living Index (Lawton &Broday 1969); pts= patient; PT= physiotherapist; RDRS= Rappaport Disability Rating Scale (Rappaport et 
al 1982);SEM= Standard Error of Measurement; TBI = Traumatic Brain Injury 
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Appendix 4 
 GCP certification   All letters confirming ethical approval  
o National Research Ethics Study 1 
o National Research Ethics Study 2 
o University of Huddersfield, School Research Ethics Panel 
o Leeds Teaching Hospitals NHS Trust 
o Airedale NHS Foundation Trust 
o Mid Yorkshire Hospitals NHS Trust 
o NHS Leeds  Study 1, Phase 2: Participant information sheet and consent form   Study 2, Phase 1: Participant information sheet and consent form   Study 2, Phase 2: Physiotherapy manager information sheet and consent form   Study 2, Phase 2: NHS physiotherapist participant information sheet and consent 
form  Study 2, Phase 3: Patient participant information sheet and consent form  Study 3: Expert physiotherapist participant information sheet and consent form 
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Leeds (Central) Research Ethics Committee 
Room 5.2, Clinical Sciences Building 
St James's University Hospital 
Beckett Street 
Leeds 
West Yorkshire 
LS9 7TF 
 
Telephone: 0113 2065652  
Facsimile: 0113 2066772 
9 April 2008 
 
Ms Denise H Ross 
Clinical Specialist Physiotherapist 
Physiotherapy Department 
Lincoln Wing 
St James University Hospital 
Beckett Street 
Leeds 
LS9 7TF 
 
 
Dear Ms Ross 
 
Full title of study: Measuring Movement Performance: A study to develop 
the Leeds Movement Performance Index within the 
clinical setting 
REC reference number: 08/H1313/23 
 
Thank you for your letter of 19 March 2008, responding to the Committee’s request for 
further information on the above research and submitting revised documentation. 
 
The further information was considered at the meeting of the Sub-Committee of the REC 
held on 7 April 2008.  A list of the members who were present at the meeting is attached. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the 
above research on the basis described in the application form, protocol and supporting 
documentation as revised. 
 
Ethical review of research sites 
 
The Committee has designated this study as exempt from site-specific assessment (SSA).  
There is no requirement for other Local Research Ethics Committees to be informed or for 
site-specific assessment to be carried out at each site. 
 
Conditions of approval 
 
The favourable opinion is given provided that you comply with the conditions set out in the 
attached document.  You are advised to study the conditions carefully. 
 
Approved documents 
 
The final list of documents reviewed and approved by the Committee is as follows: 
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Document  Version  Date   
Application   03 March 2008  
 
Investigator CV   05 February 2008  
 
Protocol  2  31 January 2008  
 
Letter from Sponsor   25 February 2008  
 
Participant Information Sheet  2  25 March 2008  
 
Participant Consent Form  2  19 March 2008  
 
Response to Request for Further Information   19 March 2008  
 
The LEEDS Movement Performance Index  1  31 January 2008  
 
 
R&D approval 
 
All researchers and research collaborators who will be participating in the research at NHS 
sites should apply for R&D approval from the relevant care organisation, if they have not yet 
done so.  R&D approval is required, whether or not the study is exempt from SSA.  You 
should advise researchers and local collaborators accordingly. 
 
Guidance on applying for R&D approval is available from 
http://www.rdforum.nhs.uk/rdform.htm. 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
 
After ethical review 
 
Now that you have completed the application process please visit the National Research 
Ethics Website > After Review  
 
Here you will find links to the following 
a)   Providing feedback. You are invited to give your view of the service that you have 
received from the National Research Ethics Service on the application procedure. If 
you wish to make your views known please use the feedback form available on the 
website. 
b)   Progress Reports. Please refer to the attached Standard conditions of approval by 
Research Ethics Committees. 
c)   Safety Reports. Please refer to the attached Standard conditions of approval by 
Research Ethics Committees. 
d)   Amendments. Please refer to the attached Standard conditions of approval by 
Research Ethics Committees. 
e)   End of Study/Project. Please refer to the attached Standard conditions of approval by 
Research Ethics Committees. 
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We would also like to inform you that we consult regularly with stakeholders to improve our 
service. If you would like to join our Reference Group please email 
referencegroup@nationalres.org.uk . 
 
 
 
 
 
 
08/H1313/23 Please quote this number on all correspondence 
 
With the Committee’s best wishes for the success of this project 
 
Yours sincerely 
 
 
 
Dr Margaret L Faull 
Chair 
 
Email: ann.prothero@leedsth.nhs.uk 
 
 
Enclosures: List of names and professions of members who were present at the 
meeting and those who submitted written comments 
 
Standard approval conditions  
 
Copy to: Dr Derek Norfolk, Leeds Teaching Hospitals NHS Trust 
 
 
 
 
 
 
 
Members of the Sub-Committee which reviewed the response: 
 
 
Mrs Dee Alton, Nurse 
Dr Richard Baker, Consultant Renal Physician 
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NHS Physiotherapist Participant Information Sheet Study 1 Phase 2 
 
Measuring Movement Performance: A study to develop the Leeds Movement 
Performance Index within the clinical setting 
 
You are being invited to take part in a research study.  Before you decide, it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully.  Talk to others about the study if you wish. 
Part 1 tells you the purpose of this study and what will be expected of you if you take part. 
Part 2 gives you more detailed information about the conduct of the study 
Ask us if there is anything that is not clear or if you would like more information.  Take time 
to decide whether or not you wish to take part.  
 
PART 1 
 
What are the purposes of this study?  
Over the last 18 months Neuro Training Group 1 has been developing a measure of 
movement performance.  It is called ‘The Leeds Movement Performance Index’.   
We now want to refine the measurement tool, by asking senior Bobath trained 
Physiotherapists to use it during their routine record keeping  
 
Why have I been chosen? 
You have been chosen to take part in this study, because you meet the inclusion criteria for 
potential participants, that is: - 
Senior Physiotherapists band 6 or above. 
Eligible to attend Neuro Training Group 2 (a current specialist training programme for 
Physiotherapists employed by LTH) 
Access (within their current clinical setting) to a member of the research team 
 
Do I have to take part? 
No, it is up to you to decide whether or not to take part.   
You will be given this information sheet and asked to attend a training session.  You can 
then decide whether or not you would like to be involved in the project; if you do, you will be 
asked to sign a consent form.   
You are still free to withdraw at any time. 
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What will be expected of me if I take part? 
You will be asked to routinely complete a Leeds Movement Performance Index (Leeds MPI) 
data sheet during your routine clinical record keeping process.  This will mean that you will 
need to identify key aspects of the components of your patient’s movement and record them 
on a specific form. 
If you have any thoughts, problems or suggestions about the practical use of the Leeds MPI 
within your clinical practice, you will be asked to make a note of these on the data sheet. 
Towards the end of the research project, the lead researcher will meet with you and ask you 
about your experience of using the Leeds MPI. 
The lead researcher will record your comments, and take copies of the notes you have 
written on the Leeds MPI data sheet. 
 
How long the research will go on for? 
You will be asked to use the Leeds MPI within your clinical practice, for all appropriate 
patients that you work with, for 2 months. 
 
What support will I get during the research project? 
You will get written support in the form of this information sheet. 
You will receive a comprehensive in-service training session on the development and use of 
the Leeds MPI. 
You will receive support within your clinical practice from the member of the research team 
that works within your clinical area. 
Also, should you wish to read it, a copy of the research protocol is available from the lead 
researcher. 
Are there any disadvantages to taking part in this study? 
Yes, you may find that there is a small time commitment during your record keeping process, 
when you are recording your clinical observations onto the Leeds MPI data sheet. 
 
Are there any advantages to taking part in this study? 
Yes, you will gain valuable experience in taking part in and learning about an aspect of 
research.  You will have the opportunity to be directly involved in the development of a 
measure of physiotherapy intervention. 
 
Will my taking part in the study be confidential? 
Yes, all the information about your participation in this study will be kept confidential.   
During the meeting you will have with the lead researcher (when you will be giving feedback 
about your experiences of using the Leeds MPI), direct quotes from you may be recorded 
and used in future publications.  Any quotes used will be anonymous. 
Any data that you complete will have your name removed from it to ensure your anonymity. 
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The data will be kept for a minimum of 5 years; this is in line with current CSP requirements 
(in a locked filing cabinet, in a locked room) 
 
How do I contact the lead researcher? 
Denise Ross is the lead researcher, her contact details are: Physiotherapy Department, 
Lincoln Wing, St James University Hospital, ext 64375, bleep 6551 
 
Which members of staff are in the research team?  
Alan Bass  Physiotherapy Department, Chapel Allerton Hospital, ext 24523 
Jill Hall   Physiotherapy Department, Chapel Allerton Hospital, ext 24571  
Maddy Kenny  Ward 10, Chapel Allerton Hospital, ext 24510 
Liz Walker  Ward 34, St James University Hospital, ext 65734 
Kate Warner  Physiotherapy Department, Leeds General Infirmary, bleep 2036 
Cat Williams  Physiotherapy Department, Leeds General Infirmary, bleep 1544 
Karen Wood  Ward 1, Chapel Allerton Hospital, ext 24582 
 
PART 2 
 
What will happen if I don’t want to carry on with the study? 
Your decision will be respected, any information that you have already collected will be 
anonymised, used to refine the Leeds MPI, and stored in a secure and confidential manner 
as per CSP guidelines. 
 
What will happen to the results of the research study? 
The results of the study will be written up in 3 main ways: - 
1. In thesis format, for a Doctor of Physiotherapy. 
2. As a research paper for publication in a Physiotherapy related journal.   
3. Presentations regarding this research will also be submitted for physiotherapy and 
rehabilitation conferences.  
If the research can successfully demonstrate that the LMPI is an appropriate way to 
measure people who are receiving neurological physiotherapy then it can be used within 
clinical practice and for future research projects. 
 
Who is organising and funding the research? 
The research is being organised by Denise Ross, she is a Clinical Specialist Physiotherapist 
in Neurology, and works for Leeds Teaching Hospitals NHS Trust.  Denise is being 
supported academically by the University of Huddersfield 
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There is no funding for the research 
 
Who has reviewed this study? 
Leeds (Central) Research Ethics Committee 
Research Ethics Panel, School of Human and Health Sciences, University of Huddersfield 
If I have any concerns or complaints regarding this study, who should I contact? 
If you have any concerns or complaints about anything related to the study, please contact:  
 
Dr Serena McCluskey,  
Research Fellow,  
Centre for Health & Social Care    Research,  
University of Huddersfield,  
Queensgate,  
Huddersfield,  
HD1 3DH 
Telephone: 01484 422 288 
Ms Denise Ross, 
Physiotherapy Department,  
Chapel Allerton Hospital,  
Chapeltown Road,  
Leeds,  
LS7 4SA.  . 
Telephone: 01133924523 
 
 
You will be given a copy of this information sheet, and should you wish to become a 
research participant, a copy of your signed consent form. 
Thank you for taking the time to read this information and for considering taking part in this 
research study 
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Centre number………………………….................. 
Physiotherapist ID number……………………….. 
Staff ID number……………….............................. 
Research team member....................................... 
 
Consent Form 
 
Title of project: Measuring Movement Performance: A study to develop the Leeds 
Movement Performance Index within the clinical setting 
 
Name of lead researcher Denise Ross MCSP MSc 
 
1. I confirm that I have read and understood the information sheet dated 
March 2008 (version 2) for the above study.  I have had the opportunity 
to consider the information, ask questions and have these answered 
satisfactorily 
 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving reason 
 
 
3. I understand that direct quotes that I give during my reflective practice 
may be used verbatim in future publications, although they will remain 
anonymous. 
 
 
4. I agree to take part in the above study 
 
 
 
 
 Name Signature Date 
Participant 
  
   
Researcher 
  
   
      
NHS Physiotherapist participant information sheet and consent form Study 1 phase 2. When 
completed, 1 copy for participant, 1 copy for researcher (to be kept in research file) March   
2008      
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Patient Participant Information Sheet Study 2, phase 1 
 
The development and clinical testing of an index of movement performance for 
neurological physiotherapy: a mixed-methods study 
 
You are being invited to take part in the above research study.  Your physiotherapist has 
discussed this and explained what we would like you to do. However, it is important for you 
to understand why the research is being done and what it will involve before you decide 
whether or not to take part.  Please take time to read the following information carefully.  You 
are free to talk to others, for example your family, about the study if you wish.  Part 1 of this sheet tells you the purpose of this study and what will be expected of 
you if you take part.  Part 2 gives you more detailed information about the conduct of the study 
Please ask if there is anything that is not clear or if you would like more information.   
Take time to decide whether or not you wish to take part.  
 
PART 1 
 
What are the purposes of this study?  
The purpose of this study is to psychometrically and clinically test the properties of the Leeds 
Movement Performance Index (LMPI).  This is a way of measuring the effects of 
physiotherapy treatment.  The LMPI has been developed within the clinical setting, and the 
neuro-physiotherapists who have developed it feel that it reflects their assessment, clinical 
reasoning and treatment planning processes. 
 
What does this mean? 
Psychometric tests are mathematical tests that can be done using a computer software 
package; they can help us to understand if measurement tools, tests and questionnaires 
actually measure what they are supposed to.  They can also tell us if therapists score and 
test to the same standards and in a consistent way.  
Outcome measures are used to find out how people change.  In this case we are using a 
measure to define how someone moves, and to see if the physiotherapy that they are 
receiving is having an effect on their ability to move.  Sometimes it is important to prove that 
physiotherapy is effective and necessary and we hope that this research will help us to be 
able to do that. 
Neurological physiotherapy intervention is a specialist branch of physiotherapy and it 
involves assessing a patient’s movement difficulties, then planning what treatment will be 
most effective in helping that person to improve or maintain their functional abilities and 
independence. 
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Why have I been chosen? 
You have been chosen to take part in this study, because you meet the inclusion criteria for 
potential participants, that is: -  You have been diagnosed with a neurological condition that makes it somewhat 
difficult to move  You are receiving a course of neurological physiotherapy from a senior 
physiotherapist. 
 
Do I have to take part? 
No it is up to you to decide whether or not to take part.   
You are free to withdraw at any time. 
 
What will be expected of me if I take part? 
Your physiotherapist has asked you if you would consider consenting to an aspect of your 
movement being videoed and has given you this information sheet.   
If you are agreeable, the lead researcher, a senior physiotherapist, will video record an 
aspect of your movement during your normal physiotherapy session. 
Personal information regarding your age, gender, neurological diagnosis, movement 
difficulties and current physiotherapy treatment goals will also be recorded. All of this 
information will be kept strictly confidential and will be anonymised, i.e. your name and date 
of birth will be removed.  All of this information will also be stored in a secure place that is 
only accessible by the lead researcher. 
 
What will be videoed? 
Your Physiotherapist will discuss this with you, but it will probably be a movement that you 
are practicing in your physiotherapy sessions.  It is likely that your face will be visible on the 
video tape; this means that the people who watch the video could recognise you.  The only 
people who will watch your video will be those that are directly involved with this study. 
 
How long will the video be?  
Between 20 seconds and a minute 
 
What will my video be used for? 
Your video will: -  Either be used to help teach senior neurological physiotherapists in Yorkshire how to 
use the LMPI, by showing them how to measure YOUR movement using the scale.    Or, it will be used to test whether several neurological physiotherapists (from 
Yorkshire) measure movement in the same way. The therapists will observe your 
movement, and then score it using the LMPI, and then the researcher will determine 
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whether they agree with each other.  There are several tests that can be done to see 
if therapists use the LMPI in the same way and this is an important process to go 
through when a new measurement scale is being developed.  Your video will be stored on an encrypted computer that only the lead researcher has 
access to.  The people who see your video will be: 
o The physiotherapists who prepare the teaching material 
o The physiotherapists who are being taught to use the LMPI 
o The physiotherapists who will be tested to see how they use the LMPI 
 
How long will the research go on for? 
No, for the purposes of this study, you can only use the LMPI if you have been trained to use 
it by the lead researcher. 
 
How long the research will go on for? 
Your part in the research project will be for a very short time (the time it takes to video you 
move during your physiotherapy session).  But the full length of the project will last for 2 
years. Your video will be used during the first 6 months of the project. 
 
What support will I get during the research project? 
You will receive support from your physiotherapist and the lead researcher. 
 
What will happen to my video and personal information when the research is 
completed? 
When the research is completed, your video and personal information will be stored securely 
within Leeds Teaching Hospitals NHS Trust, and will not be accessible to anybody other 
than the lead researcher.  After 3 years, all confidential information from this research project 
will be destroyed.   
 
Are there any disadvantages to taking part in this study? 
No, your physiotherapy treatment will not be affected in any way, whether you decide to take 
part in the study or not. 
However, your movement difficulties will be recorded and used to help develop the LMPI. 
This means that other neurological physiotherapists working in Yorkshire will observe how 
you currently move and will score how you move, but you will not be identified.   
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Are there any advantages to taking part in this study? 
Yes, you will be helping neurological physiotherapists to measure the effects of their 
treatment.   
In future research this could be important to see whether more neurological physiotherapy 
input has an impact on a patient’s recovery of movement. 
 
Will my taking part in the study be confidential? 
Yes, all the information about your participation in this study will be kept confidential.   
Any information about you will have your name removed from it to ensure your anonymity.  
However the physiotherapists watching your video will see your face. 
If you agree, your Doctor and other members of the medical or rehabilitation teams who are 
currently working with you will be informed about your participation in this study. 
 
How do I contact the lead researcher? 
Denise Ross is the lead researcher, her contact details are:   
Physiotherapy Department, Chapel Allerton Hospital, Chapeltown Road, LEEDS, LS7 
4SA.e-maild.h.ross@leeds.ac.uk 
 
PART 2 
 
What will happen if I change my mind after the video has been made, and I decide that 
I don’t want to carry on with the study? 
Your decision will respected, your video and personal information will not be used in this 
study, your video and personal information will be destroyed. 
 
What will happen to the results of the research study? 
The results of the study will be written up in 3 main ways: - 
1. In thesis format, for a Doctor of Physiotherapy. 
2. As a research paper for publication in a Physiotherapy related journal.   
3. Presentations regarding this research will also be submitted for physiotherapy and 
rehabilitation conferences.  
If the research can successfully demonstrate that the LMPI is an appropriate way to 
measure people who are receiving neurological physiotherapy then it can be used within 
clinical practice and for future research projects. 
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Who is organising and funding the research? 
The research is being organised by Denise Ross, she is a Clinical Specialist Physiotherapist 
in Neurology, and works for Leeds Teaching Hospitals NHS Trust.  Denise is being 
supported academically by the University of Huddersfield 
There is no funding for the research 
 
Who has reviewed this study? 
Local NHS Research Ethics Committees 
Research Ethics Panel, School of Human and Health Sciences, University of Huddersfield 
If I have any concerns or complaints regarding this study, who should I contact? 
If you have any concerns or complaints about anything related to the study, please contact:  
 
Dr Serena McCluskey,  
Research Fellow,  
Centre for Health & Social Care    Research,  
University of Huddersfield,  
Queensgate,  
Huddersfield,  
HD1 3DH 
Telephone: 01484 422 288 
Ms Denise Ross, 
Physiotherapy Department,  
Chapel Allerton Hospital,  
Chapeltown Road,  
Leeds,  
LS7 4SA.  . 
Telephone: 01133924523 
 
 
You will be given a copy of this information sheet, and should you wish to become a 
research participant, a copy of your signed consent form. 
Thank you for taking the time to read this information and for considering taking part in this 
research study 
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Patient ID number............................... 
Patient Participant Consent Form Study 2 phase 1 
 
Title of project: The development and clinical testing of an index of movement 
performance for neurological physiotherapy: a mixed-methods 
study 
Name of lead researcher Denise Ross MCSP MSc 
 
1. I confirm that I have read and understood the information sheet dated 
17/09/2010 for the above study.  I have had the opportunity to consider 
the information, ask questions and have these answered satisfactorily 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving reason 
 
3. I understand that a small piece of video recording my movement will be 
taken and used by the lead researcher to either: - 
a)  Help in the training of senior neurological physiotherapists to use the 
Leeds Movement Performance Index (LMPI) 
OR 
b) To test that senior neurological physiotherapists use the LMPI to a 
similar standard in a consistent way.  
 
4. I understand that personal information such as: - 
a) My age 
b) My gender 
c) My neurological diagnosis  
Will be used in this research study, and may be used within future 
physiotherapy and rehabilitation publications and professional 
conferences but all the information about me will remain confidential and 
anonymous. 
 
5. I agree to take part in the above study, and I agree that my Doctor and 
other members of the medical or rehabilitation teams who are currently 
working with me  can be told that I am participating in this study 
 
 
 Name Signature Date 
Participant 
  
   
Researcher     
 
Patient participation information sheet and consent form final version study 1 phase 1. When 
completed, 1 copy for participant, 1 copy for Physiotherapist (to be kept in patient’s medical 
notes), 1 copy for lead researcher. 17/09/2010 
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Physiotherapist Participant Manager Information Sheet 
 
The development and clinical testing of an index of movement performance for 
neurological physiotherapy: a mixed-methods study 
 
Denise Ross, the lead researcher for this study, would like your consent for neurological 
physiotherapists who deliver your local physiotherapy service to be approached by her and 
asked if they would like to participate.   
Before you decide, it is important for you to understand why the research is being done and 
what it will involve.  Please take time to read the following information carefully.    Part 1 tells you the purpose of this study and what will be expected of your local 
neuro-physiotherapists if they take part.  Part 2 gives you more detailed information about the conduct of the study 
Please ask if there is anything that is not clear or if you would like more information.   
Take time to decide whether or not you wish for your local neuro-physiotherapists to take 
part.  
PART 1 
 
What are the purposes of this study?  
The purposes of this study are to psychometrically and clinically test the properties of the 
Leeds Movement Performance Index (LMPI).  This is an outcome measure that reflects 
neurological physiotherapy intervention.  It has been developed within the clinical setting, 
and the neuro-physiotherapists who have developed it feel that it reflects their assessment, 
clinical reasoning and treatment planning processes; this means that the measure is 
clinically meaningful and potentially useful to be used in both clinical practice and research. 
 
What would you like me to do? 
The lead researcher would like you to give her permission to approach potential research 
participants that meet the inclusion criteria, i.e. those that:  Are employed as band 6 Physiotherapists or above  Have had post-graduate training within neurological physiotherapy either formally at 
M level or equivalent, within the Bobath concept or equivalent, or informally via in-
service or on the job training.  Work predominantly with patients who have neurological diagnoses  
Once you have identified potential participants, the lead researcher would like you to give 
them a participant information sheet.  The therapists will then be approached by the lead 
researcher, and be invited to attend a training session.  If they attend the training session, 
they will then need to decide whether or not they would like to be involved in the project; if 
they do, they will be asked to sign a consent form.  
 They are free to withdraw at any time. 
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Where will the training session take place? 
The training session will take place in a place convenient to your therapists, if possible on 
your local Trust premises. 
 
Do the neuro-physiotherapists who work for me have to take part? 
No, it is up to them to decide whether or not to take part.   
 
What will be expected of them if they take part? 
After the training session, they will be asked to take part in a short study to test the 
agreement between and within users (or raters) of the LMPI.  This means that they will be 
asked to watch 6 videos of patients’ movements, and complete the LMPI.  After two weeks, 
they will be asked to again watch the 6 videos of patients’ movements, and complete the 
LMPI.  The results will be tested for inter and intra rater and test re-test reliability using a 
computer software package (SPSS)  
After the above tests are complete: - 
1. The therapists will be asked to complete a LMPI data sheet for all appropriate 
patients during their routine clinical record keeping practice.  This will mean that they 
will need to identify key aspects of the components of the movements of each of their 
patients and record them on a specific form, alongside patient information such as 
age, gender, diagnosis, and the specific movement that they are recording.  They will 
then be asked to re-score the same movement, using the LMPI, 6 weeks later, or on 
discharge from treatment/hospital if this occurs earlier.  They will also be asked to 
complete a Berg Balance Scale (BBS) each time they complete a LMPI data sheet.  
The analysis of this information is part of the validity testing of the LMPI. 
 
2. They will be asked to gain informed consent from their patients to become 
participants in this research study.  In order for them to do this in such a way that 
conforms to good research practice requirements, initial training and on-going advice 
will be given by the lead researcher.  In practice, they will find that gaining full 
informed consent from their  
 
3. When the research is complete, the lead researcher will send the therapists a 
reflective practice form and ask that they complete it and send her a copy.  This is so 
that she can understand how using the LMPI has impacted on their clinical practice – 
both personally and professionally, and whether they found it useful and meaningful. 
 
How much time will this study take out of my staffs’ clinical obligations? 
The researcher expects that a full half day will be needed to complete the training and the 
initial testing of the LMPI.  The re-testing (after 2 weeks) should take between 30 and 45 
minutes.   
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The on-going use of the LMPI within routine clinical practice should take minimal time in 
comparison to other measures of outcome that are generally used   
 
Can anybody else use the LMPI? 
No, for the purposes of this study, only therapists can use the LMPI if they have been trained 
to use it by the lead researcher. 
 
How long the research will go on for? 
The neuro-physiotherapists will be asked to use the LMPI within their clinical practice, for all 
appropriate patients that they work with, until at least 100 data sheets (in total for the whole 
study) have been collected. There will be several neuro-physiotherapists who have given 
consent to be recruited into this study, and who will also be collecting data sheets. 
 
What support will the therapists get during the research project? 
They will get written support in the form of an information sheet similar to this one. 
They will receive a comprehensive in-service training session on the development and use 
of the LMPI. 
They will receive a copy of the LMPI guidelines 
They will receive training on the gaining of full informed consent from their patients, who will 
be research participants and will also be provided with written information. 
They will be able to contact the researcher for advice and guidance via e mail. 
The researcher will visit your staff during the data gathering period, in order to provide 
support and solve any issues that arise, and to ensure that research ethical requirements 
are being met. 
 
Are there any disadvantages to taking part in this study? 
Yes, there is a half day of time that your neuro-physiotherapists will need to commit to in 
order to be trained to use the LMPI and participate in study 1b. 
They may also find that there is a small time commitment during their record keeping 
process, when they are recording their clinical observations onto the LMPI data sheet. 
 
Are there any advantages to taking part in this study? 
Yes, they will gain potential valuable experience in taking part in and learning about an 
aspect of research.   
They will have the opportunity to be directly involved in the development of a measure of 
neurological physiotherapy intervention.  
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They will receive training in gaining informed consent for research purposes.   
They will be able to use this experience to provide evidence to meet some of their KSF 
requirements. 
 
Will taking part in the study be confidential? 
Yes, all the information about your staff’s participation in this study will be kept confidential.   
Any data that is completed will have their names removed from it to ensure anonymity. 
During the research study, written comments that are made (via e mail or from the reflective 
practice sheet) regarding the use of the LMPI may be used verbatim within future 
publications.  However, any quotes will remain anonymous 
All data gathered during the course of this study will be kept in a secure place, only 
accessible by the lead researcher. 
The data will be kept for a minimum of 3 years; in a locked filing cabinet, in a locked room. 
How do I or my staff contact the lead researcher? 
Denise Ross is the lead researcher, her contact details are:  Physiotherapy Department, 
Chapel Allerton Hospital, Chapeltown Road, LEEDS, LS7 4SA.   
e-maild.h.ross@leeds.ac.uk 
 
PART 2 
 
What will happen if the therapists don’t want to carry on with the study? 
Their decision will be respected.  Their decision will not affect any future or current working 
relationships with the lead researcher.  Any information about them that has already been 
gathered by the lead researcher will be destroyed and will not be used in the study. 
 
What will happen to the results of the research study? 
The results of the study will be written up in 3 main ways: - 
1. In thesis format, for a Doctor of Physiotherapy. 
2. As a research paper for publication in a Physiotherapy related journal.   
3. Presentations regarding this research will also be submitted for physiotherapy and 
rehabilitation conferences.  
If the research can successfully demonstrate that the LMPI is an appropriate way to 
measure people who are receiving neurological physiotherapy then it can be used within 
clinical practice and for future research projects. 
The researcher will offer to return to your Trust, in order to give feedback regarding the 
progress and results of the research. 
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Who is organising and funding the research? 
The research is being organised by Denise Ross, she is a Clinical Specialist Physiotherapist 
in Neurology, and works for Leeds Teaching Hospitals NHS Trust.  Denise is being 
supported academically by the University of Huddersfield.   
There is no funding for the research 
 
Who has reviewed this study? 
Local NHS Research Ethics Committees 
Research Ethics Panel, School of Human and Health Sciences, University of Huddersfield. 
If I have any concerns or complaints regarding this study, who should I contact? 
If you have any concerns or complaints about anything related to the study, please contact:    
 
Dr Serena McCluskey,  
Research Fellow,  
Centre for Health & Social Care    Research,  
University of Huddersfield,  
Queensgate,  
Huddersfield,  
HD1 3DH 
Telephone: 01484 422 288 
Ms Denise Ross, 
Physiotherapy Department,  
Chapel Allerton Hospital,  
Chapeltown Road,  
Leeds,  
LS7 4SA.  . 
Telephone: 01133924523 
 
 
Thank you for taking the time to read this information and for considering that the 
neurological physiotherapists who work for you may be approached by the lead researcher 
for inclusion in this research project. 
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Physiotherapy Manager Consent 
 
Title of project The  development and clinical testing of an index of movement 
performance for neurological physiotherapy: a mixed-methods 
study 
 
 
Name of lead researcher Denise Ross MCSP MSc 
 
1. I confirm that I have read and understood the information sheet dated 
26/09/2010 for the above study.  I have had the opportunity to consider 
the information, ask questions and have these answered satisfactorily 
 
 
2. I understand that the participation of the neuro-physiotherapists who 
work for me is voluntary and that they are free to withdraw at any time, 
without giving reason 
 
 
 
3. I understand that direct quotes that my staff given during their written 
communication with the lead researcher, or within their reflections for 
study 2b may be used verbatim within future publications, although they 
will remain anonymous. 
 
 
 
4. I agree that the lead researcher may approach staff who meet the 
inclusion criteria to take part in the above study 
 
 
 
 
 
 Name Signature Date 
Manage
  
   
Researcher 
  
   
      
Physiotherapy Manager information sheet and consent form final version. When completed, 
1 copy for Manager, 1 copy for lead researcher. 26/09/2010                        
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NHS Physiotherapist Participant Information Sheet 
 
The development and clinical testing of an index of movement performance for 
neurological physiotherapy: a mixed-methods study 
 
You are being invited to take part in a research study but before you decide it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully.  Talk to others about the study if you wish.  Part 1 tells you the purpose of this study and what will be expected of you if you take 
part.  Part 2 gives you more detailed information about the conduct of the study 
Please ask if there is anything that is not clear or if you would like more information.   
Take time to decide whether or not you wish to take part.  
 
PART 1 
 
What are the purposes of this study?  
The purposes of this study are to psychometrically and clinically test the properties of the 
Leeds Movement Performance Index (LMPI).  This is an outcome measure that reflects 
neurological physiotherapy intervention.  It has been developed within the clinical setting, 
and the neuro-physiotherapists who have developed it feel that it reflects their assessment, 
clinical reasoning and treatment planning processes. 
 
Why have I been chosen? 
You have been chosen to take part in this study, because you meet the inclusion criteria for 
potential participants, that is: -  You are a senior Physiotherapist band 6 or above  You have attended post-graduate training within neurological physiotherapy (at M 
level, in-service or on the job training)  You work predominantly with patients who have neurological diagnoses  You work within Yorkshire 
 
Do I have to take part? 
No, it is up to you to decide whether or not to take part.   
You will be given this information sheet and asked to attend a training session.  You can 
then decide whether or not you would like to be involved in the project; if you do, you will be 
asked to sign a consent form.   
You are still free to withdraw at any time 
 
. 
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What will be expected of me if I take part? 
After the training session, you will be asked to take part in a short study to test the 
agreement between and within users (or raters) of the LMPI.  This means that you will be 
asked to watch 6 videos of patients’ movements, and complete the LMPI.  After two weeks, 
you will be asked to watch the 6 videos of patients’ movements again and complete the 
LMPI.  The results will be tested for inter and intra rater and test re-test reliability using a 
computer software package (SPSS). 
 
After you have been trained: -  
1. You will be asked to complete a LMPI data sheet for all appropriate patients during 
your routine clinical record keeping.  This will mean that you will need to identify key 
aspects of the components of the movements of each of your patients and record 
them on a specific form, alongside patient information such as age, gender, 
diagnosis, and the specific movement that you are recording. You will then be asked 
to re-score the same movement, using the LMPI, 6 weeks later, or on discharge from 
treatment/hospital if this occurs earlier.  You will also be asked to complete a Berg 
Balance Scale (BBS) each time you complete a LMPI data sheet.  The analysis of 
this information is part of the validity testing of the LMPI.  
 
2. You will be asked to gain informed consent from your patients to become participants 
in this research study (to give permission for their personal information to be sent to 
the lead researcher for statistical analysis).  In order for you to do this in such a way 
that conforms to ethical approval and good research practice requirements, initial 
training and on-going advice will be given by the lead researcher.  In practice, you 
will find that gaining full informed consent from your patients for treatment is a similar 
process to that of gaining full informed consent for research activities. 
 
3. When the data sheets are complete, the researcher asks that you return the data 
sheets to her.  This is so that concurrent, construct, internal consistency validity and 
scale sensitivity can be tested.  This will be done using SPSS  
 
4. When the research is complete, the researcher will send you a reflective practice 
form, with some guidance questions, and ask that you complete it and send her a 
copy.  This is so that she can understand how using the LMPI has impacted on your 
clinical practice – both personally and professionally - and whether or not you found it 
useful and meaningful. 
 
How much time will this study take out of my clinical obligations? 
The researcher expects that a full half day will be needed to complete the training and the 
initial testing of the LMPI. 
The re-testing (after 2 weeks) should take between 30 and 45 minutes. 
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The on-going use of the LMPI within routine clinical practice should take minimal time in 
comparison to other measures of outcome that are generally used. 
 
Can anybody else use the LMPI? 
No, for the purposes of this study, you can only use the LMPI if you have been trained to use 
it by the lead researcher. 
 
How long the research will go on for? 
You will be asked to use the LMPI within your clinical practice, for all appropriate patients 
that you work with, until at least 100 data sheets (in total for the whole study) have been 
collected. There will be several neuro-physiotherapists who have given consent to be 
recruited into this study, and who will also be completing data sheets. 
 
What support will I get during the research project? 
You will get written support in the form of this information sheet. 
You will receive a comprehensive in-service training session on the development and use of 
the LMPI. 
You will receive a copy of the LMPI guidelines. 
You will receive training on the gaining of full informed consent from your patients, who will 
be research participants and will also be provided with written information. 
You will be able to contact the researcher for advice and guidance via e-mail. 
The researcher will visit you during the data gathering period, in order to provide support and 
solve any issues that arise. 
 
Are there any disadvantages to taking part in this study? 
Yes, there is a half day of time that you will need to commit to in order to be trained to use 
the LMPI and participate in study 1b. 
There is also a small time commitment during your record keeping process, when you are 
recording your clinical observations onto the LMPI data sheet. 
 
Are there any advantages to taking part in this study? 
Yes, you will gain potentially valuable experience in taking part in and learning about an 
aspect of research.   
You will be directly involved in the development of a measure of neurological physiotherapy 
intervention.   
You will receive training in gaining informed consent for research purposes.   
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You will be able to use this experience to provide evidence to meet some of your KSF 
requirements. 
 
Will my taking part in the study be confidential? 
Yes, all the information about your participation in this study will be kept confidential.   
Any data that you complete will have your name removed from it to ensure your anonymity. 
During the research study, written comments that you make (via e mail or from the reflective 
practice sheet) regarding the use of the LMPI may be used verbatim within future 
publications.  However, any quotes will remain anonymous 
All data gathered during the course of this study will be kept in a secure place, only 
accessible by the lead researcher. 
The data will be kept for a minimum of 3 years; in a locked filing cabinet, in a locked room. 
 
How do I contact the lead researcher? 
Denise Ross is the lead researcher, her contact details are:  Physiotherapy Department, 
ChapelAllertonHospital, Chapeltown Road, LEEDS, LS7 4SA.  
e-maild.h.ross@leeds.ac.uk 
 
PART 2 
 
What will happen if I don’t want to carry on with the study? 
Your decision will respected.  Your decision will not affect any future or current working 
relationships with the lead researcher. Any information about you that has already been 
gathered by the lead researcher will be destroyed and will not be used in the study. 
 
What will happen to the results of the research study? 
The results of the study will be written up in 3 main ways: - 
1. In thesis format, for a Doctor of Physiotherapy. 
2. As a research paper for publication in a Physiotherapy related journal.   
3. Presentations regarding this research will also be submitted for physiotherapy and 
rehabilitation conferences.  
If the research can successfully demonstrate that the LMPI is an appropriate way to 
measure people who are receiving neurological physiotherapy then it can be used within 
clinical practice and for future research projects. 
The researcher will offer to return to your Trust, in order to give feedback regarding the 
progress and results of the research 
. 
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Who is organising and funding the research? 
The research is being organised by Denise Ross, she is a Clinical Specialist Physiotherapist 
in Neurology, and works for Leeds Teaching Hospitals NHS Trust.  Denise is being 
supported academically by the University of Huddersfield 
There is no funding for the research 
 
Who has reviewed this study? 
Local NHS Research Ethics Committees 
Research Ethics Panel, School of Human and Health Sciences, University of Huddersfield 
If I have any concerns or complaints regarding this study, who should I contact? 
If you have any concerns or complaints about anything related to the study, please contact:  
 
Dr Serena McCluskey,  
Research Fellow,  
Centre for Health & Social Care    Research,  
University of Huddersfield,  
Queensgate,  
Huddersfield,  
HD1 3DH 
Telephone: 01484 422 288 
Ms Denise Ross, 
Physiotherapy Department,  
Chapel Allerton Hospital,  
Chapeltown Road,  
Leeds,  
LS7 4SA.  . 
Telephone: 01133924523 
 
 
You will be given a copy of this information sheet, and should you wish to become a 
research participant, a copy of your signed consent form. 
Thank you for taking the time to read this information and for considering taking part in this 
research study 
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Centre number………………………….................. 
Physiotherapist ID number……………………….. 
Number of years post graduate............................. 
Post graduate training within neurology (include M level, IST, on the job training) 
...................................................................................................................................................
................................................................................................................................................... 
 
NHS Physiotherapist Consent Form 
 
Title of project: The development and clinical testing of an index of movement 
performance for neurological physiotherapy: a mixed-methods 
study 
 
Name of lead researcher Denise Ross MCSP MSc 
 
1. I confirm that I have read and understood the information sheet dated 
26/09/2010 for the above study.  I have had the opportunity to consider 
the information, ask questions and have these answered satisfactorily 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving reason 
 
3. I understand that direct quotes that I give during my reflective practice 
may be used verbatim in future publications, although they will remain 
anonymous. 
 
4. I agree to take part in the above study  
 
 
 
 Name Signature Date 
Participant 
  
   
Researcher 
  
   
      
NHS Physiotherapist participant information sheet and consent form Studies 2 & 3. When 
completed, 1 copy for participant, 1 copy for researcher (to be kept in research file) 
26.09.2010  
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Patient Participant Information Sheet Study 2, phase 3 
 
The development and clinical testing of an index of movement performance for 
neurological physiotherapy: a mixed-methods study 
 
You are being invited to take part in the above research study.  Your physiotherapist has 
discussed this and explained what we would like you to do. However, it is important for you 
to understand why the research is being done and what it will involve before you decide 
whether or not to take part.  Please take time to read the following information carefully.  You 
are free to talk to others, for example your family, about the study if you wish.  Part 1 of this sheet tells you the purpose of this study and what will be expected of 
you if you take part.  Part 2 gives you more detailed information about the conduct of the study 
Please ask if there is anything that is not clear or if you would like more information.   
Take time to decide whether or not you wish to take part.  
 
PART 1 
 
What are the purposes of this study?  
The purpose of this study is to psychometrically and clinically test the properties of the Leeds 
Movement Performance Index (LMPI).  This is a way of measuring the effects of 
physiotherapy treatment.  The LMPI has been developed within the clinical setting, and the 
neuro-physiotherapists who have developed it feel that it reflects their assessment, clinical 
reasoning and treatment planning processes. 
 
What does this mean? 
Psychometric tests are mathematical tests that can be done using a computer software 
package; they can help us to understand if measurement tools, tests and questionnaires 
actually measure what they are supposed to.  They can also tell us if therapists score and 
test to the same standards and in a consistent way.  
Outcome measures are used to find out how people change.  In this case we are using a 
measure to define how someone moves, and to see if the physiotherapy that they are 
receiving is having an effect on their ability to move.  Sometimes it is important to prove that 
physiotherapy is effective and necessary and we hope that this research will help us to be 
able to do that. 
Neurological physiotherapy intervention is a specialist branch of physiotherapy and it 
involves assessing a patient’s movement difficulties, then planning what treatment will be 
most effective in helping that person to improve or maintain their functional abilities and 
independence. 
 
 
  
297 
 
 
 
 
 
 
Do I have to take part? 
No it is up to you to decide whether or not to take part.   
You are free to withdraw at any time. 
 
What will be expected of me if I take part? 
Your physiotherapist has asked you if you would consider to consent to your movement 
difficulties being recorded by the LMPI.  This means that the physiotherapist will record your 
movement difficulties (as they normally would) and also score them using the LMPI.  They 
will also score your movement using the Berg Balance Scale (BBS); this is something that 
they may already routinely do.  The BBS measures your balance and your ability to do 
movements such: sit on the edge of a bed, stand up, sit down, turn and look over your 
shoulder. 
Your physiotherapist will score your movement using the LMPI and the BBS; once, at or 
near the beginning of your course of treatment, and then again 6 weeks later or when you 
leave hospital, or finish your course of physiotherapy (whichever is the sooner).   
Personal information regarding your age, gender, neurological diagnosis, movement 
difficulties and current physiotherapy treatment goals will also be recorded. 
All of this information will be kept strictly confidential, and will be anonymised i.e. your name 
and date of birth will be removed. 
All of this information will then be used to test the LMPI using a computer software statistics 
package. 
 
How long the research will go on for? 
Your part in the research project will be for a very short time (the time it takes to video you 
move during your physiotherapy session).  But the full length of the project will last for 2 
years. Your video will be used during the first 6 months of the project. 
What support will I get during the research project? 
You will receive support from your physiotherapist. 
 
What will happen to my personal information when the research is completed? 
When the research is completed, your personal information will be stored securely within 
Leeds Teaching Hospitals NHS Trust, and will not be accessible to anybody other than the 
lead researcher.  After 3 years, all confidential information from this research project will be 
destroyed.   
 
Are there any disadvantages to taking part in this study? 
No, your physiotherapy treatment will not be affected in any way, whether you decide to take 
part in the study or not. 
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However, your movement difficulties and personal information will be recorded and used to 
help develop the LMPI.   
 
Are there any advantages to taking part in this study? 
Yes, you will be helping neurological physiotherapists measure the effects of their treatment.   
In future research this could be important to see whether more neurological physiotherapy 
input has an impact on a patient’s recovery of movement. 
 
Will my taking part in the study be confidential? 
Yes, all the information about your participation in this study will be kept confidential.   
Any information about you will have your name and date of birth removed from it to ensure 
your anonymity. 
If you agree, your Doctor and other members of the medical or rehabilitation teams who are 
currently working with you will be informed about your participation in this study. 
 
How do I contact the lead researcher? 
Denise Ross is the lead researcher, her contact details are:   
Physiotherapy Department, Chapel Allerton Hospital, Chapeltown Road, LEEDS, LS7 
4SA.e-mail d.h.ross@leeds.ac.uk     
 
PART 2 
 
What will happen if I change my mind after the video has been made, and I decide that 
I don’t want to carry on with the study? 
Your decision will be respected and your personal information will not be used in this study. 
Any information that has already been sent to the lead researcher will not be used in the 
study and will be destroyed.  
 
What will happen to the results of the research study? 
The results of the study will be written up in 3 main ways: - 
1. In thesis format, for a Doctor of Physiotherapy. 
2. As a research paper for publication in a Physiotherapy related journal.   
3. Presentations regarding this research will also be submitted for physiotherapy and 
rehabilitation conferences.  
If the research can successfully demonstrate that the LMPI is an appropriate way to 
measure people who are receiving neurological physiotherapy then it can be used within 
clinical practice and for future research projects. 
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Who is organising and funding the research? 
The research is being organised by Denise Ross, she is a Clinical Specialist Physiotherapist 
in Neurology, and works for Leeds Teaching Hospitals NHS Trust.  Denise is being 
supported academically by the University of Huddersfield 
There is no funding for the research 
 
Who has reviewed this study? 
Local NHS Research Ethics Committees 
Research Ethics Panel, School of Human and Health Sciences, University of Huddersfield 
 
If I have any concerns or complaints regarding this study, who should I contact? 
If you have any concerns or complaints about anything related to the study, please contact:  
 
Dr Serena McCluskey,  
Research Fellow,  
Centre for Health & Social Care    Research,  
University of Huddersfield,  
Queensgate,  
Huddersfield,  
HD1 3DH 
Telephone: 01484 422 288 
Ms Denise Ross, 
Physiotherapy Department,  
Chapel Allerton Hospital,  
Chapeltown Road,  
Leeds,  
LS7 4SA.  . 
Telephone: 01133924523 
 
 
You will be given a copy of this information sheet, and should you wish to become a 
research participant, a copy of your signed consent form. 
Thank you for taking the time to read this information and for considering taking part in this 
research study 
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Centre number…………………………  
Physiotherapist ID number……………………….. 
 
Patient Participant Consent Form Study 2 phase 1 
 
Title of project: The development and clinical testing of an index of movement 
performance for neurological physiotherapy: a mixed-methods 
study 
 
Name of lead researcher Denise Ross MCSP MSc 
 
1. I confirm that I have read and understood the information sheet dated 
17/09/2010 for the above study.  I have had the opportunity to consider 
the information, ask questions and have these answered satisfactorily 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving reason 
 
3. I understand that personal information such as: - 
a) My age 
b) My gender 
c) My neurological diagnosis  
d)The results of the Berg Balance Scale and Leeds Movement 
Performance Index 
Will be used in this research study, and may be used within future 
physiotherapy and rehabilitation publications and professional 
conferences but all the information about me will remain confidential and 
anonymous. 
 
4. I agree to take part in the above study, and I agree that my Doctor and 
other members of the medical or rehabilitation teams who are currently 
working with me  can be told that I am participating in this study 
 
 
 
 Name Signature Date 
Participant 
  
   
Researcher     
 
 
Patient participation information sheet and consent form final version study 1 phase 1. When 
completed, 1 copy for participant, 1 copy for Physiotherapist (to be kept in patient’s medical 
notes), 1 copy for lead researcher. 17/09/2010                          
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Physiotherapist Participant Information Sheet Study 3 
 
The development and clinical testing of an index of movement performance for 
neurological physiotherapy: a mixed-methods study   
You are being invited to take part in a research study but before you decide it is important for 
you to understand why the research is being done and what it will involve.  Please take time 
to read the following information carefully.  Talk to others about the study if you wish.  Part 1 tells you the purpose of this study and what will be expected of you if you take 
part.  Part 2 gives you more detailed information about the conduct of the study 
Please ask if there is anything that is not clear or if you would like more information.   
Take time to decide whether or not you wish to take part.  
 
PART 1 
 
What are the purposes of this study?  
The purposes of this study are to psychometrically and clinically test the properties of the 
Leeds Movement Performance Index (LMPI).  This is an outcome measure that reflects 
neurological physiotherapy intervention.  It has been developed within the clinical setting, 
and the neuro-physiotherapists who have developed it feel that it reflects their assessment, 
clinical reasoning and treatment planning processes. 
Why have I been chosen? 
You have been chosen to take part in this study, because you meet the inclusion criteria for 
potential participants, that is: -  You are a member of the British Bobath Tutors Association (BBTA) 
 
Do I have to take part? 
No, it is up to you to decide whether or not to take part.   
You will be given this information sheet and asked to attend a training session.  You can 
then decide whether or not you would like to be involved in the project; if you do, you will be 
asked to sign a consent form.   
You are still free to withdraw at any time. 
 
What will be expected of me if I take part? 
You will be asked to routinely complete a LMPI data sheet during your routine clinical record 
keeping practice.  This will mean that you will need to identify key aspects of the 
components of your patient’s movement and record them on a specific form.  You should 
keep the data sheets within your clinical records, these will not be used within the research. 
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After six months, the lead researcher will ask you to participate in one of two focus groups. 
Your focus group will last for about an hour, and will take place at some point during a BBTA 
 meeting.  
The focus groups will be centred around how you used the LMPI and whether it was useful 
and meaningful to you in your clinical practice.  Before the focus groups are run, ground 
rules will be agreed with all participants. 
The focus groups will be audio taped, the content will then be transcribed.  If you wish, you 
may review the transcription from your focus group for accuracy; this means that you will 
also have the opportunity to review and request removal of information pertaining to you 
from the transcript. 
Once the transcripts have been agreed, they will be analysed by the lead researcher. 
The lead researcher requests that all focus group participants maintain confidentiality 
regarding the views of other participants.  
The audio tapes and transcripts will be kept in a secure location, accessible only to the lead 
researcher. 
 
What happens if I become distressed during the focus group? 
If this happens, there will be someone that you know available to support you.  Should you 
wish to remove yourself from the group, your decision will be respected and if you wish it, all 
the evidence that you have contributed will not be used in the study and will be destroyed. 
 
How much time will this study take out of my clinical obligations? 
The researcher expects that approximately 1 hour will be needed to complete the training to 
use the LMPI.   
The on-going use of the LMPI within routine clinical practice should take minimal time in 
comparison to other measures of outcome that are generally used. 
 
Can anybody else use the LMPI? 
No, for the purposes of this study, you can only use the LMPI if you have been trained to use 
it by the lead researcher. 
 
How long will the research go on for? 
You will be asked to use the LMPI within your clinical practice, for six months (between 
BBTA meetings).   
 
What support will I get during the research project? 
You will get written support in the form of this information sheet 
You will receive a comprehensive training session on the development and use of the LMPI. 
You will receive a copy of the LMPI guidelines 
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You will be able to contact the researcher for advice and guidance via e mail. 
 
Are there any disadvantages to taking part in this study? 
Yes, you may find that there is a small time commitment during your record keeping process, 
when you are recording your clinical observations onto the LMPI data sheet. 
There is a time commitment of one hour whilst you participate in the focus group.  During the 
focus group you will be asked to be positively critical and open during a discussion about the 
clinical use and efficacy of the LMPI 
 
Are there any advantages to taking part in this study? 
Yes, you will gain potentially valuable experience in taking part in and learning about an 
aspect of research.  You will have the opportunity to be directly involved in the development 
of a measure of physiotherapy intervention. 
 
Will my taking part in the study be confidential? 
Yes, all the information about your participation in this study will be kept confidential.  The 
information will be kept in a secure location and only accessible to the lead researcher.  
Any information about you will have your name removed from it to ensure your anonymity. 
Written comments you make, via e mail regarding the use of the LMPI, may be used 
verbatim within future publications.  However, any quotes from you will remain anonymous 
Your contribution to the focus group discussion will be kept confidential. 
During the focus groups, verbal comments you make regarding the use of the LMPI, may be 
used verbatim within future publications.  However, any quotes from you will remain 
anonymous 
 
How do I contact the lead researcher? 
Denise Ross is the lead researcher, her contact details are:  Physiotherapy Department, 
Chapel Allerton Hospital, Chapeltown Road, LEEDS, LS7 4SA.  e mail d.h.ross@leeds.ac.uk 
 
PART 2 
 
What will happen if I don’t want to carry on with the study? 
Your decision will respected.  Your decision will not affect any future or current working 
relationships with the lead researcher. Any information about you that has already been 
gathered by the lead researcher will be destroyed and will not be used in the study. 
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What will happen to the results of the research study? 
The results of the study will be written up in 3 main ways: - 
1. In thesis format, for a Doctor of Physiotherapy. 
2. As a research paper for publication in a Physiotherapy related journal.   
3. Presentations regarding this research will also be submitted for physiotherapy and 
rehabilitation conferences.  
If the research can successfully demonstrate that the LMPI is an appropriate way to 
measure people who are receiving neurological physiotherapy then it can be used within 
clinical practice and for future research projects. 
The researcher will offer to return to your Trust, in order to give feedback regarding the 
progress and results of the research. 
 
Who is organising and funding the research? 
The research is being organised by Denise Ross, she is a Clinical Specialist Physiotherapist 
in Neurology, and works for Leeds Teaching Hospitals NHS Trust.  Denise is being 
supported academically by the University of Huddersfield 
There is no funding for the research 
 
Who has reviewed this study? 
Local NHS Research Ethics Committees 
Research Ethics Panel, School of Human and Health Sciences, University of Huddersfield 
 
If I have any concerns or complaints regarding this study, who should I contact? 
If you have any concerns or complaints about anything related to the study, please contact:  
 
Dr Serena McCluskey,  
Research Fellow,  
Centre for Health & Social Care    Research,  
University of Huddersfield,  
Queensgate,  
Huddersfield,  
HD1 3DH 
Telephone: 01484 422 288 
Ms Denise Ross, 
Physiotherapy Department,  
Chapel Allerton Hospital,  
Chapeltown Road,  
Leeds,  
LS7 4SA.  . 
Telephone: 01133924523 
 
You will be given a copy of this information sheet, and should you wish to become a 
research participant, a copy of your signed consent form. 
Thank you for taking the time to read this information and for considering taking part in this 
research study 
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Physiotherapist ID number……………………….. 
 
Physiotherapist Participant Consent Form Study 3 
 
Title of project: The development and clinical testing of an index of movement 
performance for neurological physiotherapy: a mixed-methods 
study 
 
Name of lead researcher Denise Ross MCSP MSc 
 
 
1. I confirm that I have read and understood the information sheet dated 
17/09/2010 for the above study.  I have had the opportunity to consider 
the information, ask questions and have these answered satisfactorily 
 
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving reason 
 
3. I understand that verbatim quotes that I give during the focus group or 
during written communication may be used in future publications, 
although they will remain anonymous. 
 
 
4. I agree to keep the discussion within my focus group confidential  
5. I agree to take part in the above study  
 
 
 
 Name Signature Date 
Participant 
  
   
Researcher 
  
   
      
Physiotherapist participant information sheet and consent form Study 3 
When completed, 1 copy for participant, 1 copy for researcher (to be kept in research file) 
17/09/2010      
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Appendix 5 
 The themes and structure for the Focus Groups 
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Themes and structure for focus groups 
(18th November 2011) 
 Prior to Focus group starting, discuss:  Focus group rules 
o Confidentiality  For me - talk amongst yourselves but not outside BBTA  For participants – anonymised transcripts of this audio-recording 
o Feel free, unconstrained and comfortable to speak as you feel 
o My role is to put questions to you, possibly probe, and guide you 
o The assistant’s role is to time keep, and to scribe key points that you discuss. 
You will have opportunity to correct / expand / alter these points for 10 
minutes at the end of 45 minutes.  Length of time it will run 
o 45 minutes of discussion 
o 10 minutes of feedback from the flip chart key points that Alan will make 
during your discussion 
o 5 minutes for change over 
o STRICT timekeeping by assistant   This will be hard work, because we only have 1 hour, I would like you to make sure 
that you have discussed everything that you need to, and to try not to become side 
tracked….. you don’t need to repeat points - - everything is recorded.  Typed out verbatim and anonymised  Analysed  Feedback of research findings 
 
Clinical application  
theme 
Quick and easy theme Theoretical underpinning 
to practice theme 
Does the scale recognise 
the individual nature of your 
patient’s movement? 
 
Does it take long to use? 
 
Do you think the items in the 
scale are hierarchical in 
nature? - (but I’m not 
psychometrically testing 
this, this will be on face 
value only)  
Can you use it for all of 
your patients? 
 
Is it achievable, realistic and timely? 
I.e. does it take a reasonable length 
of time to complete  
 
What patient phenotypes 
did you use it with?  
 How does it compare to 
other outcome measures 
that you use or have used? 
What clinical settings have 
you used the LMPI in? 
Within the patient Rx process, when 
do you complete it? 
 
Is the scale sensitive 
enough to measure 
change?  
 Does it reflect your 
conceptual approach to 
clinical practice? 
Can the LMPI be related to 
function? 
 
  
Have you found it to be a 
meaningful and useful 
outcome measure? 
  
Is there anything missing (don’t include cognition or sensation, i.e. movement only)? 
What are it’s strengths? 
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Appendix 6 
 LMPI guidelines  LMPI data sheet 
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The LEEDS Movement Performance Index 
 
 
PAS LABEL 
 
 
 
Name:  
 
Hospital number: 
  Age  …………     Gender …………    Diagnosis  ……………………………………..       Time since onset  ……………………………………..      Other factors affecting the patients theoretical normal (e.g. PMH, bariatric etc) 
……………………………………..……………………………………..  Environment (on hospital bed, type of chair, treatment plinthetc)  
……………………………………..……………………………………..  Location (at home, out-patient department etc)  ..…………………..    What is being measured ……………………………………………   
…………………………………….……………………………………...  
 …………………………………….……………………………………...  
 …………………………………….……………………………………...  
 …………………………………….……………………………………...  
 …………………………………….……………………………………...  
 …………………………………….……………………………………...  
 …………………………………….……………………………………...  Comments …………………………………….………………………   
…………………………………….……………………………………... 
…………………………………….……………………………………...  
 …………………………………….……………………………………...  
 …………………………………….……………………………………...  
 …………………………………….……………………………………...  
 …………………………………….……………………………………...  
 …………………………………….……………………………………...  
 …………………………………….……………………………………... 
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The LEEDS Movement Performance Index 
Score Definition of score 
3 =  Normal Based on what the person’s theoretical optimum normal should be 
2 = Mild The ability to meet more than half OR the majority of the components of the item, based on what the person’s theoretical 
optimum normal should be 
1 = Moderate The inability to meet more than half OR the majority of the components of the item, based on what the person’s theoretical 
optimum normal should be 
0 = Severe An inability to meet any of the components of the item, based on what the person’s theoretical optimum normal should be 
 Score 1 Score2 
DATE   
Alignment 
‘The position / posture of muscles, joints and body parts from which movement / activity is most 
anatomically correct and therefore efficient and effective’ 
  
Interaction 
The ongoing adjustment between body parts within a posture or during movement with respect to its 
BOS; that allows the maintenance of the posture on a background of balance correction, strength and 
endurance. 
  
Timing 
‘The appropriate sequence of activation and de-activation of automatic and selective movement in 
order to complete a task.’ 
  
Speed 
‘The ability to choose how fast or slowly a movement can occur. An optimum speed would be one 
which allows coordination, control, use of minimal energy and allow an effective goal to be achieved’ 
  
Selective movement 
The ability to achieve an isolated, specific and desired movement on a background of stability 
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Appendix 7 
 Ross, DH. (2008). Measuring Movement Performance in the Acute  Setting: The 
development of the LEEDS Movement Performance Index. Synapse Journal of 
ACPIN, Spring, 1-4. 
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Measuring Movement Performance in the Acute Setting: The development of the LEEDS 
Movement Performance Index 
 
Name of author:  Denise Ross MCSP, PGDip, MSc. 
Address of author: Physiotherapy Department,  
 Lincoln Wing,  
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 Beckett St., 
 LEEDS, LS7 9TP.  
Email of author:denise.ross@leedsth.nhs.uk 
Names of Consensus group members:  Alan Bass, Sally Bowes, Jill Hall, Maddie Kenny, 
Gill Lether, Denise Ross, Liz Walker, Kate Warner, Cat Williams, Karen Wood, 
 
Introduction  
Within the field of neurological rehabilitation, a Bobath trained physiotherapist assesses and 
treats the underlying impairments that constrain function and participation, for example the 
patient may have an inability to stabilise their scapula on their thorax and therefore suffer 
from impaired upper limb function, and be dependent on carer support during ADL.  The 
impairment is treated specifically before enabling activity within the context of meaningful 
function.  In other words, the ‘micro detail’ is changed during treatment to give more efficient 
bio-mechanics of the movement which alters the efficiency of the ‘macro’ detail of function 
(IBITA 2006, Edwards 2002, Shumway-Cook & Woollacott 2001, Stokes 1998). 
There is an abundance of validated outcome measures that measure movement and 
function currently available for neurological physiotherapists to use, for example the Berg 
Balance Scale (Berg et al 1992), the Ten Metre Walk (Wade 1992) the Trunk Control Test 
(Frangignoni et al 1997), the Postural Assessment Scale for Stroke (Benaim et al 1999), the 
Modified Rivermead Mobility Index (Lennon, Johnson 2000), the Motor Assessment Scale 
(MAS) (Carr et al 1985) and TELER (Le Roux 1993, Mawson 1995, 2002).  However, it is 
difficult to find a tool that measures change affected during physiotherapy intervention at 
component or impairment level.  
Boyce et al (1993) developed a scale that measured the quality or performance of the 
cerebral palsied child’s movement, which could be used in conjunction with a previously 
developed scale of motor function.  In practical terms, the resulting measurement tool could 
be used to measure change over time, compare change to intensity of input, and compare 
change to surgical intervention.  The tool could also be used to support clinical reasoning for 
physiotherapy treatment planning and the demonstration of treatment effectiveness. 
Within the last thirteen years there has been a significant amount of research within the field 
of balance and postural control in adult neurology focusing on the measurement of outcome 
at impairment rather than at functional level.  Nieuwboer et al (1995) developed a scale, 
based on the visual observation of balance posture and trunk activity in sitting, for stroke 
patients.  The tool was designed to be used by physiotherapists for the monitoring of clinical 
progress, treatment outcome, effect of intervention and to be quick, easy, reliable and valid 
for use.  This study found that the items which did not measure the quality of the movement 
or posture had good reliability, whereas the items which did measure the quality of the 
movement (assessment of selective and symmetrical movement) only achieved moderate or 
slight reliability, possible due to the variance of clinical knowledge and experience between 
the testers, resulting in measurement error.  ,  
During a more recent study by Verheyden, Nieuwboer et al (2004) the Trunk Impairment 
Scale was developed by removing some items of poor reliability and redefining other items. 
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The authors state that this scale could be used as a guide for physiotherapy treatment, but it 
only looks at trunk control in sitting.  It could be that the measurement of the quality of trunk 
control in sitting is generalisable and a predictor to the patients’ overall quality of their 
postural control, but this isn’t claimed in the study.   
Mawson (1995) developed a set of movement indicators for use by physiotherapists when 
treating neurologically damaged patients.  The movement indicators were developed to fit 
with the TELER technique of measurement. They were developed during a two-year project, 
using the clinical experience of a group of senior neurological physiotherapists.  The 
indicators were given face validity by the British Bobath Tutors Association, and given 
concurrent validity when compared with the MAS (Mawson 2002).  On face value, these 
indicators appear to be applicable to individual patients and sit well within the Bobath 
concept, however, although clinical standards of ‘normal movement’ were specifically 
addressed, they do not consider the quality or performance of the patients’ movement and 
postural control.   
Daley et al (1999), Wang et al (2002) and Ahmed et al (2003) have demonstrated the Stroke 
Rehabilitation Assessment of Movement Measure (STREAM) to be a psychometrically 
strong outcome measure for stroke, for use in research and clinical practice.  The STREAM 
measures a mix of selective motor activity and function that may be appropriate for use in 
clinical practice.  The scoring criterion although initially appearing to be complex; assesses 
and scores depending on whether the movement is complete, normal or deviated.  This 
outcome measure therefore recognises the necessity of measuring the quality of movement 
in clinical practice. 
It is important to measure change in the patients’ ability and performance of movement as a 
result of physiotherapy intervention.  The measures of change that are available are, in 
general, function orientated and are not specifically related to neuro physiotherapy clinical 
practice, which is: -  analysis of movement and posture  problem identification  functional goal setting  treatment planning  ‘hands on’ facilitation of movement and postural activity 
There is a need to support current subjective observation of our patients’ ability pre and post 
treatment in order to validate physiotherapy intervention. 
Because quality or performance of posture and movement is important, the understanding of 
what is meant by ‘quality’, and what components of this are needed in order to achieve a 
successful performance, is essential. 
The purpose of this study was to establish:-   What Bobath trained therapists mean by ‘quality of movement and posture’.  The parameters of quality that are referred to in clinical practice.  The potential to develop a measurement tool that could quantify these qualitative 
observations. 
Methodology 
The senior neuro training group within Leeds Teaching Hospitals NHS Trust Physiotherapy 
Department worked together as a consensus group, facilitated by one of the clinical 
specialists.  The membership of the group is diverse in terms of specialist knowledge, 
representing a broad clinical spectrum within neurology (acute neurosurgery, acute neuro 
rehabilitation, stroke unit, community stroke rehabilitation, community neuro rehabilitation 
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unit, neuro out-patients and MS specialist service).  Its membership consists of ten 
experienced clinicians, with a range of between four and twenty five years experience of 
working at band seven levels or above in neurological rehabilitation.  A series of consensus 
group meetings and Delphi type methodology was used to develop ‘The LEEDS Movement 
Performance Index’.  (figurei) 
Results 
During their first meeting in July 2006, the consensus group identified and agreed two 
definitions of what ‘quality of movement and posture’ meant to them.  They then identified 
different components of quality of movement, and agreed on five key components. 
A Delphi type methodology was used within the group, in order for individuals to 
anonymously define and describe the five key components of quality of movement and 
posture. 
In November 2006, the consensus group met again.  A simple scoring system based on 
what the patients ‘theoretical optimum normal’ should be was agreed, and the resulting 
measure was named ‘The LEEDS Movement Performance Index’ (LEEDS MPI).   
Each group member was randomly allocated two items of the index and used it during their 
routine physiotherapy record keeping process for two months.  There were no constraints 
placed on how or when the measure should be used, only that it should be at the clinical 
judgment of each group member.  During this trial period, the groups’ facilitator visited each 
of the group in their clinical setting and gathered information and knowledge about how 
clinically useful the performance index was in practice. 
A consensus group meeting in March 2007 resulted in the decision to trial and use all five 
items in clinical practice.  This was done during June and July 2007.  
Discussion 
During their year of research, the consensus group developed a measure that could support 
their qualitative analysis of selective components of movement and posture during the 
assessment, which underpinned the functional goal setting and treatment of their patients.  
There were no floor or ceiling effects as the index could be used to analyse a part of, or the 
whole of, a pattern of movement.  It was unanimously agreed that the index was supportive 
of the clinical reasoning process, and was closely related to patients’ treatment goals and 
treatment plan.   
During consensus group meetings it was recognised that the LEEDS MPI could also be 
developed for use as a tool to support the development of less experienced 
physiotherapists. 
The group has developed a measure of intervention of treatment of neurologically impaired 
adults, based on a sound research structure, thus achieving robust face and content validity.   
The consensus group recognizes that there may be an element of bias within this study, as 
all group members are very specifically Bobath trained and work at specialist level.  The 
LEEDS MPI could be observed to be very technical, in terms of ease of use and language, 
by non-Bobath trained therapists.  It would also be impossible to use the index for 
comparison between groups of patients due to the variety and individualized nature of 
physiotherapy treatment goals and plans.   
Future work and dissemination 
It is intended by the researcher and the consensus group participants, that the LEEDS MPI 
be further developed, in order to: -   Explore reliability during use by senior Bobath trained therapists.  Explore the validity for use by senior Bobath trained therapists, as an objective 
tool to measure intervention. 
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 Support the more subjective descriptions currently used during the 
documentation of neurological therapy clinical practice.   Explore the development of use as a training aid for less experienced therapists 
or therapy students. 
It is intended that dissemination of the work will be via presentation and publication, in order 
to gain peer review and feedback. 
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Figure (i): research process 
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Appendix 8 
 All ten definitions of each item within the LMPI 
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All ten definitions of each item within the LMPI 
 
 
Alignment 
1 The way in which one body segment or joint is actively ‘stacked’ or line up with each other in 
different postures and during activities.  
2 Alignment of key body parts in a specified posture. Something being positioned correctly 
over or next to something else (muscles, joints etc). 
3 The anatomical position of body parts in relation to each other. 
4 The position/posture of muscles, joints and body parts from which movement/activity 
is most anatomically correct and therefore efficient and effective. 
5 Alignment must take into consideration joint, ligament, muscle and tendon i.e. there is a 
mechanical aspect to alignment. But crucially, for function to occur there must be muscle 
activity. Appropriate muscle activity is intrinsically linked with alignment.   
6 The correct / optimum position of body parts to each other to allow normal function. 
Alignment means correct muscle length and joint positions so allowing proper proprioception 
from muscles and joints and efficient muscle activation i.e. correct timing and recruitment of 
stabilizer, mobiliser muscle groups. 
7 The relationship between joints, soft tissues and muscles, in respect to the posture and 
movement of the whole body, is recognisable within the variability of what is commonly 
accepted as ‘normal’.   
8 The optimum position of body segments including the skeleton and soft tissues. 
9 The relationship between body parts. 
10 The arrangement of body segments/parts to one another within 3 planes which have a 
dynamic interaction with each other via the neuro-musculo-skeletal system. 
 
Interaction 
1 How well a person relates to the given environment. 
2 Ability to receive sensory information, integrate it and produce a motor output as a response. 
In relationship to body parts (alignment), base of support and environment. 
3 The ability of body segments to move, and be in awareness of each other- also to include an  
awareness of the related contact surfaces. 
4 The ongoing adjustment between body parts within a posture or during movement 
with respect to its BOS; that allows the maintenance of the posture on a background 
of balance correction, strength and endurance. 
5 The ability of body segments to cooperate  with each other or with a supporting surface to 
produce, sustain or limit a movement. 
6 This is the way in which the body is dynamic and changeable in different postures to allow 
movement to occur.  
7 A mutual or reciprocal action between body parts which enhances or allows selective 
movement to occur. 
8 a/ with the BOS, the ability for the part of the body in contact with the supporting surface to 
adapt to it. 
b/ of the body parts with each other, the ability of 1 body part to adapt and allow another to 
work and for body parts to move in relation to each other. 
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9 Interaction occurs between the supporting surface and the body parts in contact with that 
supporting surface i.e. a base of support is the outcome of that interaction. Interaction is the 
active working relationship within and between body segments with respect to the base of 
support. 
10 How a body part moves or aligns with another and its response to the environment around it. 
 
Timing 
1 The initiation, speed and coordination of muscle and joint activity. 
2 Smooth and harmonious muscle activity for function is linked to the timing of recruitment of 
muscle fibre. This is governed by the Heinemann Recruitment Principle. Timing of 
recruitment occurs within a muscle and between muscle groups. 
3 Appropriate sequential movement relevant to the task being performed. 
4 That the appropriate recruitment of activity occurs in the accepted order to achieve smooth 
and accurate movement. 
5 Correct timing ensures sequential firing of specific muscles  to produce coordinated, efficient  
movement. 
6 Coordinated sequenced recruitment of muscle activity for efficient movement. 
7 The interval between key components of a movement or action. 
8 The way in which the body works in an order or sequence so to produce an efficient 
movement. The way in which the body must gain stability at a joint or body segment before 
movement can occur. 
9 The ability to switch muscle activity on and off appropriately. ie stabilizers switch on before 
mobilisers.  Also, the grading of agonist / antagonist activity. 
10 The appropriate sequence of activation and de-activation of automatic and selective 
movement in order to complete a task. 
 
Speed 
1 The speed of a person’s movement should be appropriate to the task and to the 
environment, within this movement there should be an appropriate degree of variability and 
choice of speed. 
2 Varying dependent on the movement being performed, timely to allow the movement  to be 
appropriate. 
3 To include an awareness of rate, pattern and frequency. 
4 Appropriate velocity for the sequencing and recruitment of muscle activity for efficient 
movement. 
5 The time taken to achieve the required goal indicates efficiency and precision of movement 
and is easily measurable. 
6 Speed should be able to be variable without losing efficiency of movement. 
7 The speed of a movement should appear appropriate for the movement being performed. It 
should not appear too fast or too slow to allow for a safe and smooth movement or pattern. 
8 How fast or slowly a movement can occur. An optimum speed would be one which 
allows coordination, control, use of minimal energy and allow an effective goal to be 
achieved. 
  
322 
 
9 Speed is a variation in the timing of recruitment. For efficiency there will be an optimum (or a 
range of optimum) speeds, i.e. a natural timing of recruitment that will result in effortless 
function. 
10 The rate at which an action occurs. 
 
Selective movement 
1 This movement is a product of good alignment between interaction and body parts.  It is 
precise efficient movement performed with appropriate timing. 
2 Movement that has all the above components - correct timing, speed and varying interaction 
between joints, muscles etc. to allow a task to be performed with as little effort as possible. 
3 The movement of a body part that can occur freely, and that can be appropriately 
independent of other body parts, this could be: During functional movement / During 
selective limb activity. 
4 The way in which the body provides a background of control so the limbs or one body part 
can move freely against another, and can be ready to work if demanded by the individual. 
5 Ability to achieve an isolated, specific and desired movement on a background of 
stability 
6 Movement performed using the correct components for a particular activity. 
7 Selective movement is the ability to isolate movement to one body part or to one limb. 
Appropriate selection of movement is determined by the function to be achieved. Stability of 
an associated body part is essential for the agonist and antagonist to work harmoniously 
together for selective movement.   
8 Recruitment of the appropriate muscle groups working in synergy to efficiently achieve the 
desired outcome. 
9 A movement which is precise and free from interference from reflex activity, abnormal 
fixation, compensation or movement of other body parts. The ability to select one movement 
to the exclusion of others. To be able to pick out or choose a specific, discrete movement. 
Requires correct postural background activity. It is not possible to have selective movement 
with a background of low or high muscle activity; it requires synergic control and reciprocal 
innervation. 
10 Isolated, specific movement of one joint or joints based on stability through appropriate 
muscle activity. 
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Appendix 9 
 The Microsoft PowerPoint presentation used to teach Studies 2 and 3 participants 
how to use the LMPI 
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Appendix 10 
 Ross, DH., McLuskey, S., Fletcher-Cook, P. & Stephenson, J. (2014). The 
reliability of the Leeds Movement Performance Index (LMPI): a new tool for 
neurological physiotherapy. Physiotherapy Theory and Practice, 30(8), 581–587. 
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The Reliability of the Leeds Movement Performance Index (LMPI): A New Tool for 
Neurological Physiotherapy.  
ABSTRACT 
Background: Measuring movement performance in people with neurological damage 
requires a tool that reflects physiotherapy assessment and clinical reasoning. The LMPI was 
previously developed by a group of neurological physiotherapists to fulfil these requirements. 
Objective: to assess the reliability of the LMPI for use in neurological physiotherapy practice. 
Methods: Twelve senior neurological physiotherapists were trained to use the LMPI, and 
then asked to measure the movement performance of 5 patients whose movement had been 
previously video-recorded for this purpose. A retest session was completed after 2 weeks. 
Data were analysed to establish internal and external reliability.  Results: Internal reliability 
was assessed using Cronbach’s alpha coefficient, applied to the entire scale (0.862) and to 
each item (range 0.795 - 0.892). External (inter-rater) reliability was assessed by a 
calculation of the intraclass correlation coefficient for scores awarded by multiple raters 
(0.959), with individual item reliability ranging from 0.874 - 0.968.  External (test-retest) 
reliability was assessed by calculating the Spearman’s rank correlation coefficient between 
scores obtained on 2 testing occasions (0.792) with values of individual items ranging from 
0.397 - 0.674.  A variance components analysis partitioned variance into components arising 
from between-patient variability (83.3%) between-therapist variability (7.8%), and between-
testing variability (2.8%). Conclusions: Results indicate that the LMPI is a reliable 
measurement tool when used by senior neurological physiotherapists.   
BACKGROUND 
The use of outcome measures is strongly advised within neurological physiotherapy clinical 
practice (Hammond 2000), but the literature consistently illustrates that they are not well 
used (Van-Peppen et al 2008; Wedge et al 2012).  A possible reason for this is that available 
outcome measures that are appropriate for use within neurological physiotherapy practice 
(Berg Balance Scale (Berg, Wood-Dauphinee, Williams, Gayton1989); Ten Metre Walk 
(Wade 1992);  Goal Attainment Scale (Turner Stokes 2009);  Motor Assessment Scale (Carr, 
Shepherd and Nordholm 1985); TELER (Le Roux 1993; Mawson 1995; 2002)) measure that 
the patient can perform a movement e.g., stand up, roll over in bed, sit down etc., but not 
how well they can perform it.  These ways of measuring outcome all largely represent the 
‘activity’ domain of the World Health Organisation’s bio psychosocial model that classifies 
Impairment, Function, Disability and Health (ICF) (WHO 2001) (see figure 1).  This paper 
examines the measurement properties of a new outcome measure, which reflects 
neurological physiotherapy assessment and treatment, and is focussed on how well a 
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patient can move.  The emphasis is on the physiotherapy intervention, which is centred 
within the ‘body functions and structures’ domain. 
 
 
 
The World Health Organization (WHO) define ‘impairment’ as: problems with joint mobility, 
muscle power, muscle tone, involuntary movements and pain.  Its definition of the ‘activity 
and participation’ domains include: lifting and carrying objects, fine hand use (e.g. writing 
and cooking), walking, driving, self-care and domestic life.  Those of the ‘environment’ and 
‘personal factors’ domains include products, technology services, attitudes, support and 
relationships (WHO 2003 p3-4). 
Shumway-Cook and Woollacott (2012) perfectly demonstrate how the WHO’s ICF can be 
applied into physiotherapy practice, where movement has to be considered in relationship to 
the task that is being performed, the individual (in terms of their impairments and personal 
factors) and the environment in which the task is being performed (see figure 2). 
 
 
 
 
Body functions and 
structures Activity 
Participation 
Environmental factors Personal factors 
Health condition (disorder or disease) 
figure 1: Interactions between components of the ICF (WHO 2002 p9) 
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Figure 2: Movement emerges from an interaction between the individual, the task, and the 
environment. Shumway-Cook and Woollacott (2012, p4) 
 
To place this within the specific context of neurological physiotherapy clinical practice, a 
stroke patient may have an inability to stabilise their scapula on their thorax and therefore 
suffer from impaired upper limb function and be dependent on carer support during dressing.  
The impairment (scapula stability) is treated specifically before enabling activity (arm 
movement) within the context of meaningful function (dressing).  There are no available 
measurement tools that can: 1) measure the patient’s improved movement performance and 
change of their quality of movement achieved as a result of physiotherapy intervention; and 
2) also reflect the process of observational assessment and clinical reasoning used within 
practice. 
In order to address this need, an outcome measure entitled the Leeds Movement 
Performance Index (LMPI) (appendix 1: The LMPI data sheet), was developed by a 
Physiotherapist Research Group (a group of senior neurological physiotherapy clinicians 
who work in an acute hospital setting) (Ross 2008a, 2008b).  The group wanted to develop a 
measurement tool that could capture the ‘quality’ of their patients’ movement.  Consensus 
group and Delphi methods were used to: 1) define their understanding of the term 
‘movement quality’ and 2) identify and define the key components of ‘movement quality’ that 
they felt were important within their clinical practice.  Movement quality was defined as “an 
efficient way to achieve a desired outcome or goal with the least effort, timely, smooth and 
precise; within the context of the individual, the task and the environment.” (Ross 2008b).  
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The 5 key components of movement within this definition were: “Alignment, Interaction, 
Timing, Speed and Selective Movement” (Ross 2008b), forming the basis of the 5 scale 
items within the LMPI.  A unique premise of the LMPI is that it enables deconstruction of 
movement into these 5 different but inter-related scale items, allowing a more in-depth and 
meaningful assessment of movement performance compared to existing outcome measures. 
The LMPI is used to assess the patient’s quality of movement during a specific task or 
movement and is generally completed post-treatment during the physiotherapist’s routine 
record keeping process. With familiarity of use it has potential to become part of the clinical 
reasoning process, both during and post-treatment.  Any aspect of the patient’s movement 
can be chosen to be measured (e.g. “foot on floor during the stance phase of gait”, “the 
pelvis during sit to stand”, “the hemi-paretic arm during walking”) but it should be related to 
the patient’s and therapist’s treatment goals.  The ordinal score system (see appendix 1) of 
the LMPI, where: 0 = severe, 1 = moderate, 2 = mild and 3 = normal, was designed by the 
Physiotherapy Research Group in an attempt to reflect the prognostic element of the 
physiotherapist’s assessment (Ross 2008b). Shumway-Cook and Woollacott describe a 
similar score criteria (2012, p124) when they discuss Schmitz’s non-equilibrium tests used to 
diagnose specific pathology in the cerebellum.    
Although the LMPI scoring system involves a subjective clinical judgement, it is important, is 
supported by the experience, knowledge and skill of the physiotherapist and is used to guide 
realistic goals for the patient. No intentional hierarchy is given to the scale items, and the 
LMPI is intended to be applied to any movement or functional activity that is appropriate to 
the patient’s rehabilitation and their physiotherapy intervention.  It is intended that the LMPI 
be used within teams of physiotherapists (e.g. the team of physiotherapists working on an 
acute stroke rehabilitation unit) or singly (e.g. a lone practitioner in an out-patient department 
or in a patient’s home).   
The measurement tool sits within the conceptual framework of modern UK clinical practice, 
which is a need identified by Horner and Larmer (2006) who support this need when they 
state that health outcome measures used within the health setting should be practical and 
“responsive for a particular purpose in a particular population” (p23).    Although during its 
development, preliminary face and content validity has been established; further, more 
robust examination of the measurement properties of the LMPI is now required in order to 
establish its reliability, validity and clinical utility within neurological physiotherapy practice.  
This paper presents the methods used to investigate the internal and external (inter-rater 
and test-retest) reliability of the LMPI and the results.   
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Ethical issues: Ethical approval for this research project was granted by the UK National 
Health Service (NHS) research ethics committee (reference number: 10/H1302/82) and 
permissions were obtained by all 4 of the participating organisations. 
METHODS 
Research Design 
Video recordings of patient’s movements were observed and scored using the LMPI by 
senior neurological physiotherapists.  The data gathered were analysed using standard 
psychometric tests to determine internal and external reliability.  This study ran sequentially 
through 2 phases.  Phase 1 focussed on the preparation of research tools; phase 2 
examined internal and external reliability of the LMPI. 
Phase 1: preparation of research tools 
Short (from 7 to 48 seconds) video recordings of patients were made, with each patient 
performing a simple movement.  The video recordings were: 1) incorporated into a training 
package to train physiotherapists to use the LMPI or 2) incorporated into a testing process, 
to test the LMPI during phase 2 of this study. 
The available literature related to the use of video for testing the measurement properties of 
outcome measures varies widely in both the number of raters, and number of videos.  For 
example:  Mosely et al (2003) used 20 videos and 3 raters; Carr et al (1985) used 5 videos 
and 20 raters; Whitall et al (2006) used 10 videos and 3 raters.  Therefore, a pragmatic 
decision (based on resources available, experience of teaching and statistical guidance) was 
made by the authors and the Physiotherapy Research Group to use 3 patient videos to help 
teach the physiotherapists how to use the LMPI, and 5 videos within the test protocol. 
Eligibility and inclusion criteria 
Patients who were resident on the acute and rehabilitation wards or attending out-patient 
appointments at a large teaching hospital were eligible to be recruited if they met the 
following criteria: over 18 years of age, neurological diagnosis having an effect on motor 
control, receiving treatment from a neurological physiotherapist and considered (by their 
physiotherapist) to be cognitively able to consent to being videotaped whilst performing a 
simple movement (e.g. stand up, walk etc.). 
Recruitment and consent  
Patients identified by their physiotherapist as meeting the inclusion criteria were approached 
by the researcher, who verbally explained the research process, and provided supporting 
written information sheets.  Patients were included if they provided written informed consent 
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to be videotaped whilst performing a simple movement during their physiotherapy treatment 
session. 
Data collection  
Fifteen patients were recruited, and the researcher video-recorded a short episode of 
movement from each patient using a single hand-held digital camera, so that only 1 
viewpoint was seen. 
Data analysis  
Nine men and 6 women were recruited; their ages ranged from 28 to 91 years with a mean 
age of 55 years (SD 16 years).  Nine patients had suffered a stroke, 2 had multiple sclerosis 
and the others presented with peripheral neuropathy or retro-spinal craniectomy or 
subarachnoid haemorrhage or traumatic brain injury.  The movements videoed varied, and 
included: walking, sit to stand, forward reach to grasp cup, in supine - elbow flexion with 
active grasp, supine to sit on edge of bed and 2-handed reach and place hands.  The 
majority of the tasks were functional.  All were chosen by the patient and their 
physiotherapist and reflected their goals and treatment plan. 
Once the videos had been recorded and stored, they were reviewed by the Physiotherapist 
Research Group who allocated videos for either training physiotherapist participants in the 
use of the LMPI, or testing the LMPI measurement properties based on the following criteria: 
-  
 A variety of problems should be presented so that physiotherapists could learn to apply 
the concepts of the LMPI to different movement problems.   The patient’s movement / motor control difficulties should be sufficiently complex to 
initiate discussion around the concepts of their bio-mechanical impairments; so that the 
principals of the use of the LMPI could be applied.  The motor control difficulties that the patient presented should be fairly typical of 
movement difficulties commonly observed in clinical practice  Patient movement should be clearly visible (normally physiotherapists observe their 
patient’s movement difficulties in 3 dimensions: for the purposes of the testing of the 
LMPI they were asked to make judgements in only 2 dimensions). 
Phase 2: Testing the measurement properties of internal and external reliability 
Aim: to examine the internal reliability and external reliability of the LMPI in order to establish 
confidence that: 1) the 5 different components were all necessary parts of the scale, 2) the 
LMPI can be used by the same physiotherapist to reliably measure pre- and post-treatment, 
or course of treatment; and 3) the scale can be used by a team of therapists treating the 
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same patient, or during transfer between therapists, as part of the clinical information that 
follows the patient along their rehabilitation pathway. 
Design 
Physiotherapists were trained to use the LMPI, and then followed a testing protocol designed 
to examine its internal and external reliability.  Five video recordings were watched and rated 
using the LMPI.  Two weeks later, the video recordings were re-watched and re-rated. 
Eligibility and inclusion criteria  
Physiotherapists who worked for the participating organisations and who met the following 
inclusion criteria were recruited into the study: majority of caseload spent treating patients 
who had a neurological diagnosis, working as a senior therapist, permission from their 
manager to participate. 
Recruitment and consent 
Neurological physiotherapy service managers from 3 participating organisations were 
approached; they identified eligible physiotherapists who agreed to meet with the 
researcher.  Both verbal and written information about the study were given to prospective 
physiotherapist participants by the researcher prior to the gaining of informed consent. 
Data collection 
Training protocol: In groups of 3 or 4, the physiotherapist participants were trained to use the 
LMPI by the researcher using the research material developed during phase 1.  The training 
took place in participants’ workplaces within their normal working hours.  Group work and 
problem solving discussions about the patients’ videoed movement enabled the 
physiotherapist participants to apply the LMPI to clinical problems and use the clinical 
reasoning process to underpin observational assessment and analysis of patient movement. 
Once the physiotherapist participants expressed verbally that they understood how to use 
the LMPI, they progressed to the testing protocol. 
Testing protocol: Participants were shown 5 further video recordings of patients.  Each video 
was played repeatedly, while the physiotherapist participants each used a paper datasheet 
of the LMPI to ‘rate’ the patient’s movement, until they expressed that they had completed 
each component and were satisfied with the score.  Two weeks later, the use of the LMPI 
was reviewed with the participants, who then re-watched the same videos and re-rated the 
patient’s movement.  On both occasions the participants were blinded to each other’s 
scores. All data were gathered together and stored confidentially and securely by the 
researcher prior to the analysis of reliability. 
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Data analysis:  Based on the recommendations of Fitzpatrick, Davey, Buxton and Jones 
(1998), the most appropriate standardised psychometric tests were used to establish the 
LMPI’s internal reliability, its external reliability (inter-rater reliability and test-retest reliability), 
and an analysis of the components of variance of the data  (Kirkwood, Sterne 2003; Norusis 
2003; Kinnear, Gray 2009). 
 Internal reliability was assessed using Cronbach’s alpha coefficient, applied to the entire 
scale and to each individual item   External (inter-rater) reliability was assessed by calculation of the intraclass correlation 
coefficient (ICC) for the scores awarded by multiple raters, appropriate for the analysis of 
numerical data  External (test-retest) reliability was assessed by calculation of Spearman’s rank 
correlation coefficient for scores obtained on 2 testing occasions  A variance components analysis was also undertaken. This procedure estimates the 
contribution of each random effect to the variance of the dependent variable. Hence in the 
current context, variance in LMPI score is partitioned into components arising from 
between-patient variability, between-therapist variability and between-testing variability; 
as well as from residual variability; to assess the proportion of variability in LMPI score 
that might arise from instability of the instrument when applied by multiple 
physiotherapists or across multiple measurement occasions.  Thus the procedure 
determines where attention should be focussed in order to reduce the variance. In this 
process it is assumed that the practitioners and patients featured in the sample represent 
random selections from larger populations. 
All analyses were undertaken using SPSS Version 20.0. 
RESULTS 
Internal reliability:  Table 1 summarises the values of Cronbach’s Alpha Coefficient 
calculated for both the overall scale and for each individual item. The alpha value for all 
items (0.862) indicates high overall reliability; the alpha values of the scale with individual 
items deleted also indicates high reliability (range from 0.795 to 0.892), implying that the 
reliability of the scale decreases with the deletion of all scale items except Alignment; the 
deletion of which is associated with a very small increase in reliability. 
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table 1: Internal reliability 
Cronbach's Alpha, overall scale 0.862 
Cronbach's Alpha if Item Deleted  
Alignment 
Interaction 
Timing 
Speed 
Selective Movement 
0.892 
0.833 
0.811 
0.816 
0.795 
 
 
External (inter-rater) reliability:  Table 2 summarises the assessment of the consistency of 
the scores made on different measurement occasions, and by different physiotherapists 
using the intraclass correlation coefficient (ICC).  Overall external reliability was high (0.959), 
with individual item reliabilities ranging from 0.874 to 0.968; implying that the LMPI has 
strong inter-rater reliability.  The corresponding p-values (<0.001 in all cases) demonstrate 
statistical significance of all items. 
table 2: External reliability 
Intraclass Correlation Coefficient p-value 
Average measures all items 0.959 <0.001 
Alignment 
Interaction 
Timing 
Speed 
Selective Movement 
0.874 
0.931 
0.957 
0.935   
0.968 
<0.001 
<0.001 
<0.001 
<0.001 
<0.001 
 
Test-retest reliability: Table 3 summarises the results of an item-total rank correlation 
analysis to assess test-retest reliability; the value of the correlation coefficient for the full 
scale is high (0.792) with values of individual items ranging from 0.397 to 0.674.  
Furthermore, the corresponding correlation coefficients for individual items of the scale were 
all statistically significant (p<0.002 in all cases), with effects of medium size or greater being 
observed in the majority of cases.   
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table 3: Test re-test reliability 
Spearman's rho Rank Correlation Coefficient p-value 
All items  0.792 <0.001 
Alignment 
Interaction 
Timing 
Speed 
Selective Movement 
0.397 
0.674 
0.516 
0.655 
0.655 
<0.002 
<0.001 
<0.001 
<0.001 
<0.001 
 
Table 4 summarises a variance components analysis that was used to examine the 
variability of the results, to partition variance into components arising from between-patient 
variability, between-therapist variability and between-testing variability; as well as from 
residual variability. The low proportions of variability between therapists and between 
measurement occasions calculated from this procedure (7.8% and 2.8% of total variability 
respectively) provide further evidence of the stability of the scale; with, as might be 
expected, the largest component of variance (83.3%) arising from natural between-patient 
variability.  
table 4: Variance components analysis 
Component Variance 
Estimate 
% of total 
Variance between Physiotherapists 
Variance between Patients 
Variance between replicate measurement 
occasions  
Residual variance 
0.467 
 3.317 
0.17 
 
2.056 
7.8% 
55.2% 
2.8% 
 
34.2% 
 
DISCUSSION 
The results of this study indicate that the LMPI is a reliable measure of movement 
performance, potentially providing a unique measurement tool for use in neurological 
physiotherapy practice, both by individual physiotherapists or teams of physiotherapists over 
time.  The internal and external reliability of the LMPI were examined in order to establish 
confidence that:- 
1) All 5 scale items were necessary components of the scale. It has been recognised that 
redundant items could “artificially inflate a score”, thus reducing clinical usefulness and 
wasting “time and effort” for both the patient and the therapist (Tyson and Connell, 2009, 
p836).  
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2) The LMPI can be used by the same physiotherapist to reliably score pre- and post-
treatment, or course of treatment.   
3) The scale can be used by a team of therapists treating the same patient, or during 
transfer between therapists as part of the clinical information that follows the patient along 
their rehabilitation pathway. 
The results of the internal reliability tests were strong (Jorstad, Hauer, Becker and Lamb 
2005; Pallant 2007; Field 2009), with alpha values of 0.862 for all items and a range from 
0.795 to 0.892 for individual items. Hence such items may be considered to add value in 
terms of scale reliability. Furthermore, on clinical grounds, the small decrease in reliability 
arising from the exclusion of the Alignment item does not merit the deletion of this item from 
the scale results.  
External (inter-rater) reliability of the LMPI was high (0.959) (Pallant, 2007; Field, 2009) 
indicating that a team of physiotherapists can use the scale on the same patient with high 
confidence of agreement.  Individual item reliabilities ranged from 0.874 to 0.968, inferring 
that during the analysis of movement dysfunction, the individual items could also be used in 
a ‘stand-alone’ manner and scored with good confidence of agreement. 
The test re-test reliability of the LMPI, using a Spearman’s rank correlation coefficient on all 
items is high (0.792) with the corresponding correlation coefficients for individual items of the 
scale being statistically significant (p<0.002 in all cases). Lone practitioners can therefore 
use this scale with confidence that any changes in the patients’ scores would be due to 
changes in their movement performance as opposed to scale error. Clinicians with an 
interest in the score of a particular item (e.g. ‘timing’ of the pelvic movement during sit to 
stand) may also be confident that significant variation in scoring of that item between 
repeated measurement occasions is likely to be low; i.e., any change noted in the patient’s 
movement quality is likely to be due to the patient, as opposed to the scale’s instability. 
The findings of the variance components analysis underpin and reinforce the findings of the 
reliability assessments.  Furthermore, it has been shown that variability between therapists 
and between measurement occasions is low compared to natural between-patient variability. 
Between-patient variability (83.9%) accounts for more than 5 times as much variance in the 
outcome as all other known sources of variance. 
Clinical utility: In their study, Skjaerven, Kristoffersen and Gard (2010) used a 
phenomenological approach to gain a rich understanding of how physical therapists perceive 
and teach or re-educate movement quality.   The results found that there are 3 key areas 
that are imperative to the promotion of movement quality: 1) the therapist’s awareness and 
knowledge of their own movement, 2) the creation of learning situations that are meaningful 
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for the patient, and 3) strategies for promoting movement quality.  The development of the 
LMPI adds to this field, because: - 
 it can be reliably used to measure the quality of movement   it could potentially be used within clinical practice to underpin the therapists awareness 
and knowledge of movement  it could potentially be used flexibly to suit the patients’ goals  it could potentially be used to enhance the patients’ awareness of their own quality of 
movement. 
Concurrent research will investigate these potential applications further (Ross, McCluskey 
2013). 
A particular strength of this study was the use of video recordings. They minimised the 
stress for patient participants because patients only needed to perform their movement task 
once for the physiotherapy participants to observe and score with the LMPI in different 
locations and at different times. This is supported by Carr, Shepherd and Nordholm (1985); 
who also found that video avoided variability in the presentations of the patient’s movement.  
Videos were also effective  in teaching the physiotherapist participants how to understand 
and use the LMPI by ensuring a standardised, consistent training protocol, therefore 
improving reliability, as was found by Mazzone et al (2009).     
Another particular strength of the study was that research reflected a ‘real-life’ setting. In the 
UK, physiotherapists work within clinical teams’ e.g. acute neuro-surgery and stroke 
rehabilitation.  Teams are ‘skill mixed’ to include specialist, senior and junior grade staff to 
meet the needs of complex patient presentation and efficient financial service delivery.  
Junior staff are educated and developed via support and supervision without having direct 
responsibility for assessment and analysis.  To become a skilled analyst, it is necessary for a 
physiotherapist to gain clinical skills from both within their job and through specialist training. 
Therefore, physiotherapist participants who all worked at senior grades were recruited, 
whereby patient participants were recruited from various clinical settings in an attempt to 
gain a variety of clinical diagnoses so that the results were more generalizable. It is 
interesting to note that the gender representations in this study are similar to those found by 
Skjaerven, Kristoffersen and Gard (2010), reflecting the higher proportion of women working 
within this clinical field compared to men. 
However, it is acknowledged that the patient participants recruited were only representative 
of the then current caseload.  Another limitation of this study is that the LMPI has been 
tested for reliability using senior physiotherapists only; but these are representative of the 
staff who will be ultimately using it. Hence, while the LMPI is a highly reliable instrument 
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when used by senior physiotherapists, reliability may be lower amongst other members of 
the profession, such as undergraduate physiotherapy students. However, it would be 
expected that in the majority of cases, the LMPI will be used by senior professionals, in 
whom reliability has been well demonstrated. Within clinical practice, not only do outcome 
measures need to be meaningful for the patient and their therapist, they also need to be 
interpretable for the rest of the multi-disciplinary team in order to support clinical decisions 
(Fitzpatrick, Davey, Buxton and Jones 1998).  Because of its technical language and 
specialist application it is unlikely that the LMPI will meet this requirement.  It is therefore 
suggested by the authors that the LMPI be used by physiotherapists for the benefit of their 
patients and themselves; in conjunction with an outcome measure that is meaningful to their 
colleagues, e.g. the 10 metre walk test (Wade 1992). 
It could also be argued that the LMPI is biased towards the Bobath concept of treatment 
(Shumway-Cook and Woollacott 2012; Edwards 2002; BBTA 2013; Raine, Meadows and 
Lynch-Ellerington 2009; Vaughan-Graham et al 2009), because the physiotherapists who 
developed the tool work within this concept and the majority of therapists recruited to test the 
tool have postgraduate Bobath educational backgrounds.  However, 2 of the 
physiotherapists recruited into this study do not have a ‘Bobath’ background, and the data 
suggest that their results are comparable. 
CONCLUSION 
The results presented in this paper indicate that the LMPI is a reliable measure of movement 
performance, when used by senior neurological physiotherapists, potentially providing a 
unique measurement tool for use in neurological physiotherapy practice, both by individual 
physiotherapists or teams of physiotherapists over time.  
IMPLICATIONS FOR PHYSIOTHERAPY PRACTICE 
This research suggests that the LMPI is a new outcome measure which more accurately 
reflects and supports the assessment and treatment approaches of neurological 
physiotherapists.  Future research will focus on the validity and clinical utility of the LMPI. 
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Appendix 11 
 The Senior Physiotherapist Participants Group demographic data. 
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The Senior Physiotherapist Participants Group demographic data 
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1 F Community stroke team LCHCT 1 8 ½ yes 
 
yes yes 
 
yes 
      
2 F Community Rehabilitation Unit LCHCT 1 5 
  
yes yes yes 
  
yes 
    
yes 3 M Community Neurology Team LCHCT 1 11 
yes yes yes 
     
yes 
 
yes yes 
4 F Community Neurology Team MYHNHSFT 11 
  
yes yes yes yes 
 
yes 
    
5 F Community Neurology Team MYHNHSFT 26 yes 
 
yes 
 
yes yes 
      
6 F Neurological Rehabilitation Unit MYHNHSFT 20 
  
yes yes yes 
 
yes 
  
yes 
  
7 F Community Stroke Team LCHCT 2 10 
  
yes yes 
 
yes 
      
yes 8 F Community Neurology Team LCHCT 2 16 yes 
 
yes 
 
yes yes 
 
yes 
 
yes 
  
9 F Neurology Out-patients ANHSFT 23 
  
yes yes yes yes 
 
yes 
 
yes 
  
10 F Stroke Rehabilitation Unit ANHSFT 24 
  
yes yes 
 
yes 
   
yes 
  
11 F Neurological Out-Patients ANHSFT 11 
  
yes yes 
 
yes 
 
yes 
    
12 F Neurological Out-patients ANHSFT 31 yes 
 
yes yes 
 
yes 
      
Total 5 1 12 9 6 9 1 5 1 4 1 1 
 
41% 8% 100% 75% 50% 75% 8% 41% 8% 33% 8% 8% 
The Leeds Community Health Care Trust (LCHCT 1 = group 1, LCHCT 2 = group 2), The Mid Yorkshire Hospitals NHS Foundation Trust (MYHNHSFT), Airedale NHS 
Foundation Trust (ANHSFT). 
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Appendix 12 
 Data from Study 2, Phase 2: testing the measurement properties of internal 
consistency and external reliability of the LMPI 
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Data from Study 2, Phase 2: testing the measurement properties of internal consistency and external reliability of the LMPI – 1. 
NHS site: The Leeds Community Health Care Trust group 1                           Test 1 = 01/04/11                              Re-Test =18/04/2011 
 Patient 1 
scores 
Patient 2 
scores 
Patient 3 
scores 
Patient4 
scores 
Patient5 
scores 
Test Re-Test Test Re-Test Test  Re-Test Test Re-Test Test Re-Test 
Physiotherapist 1 
 
Item  
 Alignment  2 1 2 1 2 2 1 0 2 2 
 Interaction  1 1 1 1 2 2 1 1 0 0 
 Timing  1 1 1 2 1 2 1 1 0 0 
 Speed 1 1 2 2 1 2 1 1 0 0 
 Selective movement  0 1 1 2 1 2 0 0 0 0 
 Total  5 4 7 8 7 10 4 3 2 2 
Physiotherapist 2 
 
Item  
 Alignment  1 1 2 1 1 1 1 0 1 2 
 Interaction  1 1 1 1 1 1 1 1 0 0 
 Timing  1 1 2 2 1 1 1 1 0 0 
 Speed 1 1 2 2 0 0 0 0 0 0 
 Selective movement  1 1 1 1 1 1 1 0 0 0 
 Total  5 5 8 7 4 4 4 2 1 2 
Physiotherapist 3 
 
Item  
 Alignment  1 1 2 2 1 2 1 1 0 1 
 Interaction  2 0 2 2 0 1 0 1 0 0 
 Timing  1 1 1 1 1 2 1 1 1 1 
 Speed 1 1 2 2 1 2 1 1 0 1 
 Selective movement  1 1 1 2 1 2 0 0 0 0 
 Total  6 4 8 9 4 9 3 4 1 3 
NB: numbers in bold font highlight scores in agreement 
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Data from Study 2, Phase 2: testing the measurement properties of internal consistency and external reliability of the LMPI – 2. 
NHS site: The Mid Yorkshire Hospitals NHS Foundation Trust:               Test 1 = 21/06/11       Re-Test =05/07/2014 
 Patient 1 
scores 
Patient 2 
scores 
Patient 3 
scores 
Patient4 
scores 
Patient5 
scores 
Test Re-Test Test Re-Test Test  Re-Test Test Re-Test Test Re-Test 
Physiotherapist 4 
 
Item  
 Alignment  1 1 2 2 1 2 1 1 1 2 
 Interaction  1 1 1 1 2 2 0 2 0 0 
 Timing  1 1 2 1 1 2 1 1 0 0 
 Speed 1 1 2 1 1 1 1 1 0 0 
 Selective movement  1 1 1 1 1 2 0 1 0 0 
 Total  5 5 8 6 6 9 3 6 1 2 
Physiotherapist 5 
 
Item  
 Alignment  1 1 1 1 2 2 1 0 2 1 
 Interaction  1 1 1 1 2 2 0 1 0 0 
 Timing  1 1 1 1 2 1 0 0 1 0 
 Speed 1 2 1 2 1 2 0 1 1 1 
 Selective movement  1 1 1 1 1 2 0 0 1 1 
 Total  5 6 5 6 8 3 1 2 5 3 
Physiotherapist 6 
 
Item  
 Alignment  1 1 1 1 2 1 1 1 0 1 
 Interaction  1 1 1 1 2 2 1 1 1 1 
 Timing  0 1 1 1 2 1 1 1 0 0 
 Speed 0 0 1 1 2 1 0 1 0 0 
 Selective movement  0 1 1 1 2 2 0 0 0 0 
 Total  2 4 5 5 10 7 3 4 1 2 
NB: numbers in bold font highlight scores in agreement 
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Data from Study 2, Phase 2: testing the measurement properties of internal consistency and external reliability of the LMPI – 3. 
NHS site: The Leeds Community Health Care Trust group 2:                 Test 1 = 28/06/11           Re-Test =13/07/2014 
 Patient 1 
scores 
Patient 2 
scores 
Patient 3 
scores 
Patient4 
scores 
Patient5 
scores 
Test Re-Test Test Re-Test Test  Re-Test Test Re-Test Test Re-Test 
Physiotherapist 7 
 
Item  
 Alignment  0 1 1 1 1 1 1 0 1 1 
 Interaction  0 0 0 0 0 1 0 0 0 1 
 Timing  1 0 0 1 1 0 1 1 0 0 
 Speed 0 0 0 1 0 0 1 0 0 0 
 Selective movement  1 0 1 1 0 0 0 0 0 0 
 Total  2 1 2 4 2 2 3 1 1 2 
Physiotherapist 8 
 
Item  
 Alignment  2 1 2 1 1 1 1 0 1 1 
 Interaction  1 1 0 1 1 1 1 1 0 0 
 Timing  1 1 1 1 1 1 0 1 0 0 
 Speed 1 1 0 1 0 1 0 1 0 0 
 Selective movement  1 1 1 1 1 1 1 0 0 0 
 Total  6 5 4 5 4 5 3 3 1 1 
 
NHS site: Airedale NHS Foundation Trust:                                                Test 1 = 29/06/11             Re-Test  = 13/07/2014 
Physiotherapist 9 
 
Item  
 Alignment  1 1 2 2 1 1 1 0 1 1 
 Interaction  1 1 1 1 1 1 0 1 0 0 
 Timing  1 1 1 1 1 1 1 0 0 0 
 Speed 1 1 1 1 1 1 1 1 0 0 
 Selective movement  1 1 1 1 1 1 0 1 0 0 
 Total  5 5 6 6 5 5 3 3 2 2 
NB: numbers in bold font highlight scores in agreement 
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Data from Study 2, Phase 2: testing the measurement properties of internal consistency and external reliability of the LMPI – 4. 
NHS site: Airedale NHS Foundation Trust   (continued) 
 Patient 1 
scores 
Patient 2 
scores 
Patient 3 
scores 
Patient4 
scores 
Patient5 
scores 
Test Re-Test Test Re-Test Test  Re-Test Test Re-Test Test Re-Test 
Physiotherapist 10 
 
Item  
 Alignment  1 1 1 1 1 1 1 0 1 0 
 Interaction  1 1 1 1 1 1 0 0 0 0 
 Timing  1 1 1 1 1 1 1 1 0 0 
 Speed 1 1 1 1 2 1 1 1 0 0 
 Selective movement  1 1 1 1 1 1 1 0 0 0 
 Total  5 5 5 5 6 5 4 3 2 0 
Physiotherapist 11 
 
Item  
 Alignment  1 1 1 1 1 1 1 1 1 1 
 Interaction  1 1 1 1 1 1 0 0 0 0 
 Timing  1 1 1 1 1 1 2 1 0 0 
 Speed 1 1 2 1 1 1 2 1 0 0 
 Selective movement  1 1 1 1 1 1 1 0 0 0 
 Total  5 5 6 5 5 5 6 3 1 1 
Physiotherapist 12 
 
Item  
 Alignment  2 1 1 1 1 1 0 0 1 1 
 Interaction  1 2 1 1 1 1 1 1 0 0 
 Timing  1 1 2 1 2 1 2 0 0 0 
 Speed 1 1 1 2 2 1 2 1 0 0 
 Selective movement  1 1 1 1 2 1 0 0 0 0 
 Total  6 6 6 6 8 5 5 2 1 1 
NB: numbers in bold font highlight scores in agreement 
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Appendix 13 
 Data from study 2, Phase 3: Patient participant demographic information and test 
results 
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Patient participant demographic information and data gathered during Study 2 Phase 3 – 1. 
Patient 
number 
Age Gender Diagnosis Location PT 
number 
What the therapists chose 
to measure using the LMPI 
LMPI BBS Number of 
weeks 
between pre 
& post 
intervention  
  
 
pre Rx  
 
post Rx 
 
 pre Rx 
 
post Rx 
1 65 F Stroke,L  
hemiplegia 
Home  1 L leg during sit to stand - from 
own chair 
8 13 40 49 5 
2 49 M Stroke, L  
hemiplegia 
Home 1 L leg during gait – in living 
room 
10 13 52 56 9 
3 60 F Stroke, R sided 
weakness 
Home 1 Whole body during gait – in 
kitchen 
5 9 45 50 7 
4 59 M SAH, EDH 
drained, 
aneurysm 
clipped, VP 
shunt,                
L hemiplegia 
Ward  11 Trunk during movement of 
placing L foot onto foot plate 
of wheelchair (R foot already 
on foot plate) 
6 12 4 4 7 
5 52 F MS Clinic 12 Transfer from treatment plinth 
to chair 
6 7 42 44 5 
6 49 F BG 
haemorrhage 
Clinic  11 Hemiplegic arm during reach 
from table to mouth and back 
with polystyrene cup 
5 8 44 52 4 
7 62 F Stroke,              
R hemiplegia 
Ward  12 R leg during swing phase of 
walking 
6 9 38 38 4 
8 41 F Fronto-parietal 
haemorrhage,    
L  hemiplegia 
Ward  12 Pelvis during sit to stand from 
treatment plinth 
7 10 38 50 6 
9 62 M PCA infarct Ward 12 Position of pelvis over feet 
during sit to stand, from 
treatment plinth @ 53cm 
8 13 28 54 4 
10 44 M Cerebella Ataxia Clinic 9 Walking 11 11 52 52 8 
  
352 
 
Patient participant demographic information and data gathered during Study 2 Phase 3 – 2. 
Patient 
number 
Age Gender Diagnosis Location PT 
number 
What the therapists chose 
to measure using the LMPI 
LMPI BBS Number of 
weeks 
between pre 
& post 
intervention  
pre Rx post Rx pre Rx post Rx 
11 62 M Fall, ICH, L 
hemiplegia, 
Stroke 9 years 
ago secondary 
to myocarditis 
Clinic  9 L arm during walking 6 10 56 56 8 
12 76 M Haemorrhagic 
stroke R sided 
weakness, 
bronchiolitis, 
pneumonia L 
lung 
Home  7 L leg during sit to stand from 
perching stool 
1 4 19 26 incomplete 
13 39 M Stroke, L 
hemiplegia 
Home  1 L upper limb in sit to stand 
from wheelchair 
0 1 49 51 7 
14 62 M R acute on 
chronic SDH, 
evacuation and 
mini-craniotomy, 
#C7 
Home  4 Sit to stand from wheelchair, 
whole movement without 
verbal prompts 
6 8 9 23 5 
15 51 M MI, triple CABG 
and valve 
replacement, 
stroke, polio as 
child 
Home  4 Walking in living room on 
carpet,  whole movement but 
with help from 2 therapists 
5 7 5 9 4 
16 76 F Stroke,             R 
hemiplegia, 
dementia 
Home  5 R foot, knee and hip in 
symmetrical stand, holding 
onto a ZF, no support 
4 5 4 6 6) 
17 19 M Traumatic Brain 
Injury 
Home  5 L Pelvis hip and knee and foot 
whilst moving L foot on and 
off the bottom step 
7 9 50 54 3 
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Patient participant demographic information and data gathered during Study 2 Phase 3 – 3. 
Patient 
number 
Age Gender Diagnosis Location PT 
number 
What the therapists chose 
to measure using the LMPI 
LMPI BBS Number of 
weeks 
between pre 
& post 
intervention  
pre Rx post Rx pre Rx post Rx 
18 73 M Stroke – infarct L 
frontal lobe 
Home  4 Ascending stairs with handrail 
on the L 
7 11 16 39 6 
19 36 M Moyamoya 
disease 
Ward 6 Alignment of R lower limb 
during sit to stand from a 
raise plinth (24”) 
8 19 25 36 2 
20 72 M Stroke,              
L hemiplegia 
Home  5 L hip/knee and ankle foot in 
step through of walking with a 
Z/F and no facilitation 
0 2 5 8 6 
21 63 M Stroke, pontine 
infarct 
Home  1 Sit to stand from wheelchair – 
whole body 
6 11 28 52 7 
22 48 F MS Clinic  7 Ability to stand from sitting on 
a plinth 
10 10 47 46 4 
23 63 M Stroke, R 
hemiplegia 
Clinic  11 R Foot during sit to stand 0 6 4 12 4 
24 64 F SAH Clinic  11 R leg during swing phase 7 11 40 55 9 
25 74 M Thalamic stroke 
2006, L sided 
weakness 
Clinic  11 Left leg sit to stand from plinth 5 5 27 28 17 
26 58 M SAH Clinic  11 L pelvis over L foot on sit to 
stand from chair 
6 10 40 53 5 
27 56 M Excision of 
recurrent 
parasagittal 
meningioma,      
L hemiparesis 
Home  5 In standing, lifting left hand on 
and off kitchen worktop 
without therapists help, hand 
and arm measured 
6 6 33 41 4 
PT= Physiotherapist, L= left, R= right, SAH= Sub-Arachnoid Haemorrhage, EDH= Extra-Dural Haematoma, VP= ventriculo-peritoneal, BG= Basal Ganglia, PCA= Posterior Cerebral Artery, ICH= intra-cerebral haemorrhage, 
MI= Myocardial Infarct, CABG= Coronary Artery Bypass Graft, SDH= Sub-Dural Haematoma, #= fracture, C7= 7th Cervical vertebrae, Z = zimmer frame, MS= Multiple Sclerosis, Rx= course of treatment. 
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Appendix 14 
 The reflective questionnaire Study 3, Phase 2. 
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Reflective thoughts and comments regarding your experiences of using the LMPI within your 
clinical practice. 
 
THE CAPITAL TYPE WRITTEN WORDS ARE THE SUBJECT AREAS THAT I WOULD 
LIKE YOU TO WRITE ABOUT. 
 
The more you write the better!  It will mean that I will have more information to analyse about 
the LMPI 
 
The text in italics is there to give you some prompts 
 
Please could you type directly into the blank boxes, they will just expand if you need extra 
space. 
 
Don’t worry about formatting the document 
 
CLINICAL APPLICATION 
 
o Does it recognise the individual nature of your patient’s movement, if yes, how does it? 
If no, why doesn’t it? 
o Could you use it for all of your patients? 
o What sort of patients have you used it with? (clinical area, patient diagnosis) 
o Were there patients you couldn’t use it for, and why? 
o Did the research project constrain your use of the LMPI? 
o Does the scale measure change sensitively; did it measure the change that you had 
made to your patient’s movement control?  
o Could you relate the scale to your patient’s function? Or their goals? Could you give an 
example? 
 
Write here: 
 
EASE OF USE 
 
o Does it take long to use? 
o Could you compare using the BBS (and / or other outcome measures) to the LMPI? 
And discuss strengths, weaknesses, clinical usefulness,  
o Did your patients like you using the outcome measures? 
o When did you complete the LMPI? Beginning of treatment session? End? During record 
keeping? 
o Did using the LMPI have any impact on your communication with your patient? Or with 
other members of your team? 
 
Write here: 
 
THEORETICAL UNDERPINNING OF CLINICAL PRACTICE 
 
o Did using the LMPI have any impact on, or affect or reflect your assessment, clinical 
reasoning, and treatment planning process? 
o Do you feel the items within the scale are hierarchical in nature?   
o Do you think that using the LMPI underpinned your approach to clinical practice? ฀  If yes, how did it? ฀  If no, why didn’t it? 
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Write here: 
 
WOULD YOU CHANGE THE LMPI? 
 
o If yes, how would you change it?  
o Is there anything missing? 
o What are its strengths? 
o What are its weaknesses? 
 
Write here: 
 
ANY PROBLEMS USING IT? 
 
 If yes, how did you deal with the problems? 
 
Write here: 
 
YOUR INVOVLEMENT IN THE RESEARCH PROJECT 
 
o How did it feel to be involved in a clinically focused physiotherapy research project? ฀ What would have made it easier? 
o Have you been involved in other research projects? ฀      If yes, were there any comparisons? 
o Were there any problems during the recruitment of your patients 
 
Write here: 
 
THE TRAINING PACKAGE 
 
Do you have any thoughts about the training package for the LMPI? 
Was it useful / helpful? 
 
Write here: 
 
TESTING EXPERIENCE 
 
What did you think of the experience of the testing part of the research project? 
 
Write here: 
 
Do you wish to add anything else? 
 
Write here: 
 
 
 
Thank you very much for the time and effort that you have put into this piece of work. 
 
With very best wishes 
 
Denise 
 
 
  
357 
 
Appendix 15 
 The complete results of the Template Analysis described within Chapters 9 and 10 
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The complete results of the Template Analysis described within chapters 9 and 10  
ANONYMISED CODE TEMPLATE 
Process  
Coding template from       
interviews with 
therapists          
 
Additional codes that       
were identified                  
Additional codes that       
were excluded                 
Final coding 
template that 
was used for 
analysis 
 Atwal, Wiggett and McIntyre (2011) 
The process that was followed 
1 read several times – all documents – FG transcripts and reflective transcripts 
2 highlighted ‘interesting things’ identified themes 
3 grouped the themes around the priori codes 
4 identified new codes 
5 used post its and fridge door / kitchen walls to extract all the themes and codes and try to 
organise them 
6 Resulted in a confusingly large amount of information with a very real risk of not seeing 
the important issues and becoming inappropriately ‘stuck’ on the less important issues 
(King) 
7 Reflected on the problem and:  
a. Acknowledged position of knowing the transcripts well 
b. re-visited the literature (King – refs, other papers/authors that have used template 
analysis) 
c. reflected on the need to re-visit and re-look at the transcripts with a fresh pair of eyes, 
based this work on the coding template used by Atwal, Wiggett and McIntyre 2011 
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a-priori themes that 
emerged during the 
development of the LMPI 
additional themes that emerged 
as a result of my reflexivity during 
study 1 
Initial emergent themes from the focus groups Additional themes that emerged during the 
analysis of the reflective questionnaires 
  
Teaching tool 
if you were working with junior staff it could be really useful 
because you could actually be very specific you would say  “when 
we are looking at alignment of the leg these are the things we are 
look for” (FG1/ EP5/ line48) 
 
And maybe that is why I was thinking about it too much, over 
worrying about it too much, what is the right timing?  In the end 
the categories are really good so the delineation in the different 
areas is great because they are things that you actually want to 
get across about how people move so that is why I definitely think 
that as a teaching tool a training tool for junior / staff grades it is 
very useful because it really homes in on the key things you want 
people to look at in movement rather than - can they can’t they?- 
sit to stand? - tick (FG1/ EP3/ line60) 
 
as a reflection - I think it would still have great value and I think 
that would be useful particularly in education in developing it, but if 
you had categories already then it would be easier to score it.  
(FG1/ line/ EP1/ 411) 
 
We have done one with the junior, and they liked the working out 
of the problems and help them clinically reason the main things 
they are looking at the main things of the patient. (FG2/ EP9/ 
line220) 
 
It has a feel that it good be a good nurturing  tool in a teaching 
situation for supervision and  looking at the components  - and 
you have picked your 16 components your junior has three 
.......what components were they missing  - and I think it could be 
a good teaching tool for supervision in that respect.(FG2/ EP8/ 
line223) 
 
it does have a feel of being a nurturing  tool (FG2/ EP7/ line236) 
 
that it could be a tool  that has  a use on the course but to fit in 
with my way of teaching and observational analysis of what the 
patient was doing it would just sit better with me if it was alignment 
interaction selective movement timing speed. (FG2/ EP7/ line238) 
 
Working with the junior staff it was nicer to work through those 
elements of speed alignment timing for them to work with and to 
look at it.(FG2/ EP9/ line250)    
 
We need as many tools on the course as we can to get the course 
 
 
Some of our team are now using the OM and 
finding it quick and easy to use and a good way of 
teaching junior staff and students.  Also it is useful 
for the senior staff to bring us back to the ‘bread 
and butter’ analysis of human movement. 
P3Lline75) 
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participants to be able to see what we  see and understand what 
we understand and to get to the point that Claire was making in 
that   her junior saw 3 components and   she had six components 
and we want our course  participants - if we saw six components 
we want the course participants  to see six components - and this 
does break movement down into components, so we are asking 
the person to look at different components of movement like 
alignment like timing like selectivity,  so I think there is a scope 
there for it to be used in BBTA - as opposed to me as an 
individual.(FG2/ EP7/ line267) 
 
it makes the less skilled practitioner to look more closely at what 
they are doing, then they could use it at the beginning of the 
course – a three week basic course or an advanced course – 
maybe it is a better tool for the advance course for themselves or 
with their partner - scored the patient on day one and then 
rescored the patient on day five.(FG2/ EP7/ line282) 
 
Woman               Maybe its best points are  that -    it fosters and 
nurtures learning then - I think that is great and I think take those 
things from it but I am not sure  then that it is a measure.  
Woman      It is showing a change then it will be a 
measure 
Woman   Yes if it is showing a change. Yes (FG2/ EP9&10/ 
line289) 
 
  
 Teaching the patient 
Using the LMPI meant that an explanation was 
given to the patient about quality of movement, and 
also to junior staff.  Therefore it was useful as a 
teaching aid.( P5 line37) 
 
I found I was able to use the measure to engage 
successfully with one of my patients’, who has 
ataxia, The joint goal was to be able to transfer 
from bed to chair safely and with control. The 
patient was aware this was the outcome being 
assessed and during treatment the specific 
components, timing, speed of the movement etc 
were broken down for her and she went away and 
practised between therapy sessions and achieved 
an excellent result.(P12line11) 
 
Clinical application Clinical reasoning  
promoted discussion about 
movement analysis (S1line31) 
 
the LMPI is best done during record 
The fact that it is very individual and it is subject to someone, 
sometimes its very helpful, for some of our patients, to support, to 
show the changes that they have.  (FG2/ EP9/ line218) 
 
We took two aspects of movement we took sitting alignment on 
When the LMPI was discussed with other team 
members it helped to identify problems and focus 
treatment objectives.  As with all outcome 
measures time constraints often limit their use. 
(P9line51) 
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keeping, where you can reflect on 
the pts movement and own clinical 
reasoning (S1line94) 
one patient who was very asymmetrical and who became much 
more symmetrical and  she was seen on two consecutive  days 
and  then another patient we were looking at sit to stand where 
you can put in lots of components and all the different categories 
were applicable and we did that really fast.  (FG2/ EP8/ line58) 
 
I think it actually does reflect the complexity of movement in that it 
throws up a lot of questions for me ...that is what I felt about 
it.(FG1/ EP2/ line57) 
 
Man  I wonder in relation to those points the challenging 
aspect of it is because actually when you  are clinically reasoning 
in practice. And  I agree I think that categories are really nice 
categories and really pertinent categories to consider  but when 
you are working with a patient you are kind of considering them in 
relation / together / as a whole to each other so if we are going to 
improve the interaction  between  body parts or body segments  
you are considering in relation to alignment  in relation to 
background activity. 
Woman  So you do not put them down to separate 
things 
Man So it almost seems like a big hurdle.... slightly unnatural 
to split them up and score each individual one.  I think your 
perception in practice is that it is all so interrelated anyway  - that 
for me to separate the scoring is quite difficult   - or  that is what it 
felt like to me,  but by the same token I can see very much see the 
point for some people in some cases.. to actually do that and to 
highlight the fact that there is these different contributions to 
movement could be very useful. 
Woman  Yes Yes. (FG1/ EP6,3&2/ line71) 
 
...   I would score it in relation to sit to stand, but then there  was 
another part of the scoring which in a way   needed to be related 
to the most significant aspect of impairment as part of that sit to 
stand  - so in a way that is how  you would use it -  and you can 
have more than one  - and I think that there is potential -  real 
usefulness in this - in terms of whether it is analysing, whether its  
for your own reflection  - whether it is only making that definite 
measurement link if we change this impartment  - if we influence 
this  impairment does that impact on the function  of the activity -  
and maybe that was an easier scenario to use than just  one   
component of movement or one aspect of movement control.  
What ever  you want to call it.(FG1/ EP6/ line144) 
 
In terms of an outcome measure the other difficulty I had was, 
when I had my score and it was related to lower limb alignment I 
could see the score I had my totals I could see the change   so it 
did reflect change. “OK that is great I have made a change and 
 
I felt the LMPI does recognise the individual nature 
of pts movement. It makes you look more 
specifically(P10line1) 
 
Made me much more specific, looking at one or two 
particular movements, rather than a more gross 
functional movement(P10line22) 
 
Using the LMPI made me more aware of quality of 
movement and helped me develop my 
observational and analytical skills.(P5 line40) 
 
The biggest impact I felt personally, was on my 
clinical reasoning and treatment 
planning/implementation, using the tool I felt 
clarified/justified my reasoning and made my 
treatments much more goal specific. (P12line30) 
 
felt use of LMPI supported clinical reasoning and 
treatment planning but did not alter it.(P6line36) 
 
Helped tailor analysis and treatment plan and 
remind me its ok to focus on one part during a 
treatment session eg arm and that can influence 
the whole patient and their movement patterns 
more effectively sometimes than spending a little 
time on the whole of them(P11line23) 
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the patient has improved but what did that mean?”  because in 
terms fitting in with the other measures that have to be done in my 
work place it was not a recognised functional outcome measure 
(FG1/ EP3/ line174) 
   In comparison with other outcome measures 
The patient was often unaware that I was using the 
measure.  In contrast to the BBS or timed walk etc 
needs the patient to cooperate which can have an 
effect on the outcome,( P9line45) 
 
Could use LMPI for all patients, but more likely to 
use it for patients where other OM’s do not fit. For 
example, low level patients who may score 0 on 
Trunk Control Test on admission and discharge, 
but may actually demonstrate improvement in 
posture, head control, etc. This would be detected 
on LMPI but not necessarily on TCT. Could also be 
used for patients with bilateral deficit, for example 
GBS or TBI where OM’s such as MAS do not fit. 
Also useful for UL changes, which may not be 
functional but may demonstrate an improvement in 
posture, alignment or hand contractual response. 
This would not be obvious from other UL 
OM’s(P6line1). 
 
Quicker than BBS or MAS.( P6line26) 
   In comparison with the BBS 
Compared to the Berg Balance Score, the LMPI is 
quicker and easier to use and requires less 
additional testing for the patient.  However the Berg 
does allow you to compare one person’s functional 
level to another’s and have some idea how a score 
will relate to function e.g. a score of under x means 
an increased falls risk.  The Berg is not as sensitive 
to change as the LMPI however and like many 
OMs, suffers from floor and ceiling effect which the 
LMPI does not. 
 
  In comparison with the GAS 
I think if I am honest I would use a  GAS goal to give me a change 
in score for my own measuring, but,  because it is more familiar to 
me so I would find this easier than me having to think and work it 
out but I think one of the strengths of this is the categorisation (but 
also it is a weakness) in that you have to understand  - and 
anyone who is using it has to have the same understanding -  of 
the components particularly if you were doing a task like sit to 
stand or walking or even things like limb alignment (FG1/ EP5/ 
line156) 
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For me it is almost quite subjective like the GAS goal where you 
can choose and you can fit it to your patient population because 
you can choose any aspect of movement to look at different 
components and then allocate it  so it should fit to any patient but 
it is quite complicated to do  - as is GAS.  I found then both.   I 
think GAS might give me more if I was choosing it as a measure   
rather than this  in terms of   adding some qualitative   aspect of  
movement  analysis - for me I felt it was quite subjective (FG2/ 
EP8/ line24) 
 
The GAS you can add up the scores to have a  score so it was 
again looking at how you would use  that as a measure of change 
ongoing.  If you like have a score at the end(FG2/ EP3/ line71) 
 
This is looking at the qualitative normal movement aspect but on 
the GAS score you can only have one or two variables – one 
variable really – so you can have  lots more variable with this 
measure.(FG2/ EP8/ line161) 
 
when we had to practice doing the GAS and they had to work out 
breaking up a problem - but that (the LMPI) was more so for them 
(the junior staff liked the LMPI more than the GAS in the ‘working 
out a movement problem for a patient situation)  - they liked 
that.(FG2/ EP9/ line253) 
 
It had more movement components in it than the GAS, the GAS 
has more functional components (FG2/ EP8/ line256) 
 
 
  When did you use it? 
I thought I quite liked the idea of best performance (FG1/ EP5/ 
line195) 
When using the LMPI, I generally scored from 
memory during the record keeping and the patient 
usually had no awareness of the process other 
than the initial consent.(P5 line34) 
 
, I tended to complete the paperwork at the end of 
the session when completing the patient clinical 
records.(P12line28) 
 
Completed LMPI at beginning of treatment, to see if 
there was any carry over from previous sessions, 
and occasionally during record-keeping. 
(P6line31) 
 
I completed it when writing my SOAP notes and 
found it helped formulate my analysis and target 
my treatment plan more than other OMs which you 
just use as an adjunct to therapy to show a 
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change(P11line14) 
 
  About the LMPI as an outcome measure 
so yes it has got that capacity to tell me something about 
movement and the performance of movement  in that  individual  
and I  absolutely go with the fact that it is very very individual in 
terms of its orientation -  but I am not quite sure it feels like an 
outcome measure at this stage -  but that is maybe more to do 
with what kind of  what outcome measures we are used to and the 
way that they are framed and the constructs that they are set 
around, I think that this something quite different (FG1/ EP6/ line 
218) 
 
What has come up with in my mind for what it is worth is it is a bit 
like ice dancing and standing up with high performance - 6 
technical merit - and 5.8 for artistic impression rather than it being 
in the Olympics -  it would be the timed race -  the outcome 
measure would be the timed race it is who is first at the post it is a 
quantitative measure  - where this is much more the ice dancing 
of the measure. 
Man or another woman)  But that is a very good 
analogy(FG1/ EP1&4/ line226) 
 
and  this is another thing it gets back to in the  philosophy  of 
practice and where you are coming from.  We  probably spend all 
our time saying we are interested  in the individual scores not in 
the timed race - do you see what I mean  - so in that sense we are 
saying “ well actually it is”  it is doing that job - to some extent -  in 
kind of thinking about - in given that depth in terms  of movement 
analysis for that very reason.  (FG1/ EP4/ line 232) 
 
- I am no expert of using TELER but my understanding is that you 
have your components on a scale at that particular movement it is 
kind of there  -  we could all  subscribe to that scale and measure 
from that -  whereas this is much more individual.  It’s up to you.  
That could be a merit  definitely because TELER would  not give 
you the level  of  analysis of movement performance  that this 
would ,but this to me feels  like you do have to work harder to get 
that and maybe you know..  (FG1/ EP6/ line416) 
 
It is just as a score I am not sure what the score means – the 
bottom line.(FG2/ EP10/ line230) 
 
I thought it was quite important (the LMPI) because  there are a lot  
of things  that you look at in terms of measuring although it is  
quite subjective (the LMPI is subjective) do not reflect the timing  
and speed (other outcome measures don’t reflect timing and 
speed)(FG2/ EP11/ line176) 
The LMPI was effective in helping to analyse the 
nature of movement control.  The 5 items allowed 
me to measure patient’s activity in terms of 
alignment, interaction, timing, speed and selective 
movement(P9line4) 
 
as it enable the clinician to pick from numerous 
possibilities of movements for measuring.(P5 line2) 
 
one’s patient’s results cannot be compared to 
another’s because you are nearly always 
measuring something different.  Because of this I 
am not sure how useful it would be as an outcome 
measure in a research trial, but it would be useful 
on an individual patient level to show 
improvement.(P5 line5) 
 
We gave a short IST to 2 of our staff – 1 B7 and 
1B6.   Both were impressed and felt they would like 
to try using the LMPI. They felt it was good for 
analysing and looked quick and easy to use. 
(P5 line79) 
 
LMPI clinically useful and more individual to 
patient. (P6line26) 
 
the LMPI acknowledges grades of deficits rather 
than an individual movement patterns(P2line2) 
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  What pathologies did you use it with? 
Woman  Stroke and TBI are mine 
Woman  Stroke and yes spinal, stroke  
Man Stroke.  I have used it with other neurological conditions 
one was  - I had a lady was chiari malformation, and used it with 
her  -  I did not feel constrained by the condition. 
Women  Agreeing 
I think it could be used for any condition.  I think you could use it 
with any condition - not just neurological conditions -anything 
about movement and the indicators and categories apply to any 
bodies movement    - for anyone, any area. 
 Yes.  I think so. (FG1/ EP1,2&6/ line 353) 
 
For my other patients who had degenerative 
conditions I found the scores less useful, as the 
scores didn’t change.(P9line21) 
 
I did like the LMPI measuring tool for use with 
neurology patients.  Its focus on the analysis of 
movement control is unlike any other outcome 
measure I have used.(P9line95) 
 
I could not use it for all my patients as many of our 
patients are very early strokes. 
It was more suitable for patients who were a few 
weeks into their rehab and outpatients(P5 line3) 
 
all types of neuro pathologies and all levels of 
impairments.  The types of pathologies I used 
were: stroke, MS brain tumour but I could see it’s 
use in other neuro pathologies.(P5 line10) 
 
: a severe head injury with major tonal changes 
may change subjectively/objectively during a 
session but they may still have severely altered 
movement patterns which the scale may not be 
sensitive enough to record.  (P2line9) 
 
  Sensitivity 
and I found the high level patient I could not get a reasonable 
picture  of the high the high level patients using the scale so it was 
more useful with the complex patient who had more  serious 
alignment, impairment,  movement dysfunction issues Than the 
high level patient who made, for me in respect of their goals for 
the weeks treatment, made significant changes but were difficult 
to record.  I needed something that was more sensitive (FG2/ 
EP11/ line6)   . 
 
and found it very difficult using the score to see,  first of all to see 
a snap shot of her ability from the score did not seem to give me a 
picture  of what she was doing or what she could struggle with but 
it I did not see much change from the start of using it to  finishing 
it.  The lady changed but I did not feel the measure gave a good 
picture of that (FG2/ EP11/ line15) 
 
very specific to each patient and this means that it 
can be sensitive(P5 line4) 
 
possibly not good to use for severely neurologically 
impaired patients as may not be sensitive enough 
to small changes. This may also apply to high level 
patients who may also have subtle 
changes.(P2line36) 
 
Ease of use 
 It was very fast it gave us a good score and showed big change 
(FG2/ EP8/ line34) 
 
we were much faster than I was in my own practice …strongly 
attracted to using the tool (takes too long) (FG2/ EP7/ line43) 
 
Once I was familiar with the 5 items I found the 
LMPI quite easy to use, although I made 
judgements while working with the patients I could 
complete the form afterwards while writing up 
notes.  (P9line43) 
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The LMPI tool itself does not take long to use and 
because of this it will be very useful clinically and 
more likely that clinicians will use it.(P5 line24) 
 
quick and easy tool to try and bring quality of 
movement back into a busy workload(P5 line50) 
 
Quick to use, although deciding on what to 
measure, why and how takes a little 
longer.(P6line24) 
 
LMPI doesn’t take long to use at all especially 
compared to BBS which seemed to take up a lot of 
the treatment session time(P11line13) 
 difficult to use 
found it difficult to judge what the pts 
optimal would be (S1line70) 
and I thought it would be straight forward and I actually found it 
much more difficult than  I expected  to (FG1/ EP3/ line7) 
 
because you could not say you are only looking at the alignment 
of one area you could be very very specific in terms of if you want 
to look at someone’s head position or if you want to look at 
something big either their walking or shoulder position so you can 
use it for anything so in one way that makes it  very useful 
because  you can use it for any area, but also in a way that gave 
me   variability  that gave me another problem because... which 
one would I do. (FG1/ EP5/ line21) 
 
I would have to say when I started using it  - and I did a couple  - I 
thought I had missed the point  I thought I was getting something 
fundamentally wrong because I was feeling so challenged by it.   I  
found that quite difficult. (FG1/ EP5/ line28) 
 
I think I just found it hard because I think it is probably I did not 
think about that point, I think your point XXXX about dividing it up 
is what made it difficult.  I still think if I was using it with someone 
junior,  you could say now we are looking at  sit to stand , now we 
are going to look at their  alignment and we are going to score 
that, now we are going to look at their interaction, now we are 
going to look at their timing  now their speed  of their movement. It 
would be very useful but I think that for us - when you are working  
- that actually that dividing tool,  your overall picture because you 
are working on a whole  it is the continuum of movement and the 
continuum of  almost clinical reasoning  it becomes more 
chunkeyit takes you back to dechunking - chunking down is 
probably the word. (FG1/ EP2/ line 90) 
 
More complicated to use for me, more difficult.  I know it is new to 
me but I was taking half an hour to identify what scores I wanted 
and thinking it through so for me it was more effortful.(FG2/ EP10/ 
at times I had to re-read the instructions to remind 
myself exactly what each item was referring 
to.(P9line7) 
 
Scoring sometimes felt a little like a stab in the 
dark!(P6line54) 
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line21)     
 
but I felt  that I  did not understand what I was doing  fully and I  
still  think I  do not understand what I am doing fully.  (FG2/ EP7/ 
line77) 
 
were flashes of greater understanding through discussion with my 
colleagues that I had not had when I had done it on my own (FG2/ 
EP7/ line85) 
 
I found the timing one difficult - I am sure   that was just about my 
skill level but I found trying to make an objective decision about  
whether the sequence of  activation  was correct or not was very 
difficult. I wonder if I would ever be able to do that.(FG2line183) 
 
I did better at using it in a  group situation than  I did alone 
(FG2line237) 
 
point I feel  that I am missing something and feel  that it  maybe it 
needs more practice -maybe it needs more training  - I think it is 
both actually – I think need more training and needs more 
discussion to understand it and needs more practice  (FG2/ EP7/ 
line261) 
   General issues of use 
I wasn’t always sure what to measure and often 
tended to use functional activities rather than 
specific muscle activity(P9line23) 
  Time it takes to use 
I think that in real world people increasing under pressure with 
time it that would be pursued as a negative I think even if it was 
useful it would be take too long I think.(FG1/ EP3/ line424) 
 
  Subjective 
when I did it in combination  with two of  my tutors it felt like  you 
could pick something  and you could  quickly  go through it but it 
was slightly subjective(FG2/ EP8/ line31) 
 
intrinsically it is a subjective measure (which could 
be a weakness), but because of the items in the 
framework which are very clear and specific this 
makes it as objective as possible(P12line18) 
 
more than ½, less than ½” – quite subjective, and 
sometimes difficult to call.(P6line52) 
 
Underpins practice Quality of movement 
For 1 pt the LMPI was good because 
its not just that they can perform the 
function, but how well they can 
perform it. (S1line89) 
 . It is easy in community to become quite 
functionally focused and using the LMPI has been 
a good reminder to look at quality of movement 
first.(P5 line41) 
 
. Only outcome measure I have come across that 
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looks at each component of normal movement 
measuring quality rather than just ability(P11line5) 
 
Individual nature of movement 
but I think in essence it does recognise an individual nature (FG1/ 
EP6/ line15) 
 
a strength of it  is  it breaks movement down  into  component  
which is reflective  how we teach the “Bobath concept”(FG2/ EP7/ 
line447) 
 
It prompts you to break things down into components.  The 
Measure itself does not break them down.  It prompts the clinician 
to.(FG2/ EP10/ line466) 
 
 
The LMPI helped to analyse the movement control 
in terms of the 5 items.  This helped to identify 
where movement was less than the theoretical 
normal and guided treatment planning.(P9line64) 
 
I felt LPMI reflected not only the treatment goal but 
considered how the goal was achieved, by 
measuring the various components involved such 
as; timing / interaction etc which are often over 
looked in other tools, this I thought made it quite a 
sensitive measure.(P12line4) 
 
 
 
 related to function 
I think on one person I did just look at the alignment of their leg. 
Just leg alignment in standing and I could do that, which is fine, I 
had my scores but then I was left with so I have changed their leg 
alignment but in the bigger scheme of things what would that lead 
too (FG1/ EP2/ line40) 
 
I was looking at a particular alignment issue with regard to a very 
small body part I was not relating it to function but I thought it 
might work out that way but it did not.(FG1/ EP1/ line104) 
 
it was those patients where  you inherently know they are  not 
going to look hugely  different but they can feel different but that 
can be very relevant to them in their overall function.(FG1/ EP6/ 
line374) 
 
Could be related to patients function and goals, for 
example, for patient to be able to stand up from 
wheelchair, symmetrically, with supervision. Able to 
look at- 
- weight-bearing through affected LL 
- adaptability of foot during movement 
- trunk and UL alignment during movement 
(P6line16) 
 
 
 
Items in the scale 
“the interaction with the base of support” is also a huge strength of 
it because it gets missed in a lot of measures it is important to the 
concept that I practice(FG2/ EP8/ line215) 
 
I liked the fact that it has alignment in it because that is where we 
often start and I think that is useful with all of the patients we 
looked at because you are looking at an optimal alignment to 
underpin the other things so an optimal alignment will underpin 
the ongoing interaction of the patient with gravity and their 
supporting surface and the ongoing -  the alignment will underpin 
the timing,  the sequence of movement, the speed  and the 
selectivity.  That I think is a strength - it really, that it facilitates  the 
person who is doing the measure to look critically at the alignment 
and not just function – the task.(FG2/ EP7/ line207) 
 
Woman I          think if I was in charge of it..... if it was mine I 
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would re write the order I would go alignment  interaction selective 
movement timing speed. 
Q       Why? 
Woman     just because it makes more sense to me. 
(FG2/ EP7/ line231) 
 
 About the LMPI 
Different terms /jargon would be 
easier (S1line6) 
 
The Speed bit very difficult to deal with because you say the 
ability to choose how fast or slowly  - well it depends and that 
made it very hard to categorise - put a number to that.(FG1/ EP1/ 
line106) 
 
 
  Anything missing from it? 
From a movement component perspective – I don’t think so, it 
covers all bases.  (FG2/ EP8/ line305) 
 
It would be nice to have a section on it that was entitled 
goals(FG2/ EP10/ line307) 
 
Most things are covered aren’t they - in terms of patients 
movements are slower more jerky. Usefulness comes in a lot. A 
lot of those components come in.  You don’t want to make it more 
complicated when a lot of things are already there.(FG2/ EP8/ 
line327) 
 
from that point of view (is there anything missing?) it is 
comprehensive and appropriate(FG2/ EP7/ line334) 
With most of my patients I chose an activity for 
which the patients had some ability and so rarely 
used O score.  Likewise I would choose an area 
where a problem was identified and so a score 3 
would not be possible for all items.  This meant in 
most cases I was choosing between 1 moderate 
and 2 mild. An extra score i.e. 1 ½ may have been 
useful and more sensitive to change.( P9line24) 
 
Sometimes it is hard to pick a score from 0-3 and 
wonder whether allowing ½ scores would be 
useful.(P5 line53) 
 
reflection I think making it too detailed would make 
it less objective and in some respects it made me 
more decisive.(P12line41) 
 
Possibly compare to “normal”, rather than patients 
“theoretical” normal, with possibly extra point on 
scale to reflect this?(P6line43) 
 
could be more sensitive with 5 scores allowed, to 
help distinguish between scores of 2 and 
3(P4line9) 
  Theoretical optimum 
Woman  They could never be a three because they were never 
going to have enough recovery to be back to their previous level it 
was the theoretical optimal performance and I was not clear on 
that whether I should be judging  them against : prior to their 
assault or the best  I thought they could be post lesion.   
Woman  Your best prognosis. 
Man  Which is what I was doing (FG1/ EP3,4 &6/ 
line123) 
 
Discussion about the optimum…might it be different with different 
skills of therapist?(FG1/ EP6,2&1/ line 251+) 
 
Scale somewhat subjective. Quite difficult at times 
to consider patients “theoretical” normal(P6line11) 
 
What if patient surpasses their theoretical normal? 
Is there a ceiling effect? Or does it mean we have 
scored wrong previously?(P6line14) 
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But actually  you might say  - if you did that -  or  if you worked on 
their selective planter flexion they would improve and their heel 
stroke would be much better.  I would think I do not know how to 
get that. That is my optimal.    I think we would have the variability 
within ourselves as well as the difference seniority level – it is just 
experience and skill, knowing what you can achieve.(FG1/ EP5/ 
line398) 
 
 
I think that there are so many variability’s but in terms of prognosis 
it depends on what time frame you are working with. What I did 
like was the pre and post treatment idea I think that is very useful 
as a snap shot because once you start and broaden the context 
then the variables are so huge then it is quite difficult to feel 
confident that you are also capturing something of use and 
value.(FG1/ EP4/ line277) 
 
-  in the first instance have you really defined your optimal as 
clearly in your own mind as  you need to – you see what I mean. 
To me,  this optimal thing - if we have different perceptions of it  - 
then it is quite a crucial thing if you do not define the optimal how 
do you define your scores underneath it.(FG1/ EP6/ line384) 
 
  I found that extremely difficult because I did not know whether if I 
was looking that the “theoretical optimal performance”  of that 
person before their injury  or after.(FG2/ EP10/ line91) 
 
Woman So if your complex person achieved the best optimum 
they had ever achieved  - if you did may be measuring him   over 
a few months would that new awareness in your mind that he can 
be that good which  you had never seen before does that kind of 
shift the whole measure because you would not have thought last 
month that was his optimum but that is what  you were asked to 
measure him against. 
Woman But you would have moved to another goal.   
Woman You would have moved on because you had achieved 
that so you would have moved on to something different – that 
was my understanding 
Woman So the  “Theoretical Optimal Performance” is based on 
the changing goal. 
Woman Yeh (FG2/ EP11,8&10/ line127) 
 
Woman I would have thought that because this is a normal 
movement indicator you would always have what was normal as 
you are comparing your post injured patient from your mild / 
moderate or severe 
Woman I am now really confused now really confused (FG2/ 
EP8&4/ line167) 
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One of the things that I liked in the patient I started on one of them 
- who would never have – the possibility of having what most 
clinicians would consider as normal movement - so it was quite 
useful to  have  a theoretical normal movement or theoretical goal 
to work towards or think about -  rather than perhaps what 
therapists might  think about -  would he move like me - and the 
question -   no and he never will  - no. So it was worth having that 
thought.(FG2line337) 
 
Woman  So how did you score optimal how did you score his 
theoretical optimal performance? 
Woman          Against what I thought he might be able to 
achieve 
Woman  With his diagnostic 
Woman Yeh along with the patients diagnosis. But obviously I 
had no idea of where he might be able to go to - and this is a guy 
who declined in  terms of his functional ability over a period of 
time so I was trying to move him back. 
Woman  To where it was. To where his optimal was.(FG2/ 
EP7&11/ line344) 
 
 
  What do you do with the score? for example measuring sit to 
stand  - well yes I could get a different set of scores as part of the 
overall  sit to stand  - but it  is a bit like what Catherine says -  I am 
not quite sure what we do with them  at this stage do you add 
them up, do you highlight,  that is where the score changed, that 
is where the score did  not change, and the aspect of sit to stand 
that you are actually recording change of  very much impairment 
level aspects -  you see what I mean.(FG1/ EP6/ line207) 
 
The other thing that I felt was hard, to decide if they were meeting 
half or more than half of the components of the item(FG2/ EP10/  
line102) 
 
 
  Is it hierarchical? I was working with a patient who needed to 
improve his selective planter flexion in terms of terminal stance  
and sit to stand so I was working very specifically on his selective 
movement of his planterflexors so that was the most important 
aspect, because that was effecting everything else and strength 
was an issue,  so in that respect the most important thing for him 
was... the hierarchy did not even come into it. (FG1/ EP2/ 
line315) 
 
It is basically understanding those relationships between those 
different factors.  Rather than you get one and then you go on to 
the next and then on to the next.(FG1/ EP3/ line348) 
The “ importance” of the items in the scale varied 
with each individual patients, for example; in some 
patients selective movement was the key limiting 
factor, in others it was alignment and in some 
patients all items were equally affected. Therefore 
there was a hierarchy of sorts(P12line34) 
 
Don’t feel items are hierarchical. Some patients 
demonstrated improvements lower down scale 
before further up. Also depends on what you are 
measuring i.e. whole body v specific body part. 
(P6line38) 
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   Strengths  
Easy to complete 
Quick to complete 
Focuses on normal movement 
Appropriate for patients with neurological problems 
(P9line70) 
 
aids analysis and observation of movement.  It is 
quick and easy to use and adaptable and sensitive. 
( P5 line55) 
 
easy to use, facilitates treatment planning and goal 
setting, I found it a sensitive measure. (P12line44) 
 
same thought process we use every day 
looks at quality (P6line46) 
 
   Weaknesses 
Not always sensitive enough 
Would reflect negatively on patients with 
progressive disorders 
Limited to therapists with neurological interest 
(P9line75) 
 
the items feel a little repetitive as there is a blurring 
of meaning between some of them.  For instance, 
alignment is similar to interaction and timing is 
similar to selective movement.  Sometimes it is 
hard to draw a distinction between items that are 
only subtly different (P5 line58) 
 
Not always as easy for  the patient  to understand 
what we were measuring  ( compared to say the 
Berg) (P12line46) 
 
not well enough known yet 
unable to compare patients (if we wanted to!) 
Use of jargon (wordy, even for junior staff) 
(P6line49) 
 
 
 About testing in study 1b 
they cannot remember their scores 
1st time around and they thought 
they would (S1line 19) 
 
Participants felt they were being 
quicker with their scoring, they felt 
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more confidant, they were just ‘going 
for it’. Felt they were being harsher 
with scores.  Using the LMPI felt 
easier (S1line60) 
 
  Inter and intra-rater reliability 
Man  It does wonder about the inter 
Woman   The  inter-rator is the problem                                             
Man  As oppose to the intra 
Woman  That is what I thought would be difficult 
Woman   unless you really clearly defined what your idea of the 
components were   at the initial time you did it. 
Woman yes  -As you as the filler outer had to record that it then 
becomes onerous it then becomes a chore because you  now 
have to do a lot more writing (FG1/ EP5&6/ line405) 
 
Woman Does it always have to be the same person who is 
doing the measure - presumably. 
Woman So that then  you  knew -  my perception is  that is that 
the inter-rater reliability might be quite low and therefore – yeh 
that would be a concern to me. (FG2/ EP11&7/ line113) 
 
 
 
I was a little unsure initially, but it was done in a 
relaxed, pressure free manner. (P9line92) 
 
This was a bit challenging in that there was some 
anxiety as to whether the results might vary widely, 
but it was a good task to do from a personal 
development aspect (P5 line73) 
 
The re-testing was absolutely fine, less threatening 
than anticipated. Once I realised my score was only 
being measure against my previous score. 
(P12line65) 
 
The test re-test was good, I had no recollection of 
what I’d recorded in the 1st session so it was 
planned in a timely manner.( P2line55) 
 
  Using outcome measures 
Woman    We at Xxxxxx last week we were trying to get relatively 
skilled practitioner’s to use GAS but it was difficult very difficult. 
Woman I think it is the time 
Woman They had the time on the course – they had the time. 
Woman Lack of experience was a big excuse.  There is a huge 
lack of experience no matter how much we talk about this health 
service and the fact that every practitioner should be measuring 
change on their patient.  We found amongst 18 course members 
last week we found quite considerable lack of ability to do 
that.(FG2/ EP10,7,9&8/ line294) 
 
I think the LMPI, or some similar measure should 
underpin the therapists approach to clinical 
practice, but doesn’t always because of time 
constraints and the need sometimes for function 
and safety within a home environment ( P5 line47 
   Involvement in the research project 
Initially I felt some reluctance to take part due to 
limited time and extra demands to fill in forms and 
attend meetings.  However I found the research of 
particular interest as it was specifically designed for 
neuro-patients.  The support and encouragement 
given to me by the lead, and other colleagues 
provided motivation (P9line80) 
 
It was good to be involved with this project and I 
feel it has helped with my own personal 
development and in my ability to teach junior staff.  
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Compared to a recent research study into how 
teams work together in intermediate care, this 
study felt more clinically relevant and interesting. 
(P5 line66) 
 
I found the whole process very interesting 
especially as the research had a very clear remit, 
physiotherapy focus, and clinically of great 
professional interest (P12line51) 
 
I was very pleased to be involved in trialling a 
sensitive outcome tool with the emphasis on the 
quality involved in achieving functional goals which 
has been sadly lacking especially for neurological 
patients. (P12line69) 
 
Regular contact and support was invaluable, and 
encouraged focus, and use of LMPI.(P6line69) 
 
1 participant did not use it within their clinical 
practice because of a time constraint – she had 4 
other outcome measures that she needed to 
complete…… participation caused burden (P9) 
 
Ethics 
The project would have been easier if patients had 
not needed to agree to taking part.  (P9line85) 
 
The only problems with recruiting patients were in 
gaining their consent.(P5 line70) 
 
about the BBS 
A less time consuming alternate measure, rather 
than the BBS would have made it easier. 
(P9line86) 
 
The Berg balance is a very objective outcome 
measure which lots of patients like as they can see 
clear measures taking place ( involving 
stopwatches and tape measures etc) however I feel 
it is a  superficial  measure looking only at tasks 
and not the quality of movement involved in 
achieving them. (P12line22) 
 
The training was really good, the video clips were 
useful and doing the training in groups where 
discussion was possible helped to gain 
understanding of the assessment. (P2line50) 
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Appendix 16 
 The assessment of the LMPI, the BBS, the TIS and GAS using the COSMIN 
framework (Terwee et al 2012) 
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The four outcome measures reviewed using the COSMIN method checklist 
Using the COSMIN checklist described by Terwee et al (2012), each of the properties for 
each of the outcome measures were examined for their ability to meet the standards.  
Constructing this table has enabled comparison of the quality of the methodology of work 
that has been done to develop and test the LMPI with the best of the other available 
outcome measures; according to the criteria that were set within the literature review of 
Chapter 3.  Some properties, such as clinical utility were not included within the COSMIN 
framework and some indicators within the COSMIN framework were not included in any of 
the research surrounding the BBS, TIS or GAS. 
Although only relatively small scale research has been carried out, in some areas, the LMPI 
stands strongly next to the BBS, TIS and GAS in some areas, further work is identified for 
the LMPI 
The COSMIN checklist categories 
Box A - Internal consistency  
The LMPI, BBS and the TIS all met the requirements stated by COSMIN and this property 
was not assessed within any of the GAS studies examined. 
Box B – Reliability 
All four outcome measures met the requirements of COSMIN, although, with the exception 
of the BBS studies, small sample sizes were used. 
Box C - Measurement error 
Measurement error has strongly been tested within the BBS, and only one study has 
considered this property for the TIS. 
Box D - Content validity 
All four studies met this COSMIN requirement, although because of the methodology used 
within the LMPI studies it was established in significantly greater depth than the others.  
Clinical utility was investigated within the LMPI and to a small extent within the BBS, TIS and 
GAS.  Respondent burden was only investigated within the LMPI. 
Box E - Structural validity 
This was not considered within any of the papers; however, predictive validity - in terms of 
prediction in time(was assessed for the BBS and the TIS), but not prediction of scale total 
score. 
Box F - Hypotheses testing 
No hypotheses related to the outcome of tests of validity were used within any of the papers. 
Box G - Cross-cultural validity 
This was not assessed in any of the papers examined, however some research papers may 
have been excluded because of the criteria within the literature searches limiting to English 
language. 
Box H - Criterion validity 
Criterion validity was assessed in a satisfactory manner for all four outcome measures, 
although the sample size used within the LMPI study was small. 
Box I – Responsiveness 
Effect size was tested for the LMPI, BBS and GAS but not for the TIS, however with the 
exception of BBS papers, small sample sizes were used. 
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Box J – Interpretability 
This was not generally tested, with the exception of floor and ceiling effects within the BBS 
and the TIS; however, neither the LMPI or GAS have issues with floor or ceiling effects due 
to the nature of the measurement tools. 
Determining generalisability of the results 
Within the BBS, this is good and it can be used with minimal training or equipment.  On the 
other hand, the TIS requires some specialist skills (all the raters used within the TIS studies 
were physiotherapists).  The LMPI and the GAS both require the skills of prediction and 
prognosis of the patient’s ability to change, plus the potential ability of the patient to change 
according to the intervention and the treatment skills of the physiotherapist. 
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
Internal 
consistency 
 
Cronbach’s alpha 
coefficient, 
applied to the 
entire scale and 
to each item 
 
Study 2:  
5pts, 12 PTs, 
rated patients 
movement 
using video; re-
rated 2 weeks 
later. 
 
 
 Overall = 0.862,  
“excellent” 
 
 
with individual 
items ranging from 
0.795 to 0.892.    
 
“good to excellent” 
 
Berg et al 1989 
14 pts, 5 
PTsCronbach’s 
…………….. 
Berg et al 1995 
30pts, 5 raters 
Cronbach’s 
 
 
……………… 
Mao et al 2002 
112pts,2OTs, 
Chronbach’s 
……………… 
Franchignoni et 
al 2005     
70pts, unknown 
raters, 
Chronbach’s 
 
Overall = 0.83 
to 0.95 
“excellent” 
……………….. 
with individual 
items ranging 
from 0.41 to 
0.64 
“inadequate” 
……………… 
 
0.92 to 0.98 
“excellent” 
……………….. 
0.62  to 0.81 
“inadequate to 
excellent”  
 
 
Verheyden et al 
2004             
28pts, 2PTs 
Chronbach 
………………. 
Verheyden & 
Kersten 2010 
162 pts, Rasch 
 
 
0.65 to 0.89 
“moderate to 
perfect” 
 
……………….. 
Removal of static 
sitting balance 
subscale 
improved internal 
validity 
Tennant 2007, 
Rasch, 
simulated data 
Does not fit 
Rasch model, 
unless 
instrument is 
altered. 
Cronbach’s alpha 
coefficient 
excellent =  ≥ 0.8  
good =  ≥ 0.7  
inadequate = < 0.7 
Box A Internal consistency. The absolute percentage of agreement is inadequate, because it does not adjust for the agreement attributable to chance 
1. Was the 
sample size 
included in the 
internal 
consistency 
analysis 
adequate? 
Rules-of-thumb 
vary from four to 
10 subjects per 
variable, 
Yes  Yes  Yes  No  
Cronbach’s 
alpha(s) 
calculated per 
dimension  
AND Cronbach’s 
alpha(s) 
between 0.70 and 
0.95; 
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
3. Was an 
internal 
consistency 
statistic 
calculated for 
each 
(unidimensional) 
(sub)scale 
separately? 
Yes  Yes  Yes  No  
 
5. for Classical 
Test Theory 
(CTT): Was 
Cronbach’s alpha 
calculated? 
Yes  Yes  Yes   
 
Test re-test 
reliability 
 
Spearman’s rank 
correlation 
coefficient 
 
Study 2:  
5 pts, 12 PTs, 
rated patients 
movement 
using video; re-
rated 2 weeks 
later.  
 
 
 
 
 
 
 
……………….. 
Study 2: 
A variance 
components 
analysis:  
for overall scale = 
0.792  
and individual 
items of selective 
movement 
(0.655), speed 
(0.655)  and 
interaction(0.674).  
“substantial” 
 
reliability for timing 
(0.516) and 
alignment (0.397). 
“moderate”  
………………… 
Variance between 
physiotherapists 
(7.8%)and 
between the  
Berg et al 1989 
14pts, 5PTs, 
ICC 
 
Berg et al 1995 
31pts , 7 raters, 
ICC 
 
Liston & 
Brouwer 1996 
20pts, unknown 
raters ICC 
 
Farlow et 
al1997       
18pts, 2 raters, 
ICC 
 
. 
 
 
 
 
 
 
 
for overall scale 
consistently 
above 0.91 
 
 
“almost perfect” 
 
 
 
 
 
 
 
Verheyden et al 
2004 ICC 
……………….. 
 
Verheyden et al 
2006b, 30pts, 
2PTs, ICC, 
Bland Altman 
…………………. 
 
Verheyden et al  
2006c, 30pts, 2 
researchers, 
ICC 
for overall scale = 
0.96 “excellent” 
………………… 
 
0.95 “excellent” 
Bland Altman 
93% within 2SDs 
 
………………….. 
 
0.88 “excellent” 
 
Not tested 
 Spearman’s rank 
correlation 
coefficient 
 
almost perfect: >  
0.8       
substantial: 0.6 to 
0.8    
moderate:  0.41 to 
0.6  
poor:  < 0.4       
 
 380 
 
Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
 between-patient, 
between 
therapist, 
between testing 
variability  
 
replicate 
measurement 
occasions 
(2.8%) were 
small, whereas 
the variance 
between the 
patients were 
large (55.2%) as 
expected 
Mao et al 2002 
112pts 2 OTs, ICC 
 
Bennie et al 2003, 
20pts, 2 raters, 
ICC 
 
Newstead et al 
2005           5pts, 2 
raters, ICC 
 
Steffen & Seney  
2008 37pts, 
unknown raters, 
ICC 
 
Hiengkaew et al 
2012         61pts, 2 
PTs, ICC 
………. 
Conradsson et al 
2007          45pts, 
1rater, ICC, Bland 
Altman 
……….. 
Leddy  et al 2011      
24pts, 2 raters, 
ICC 
…………. 
Sackley et al 2005     
47pts, 2 raters 
Kappa. 
 
 
 
 
 
 
 
 
“almost perfect” 
 
 
 
 
 
 
 
 
 
 
…………. 
ICC 0.97 
Bland AltmanSD= 
2.7 
 
……………. 
0.8 
“excellent”  
 
 
……………… 
K 0.63-1.00 
“substantial to 
perfect” 
ICC - 0.98 
“excellent” 
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
Inter-rater 
reliability 
Study 2: 
5 pts, 12 PTs, 
rated patients 
movement 
using video; re-
rated 2 weeks 
later. 
 
ICC for total 
scores and 
individual items 
Total scale scores 
and  individual 
item scores = all 
above 0.8 
 
“excellent”  
 
Berg et al 1989 
ICC 
 
Berg et al 1995 
ICC 
 
Farlow et 
al1997 18pts, 4 
raters, ICC 
 
Bennie et al 
2003, 20tps, 2 
raters, ICC 
 
de Figueiredo et 
al 2009, 12pts, 
18PTs, ICC total 
scores 
 
Leddy  et al 
2011, 15pts, 3 
raters, ICC 
………….. 
Sackley et al 
2005 Kappa 
 
 
 
………. 
Mao et al 2002 
112pts 2 OTs, 
Kappa, ICC 
 
 
 
 
 
 
Total scale 
scores = all 
above 0.95 
 
“excellent” 
 
 
 
 
 
 
 
 
 
 
 
 
………….. 
k 0.74-1.00  
“substantial to 
perfect” 
ICC =0.99. 
“excellent” 
………….. 
k 0.59 to 0.94 
moderate to 
perfect 
ICC 0.93 to 
0.97 “excellent” 
 
Nieuwboer et al 
1996, 27pts, 
2PTs, Kappa 
……………….. 
 
Verheyden et al 
2004, 28pts, 
2PTs, ICC 
 
Verheyden et al 
2006c, 30pts, 2 
researchers, 
ICC, 
……………. 
Verheyden et al 
2006b, 30pts, 
2PTs, ICC 
 
Range “slight to 
substantial” 
 
……………….. 
 
 
 
ICC all above 
0.93 “excellent” 
 
 
 
 
……………… 
Bland Altman 
93% within 2SDs 
Joyce et al 
1994  
16pts, MDT 
raters, 
unknown 
psychometric 
test 
……………. 
Bovend'Eerdt 
et al 2011; 
29pts, 1PT,          
1 Independent 
rater, ICC 
“strong” 
 
 
 
 
 
 
……………… 
0.478 
“adequate” 
Kappa values 
0.00-0.20 = slight 
0.21-0.40 = fair 
0.41-0.60 = 
moderate 
0.61-0.80 = 
substantial 
0.81-1.00 = almost 
perfect 
 
 
 
 
 
ICC 
Excellent:   > 0.75 
Adequate: 0.40 to 
< 0.74 
Poor:   < 0.40 
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Box B Reliability: relative measures (including test-retest reliability, inter-rater reliability and intra-rater reliability)Terwee 2012 Adequate sample size (<100) Good sample size (50–99) 
Moderate sample size (30–49) Small sample size (>30) … The Pearson correlation coefficient is inadequate, because systematic differences are not taken into account … and gave a positive rating 
for reliability when the ICC or weighted Kappa is at least 0.70 in a sample size of at least 50 patients 
3.Was the sample 
size included in the 
analysis adequate?  
Small  Studies range from small to good Small  Small   
4.Were at least two 
measurements 
available? 
Yes  Yes  Yes  No  
 
5.Were the 
administrations 
independent? 
Yes  Yes  Yes  Yes  
 
6.Was the time 
interval stated? 
Yes  Yes  Yes  Yes 
 
7.Were patients 
stable in the interim 
period on the 
construct to be 
measured? 
Yes Yes Yes Yes 
 
9.Were the test 
conditions similar 
for both 
measurements? 
e.g. type of 
administration, 
environment, 
instructions 
Yes Yes Yes Yes 
 
11.for continuous 
scores: Was an 
intraclass 
correlation 
coefficient (ICC) 
calculated? 
Yes Yes Yes Yes 
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
Measurement 
error 
SEM 
SDC 
0.42 
1.16 
Stevenson 2001 
48pts 
Steffen & Seney 
2008 37pts  
Donoghue & 
Stokes 2009 
118pts 
Flansbjer et al 
2012 50pts 
Hiengkaew et al 
2012 61pts 
Quinn et al 
2013 75pts 
Godi et al 2013 
93pts 
 
MDC SEM 
SEM MDC 
 
SEM MDC 
 
SEM  
 
MDC 
 
MDC 
SEM MDC 
Verheyden et al 
2006b, MS, 
30pts, 2PTs 
SEM 1.23 to 
1.58, comparable 
with BBS 
 
  
 
Box C Measurement error: absolute measures Design requirements 
 
3.Was the sample 
size included in the 
analysis adequate?  
Not tested  Small moderate good Small  Not tested  
4.Were at least two 
measurements 
available? 
 Yes  No   
 
5.Were the 
administrations 
independent? 
 Yes  Yes   
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
6.Was the time 
interval stated? 
 Yes Yes  
 
7.Were patients 
stable in the interim 
period on the 
construct to be 
measured? 
 Yes Yes  
 
8.Was the time 
interval 
appropriate? 
    
 
9.Were the test 
conditions similar 
for both 
measurements? 
e.g. type of 
administration, 
environment, 
instructions 
 Yes Yes  
 
11.for CTT: Was the 
Standard Error of 
Measurement 
(SEM), Smallest 
Detectable Change 
(SDC) or Limits of 
Agreement (LoA) 
calculated? 
 SEM MDC SEM   
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
Face /  
Content  validity 
Qualitative 
methods : - 
Study 1: 
developed by 
clinicians, 
semi-
structured 
interviews with 
users– 
thematic 
content 
analysis 
Study 2 : rich 
note taking 
Study 3 : 2 
focus groups, 
reflective 
questionnaires, 
cross case 
template  
analysis 
 
 
Strong face and 
content validity 
 
 
Berg et al 1989, 
Use of patients 
and health care 
professionals 
during its 
development 
 
Good face and 
content validity 
Nieuwboer et 
al1996 interview 
and observation 
PT & pt. 
 
Nothing 
published about 
development of 
TIS 
 
Good content  
and face validity 
 
 
 
 
Kiresuk & 
Sherman1968 
developed for 
pts receiving 
psychcology 
intervention 
………………. 
Joyce et al 
1994, TBI 
Poor 
 
 
 
 
 
…………… 
Strong 
 
Box D Content validity (including face validity) Terwee 2012.. A clear description is provided of the measurement aim, the target population, the concepts that are being measured, and the item 
selection AND target population and investigators OR experts) were involved in item selection; 
1.Was there an 
assessment of 
whether all items 
refer to relevant 
aspects of the 
construct to be 
measured? 
Yes  Yes  Yes  Yes   
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
2.Was there an 
assessment of 
whether all items 
are relevant for 
the study 
population? (e.g. 
age, gender, 
disease 
characteristics, 
country, setting) 
Yes  Yes  Yes  Yes   
4. Was there an 
assessment of 
whether all items 
together 
comprehensively 
reflect the 
construct to be 
measured? 
Yes  Yes  Yes  Yes   
3. Was there an 
assessment of 
whether all items 
are relevant for 
the purpose of 
the measurement 
instrument? 
(discriminative, 
evaluative, 
and/or predictive) 
 Predictive and evaluative  Predictive and evaluative   
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
Predictive 
Validity 
Not tested Not tested For D/C LOS 
Feld et al 2001 Wee 
et al 1999;2003  
……………. 
Falls  
Bogle& Newton 1996 
Cattaneo et al 2006 
Maeda et al 2009 
Leddy  et al 2011 
Coote& Hogan   
(2013) 
……………….. 
Mao et al 2002, 
112pts 2 OTs,          
BBS v MAS 
Spearman's  
Moderate 
prediction  
 
………………… 
Weak 
prediction 
 
 
 
 
 
 
 
 
 
……………… 
Day 14 - 0.82 
Day 30 - 0.84 
Day 90 - 0.91 
“large” 
For D/C function 
Verheyden et al 
2007a, BI 
……………….. 
Verheyden et al 
2008, FMa, BI 
 
……………….. 
For D/C 
functionDi 
Monaco et al 
2010, 60pts, 
 
Strong prediction  
 
 
……………. 
Recovery or 
trunk, arm & leg 
have similar rates 
……………….. 
Strong prediction 
of D/C function 
Not tested 
  
Box E Structural validity  not carried out within any of the studies examined 
1. Does the scale consist of effect indicators, i.e. is it based on a reflective model? 
Design requirements 
2. Was the percentage of missing items given? 
3. Was there a description of how missing items were handled? 
4. Was the sample size included in the analysis adequate? 
5. Were there any important flaws in the design or methods of the study? 
6. for CTT: Was exploratory or confirmatory factor analysis performed? 
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Box F Hypotheses testing not carried out within any of the studies examined 
1. Was the percentage of missing items given? 
2. Was there a description of how missing items were handled? 
3. Was the sample size included in the analysis adequate? 
4. Were hypotheses regarding correlations or mean differences formulated a priori (i.e. before data collection)? 
5. Was the expected direction of correlations or mean differences included in the hypotheses? 
6. Was the expected absolute or relative magnitude of correlations or mean differences included in the hypotheses? 
7. for convergent validity: Was an adequate description provided of the comparator instrument(s)? 
8. for convergent validity: Were the measurement properties of the comparator instrument(s) adequately described? 
9. Were there any important flaws in the design or methods of the study? 
10. Were design and statistical methods adequate for the hypotheses to be tested? 
Box G Cross-cultural validity not carried out within any of the studies examined 
1. Was the percentage of missing items given? 
2. Was there a description of how missing items were handled? 
3. Was the sample size included in the analysis adequate? 
4. Were both the original language in which the HR-PRO instrument was developed, and the language in which the HR-PRO instrument was translated described? 
5. Was the expertise of the people involved in the translation process adequately described? e.g. expertise in the disease(s) involved, expertise in the construct to be measured, expertise in both languages 
6. Did the translators work independently from each other? 
7. Were items translated forward and backward? 
8. Was there an adequate description of how differences between the original and translated versions were resolved? 
9. Was the translation reviewed by a committee (e.g. original developers)? 
10. Was the HR-PRO instrument pre-tested (e.g. cognitive interviews) to check interpretation, cultural relevance of the translation, and ease of comprehension? 
11. Was the sample used in the pre-test adequately described? 
12. Were the samples similar for all characteristics except language and/or cultural background? 
13. Were there any important flaws in the design or methods of the study? 
14. for CTT: Was confirmatory factor analysis performed? 
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
Criterion / 
construct 
 
 
 
 
Convergent 
reliability 
With BBS 
 
Study 2: Senior 
Physiotherapist 
Participant 
Group, 
recruited 
patients and 
tested them 
pre and post 
intervention 
27pts  
 
1) Spearmans 
rank 
correlation 
coefficient.  
 
2)  Correlation 
between the 
averages and 
the differences 
of the pre and 
post 
intervention 
scores ( Bland 
& Altman 
2010) 
 
 
 
 
 
 
 
 
 
 
 
 
“medium” 
correlation (0.468) 
 
 
 
Standard 
Deviation ± 2, 
except for 2 
patients whose 
results lay outside 
the norm. 
Berg et al 1989, 
criterion with 
care givers 
opinion, 
Spearmans 
38pts 
………………. 
Berg et al 1992 
Criterion validity 
with; Tinetti, BI, 
TUG 31 pts 
………………. 
Mao et al 2002, 
stroke, BI, 
Convergent 
reliability, 
Spearman’s 
112pts 
…………. 
Bennie et al 
2003 
TUG; FR, 
Spearman’s 
20pts 
…………….. 
Whitney et al 
2003, 70pts 
DGI, 
Spearman’s 
……………….. 
Qutubuddin et  
al 2005 
UPDRS ; H&Y    
SE-ADL, 
Pearson’s 38pts 
 
significant but 
no results 
shown 
 
 
 
………………. 
Tinetti - 0.91 
BI – 0.67 
TUG - 0.76 large 
………………. 
Between 14 & 
180 days  
0.89 & 0.94 
“large” 
 
 
……………. 
TUG - 0.47;  
FR - 0.42 
“medium” 
 
 
…………….. 
0.71 “large” 
 
 
 
……………… 
UPDRS - 0.58 
H&Y - 0.45 
SE-ADL - 0.55 
 
 
 
Verheyden et al 
2004; BI, TCT, 
spearmans 
28pts 
……………….. 
Verheyden et al 
2006a TCT 
Tinetti FAC  
10mWT TUG 
FIMm 51pts    
………………. 
Verheyden et al 
2006b ; MDST, 
Bland Altman, 
30pts 
……………… 
Verheyden et al 
2006c ; BI, 
Spearmans 
30pts 
……………… 
Verheyden et al 
2007b, UPDRS, 
Spearman’s 
25pts  
…………. 
Di Monaco et al 
2010 ; PASS, 
FIM, 
Spearman’s 
60pts 
BI 0.86 
TCT 0.83 
“Large”  
 
……………….. 
 
“strong 
relationships” 
 
 
…………………… 
Standard 
Deviation ± 2 
 
 
………………. 
0.59 “large” 
 
 
 
…………….. 
0.41 to 0.68 
“medium to large” 
 
 
………………. 
PASS 0.85  
FIM 0.695 “large” 
Joyce et al 
1994, 
Pearson’s ; 
GCI, RDRS, 
MEDLS, KELS,  
IADL 16pts 
 
 
 
 
 
……………… 
Khan et 
al2008 ; 24pts 
with 
MS, Spearman’
s  BI, FIM, CGI 
……………… 
Turner-Stokes 
et al 2009 
FIM, BI. 
Spearman’s 
164pts 
GCI - 0.80     
“very strong” 
RDRS - 0.61 
”strong” 
MEDLS - 0.52 
“moderate” 
 KELS - 0.0039 
“very weak” 
IADL - 0.16    
“very weak” 
 
……………….. 
BI - 0.15 “small” 
FIM - 0.06 
“small” 
CGI - 0.74 
“large” 
……………….. 
FIMm – 0.39 
BI - 0.37 
“medium” 
Spearmans rank 
correlation 
coefficient.   
0.5 = large 
0.3 = medium 
0.1 = small 
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
Criterion / 
construct 
CONTINUED 
 
 
Lemay& 
Nadeau 2010 
10mWT  
TUG 
2MWT  
Pearson’s  
WISCII  
SCI-FAI, 
Spearman’s 
32pts 
 
……………… 
Franchignoni et 
al 2005, FFM, 
PCS, Pearson’s 
70pts 
2MWT - 0.78 
 
10mWT - 0.79 
TUG – 0.81 
2MWT- 0.78 
“substantial” 
 
WISCII - 0.85 
SCI-FAI - 0.74 
“large” 
 
 
 
 
…………….  
FFM - 0.67 
PCS - 0.82 
“moderate” 
 
     
Box H Criterion validity 
3.Was the 
sample size 
included in the 
analysis 
adequate? 
 
small Small  1 
Moderate  4 
Good  2 
Adequate  1 
Good 2 
Small 2 
Moderate 2 
Small 2 
Adequate 1 
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
4.Can the criterion 
used or employed 
be considered as a 
reasonable ‘gold 
standard’? 
Yes  Yes because of variety of Outcome 
Measures tested against 
Yes because of variety of 
Outcome Measures tested 
against 
Yes because of variety of 
Outcome Measures tested against 
 
6.for continuous 
scores: Were 
correlations, or the 
area under the 
receiver operating 
curve calculated? 
correlations correlations correlations correlations  
Responsiveness 
 
 
Study 2, 27pts 
tested pre and 
post 
intervention, 
cohen’s d 
statistic 
ES = 1.52 
“large” 
 
Study 2, convergent 
validity with the 
BBS, tested pre 
and post 
intervention 
……………… 
Wood-Dauphinee et 
al  
1997, Kazis  70pts 
……………… 
Amasut 2009 
Cohen  51pts 
……………… 
Hackney & Earhart 
2009 14pts 
…………….. 
Mao et al 2002, 
range from 14  & 
180 days post 
stroke, Cohen’s d 
112pts 
ES =  0.99 
 
“large” 
 
 
…………….. 
ES =  0.97 
“large” 
 
…………….. 
ES = 0.22 “small” 
 
……………… 
ES = 0.83 
“large” 
……………….. 
90 to 180 ES = 0.40 
“small” 
14 to 180 ES = 1.11 
“large” 
Not tested 
 
 
Ashford & 
Turner- Stokes 
2006, Rx with 
BTX, BI 
18pts 
 
 
……………. 
Kahn et al 2008 
Effect size, 
Cohen  24pts 
……………… 
Turner- Stokes 
et al 2009, ES 
164 pts 
………………. 
Turner-Stokes 
& Williams 
2010 243 pts 
More sensitive 
than BI, a GAS 
change of >10 
associated with 
clinically 
important 
change 
………………… 
I - 0.4 
FIM - 0.4 
GAS - 9.0 
……………… 
GAS – 3.54 
BI – 1.0 
FIMm – 0.93 
………………. 
Found altering 
score criteria 
increased 
sensitivity to 
change 
Cohen’s d 
statistic 
≥0.80 = Large 
0.50   = 
Moderate 
0.20   = Small 
 
 
 
 
Cohen d effect 
size (mean 
change/standard 
deviation [SD] 
of baseline 
score) 
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
Box I Responsiveness  
Terwee et al 2012 “Although the Delphi panel wanted to discuss responsiveness as a separate measurement property, the panel agreed that the only difference between cross-sectional (construct 
and criterion) validity and responsiveness is that validity refers to the validity of a single score, and responsiveness refers to the validity of a change score [5]. Therefore, the panel decided that the 
standards for responsiveness should be analogue to the standards for construct and criterion validity. Similarly as with criterion validity, it was agreed that no gold standards exist for change scores 
on HR-PROs, with the exception of change on the original longer version of a HR-PRO that can be considered a gold standard, when it is compared to change on its shorter version” 
3.Was the 
sample size 
included in the 
analysis 
adequate? 
Poor  Poor 2 
Good 2 
Adequate 1 
Not tested 
Poor 2 
Adequate 2 
 
4.Was a 
longitudinal 
design with at 
least two 
measurement 
used? 
Yes  Yes  
 
Yes  
 
5.Was the time 
interval stated? 
Yes  Yes  
 
Yes  
 
6.If anything 
occurred in the 
interim period 
(e.g. intervention, 
other relevant 
events), was it 
adequately 
described? 
Yes  Yes  
 
Yes  
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
7.Was a proportion of 
the patients changed 
(i.e. improvement or 
deterioration)? 
Yes  Yes  
Not tested 
Yes  
 
For constructs for 
which a gold standard 
was not available: 
8. Were hypotheses 
about changes in 
scores formulated a 
priori (i.e. before data 
collection)? 
No  No 
 
No  
 
9.Was the expected 
direction of 
correlations or mean 
differences of the 
change scores of HR-
PRO instruments 
included in these 
hypotheses? 
No  No  
 
No  
 
10.Were the expected 
absolute or relative 
magnitude of 
correlations or mean 
differences of the 
change scores of HR-
PRO instruments 
included in these 
hypotheses? 
No  No  
 
No  
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
11.Was an 
adequate 
description 
provided of the 
comparator 
instrument(s)? 
Yes  Yes  
Not tested 
Yes  
 
12.Were the 
measurement 
properties of the 
comparator 
instrument(s) 
adequately 
described? 
Yes  Yes  
 
Yes  
 
14.Were design 
and statistical 
methods 
adequate for the 
hypotheses to be 
tested? 
Yes  Yes  
 
Yes  
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
utility –within the 
clinical or 
research setting 
Qualitative 
methods : - 
Study 1: 
developed by 
clinicians, semi-
structured 
interviews with 
users– thematic 
content analysis 
Study 2 : rich 
note taking 
Study 3 : 2 focus 
groups, 
reflective 
questionnaires, 
cross case 
template  
analysis 
Strong clinical 
utility, supports 
conceptual 
approach to 
assessment and 
treatment, 
considered to be 
potentially useful 
as a teaching 
tool 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Validated for use 
with all 
neurological 
pathology during 
rehabilitation 
Lemay & 
Nadeau 2010 
ISCI population,  
 
 
 
……………… 
Datta et al 2009; 
2012 
ISCI population  
Assessed by 
examining 
patient’s scores, 
not clinicians 
perception 
…………….. 
Moderate utility 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Validated for use 
with PD, stroke, 
ABI, TBI, 
ADL,ISCI, MS, 
HD 
Verheyden et al 
2009. stroke 
population, 
tested ability to 
measure effects 
of intervention  
……………….. 
Jandt et al 2011, 
correlation with 
respiratory 
function 
Good  
 
 
 
 
 
………………… 
Good  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Validated for use 
with stroke, MS, 
TBI, PD 
Joyce et al 
1994 – TBI, 
MDT raters 
Reid & 
Chesson 1998 
– stroke, PT 
raters 
Khan et al 2008 
– MS, MDT 
raters 
Turner-Stokes 
& Williams 
2010 – neuro, 
adapted score 
criteria 
Stevens et al 
2013 literature 
review 
 
Combined 
themes 
Complex to 
calculate, 
Difficult and 
time consuming 
to use 
facilitates goal 
setting 
feasible & 
practical 
encourages 
communication 
 
 
 
 
 
Validated for 
use with all 
neurological 
pathology 
Not applicable 
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
Respondent 
burden 
Study 1: semi-
structured 
interviews with 
users 
Study 2: rich 
note taking 
Study 3: 2 
focus groups, 
plus reflective 
questionnaires 
See results in 
Chapter 10 
Not tested 
 
Not tested 
 
Not tested 
  
Floor and ceiling 
effects 
Study 2: 
Senior 
Physiotherapis
t Participant 
Group, 
recruited 
27pts and 
tested them 
pre and post 
intervention 
No floor or ceiling 
effects were 
reported 
Mao et al 2002 
112pts, stroke 
Floor effects - 
day 14 - 35% 
Ceiling effects - 
Day 90 - 22% 
Day 180 - 29% 
 
 
Verheyden et al 
2005 
…………….. 
Verheyden et al 
2006a 
Ceiling effects in 
45% of ‘normals’ 
…………………. 
“no ceiling effect” 
Not 
commented on 
 Excellent: No floor 
/ ceiling effects,   
Adequate: Floor / 
ceiling effects < 
20%,   
Poor:  Floor / 
ceiling effects for 
> 20% 
Box J Interpretability not carried out within any of the studies examined.  Terwee et al 2012 ‘‘the smallest difference in score in the domain of interest which patients perceive as beneficial”  
Mokkiink et al 2010; 2010b; “Interpretability is not considered a measurement property but an important characteristic of a measurement instrument” 
3. Was the sample size included in the analysis adequate?  
4. Was the distribution of the (total) scores in the study sample described? 
5. Was the percentage of the respondents who had the lowest possible (total) score described?  
6. Was the percentage of the respondents who had the highest possible (total) score described? 
7. Were scores and change scores (i.e. means and SD) presented for relevant (sub) groups? e.g. for normative groups, subgroups of patients, or the general population 
8. Was the minimal important change (MIC) or the minimal important difference (MID) determined? 
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
Step 4: Determining the Generalisability of the results Was the sample in which the HR-PRO instrument was evaluated adequately described? In terms of: 
1.median or 
mean age (with 
standard 
deviation or 
range)? 
Yes Yes Yes Yes  
2.distribution of 
sex? 
Yes  Yes  Yes  Yes   
3.important 
disease 
characteristics 
(e.g. severity, 
status, duration) 
and description 
of treatment? 
Yes  Yes  Yes  Yes   
4.setting(s) in 
which the study 
was conducted? 
e.g. general 
population, 
primary care or 
hospital/rehabilita
tion care 
Yes  Yes  Yes  Yes   
5.countries in 
which the study 
was conducted? 
Yes  Yes  Yes  Yes   
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Comparison of measurement properties between the BBS, TIS, GAS and LMPI, using the ‘criteria framework developed in table [ii] Chapter 2, then examined using the COSMIN checklist (Terwee et 
al 2012) 
 LMPI BBS TIS GAS Expected range 
Name of the test Methods  Results Methods   Results Methods Results Methods Results 
6.language in 
which the HR-
PRO instrument 
was evaluated? 
Limited during original literature search for outcome measures in English language only 
7.Was the 
method used to 
select patients 
adequately 
described? e.g. 
convenience, 
consecutive, or 
random 
Yes  Yes  Yes  Yes   
8.Was the 
percentage of 
missing 
responses 
(response rate) 
acceptable?    
Yes  Yes  Yes  Yes   
Abbreviations & references: 6MWT = 6 minute walk test; 2MWT = 2 minute walk test; 10mWT = 10 metre walk  test  (Wade 1992); ABI = Acquired Brain Injury; ADL = Activities of Daily Living; BI = 
Barthel Index (Wade 1992); D/C = Discharge; DGI = Dynamic Gait Index (Rehabilitation Measures database 2010); EDSS = Expanded Disability Status (Scale, Kurtzke 1983); FAC = Functional 
Ambulation Category (Holden et al 1984) ; FFm = Fugl-Meyer (motor) (Gladstone et al 2002); FIMm = Functional Independence Measure (motor) (Wright 2000); FM = Fugl-Meyer (Gladstone et al 
2002); FR = Functional Reach (Duncan et al 1990); GCI = Clinical Global Impression (Busner & Targum 2007); H&Y= Hoehn and Yahr Staging Scale (Hoehn &Yahr 1967); HD = Huntington’s 
disease; IADL = Instrumented Activities of Daily Living; ISCI = Incomplete Spinal Cord Injury; k = kappa; KELS = Kohlman Evaluation of Living Skills (Burnett et al 2009); MDC = Minimal Detectable 
Change; LOS = Length of Stay; MDT = Multi-Disciplinary Team; MDST = Melsbroek Disability Scoring Test (Verheyden et al 2006b); MEDLS = Milwaukee Evaluation of Daily Living Skills (Leonardelli 
1988); MS = Multiple Sclerosis; Neuro = patients with a neurological diagnosis; PASS = Postural Assessment Scale for Stroke (Benaim et al 1999); OTs = Occupational Therapists; PTs = 
Physiotherapists; PD = Parkinsons disease; pts = patient; RDRS = Rappaport Disability Rating Scale (Rappaport et al 1982); SCI-FAI = Spinal Cord Injury Functional Ambulation Inventory (Field-Fote 
et al 2001); SD = Standard Deviation; SE-ADL= Modified Schwab and England Capacity for Daily Living Scale (EPDA 2014); SEM = Standard Error of Measurement ; TBI = Traumatic Brain Injury; 
TCT = Trunk control Test (Collin & Wade 1990); Tinetti = (Abbruzzese 1998); TUG =Timed Up and Go (Podsiadlo & Richardson 1991); UHDRS-TM =  Unified Huntington’s Disease Rating Scale 
Total Motor Score  (UHDRS 2014); UPDRS = Unified Parkinson’s Disease Rating Scale (Goetz et al 2003); WISC II = Walking index for spinal cord injury (Dittuno et al 2001). 
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Appendix 17 
 Other publications:  
o Poster: CSP UK 2010 
o Poster: HEE conference 2013  
o Poster: CSP UK 2013. 
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